COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4alpha) GENE EXPRESSION

ABSTRACT

The present invention provides agents and compositions for modulating expression (e.g., enhanced or reduced expression) of a hepatocyte nuclear factor 4 alpha (HNF4a) gene by targeting an HNF4α expression control region and methods of use thereof for treating an HNF4α associated disorder, e.g., cirrhosis.

CROSS-REFERENCE TO RELATED APPLICATIONS

The instant application claims the benefit of priority to U.S. Provisional Application No. 62/904,178, filed on Sep. 23, 2019, the entire contents of which are incorporated herein by reference.

SEQUENCE LISTING

The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Dec. 10, 2020, is named 131717-00103_SL.txt and is 4,343,647 bytes in size.

BACKGROUND OF THE INVENTION

Master regulators are proteins, such as transcription factors, with the ability to influence the expression of a network of genes related by cell type, organ system, or response to a stimulus.

One example of a master regulator is the transcription factor Hepatocyte Nuclear Factor 4-alpha (HNF4α). HNF4α is expressed for the first time in terminally differentiated liver cells, late in embryonic development. HNF4α controls the expression of proteins necessary for the normal function of hepatocytes and other cell types in the liver (Li, et al. (2000) Genes and Devel 14:464-474). In addition, many of these proteins are secreted by the liver cells and contribute to health systemically. For example, proteins such as albumin are required to transport nutrients, hormones, lipids, and small molecule drugs in the circulation. In fibrotic liver disease, HNF4α is dysregulated and, as a result, gene expression in its network declines significantly or stops (Guzman-Lepe, et al. (2018) Hepatol Comm 2(5):582). This dysregulation of the network contributes to the pathology of liver failure in the organ itself, and to co-morbidities throughout the patient.

Recently, Nishikawa et al. (2015) demonstrated that transgenic expression of HNF4α in a rat model of cirrhosis led to the restoration of gene expression throughout the HNF4α network, restored hepatocyte function, and improved health of the animal. The transgene was delivered with an adeno-associated virus (AAV). However, transgene expression from AAV delivery does not allow subtle control or temporary modification of the expression of genes already in the genome. Once modified with AAV, the affected cells lose the ability to respond to changing conditions in the organ and body in a nimble physiologically meaningful way.

Accordingly there is a need in the art for temporary and labile effectors that offer greater control and the ability to restore cells and tissues to a nascent “normal” state and, thus, treat HNF4α-associated disease, such as fibrotic liver disease, e.g., cirrhosis.

SUMMARY OF THE INVENTION

The present invention provides agents and compositions for modulating the expression (e.g., enhancing or reducing expression) of a hepatocyte nuclear factor 4 alpha (HNF4α) gene by targeting an HNF4α expression control region. The HNF4α gene may be in a cell, e.g., a mammalian cell, such as a mammalian somatic cell, e.g., a human somatic cell. The present invention also provides methods of using the agents and compositions of the invention for modulating the expression of an HNF4α gene or for treating a subject who would benefit from modulating the expression of an HNF4α gene, e.g., a subject suffering or prone to suffering from an HNF4α-associated disease.

Accordingly, in one aspect, the present invention provides a site-specific disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region.

In some embodiments, the site-specific HNF4α targeting moiety comprises a polymeric molecule.

The polymeric molecule may comprise a polyamide, a polynucleotide, a polynucleotide encoding a DNA-binding domain, or fragment thereof, that specifically binds to the HNF4α expression control region, or a peptide nucleic acid (PNA).

In some embodiments, the expression control region comprises an HNF4α-specific transcriptional control element.

In some embodiments, the transcriptional control element comprises an HNF4α promoter, such as the nucleotide sequence of HNF4α promoter 1, or a fragment thereof, or the nucleotide sequence of HNF4α promoter 2, or a fragment thereof.

In some embodiments, the transcriptional control element comprises a transcriptional enhancer.

In some embodiments, the transcriptional control element comprises a transcriptional repressor.

In some embodiments, the site-specific HNF4α disrupting agent comprises a nucleotide sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% nucleotide identity to the entire nucleotide sequence of any of the nucleotide sequences in any one of Tables 2, 3, 4, and 9.

In some embodiments, the site-specific HNF4α disrupting agent comprises a polynucleotide encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically binds to the HNF4α expression control region.

In one embodiment, the DNA-binding domain of the TALE or ZNF polypeptide comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of any one of the amino acid sequences listed in column 5 of Table 6A or column 4 of Table 10. In one embodiment, DNA-binding domain of the TALE or ZNF polypeptide comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of ZF5.3. In one embodiment, DNA-binding domain of the TALE or ZNF polypeptide comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of ZF7. In one embodiment, DNA-binding domain of the TALE or ZNF polypeptide comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of ZF14. In one embodiment, DNA-binding domain of the TALE or ZNF polypeptide comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of ZF15.

In some embodiments, the expression control region comprises one or more HNF4α-associated anchor sequences within an anchor sequence-mediated conjunction comprising a first and a second HNF4α-associated anchor sequence.

In some embodiments, the anchor sequence comprises a CCCTC-binding factor (CTCF) binding motif.

In some embodiments, the anchor sequence-mediated conjunction comprises one or more transcriptional control elements internal to the conjunction.

In some embodiments, the anchor sequence-mediated conjunction comprises one or more transcriptional control elements external to the conjunction.

In some embodiments, the first and/or the second anchor sequence is located within about 500 kb of the transcriptional control element.

In some embodiments, the first and/or the second anchor sequence is located within 300 kb of the transcriptional control element.

In some embodiments, the site-specific HNF4α disrupting agent comprises a nucleotide modification.

The present invention also provides vectors, such as viral expression vectors and cells comprising the site-specific HNF4α disrupting agents of the invention as well as the vectors of the invention.

In some embodiments, the site-specific HNF4α disrupting agents of the invention are present in a composition, such as a pharmaceutical composition.

In some embodiments, the pharmaceutical composition comprises a lipid formulation.

In some embodiments, the lipid formulation comprises one or more cationic lipids, one or more non-cationic lipids, one or more cholesterol-based lipids, or one or more PEG-modified lipids, or combinations of any of the foregoing.

In some embodiments, the pharmaceutical composition comprises a lipid nanoparticle.

In another aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a nucleic acid molecule encoding a fusion protein, the fusion protein comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region and an effector molecule.

In some embodiments, the site-specific HNF4α targeting moiety comprises a polynucleotide encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically binds to the HNF4α expression control region.

In one embodiment, the DNA-binding domain of the TALE comprises an amino acid sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of an amino acid sequence selected from the amino acid sequences listed in column 5 of Table 6A or column 4 of Table 10.

In some embodiments, the effector molecule comprises a polypeptide or a nucleic acid molecule encoding a polypeptide.

In some embodiments, the fusion protein comprises a peptide-nucleic acid fusion.

In some embodiments, the effector is selected from the group consisting of a nuclease, a physical blocker, an epigenetic recruiter, and an epigenetic CpG modifier, and combinations of any of the foregoing.

In some embodiments, the effector comprises a CRISPR associated protein (Cas) polypeptide or nucleic acid molecule encoding the Cas polypeptide.

In some embodiments, the Cas polypeptide is an enzymatically inactive Cas polypeptide.

In some embodiments, the Cas polypeptide comprises a catalytically active domain of human exonuclease 1 (hEXO1).

In some embodiments, the epigenetic recruiter comprises a transcriptional enhancer or a transcriptional repressor.

In one embodiment, the transcriptional enhancer is a VPR (VP64-p65-Rta).

In one embodiment, the VPR comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of

(SEQ ID NO: 66) DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDD FDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSI MKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLS TINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMV SALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQ FDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIPVAPHT TEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDE DFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEG REVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLT PAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALREMADTVI PQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLT PELNEILDTFLNDECLLHAMHISTGLSIFDTSLF.

In one embodiment, the transcriptional enhancer comprises two, three, four, or five VPRs.

In one embodiment, the transcriptional enhancer is a p300.

In one embodiment, the p300 comprises an amino acid sequence having at least about 85% 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% identity to the entire amino acid sequence of

(SEQ ID NO: 67) IFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYF DIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNR KTSRVYKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLC CYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDP SQPQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHH EIIVVPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLEN RVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSG EMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQ RRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTG HIVVACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAV SERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIK ELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNKS SLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGP PAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRR AQWSTMCMLVELHTQSQD.

In some embodiments, the epigenetic CpG modifier comprises a DNA methylase, a DNA demethylase, a histone modifying agent, or a histone deacetylase.

In some embodiments, the effector molecule comprises a zinc finger polypeptide.

In some embodiments, the effector molecule comprises a Transcription activator-like effector nuclease (TALEN) polypeptide.

In some embodiments, the site-specific HNF4α disrupting agent further comprises a second nucleic acid molecule encoding a second fusion protein, wherein the second fusion comprises a second site-specific HNF4α targeting moiety which targets a second HNF4α expression control region and a second effector molecule, wherein the second HNF4α expression control region is different than the HNF4α expression control region.

In one embodiment, the HNF4α expression control region comprises a ZF5 target sequence GGCGGGGGACCGATTAACCAT (SEQ ID NO: 118) and the second HNF4α expression control region comprises a ZF7 target sequence ACTGAACATCGGTGAGTTAGG (SEQ ID NO: 126).

In one embodiment, the second effector is different than the first effector.

In one embodiment, the second effector is the same as the first effector.

In one embodiment, the fusion protein and the second fusion protein are operably linked.

In one embodiment, the fusion protein and the second fusion protein comprise an amino acid sequence that has at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid sequence identity to the entire amino acid sequence of a polypeptide selected from the group consisting of ZF5.3-VPR-tPT2a-ZF7-VPR; ZF7-VPR-tPT2a-ZF5.3-VPR; ZF5.3-VPR-tPT2a-ZF7-p300; and ZF7-p300-tPT2a-ZF5.3-VPR.

In one embodiment, the fusion protein comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid sequence identity to the entire amino acid sequence of ZF5.3-VPR.

In one embodiment, the fusion protein is encoded by a polynucleotide comprising a nucleotide sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% nucleotide sequence identity to the entire nucleotide sequence of a polynucleotide selected from the group consisting of ZF5-VPR mRNA, ZF5.1-VPR mRNA, ZF5.2-VPR mRNA, ZF5.3-VPR mRNA, ZF5.4-VPR mRNA, ZF5.5-VPR mRNA, and ZF5.6-VPR mRNA.

In one aspect, the present invention provides a site-specific HNF4α disrupting agent. The disrupting agent includes a nucleic acid molecule encoding a fusion protein, wherein the fusion protein comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of a polypeptide selected from the group consisting of ZF1-VPR, ZF2-VPR, ZF3-VPR, ZF4-VPR, ZF5-VPR, ZF5.3-VPR, ZF6-VPR, ZF7-VPR, ZF8-VPR, ZF9-VPR, ZF10-VPR, ZF11-VPR, ZF12-VPR, ZF13-VPR, ZF14-VPR, and ZF15-VPR.

In one embodiment, the polypeptide is selected from the group consisting of ZF5-VPR, ZF5.3-VPR, ZF7-VPR, ZF10-VPR, ZF14-VPR, and ZF15-VPR.

In one embodiment, the polypeptide is ZF5.3-VPR.

The present invention also provides vectors, such as viral expression vectors and cells comprising the site-specific HNF4α disrupting agents of the invention as well as the vectors of the invention.

In some embodiments, the site-specific HNF4α disrupting agents of the invention are present in a composition, such as a pharmaceutical composition.

In some embodiments, the pharmaceutical composition comprises a lipid formulation.

In some embodiments, the lipid formulation comprises one or more cationic lipids, one or more non-cationic lipids, one or more cholesterol-based lipids, or one or more PEG-modified lipids, or combinations of any of the foregoing.

In some embodiments, the pharmaceutical composition comprises a lipid nanoparticle.

In one aspect, the present invention provides a method of modulating expression of hepatocyte nuclear factor 4 alpha- (HNF4α) in a cell. The method includes contacting the cell with a site-specific HNF4α disrupting agent, the disrupting agent comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, and an effector molecule, thereby modulating expression of HNF4α in the cell.

The modulation of expression may be enhanced expression of HNF4α in the cell or reduced expression of HNF4α in the cell.

In some embodiments, the site-specific HNF4α targeting moiety comprises a polymeric molecule.

The polymeric molecule may comprise a polyamide, a polynucleotide, a peptide nucleic acid (PNA).

In some embodiments, the expression control region comprises an HNF4α-specific transcriptional control element.

In some embodiments, the transcriptional control element comprises an HNF4α promoter, such as the nucleotide sequence of HNF4α promoter 1, or a fragment thereof, or the nucleotide sequence of HNF4α promoter 2, or a fragment thereof.

In some embodiments, the transcriptional control element comprises a transcriptional enhancer.

In some embodiments, the transcriptional control element comprises a transcriptional repressor.

In some embodiments, the site-specific HNF4α disrupting agent comprises a nucleotide sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% nucleotide identity to the entire nucleotide sequence of any of the nucleotide sequences in any one of Tables 2, 3, 4, and 9.

In some embodiments, the site-specific HNF4α disrupting agent comprises a polynucleotide encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically binds to the HNF4α expression control region.

In some embodiments, the DNA-binding domain of the TALE or ZNF comprises an amino acid sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of an amino acid sequence selected from the amino acid sequences listed in column 5 of Table 6A or column 4 of Table 10.

In some embodiments, the expression control region comprises one or more HNF4α-associated anchor sequences within an anchor sequence-mediated conjunction comprising a first and a second HNF4α-associated anchor sequence.

In some embodiments, the anchor sequence comprises a CCCTC-binding factor (CTCF) binding motif.

In some embodiments, the anchor sequence-mediated conjunction comprises one or more transcriptional control elements internal to the conjunction.

In some embodiments, the anchor sequence-mediated conjunction comprises one or more transcriptional control elements external to the conjunction.

In some embodiments, the first and/or the second anchor sequence is located within about 500 kb of the transcriptional control element.

In some embodiments, the first and/or the second anchor sequence is located within 300 kb of the transcriptional control element.

In some embodiments, the site-specific HNF4α disrupting agent comprises a nucleotide modification.

In some embodiments, the effector molecule comprises a polypeptide.

In some embodiments, the polypeptide comprises a nucleic acid molecule encoding a fusion protein comprising the site-specific HNF4α targeting moiety which targets an HNF4α expression regulatory region, and the effector molecule.

In some embodiments, the fusion protein comprises a peptide-nucleic acid fusion molecule.

In some embodiments, the effector is selected from the group consisting of a nuclease, a physical blocker, an epigenetic recruiter, and an epigenetic CpG modifier, and combinations of any of the foregoing.

In some embodiments, the effector comprises a CRISPR associated protein (Cas) polypeptide or nucleic acid molecule encoding the Cas polypeptide.

In some embodiments, the Cas polypeptide is an enzymatically inactive Cas polypeptide.

In some embodiments, the Cas polypeptide further comprises a catalytically active domain of human exonuclease 1 (hEXO1).

In some embodiments, the epigenetic recruiter comprises a transcriptional enhancer or a transcriptional repressor.

In some embodiments, the transcriptional enhancer is a VPR.

In some embodiments, the VPR comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of

(SEQ ID NO: 66) DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALD DFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFK SIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTS SLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPA PAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEA LLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGI PVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPN GLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGS AISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGP VHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVK ALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESM TEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTGLSIFDTSLF.

In some embodiments, the transcriptional enhancer comprises two, three, four, or five VPRs.

In some embodiments, the transcriptional enhancer is a p300.

In some embodiments, the p300 has an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of

(SEQ ID NO: 67) IFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPM DLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCSKLSE VFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNR YHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVEC TECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTR LGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSG EMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISY LDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYI FHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTS AKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKN AKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFV IRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRA QWSTMCMLVELHTQSQD.

In some embodiments, the epigenetic CpG modifier comprises a DNA methylase, a DNA demethylase, a histone modifying agent, or a histone deacetylase.

In some embodiments, the effector molecule comprises a zinc finger polypeptide.

In some embodiments, the effector molecule comprises a Transcription activator-like effector nuclease (TALEN) polypeptide.

In some embodiments, the fusion protein comprises an enzymatically inactive Cas polypeptide and an epigenetic recruiter polypeptide.

In some embodiments, the fusion protein comprises an enzymatically Cas polypeptide and an epigenetic CpG modifier polypeptide.

In some embodiments, the site-specific HNF4α disrupting agent comprises a second nucleic acid molecule encoding a second fusion protein, wherein the second fusion protein comprises a second site-specific HNF4α targeting moiety which targets a second HNF4α expression control region and a second effector molecule, wherein the second HNF4α expression control region is different than the HNF4α expression control region.

In some embodiments, the HNF4α expression control region comprises a ZF5 target sequence GGCGGGGGACCGATTAACCAT (SEQ ID NO: 118) and the second HNF4α expression control region comprises a ZF7 target sequence ACTGAACATCGGTGAGTTAGG (SEQ ID NO: 126).

In some embodiments, the second effector is different than the effector.

In some embodiments, the second effector is the same as the effector.

In some embodiments, the fusion protein and the second fusion protein are operably linked.

In some embodiments, the fusion protein and the second fusion protein comprise an amino acid sequence that has at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to the entire amino acid sequence of a polypeptide selected from ZF5.3-VPR-tPT2a-ZF7-VPR protein, ZF7-VPR-tPT2a-ZF5.3-VPR protein, ZF5.3-VPR-tPT2a-ZF7-p300 protein, and ZF7-p300-tPT2a-ZF5.3-VPR protein.

In some embodiments, the fusion protein comprises an amino acid sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to the entire amino acid sequence of ZF5.3-VPR protein.

In some embodiments, the fusion protein is encoded by a polynucleotide having a sequence that has at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to the entire nucleotide sequence of a polynucleotide selected from the group consisting of ZF5-VPR mRNA, ZF5.1-VPR mRNA, ZF5.2-VPR mRNA, ZF5.3-VPR mRNA, ZF5.4-VPR mRNA, ZF5.5-VPR mRNA, and ZF5.6-VPR mRNA.

In some embodiments, the administration of the site-specific HNF4α disrupting agent and the second site-specific HNF4α disrupting agent has a synergistic effect in modulating the expression of HNF4α.

In some embodiments, the HNF4α expression control region comprises a ZF5 target sequence GGCGGGGGACCGATTAACCAT (SEQ ID NO: 118) and the second HNF4α expression control region comprises a sequence selected from ZF7 target sequence ACTGAACATCGGTGAGTTAGG (SEQ ID NO: 126), ZF10 target sequence CCTGCAGCCCCGCCCAGCCTA (SEQ ID NO: 138), ZF14 target sequence GGAGGGGTGGGGGTTAATGGT (SEQ ID NO: 154), and ZF15 target sequence GAAGGGGTGGAGGCTCTGCCG (SEQ ID NO: 158).

In some embodiments, the HNF4α expression control region comprises a ZF5 target sequence GGCGGGGGACCGATTAACCAT (SEQ ID NO: 118) and the second HNF4α expression control region comprises a ZF7 target sequence ACTGAACATCGGTGAGTTAGG (SEQ ID NO: 126).

In some embodiments, the fusion protein comprises a sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to the entire amino acid sequence of ZF5-VPR, and the second fusion protein comprises a sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to the entire amino acid sequence of a polypeptide selected from ZF7-VPR, ZF10-VPR, ZF14-VPR, and ZF15-VPR.

In some embodiments, the fusion protein comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% identity to the entire amino acid sequence of a polypeptide selected from the group consisting of ZF1-VPR, ZF2-VPR, ZF3-VPR, ZF4-VPR, ZF5-VPR, ZF5.3-VPR, ZF6-VPR, ZF7-VPR, ZF8-VPR, ZF9-VPR, ZF10-VPR, ZF11-VPR, ZF12-VPR, ZF13-VPR, ZF14-VPR, and ZF15-VPR.

In some embodiments, the polypeptide is selected from the group consisting of ZF5-VPR, ZF5.3-VPR, ZF7-VPR, ZF10-VPR, ZF14-VPR, and ZF15-VPR.

In some embodiments, the polypeptide is ZF5.3-VPR.

In some embodiments, the site-specific disrupting agent, the effector, or both the site-specific disrupting agent and the effector are present in a vector, such as a viral expression vector.

In some embodiments, the site-specific disrupting agent and the effector are present in the same vector.

In some embodiments, the site-specific disrupting agent and the effector are present in different vectors.

In some embodiments, the site-specific disrupting agent, the effector, or both the site-specific disrupting agent and the effector are present in a composition.

In some embodiments, the site-specific disrupting agent and the effector are present in the same composition.

In some embodiments, the site-specific disrupting agent and the effector are present in different compositions.

In some embodiments, the composition comprises a pharmaceutical composition.

In some embodiments, the pharmaceutical composition comprises a lipid formulation.

In some embodiments, the lipid formulation comprises one or more cationic lipids, one or more non-cationic lipids, one or more cholesterol-based lipids, or one or more PEG-modified lipids, or combinations of any of the foregoing.

In some embodiments, the pharmaceutical composition comprises a lipid nanoparticle.

In some embodiments, the cell is a mammalian cell, such as a somatic cell or a primary cell.

In some embodiments, the contacting is performed in vitro.

In some embodiments, the contacting is performed in vivo.

In some embodiments, the contacting is performed ex vivo.

In some embodiments, the methods of the invention further comprise administering the cell to a subject.

In some embodiments, the cell is within a subject.

In some embodiments, the subject has an HNF4α-associated disease.

In some embodiments, the HNF4α-associated disease is selected from the group consisting of fatty liver (steatosis), nonalcoholic steatohepatitis (NASH), cirrhosis of the liver, accumulation of fat in the liver, inflammation of the liver, hepatocellular necrosis, liver fibrosis, and nonalcoholic fatty liver disease (NAFLD), polycystic kidney disease, inflammatory bowel disease (IBD), and MODY I.

In another aspect, the present invention provides a method for treating a subject having an HNF4α-associated disease. The method includes administering to the subject a therapeutically effective amount of the site-specific HNF4α disrupting agent, the disrupting agent comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, and an effector molecule, thereby treating the subject.

In some embodiments, the HNF4α-associated disease is hepatocellular cancer and the site-specific HNF4α disrupting agent reduces expression of HNF4α in the subject.

In some embodiments, the HNF4α-associated disease is selected from the group consisting of fatty liver (steatosis), nonalcoholic steatohepatitis (NASH), cirrhosis of the liver, accumulation of fat in the liver, inflammation of the liver, hepatocellular necrosis, liver fibrosis, and nonalcoholic fatty liver disease (NAFLD) and the site-specific HNF4α disrupting agent enhances expression of HNF4α in the subject.

In some embodiments, the site-specific HNF4α disrupting agent and the effector molecule are administered to the subject concurrently.

In some embodiments, the site-specific HNF4α disrupting agent and the effector molecule are administered to the subject sequentially.

In some embodiments, the effector molecule is administered to the subject prior to administration of the site-specific HNF4α disrupting agent.

In some embodiments, the site-specific HNF4α disrupting agent is administered to the subject prior to administration of the effector molecule.

In one aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, wherein the HNFα expression control region comprises the nucleotide sequence of any one of the nucleotide sequences listed in column 3 of Table 1 or column 4 of Table 10.

In one embodiment, the site-specific HNF4α targeting moiety comprises a nucleotide sequence having at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% nucleotide identity to the entire nucleotide sequence of any of the nucleotide sequences in any one of Table 2, 3, 4, and 9.

In one embodiment, the site-specific HNF4α targeting moiety comprises a polymeric molecule comprising a polynucleotide encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically binds to the HNF4α expression control region.

In one embodiment, the DNA-binding domain of the TALE or ZNF polypeptide comprises an amino acid sequence having at least about 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid identity to the entire amino acid sequence of any one of the amino acid sequences listed in column 5 of Table 6A or column 4 of Table 10.

In one embodiment, the HNFα expression control region comprises a nucleotide sequence of a ZF5 target sequence GGCGGGGGACCGATTAACCAT (SEQ ID NO: 118).

In one embodiment, the HNFα expression control region comprises a nucleotide sequence of a ZF7 target sequence ACTGAACATCGGTGAGTTAGG (SEQ ID NO: 126).

In one aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF5-VPR comprising the amino acid sequence of

(SEQ ID NO: 301) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQR THTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSHKNA LQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKS FSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKC PECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA.

In another aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF5.3-VPR comprising the amino acid sequence of

(SEQ ID NO: 301) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQR THTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSHKNA LQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKS FSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKC PECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA.

In yet another aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF7-VPR comprising the amino acid sequence of

(SEQ ID NO: 302) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQR THTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKCPECGKSFSQAGH LASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKS FSTSGNLTEHQRTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKC PECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA.

In one aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF10-VPR comprising the amino acid sequence of

(SEQ ID NO: 303) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSQNSTLTEHQR THTGEKPYKCPECGKSFSERSHLREHQRTHTGEKPYKCPECGKSFSSKKH LAEHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKS FSDCRDLARHQRTHTGEKPYKCPECGKSFSQSGDLRRHQRTHTGEKPYKC PECGKSFSTKNSLTEHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA.

In another aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF14-VPR comprising the amino acid sequence of

(SEQ ID NO: 304) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGHLVRHQR THTGEKPYKCPECGKSFSTTGNLTVHQRTHTGEKPYKCPECGKSFSTSGS LVRHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKS FSRSDELVRHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKC PECGKSFSQRAHLERHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA.

In one aspect, the present invention provides a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF15-VPR comprising the amino acid sequence of

(SEQ ID NO: 305) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRNDTLTEHQR THTGEKPYKCPECGKSFSRNDALTEHQRTHTGEKPYKCPECGKSFSTSGE LVRHQRTHTGEKPYKCPECGKSFSRSDNLVRHQRTHTGEKPYKCPECGKS FSRSDELVRHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKC PECGKSFSQSSNLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA.

In one aspect, the present invention provides a bicistronic site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of a bicistronic ZF5.3-VPR-tPT2a-ZF7-VPR comprising the amino acid sequence of

(SEQ ID NO: 306) MAPKKKRKVGIHGVPAAGSSGSSGSLEPGEKPYKCPECGKSFSTSGNLTE HQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSH KNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPEC GKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKP YKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDF DLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKK KRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRR IAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALA PAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQ AGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQ GIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSG DEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVC QPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDP APAVTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSH PPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLK QAGDVEENPGPTSAGKLGSGEGRGSLLTCGDVEENPGPLEGSSGSGSLEP GEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVR HQRTHTGEKPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSR SDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPEC GKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKP TGKKTSASGSGGGSGGDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDL DMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYET FKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTI NYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPA PVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNST DPAVFTDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQ RPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREG MFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTP TGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALRE MADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLT PELNEILDTFLNDECLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAK KKKGSYPYDVPDYA.

In one aspect, the present invention provides a bicistronic site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of a bicistronic ZF7-VPR-tPT2a-ZF5.3-VPR comprising the amino acid sequence of

(SEQ ID NO: 178) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQR THTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKCPECGKSFSQAGH LASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKS FSTSGNLTEHQRTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKC PECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLKQAG DVEENPGPTSAGKLGSGEGRGSLLTCGDVEENPGPLEGSSGSLEPGEKPY KCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTH TGEKPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLT EHQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFS RSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKT SASGSGGGSGGDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGS DALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIM KKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEF PTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVL APGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVF TDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDP APAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPK PEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVH EPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALREMADTV IPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNE ILDTFLNDECLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGS YPYDVPDYA.

In one aspect, the present invention provides a bicistronic site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of a bicistronic ZF5.3-VPR-tPT2a-ZF7-p300 comprising the amino acid sequence of

(SEQ ID NO: 307) MAPKKKRKVGIHGVPAAGSSGSSGSLEPGEKPYKCPECGKSFSTSGNLTE HQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSH KNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPEC GKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKP YKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDF DLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKK KRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRR IAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALA PAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAfPPAPKPT QAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLN QGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLS GDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREV CQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLD PAPAVTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLS HPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMH ISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLL KQAGDVEENPGPTSAGKLGSGEGRGSLLTCGDVEENPGPLEGSSGSGSLE PGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLV RHQRTHTGEKPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFS RSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPE CGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEK PTGKKTSASGSGGGSGGIFKPEELRQALMPTLEALYRQDPESLPFRQPVD PQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWL YNRKTSRVYKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGK QLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQ FSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSA RTRKENKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASD KTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQE YGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGY TTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIV HDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKRE ENTSNESTDVTKGDSKNAKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDL SQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAF LTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQDSGGKRPAATKKAGQAK KKKGSYPYDVPDYA.

In one aspect, the present invention provides a bicistronic site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of a bicistronic ZF7-p300-tPT2a-ZF5.3-VPR comprising the amino acid sequence of

(SEQ ID NO: 308) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQR THTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKCPECGKSFSQAGH LASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKS FSTSGNLTEHQRTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKC PECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGIFKPEELRQ ALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKL DTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCSKLSEVFEQEIDPV MQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFN EIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQ ICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLENRV NDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYR TKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRP KCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQK IPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEG DFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKT SKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAA NSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLV ELHTQSQDSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLKQAGD VEENPGPTSAGKLGSGEGRGSLLTCGDVEENPGPLEGSSGSLEPGEKPYK CPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHT GEKPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTE HQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSR SDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTS ASGSGGGSGGDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSD ALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMK KSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFP TMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLA PGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFT DLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPA PAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHE PVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALREMADTVI PQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEI LDTFLNDECLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSY PYDVPDYA.

The present invention also provides vectors, such as viral expression vectors and cells comprising the site-specific HNF4α disrupting agents of the invention as well as the vectors of the invention.

In some embodiments, the site-specific HNF4α disrupting agents of the invention are present in a composition, such as a pharmaceutical composition.

In some embodiments, the pharmaceutical composition comprises a lipid formulation.

In some embodiments, the lipid formulation comprises one or more cationic lipids, one or more non-cationic lipids, one or more cholesterol-based lipids, or one or more PEG-modified lipids, or combinations of any of the foregoing.

In some embodiments, the pharmaceutical composition comprises a lipid nanoparticle.

In one aspect, the present invention provides a pharmaceutical composition comprising a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF5.3-VPR comprising the amino acid sequence of

(SEQ ID NO: 301) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQR THTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSHKNA LQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKS FSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKC PECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA, and a lipid nanoparticle.

In one aspect, the present invention provides a pharmaceutical composition comprising a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF5.3-VPR comprising the amino acid sequence of

(SEQ ID NO: 301) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQR THTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSHKNA LQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKS FSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKC PECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA; and

a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of ZF7-VPR comprising the amino acid sequence of

(SEQ ID NO: 302) MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQR THTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKCPECGKSFSQAGH LASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKS FSTSGNLTEHQRTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKC PECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLD MLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRK VGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAV PSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAP PQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGE GTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIP VAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDED FSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPK RLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPP RGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTG LSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA; and a lipid nanoparticle.

In one aspect, the present invention provides a pharmaceutical composition, comprising a site-specific HNF4α disrupting agent, comprising a polynucleotide encoding the amino acid sequence of a bicistronic ZF5.3-VPR-tPT2a-ZF7-VPR comprising the amino acid sequence of

(SEQ ID NO: 306) MAPKKKRKVGIHGVPAAGSSGSSGSLEPGEKPYKCPECGKSFSTSGNLTE HQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSH KNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPEC GKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKP YKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDF DLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKK KRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRR IAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALA PAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQ AGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQ GIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSG DEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVC QPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDP APAVTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSH PPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLK QAGDVEENPGPTSAGKLGSGEGRGSLLTCGDVEENPGPLEGSSGSGSLEP GEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVR HQRTHTGEKPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSR SDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPEC GKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKP TGKKTSASGSGGGSGGDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDL DMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYET FKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTI NYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPA PVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNST DPAVFTDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQ RPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREG MFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTP TGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALRE MADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLT PELNEILDTFLNDECLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAK KKKGSYPYDVPDYA; and a lipid nanoparticle.

In one aspect, the present invention provides a method of modulating expression of hepatocyte nuclear factor 4 alpha- (HNF4α) in a cell. The method includes contacting the cell with a site-specific HNF4α disrupting agent, the disrupting agent comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, and an effector molecule, thereby modulating expression of HNF4α in the cell.

The modulation of expression may be enhanced expression of HNF4α in the cell or reduced expression of HNF4α in the cell.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 depicts a chromosomal view of a portion of the upstream region and coding sequence of HNF4α and the positions of guide RNAs and pools of guide RNAs described herein.

FIG. 2 is a graph depicting the percent of HNF4α mRNA remaining in HepG2 cells at 72 hours after contacting the cells with the indicated pools of site-specific HNF4α targeting moieties and an effector molecule comprising dCas and KRAB at the indicated doses.

FIG. 3 is a graph depicting the percent of HNF4α mRNA remaining in HepG2 cells at 72 hours after contacting the cells with either the indicated site-specific HNF4α targeting moieties and an effector molecule comprising dCas and KRAB, or the indicated pools of HNF4α targeting moieties and an effector molecule comprising dCas and KRAB, at the indicated doses. Untreated cells and cells contacted with dCas9 alone were used as controls.

FIG. 4A is a graph depicting the percent of HNF4α mRNA measured in A549 cells at 48 hours after contacting the cells with the indicated pools of HNF4α targeting moieties and an effector molecule comprising dCas and VPR, at the indicated doses. SH is the abbreviation for “Safe Harbor” which is a non-target guide control.

FIG. 4B is a graph depicting the percent of HNF4α mRNA measured in LX-2 cells at 48 hours after contacting the cells with the indicated pools of HNF4α targeting moieties and an effector molecule comprising dCas and VPR at the indicated doses.

FIG. 5 is a graph depicting activation of HNF4α by dCas9-VPR in LX-2 cells with transfection using LNP formulations.

FIG. 6 is a graph depicting activation of HNF4 α by dCas9-VPR in HepG2 cells with transfection using LNP formulations.

FIG. 7 are immunohistological images depicting that HNF4α protein induced by dCas9-VPR Pool 1 is localized to the nucleus.

FIG. 8 is a schematic depicticting the structure of the human HNF4α promoter region and the isoforms of HNF4α.

FIG. 9 schematically depicticts the localization to the HNF4α promoter region of the various site-specific HNF4α targeting moieties. FIG. 9 discloses SEQ ID NOS 2519-2525, respectively, in order of appearance.

FIG. 10 schematically depicts the structure of an exemplary zinc finger-VPR fusion protein of the invention.

FIG. 11 is a graph depicting activation of HNF4α in LX-2 cells using ZF-VPR mRNAs.

FIG. 12 is a graph depicting activation of HNF4α in LX-2 cells with TAL-VPRs and ZF-VPRs.

FIG. 13 is a graph depicting activation of HNF4α in LX-2 Cells with ATUM-Codon Optimized ZF5-VPR variants.

FIG. 14 is a graph depicting the durability of VPR activation of HNF4α in K562 cells with ZF5-VPR, ZF5-p300, ZF5-VPR and ZF5-p300, and ZF5-VPR and ZF7-VPR.

FIG. 15 is a graph depicting the durability of VPR activation of HNF4α in K562 cells with ZF5-VPR and ZF7-VPR.

FIG. 16 is a graph depicting the durability of VPR activation of HNF4α in K562 cells with ZF5-VPR and ZF7-VPR, and ZF5.3-VPR and ZF7-VPR.

FIG. 17 is a graph depicting the change in expression level of biomarkers downstream of HNF4α following activation of HNF4α by dCas9-VPR in LX-2 cells.

FIG. 18 is a graph depicting the change in expression level of biomarkers of HNF4α following activation of HNF4α by ZF5-VPR, ZF5.3-VPR, ZF5-VPR and ZF7-VPR, and ZF5.3-VPR and ZF7-VPR in LX-2 cells.

FIG. 19 is a graph depicting screening of ZF11, ZF13, and ZF14 in LX-2 cells and synergy in activating HNF4α by ZF5-VPR and ZF7-VPR, and ZF5.3-VPR and ZF7-VPR.

FIG. 20 is a graph depicting activation of HNF4α using dCas9-VPR3-Pool 1 and screening of ZF-VPR combinations

FIG. 21 is a graph depicting HNF4α activation in FRG-KO mouse liver humanized hepatocytes (Yecuris human hepatocytes).

FIG. 22 is a graph depicting activation of HNF4α in LX-2 cells with bicistronic ZF5.3-VPR and ZF7-VPR.

FIG. 23 is a graph depicting the effect of repeat dosing of Yecuris hepatocytes with various ZF-VPR and ZF-p300 on HNF4α gene expression.

FIG. 24 is a graph depicting activation of HNF4α in Yecuris hepatocytes with bicistronic ZF-effector constructs.

FIG. 25 is graph depicting the 10 days durability of VPR activation of HNF4α in K562 cells with bicistronic ZF-effector constructs.

DETAILED DESCRIPTION OF THE INVENTION

The present invention provides agents and compositions for modulating expression (e.g., enhanced or reduced expression) of a hepatocyte nuclear factor 4 alpha (HNF4α) gene by targeting an HNF4α expression control region. The HNF4α gene may be in a cell, e.g., a mammalian cell, such as a mammalian somatic cell, e.g., a human somatic cell. The present invention also provides methods of using the agents and compositions of the invention for modulating the expression of an HNF4α gene or for treating a subject who would benefit from modulating the expression of an HNF4α gene, e.g., a subject suffering or prone to suffering from an HNF4α-associated disease.

The agents of the invention are referenced to herein as site-specific HNF4α disrupting agents and are described in Section II, below.

I. Definitions

In order that the present invention may be more readily understood, certain terms are first defined. In addition, it should be noted that whenever a value or range of values of a parameter are recited, it is intended that values and ranges intermediate to the recited values are also intended to be part of this invention.

The articles “a” and “an” are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article. By way of example, “an element” means one element or more than one element, e.g., a plurality of elements.

The term “including” is used herein to mean, and is used interchangeably with, the phrase “including but not limited to”. The term “or” is used herein to mean, and is used interchangeably with, the term “and/or,” unless context clearly indicates otherwise.

The term “about” is used herein to mean within the typical ranges of tolerances in the art. For example, “about” can be understood as about 2 standard deviations from the mean. In certain embodiments, about means ±10%. In certain embodiments, about means ±5%. When about is present before a series of numbers or a range, it is understood that “about” can modify each of the numbers in the series or range.

The term “at least” prior to a number or series of numbers is understood to include the number adjacent to the term “at least”, and all subsequent numbers or integers that could logically be included, as clear from context. For example, the number of nucleotides in a nucleic acid molecule must be an integer. For example, “at least 18 nucleotides of a 21 nucleotide nucleic acid molecule” means that 18, 19, 20, or 21 nucleotides have the indicated property. When at least is present before a series of numbers or a range, it is understood that “at least” can modify each of the numbers in the series or range.

As used herein, “no more than” or “less than” is understood as the value adjacent to the phrase and logical lower values or integers, as logical from context, to zero. When “no more than” is present before a series of numbers or a range, it is understood that “no more than” can modify each of the numbers in the series or range.

As used herein, the term “substantially” refers to the qualitative condition of exhibiting total or near-total extent or degree of a characteristic or property of interest. One of ordinary skill in the art will understand that biological and chemical phenomena rarely, if ever, go to completion and/or proceed to completeness or achieve or avoid an absolute result. The term “substantially” may therefore be used in some embodiments herein to capture potential lack of completeness inherent in many biological and chemical phenomena.

As used herein, the terms “hepatocyte nuclear factor 4 alpha,” “HNF4α,” and “HNF4A,” as used interchangeably herein, refer to the gene as well as the well known encoded protein which is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. HNF4α also plays a role in development of the liver, kidney, and intestines. Decreased expression of this gene has been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I (MODY I) and liver disease, e.g., cirrhosis. Dysregulated, e.g., increased, expression of this gene has been associated with hepatocellular carcinoma. The nucleotide and amino acid sequence of HNF4α is known and may be found in, for example, GenBank Accession Nos. NM_000457; NM_175914; NM_178849; NM_178850; NM_001030003; NM_001030004; NM_001258355; NM_001287182; NM_001287183; NM_001287184; XM_005260407; NP_000448.3; NP_787110.2; NP_849180.1; NP_849181.1; NP_001025174.1; NP_001025175.1; NP_001245284.1; NP_001274111.1; NP_001274112.1; NP_001274113.1; XP_005260464.1, the entire contents of each of which are incorporated herein by reference. The nucleotide sequence of the genomic region of Chromosome 20 which includes the endogenous promoters of HNF4α and the HNF4α coding sequence is also known and may be found in GenBank Accession No. NC_000020.10 (42984441 . . . 43061485).

The HNF4α gene is located on chromosome 20, with transcription regulated by two promoters (P1 and P2) and alternative splicing variants, resulting in nine distinct isoforms (α1-α9) (FIG. 8). The HNF4α locus is transcriptionally regulated through the use of two distinct promoters that are physically separated by more than 45 kb. Isoforms produced by the activity of the closer promoter are designated P1 whereas isoforms produced by the second and more distant promoter are designated P2. Isoforms most common in the liver are expressed from promoter 1 (P1), with isoforms from P2 most commonly found in fetal tissues, and in the adult kidney and small intestine.

HNF4α controls the expression of proteins necessary for the normal function of hepatocytes and other cell types in the liver. (Argemi J, et al. Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis. Nat Commun. 2019; 10(1):3126. doi:10.1038/s41467-019-11004-3; Nishikawa T, et al. Resetting the transcription factor network reverses terminal chronic hepatic failure. J Clin Invest. 2015; 125(4):1533-1544. doi:10.1172/JCI73137). In addition, many of these proteins are secreted by liver cells and contribute to health systemically. For example, proteins such as albumin are required to transport nutrients, hormones, lipids, and small molecule drugs in the circulation.

The term “site-specific HNF4α disrupting agent,” as used herein, refers to any agent that specifically binds to a target HNF4α expression control region and, e.g., modulates expression of an HNF4α gene. The modulation of expression may be permanent or transient modulation. Site-specific HNF4α disruption agents of the invention may comprise a “site-specific HNF4α targeting moiety.”

As used herein, the term “site-specific HNF4α targeting moiety” refers to a moiety that specifically binds to an HNF4α expression control region, e.g., a transcriptional control region of an HNF4α gene, such as a promoter, an enhancer, or a repressor; or an HNF4α-associated anchor sequence, such as, for example within an HNF4α-associated anchor sequence-mediated conjunction. Exemplary “site-specific HNF4α targeting moieties” include, but are not limited to, polyamides, nucleic acid molecules, such as RNA, DNA, or modified RNA or DNA, polypeptides, protein nucleic acid molecules, and fusion proteins.

As used herein, the terms “specific binding” or “specifically binds” refer to an ability to discriminate between possible binding partners in the environment in which binding is to occur. In some embodiments, a disrupting agent that interacts, e.g., preferentially interacts, with one particular target when other potential disrupting agents are present is said to “bind specifically” to the target (i.e., the expression control region) with which it interacts. In some embodiments, specific binding is assessed by detecting or determining the degree of association between the disrupting agent and its target; in some embodiments, specific binding is assessed by detecting or determining degree of dissociation of a disrupting agent-target complex. In some embodiments, specific binding is assessed by detecting or determining ability of the disrupting agent to compete with an alternative interaction between its target and another entity. In some embodiments, specific binding is assessed by performing such detections or determinations across a range of concentrations.

As used herein, the term “expression control region” or expression control domain” refers to a region or domain present in a genomic DNA that modulates the expression of a target gene in a cell. A functionality associated with an expression control region may directly affect expression of a target gene, e.g., by recruiting or blocking recruitment of a transcription factor that would stimulate expression of the gene. A functionality associated with an expression control region may indirectly affect expression of a target gene, e.g., by introducing epigenetic modifications or recruiting other factors that introduce epigenetic modifications that induce a change in chromosomal topology that modulates expression of a target gene. Expression control regions may be upstream and/or downstream of the protein coding sequence of a gene and include, for example, transcriptional control elements, e.g., promoters, ehnacers, or repressors; and anchor sequences, and anchor sequence-mediated conjunctions.

The term “transcriptional control element,” as used herein, refers to a nucleic acid sequence that controls transcription of a gene. Transcriptional control elements include, for example, anchor sequences, anchor sequence-mediated conjunctions, promoters, transcriptional enhancers, and transcriptional repressors.

A promoter is a region of DNA recognized by an RNA polymerase to initiate transcription of a particular gene and is generally located upstream of the 5′-end of the transcription start site of the gene.

A “transcriptional enhancer” increases gene transcription. A “transcriptional silencer” or “transcriptional repressor” decreases gene transcription. Enhancing and silencing sequences may be about 50-3500 base pairs in length and may influence gene transcription up to about 1 megabases away.

The term “gene,” as used herein, refers to a sequence of nucleotides that encode a molecule, such as a protein, that has a function. A gene contains sequences that are transcribed (e.g., a 3′UTR), sequences that are not transcribed (e.g., a promoter), sequences that are translated (e.g., an exon), and sequences that are not translated (e.g., intron).

As used herein, the term “target gene” means an HNF4α gene that is targeted for modulation, e.g., increase or decrease, of expression. In some embodiments, an HNF4α target gene is part of a targeted genomic complex (e.g. an HNF4α gene that has at least part of its genomic sequence as part of a target genomic complex, e.g. inside an anchor sequence-mediated conjunction), which genomic complex is targeted by one or more site-specific disrupting agents as described herein. In some embodiments, modulation comprises inhibition of expression of the target gene. In some embodiments, an HNF4α gene is modulated by contacting the HNF4α gene or a transcription control element operably linked to the HNF4α gene with one or more site-specific disrupting agents as described herein. In some embodiments, an HNF4α gene is aberrantly expressed (e.g., over-expressed) in a cell, e.g., a cell in a subject (e.g., a subject having an HNF4α-associated disease). In some embodiments, an HNF4α gene is aberrantly expressed (e.g., under-expressed) in a cell, e.g., a cell in a subject (e.g., a subject having an HNF4α-associated disease).

The term “anchor sequence” as used herein, refers to a nucleic acid sequence recognized by a nucleating agent that binds sufficiently to form an anchor sequence-mediated conjunction, e.g., a complex. In some embodiments, an anchor sequence comprises one or more CTCF binding motifs. In some embodiments, an anchor sequence is not located within a gene coding region. In some embodiments, an anchor sequence is located within an intergenic region. In some embodiments, an anchor sequence is not located within either of an enhancer or a promoter. In some embodiments, an anchor sequence is located at least 400 bp, at least 450 bp, at least 500 bp, at least 550 bp, at least 600 bp, at least 650 bp, at least 700 bp, at least 750 bp, at least 800 bp, at least 850 bp, at least 900 bp, at least 950 bp, or at least 1 kb away from any transcription start site. In some embodiments, an anchor sequence is located within a region that is not associated with genomic imprinting, monoallelic expression, and/or monoallelic epigenetic marks. In some embodiments, the anchor sequence has one or more functions selected from binding an endogenous nucleating polypeptide (e.g., CTCF), interacting with a second anchor sequence to form an anchor sequence mediated conjunction, or insulating against an enhancer that is outside the anchor sequence mediated conjunction. In some embodiments of the present invention, technologies are provided that may specifically target a particular anchor sequence or anchor sequences, without targeting other anchor sequences (e.g., sequences that may contain a nucleating agent (e.g., CTCF) binding motif in a different context); such targeted anchor sequences may be referred to as the “target anchor sequence”. In some embodiments, sequence and/or activity of a target anchor sequence is modulated while sequence and/or activity of one or more other anchor sequences that may be present in the same system (e.g., in the same cell and/or in some embodiments on the same nucleic acid molecule, e.g., the same chromosome) as the other targeted anchor sequence is not modulated. In some embodiments, the anchor sequence comprises or is a nucleating polypeptide binding motif. In some embodiments, the anchor sequence is adjacent to a nucleating polypeptide binding motif.

The term “anchor sequence-mediated conjunction” as used herein, refers to a DNA structure, in some cases, a complex, that occurs and/or is maintained via physical interaction or binding of at least two anchor sequences in the DNA by one or more polypeptides, such as nucleating polypeptides, or one or more proteins and/or a nucleic acid entity (such as RNA or DNA), that bind the anchor sequences to enable spatial proximity and functional linkage between the anchor sequences.

As used herein, the term “genomic complex” is a complex that brings together two genomic sequence elements that are spaced apart from one another on one or more chromosomes, via interactions between and among a plurality of protein and/or other components (potentially including, the genomic sequence elements). In some embodiments, the genomic sequence elements are anchor sequences to which one or more protein components of the complex bind. In some embodiments, a genomic complex may comprise an anchor sequence-mediated conjunction. In some embodiments, a genomic sequence element may be or comprise a CTCF binding motif, a promoter and/or an enhancer.

In some embodiments, a genomic sequence element includes at least one or both of a promoter and/or regulatory region (e.g., an enhancer). In some embodiments, complex formation is nucleated at the genomic sequence element(s) and/or by binding of one or more of the protein component(s) to the genomic sequence element(s). As will be understood by those skilled in the art, in some embodiments, co-localization (e.g., conjunction) of the genomic sites via formation of the complex alters DNA topology at or near the genomic sequence element(s), including, in some embodiments, between them. In some embodiments, a genomic complex comprises an anchor sequence-mediated conjunction, which comprises one or more loops. In some embodiments, a genomic complex as described herein is nucleated by a nucleating polypeptide such as, for example, CTCF and/or Cohesin. In some embodiments, a genomic complex as described herein may include, for example, one or more of CTCF, Cohesin, non-coding RNA (e.g., eRNA), transcriptional machinery proteins (e.g., RNA polymerase, one or more transcription factors, for example selected from the group consisting of TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH, etc.), transcriptional regulators (e.g., Mediator, P300, enhancer-binding proteins, repressor-binding proteins, histone modifiers, etc.), etc. In some embodiments, a genomic complex as described herein includes one or more polypeptide components and/or one or more nucleic acid components (e.g., one or more RNA components), which may, in some embodiments, be interacting with one another and/or with one or more genomic sequence elements (e.g., anchor sequences, promoter sequences, regulatory sequences (e.g., enhancer sequences)) so as to constrain a stretch of genomic DNA into a topological configuration (e.g., a loop) that the stretch of genomic DNA does not adopt when the complex is not formed.

An “effector molecule,” as used herein, refers to a molecule that is able to regulate a biological activity, such as enzymatic activity, gene expression, anchor sequence-mediated conjunction or cell signaling. Exemplary effectors are described in Section II, below, and in some embodiment include, for example, nucleases, physical blockers, epigenetic recruiters, e.g., a transcriptional enhancer or a transcriptional repressor, and epigenetic CpG modifiers, e.g., a DNA methylase, a DNA demethylase, a histone modifying agent, or a histone deacetylase, and combinations of any of the foregoing.

II. Site-Specific HNF4α Disrupting Agents of the Invention

The present invention provides site-specific HNF4α disrupting agents which, in one aspect of the invention include a site-specific HNF4α targeting moiety which targets an HNF4α expression control region. In another aspect, the site-specific disrupting agents of the invention include a site-specific HNF4α targeting moiety which targets an HNF4α expression control region and an effector molecule. As will be appreciated by one of ordinary skill in the art, such disrupting agents are site-specific and, thus, specifically bind to an HNF4α expression control region (e.g., one or more transcriptional control elements and/or one or more target anchor sequences), e.g., within a cell and not to non-targeted expression control regions (e.g., within the same cell).

The site-specific HNF4α disrupting agents of the invention comprise a site-specific HNF4α targeting moiety targeting an HNF4α expression control region. The expression control region targeted by the site-specific targeting moiety may be, for example, a transcriptional control element or an anchor sequence, such as an anchor sequence within an anchor-mediated conjunction.

Thus, site-specific HNF4α disrupting agents of the invention may modulate expression of a gene, i.e., HNF4α, e.g., by modulating expression of the gene from an endogenous promoter, an enhancer, or an repressor, may alter methylation of the control region, may alter at least one anchor sequence; may alter at least one conjunction nucleating molecule binding site, such as by altering binding affinity for the conjunction nucleating molecule; may alter an orientation of at least one common nucleotide sequence, such as a CTCF binding motif by, e.g., substitution, addition or deletion in at least one anchor sequence, such as a CTCF binding motif.

In certain embodiments, the site-specific disrupting agents and compositions described herein target an expression control region comprising one or more HNF4α-specific transcriptional control elements to modulate expression in a cell. HNF4α-specific transcriptional control elements that can be targeted include HNF4α-specific promoters, HNF4α-specific enhancers, and HNF4α-specific repressors. In one embodiment, an HNF4α-specific promoter substantially drives expression in cells of the liver, i.e., promoter 1. In one embodiment, an HNF4α-specific promoter substantially drives expression in cells of the pancreas, i.e., promoter 2. The nucleotide sequences of HNF4α promoter 1 and promoter 2 are known and may be found in, for example, GenBank Accession No. NC_000020.10 (42984441 . . . 43061485).

For example, a site-specific disrupting agent may include a site-specific targeting moiety, e.g., a nucleic acid molecule encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically targets and binds to an HNF4α expression control region, such as an HNF4α endogenous promoter region, e.g., promoter 1, and an effector molecule, such as an effector molecule that includes a transcriptional enhancer or transcriptional repressor that modulates, e.g., enhances or represses, expression of a target gene from an endogenous promoter to modulate gene expression. In one embodiment, the disrupting agent is “bicistronic nucleic acid molecule,” i.e., capable of making two fusion proteins from a single messenger RNA molecule, a first and a second site-specific targeting moiety, e.g., a nucleic acid molecule encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically targets and binds to an HNF4α expression control region, such as an HNF4α endogenous promoter region, e.g., promoter 1, and an effector molecule, such as an effector molecule that includes a transcriptional enhancer or transcriptional repressor that modulates, e.g., enhances or represses, expression of a target gene from an endogenous promoter to modulate gene expression.

In some embodiments of the invention, a site-specific disrupting agent may include a site-specific targeting moiety, e.g., a nucleic acid molecule such as a guide RNA targeting an HNF4α endogenous promoter region, e.g., promoter 1, and an effector molecule, such as an effector molecule that includes a transcriptional enhancer or transcriptional repressor that modulates, e.g., enhances or represses, expression of a target gene from an endogenous promoter to modulate gene expression.

In certain embodiments of the invention, the site-specific disrupting agents and compositions described herein target an expression control region comprising one or more HNF4α-associated anchor sequences, e.g., within an anchor sequence-mediated conjunction, comprising a first and a second HNF4α-associated anchor sequence to alter a two-dimensional chromatin structure (e.g., anchor sequence-mediated conjunctions in order to modulate expression in a cell, e.g., a cell within a subject, e.g., by modifying anchor sequence-mediated conjunctions in DNA, e.g., genomic DNA.

In one aspect, the invention includes a site-specific HNF4α disrupting agent comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region comprising one or more HNF4α-associated anchor sequences within an anchor sequence-mediated conjunction. The disrupting agent binds, e.g., specifically binds, a specific anchor sequence-mediated conjunction to alter a topology of the anchor sequence-mediated conjunction, e.g., an anchor sequence-mediated conjunction having a physical interaction of two or more DNA loci bound by a conjunction nucleating molecule.

The formation of an anchor sequence-mediated conjunction may force transcriptional control elements to interact with an HNF4α gene or spatially constrain the activity of the transcriptional control elements. Altering anchor sequence-mediated conjunctions, therefore, allows for modulating HNF4α expression without altering the coding sequences of the HNF4α gene being modulated.

In some embodiments, the site-specific disrupting agents and compositions of the invention modulate expression of an HNF4α gene associated with an anchor sequence-mediated conjunction by physically interfering between one or more anchor sequences and a conjunction nucleating molecule. For example, a DNA binding small molecule (e.g., minor or major groove binders), peptide (e.g., zinc finger, TALE, novel or modified peptide), protein (e.g., CTCF, modified CTCF with impaired CTCF binding and/or cohesion binding affinity), or nucleic acids (e.g., ssDNA, modified DNA or RNA, peptide oligonucleotide conjugates, locked nucleic acids, bridged nucleic acids, polyamides, and/or triplex forming oligonucleotides) may physically prevent a conjunction nucleating molecule from interacting with one or more anchor sequences to modulate HNF4α gene expression.

In some embodiments, the site-specific disrupting agents and compositions of the invention modulate expression of an HNF4α gene associated with an anchor sequence-mediated conjunction by modification of an anchor sequence, e.g., epigenetic modifications, e.g., histone protein modifications, or genomic editing modifications. For example, one or more anchor sequences associated with an anchor sequence-mediated conjunction comprising an HNF4α gene may be targeted for methylation modification by a DNA methyltransferase, e.g., dCas9-methyltransferase fusion, e.g., antisense oligonucleotide-enzyme fusion, to modulate expression of the gene.

In some embodiments, the site-specific disrupting agents and compositions of the invention modulate expression of an HNF4α gene associated with an anchor sequence-mediated conjunction, e.g., activate or represses transcription, e.g., induces epigenetic changes to chromatin.

In some embodiments, an anchor sequence-mediated conjunction includes one or more anchor sequences, an HNF4α gene, and one or more transcriptional control elements, such as an enhancing or silencing element. In some embodiments, the transcriptional control element is within, partially within, or outside the anchor sequence-mediated conjunction.

In one embodiment, the anchor sequence-mediated conjunction comprises a loop, such as an intra-chromosomal loop. In certain embodiments, the anchor sequence-mediated conjunction has a plurality of loops. One or more loops may include a first anchor sequence, a nucleic acid sequence, a transcriptional control element, and a second anchor sequence. In another embodiment, at least one loop includes, in order, a first anchor sequence, a transcriptional control element, and a second anchor sequence; or a first anchor sequence, a nucleic acid sequence, and a second anchor sequence. In yet another embodiment, either one or both of the nucleic acid sequences and the transcriptional control element is located within or outside the loop. In still another embodiment, one or more of the loops comprises a transcriptional control element.

In some embodiments, the anchor sequence-mediated conjunction includes a TATA box, a CAAT box, a GC box, or a CAP site.

In some embodiments, the anchor sequence-mediated conjunction comprises a plurality of loops, and where the anchor sequence-mediated conjunction comprises at least one of an anchor sequence, a nucleic acid sequence, and a transcriptional control element in one or more of the loops.

In one aspect, the site-specific disrupting agents and compositions of the invention may introduce a targeted alteration to an anchor sequence-mediated conjunction to modulate expression of a nucleic acid sequence with a disrupting agent that binds the anchor sequence. In some embodiments, the anchor sequence-mediated conjunction is altered by targeting one or more nucleotides within the anchor sequence-mediated conjunction for substitution, addition or deletion.

In some embodiments, expression, e.g., transcription, is activated by inclusion of an activating loop or exclusion of a repressive loop. In one such embodiment, the anchor sequence-mediated conjunction comprises a transcriptional control sequence that increases transcription of a nucleic acid sequence, e.g., such an HNF4α encoding nucleic acid. In another such embodiment, the anchor sequence-mediated conjunction excludes a transcriptional control element that decreases expression, e.g., transcription, of a nucleic acid sequence, e.g., such an HNF4α encoding nucleic acid.

In some embodiments, expression, e.g., transcription, is repressed by inclusion of a repressive loop or exclusion of an activating loop. In one such embodiment, the anchor sequence-mediated conjunction includes a transcriptional control element that decreases expression, e.g., transcription, of a nucleic acid sequence, e.g., such an HNF4α encoding nucleic acid sequence. In another such embodiment, the anchor sequence-mediated conjunction excludes a transcriptional control sequence that increases transcription of a nucleic acid sequence, e.g., such an HNF4α encoding nucleic acid.

Each anchor sequence-mediated conjunction comprises one or more anchor sequences, e.g., a plurality. Anchor sequences can be manipulated or altered to disrupt naturally occurring loops or form new loops (e.g., to form exogenous loops or to form non-naturally occurring loops with exogenous or altered anchor sequences). Such alterations modulate HNF4α gene expression by changing the 2-dimensional structure of DNA containing all or a portion of an HNF4α gene, e.g., by thereby modulating the ability of the HNF4α gene to interact with transcriptional control elements (e.g., enhancing and silencing/repressive sequences). In some embodiments, the chromatin structure is modified by substituting, adding or deleting one or more nucleotides within an anchor sequence of the anchor sequence-mediated conjunction.

The anchor sequences may be non-contiguous with one another. In embodiments with noncontiguous anchor sequences, the first anchor sequence may be separated from the second anchor sequence by about 500 bp to about 500 Mb, about 750 bp to about 200 Mb, about 1 kb to about 100 Mb, about 25 kb to about 50 Mb, about 50 kb to about 1 Mb, about 100 kb to about 750 kb, about 150 kb to about 500 kb, or about 175 kb to about 500 kb. In some embodiments, the first anchor sequence is separated from the second anchor sequence by about 500 bp, 600 bp, 700 bp, 800 bp, 900 bp, 1 kb, 5 kb, 10 kb, 15 kb, 20 kb, 25 kb, 30 kb, 35 kb, 40 kb, 45 kb, 50 kb, 55 kb, 60 kb, 65 kb, 70 kb, 75 kb, 80 kb, 85 kb, 90 kb, 95 kb, 100 kb, 125 kb, 150 kb, 175 kb, 200 kb, 225 kb, 250 kb, 275 kb, 300 kb, 350 kb, 400 kb, 500 kb, 600 kb, 700 kb, 800 kb, 900 kb, 1 Mb, 2 Mb, 3 Mb, 4 Mb, 5 Mb, 6 Mb, 7 Mb, 8 Mb, 9 Mb, 10 Mb, 15 Mb, 20 Mb, 25 Mb, 50 Mb, 75 Mb, 100 Mb, 200 Mb, 300 Mb, 400 Mb, 500 Mb, or any size therebetween.

In one embodiment, the anchor sequence comprises a common nucleotide sequence, e.g., a CTCF-binding motif:

(SEQ ID NO: 64) N(T/C/G)N(G/A/T)CC(A/T/G)(C/G)(C/T/A)AG(G/A)(G/T) GG(C/A/T)(G/A)(C/G)(C/T/A)(G/A/C), where N is any nucleotide.

A CTCF-binding motif may also be in the opposite orientation, e.g.,

(SEQ ID NO: 65) (G/A/C)(C/T/A)(C/G)(G/A)(C/A/T)GG(G/T)(G/A)GA (C/T/A)(C/G)(A/T/G)CC(G/A/T)N(T/C/G)N.

In one embodiment, the anchor sequence comprises SEQ ID NO: 64 or SEQ ID NO:65 or a nucleotide sequence at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% identical to either SEQ ID NO: 64 or SEQ ID NO:65.

In some embodiments, the anchor sequence-mediated conjunction comprises at least a first anchor sequence and a second anchor sequence. The first anchor sequence and second anchor sequence may each comprise a common nucleotide sequence, e.g., each comprises a CTCF binding motif. In some embodiments, the first anchor sequence and second anchor sequence comprise different sequences, e.g., the first anchor sequence comprises a CTCF binding motif and the second anchor sequence comprises an anchor sequence other than a CTCF binding motif. In some embodiments, each anchor sequence comprises a common nucleotide sequence and one or more flanking nucleotides on one or both sides of the common nucleotide sequence.

Two CTCF-binding motifs (e.g., contiguous or non-contiguous CTCF binding motifs) that can form a conjunction may be present in the genome in any orientation, e.g., in the same orientation (tandem) either 5′->3′ (left tandem, e.g., the two CTCF-binding motifs that comprise SEQ ID NO: 64) or 3′->5′ (right tandem, e.g., the two CTCF-binding motifs comprise SEQ ID NO: 65), or convergent orientation, where one CTCF-binding motif comprises SEQ ID NO: 64 and the other comprises SEQ ID NO: 65. CTCFBSDB 2.0: Database For CTCF binding motifs And Genome Organization (http://insulatordb.uthsc.edu/) can be used to identify CTCF binding motifs associated with a target gene, e.g., HNF4α.

In some embodiments, the anchor sequence-mediated conjunction is altered by changing an orientation of at least one common nucleotide sequence, e.g., a conjunction nucleating molecule binding site.

In some embodiments, the anchor sequence comprises a conjunction nucleating molecule binding site, e.g., CTCF binding motif, and site-specific disrupting agent of the invention introduces an alteration in at least one conjunction nucleating molecule binding site, e.g. altering binding affinity for the conjunction nucleating molecule.

In some embodiments, the anchor sequence-mediated conjunction is altered by introducing an exogenous anchor sequence. Addition of a non-naturally occurring or exogenous anchor sequence to form or disrupt a naturally occurring anchor sequence-mediated conjunction, e.g., by inducing a non-naturally occurring loop to form that alters transcription of the nucleic acid sequence.

In some embodiments, the anchor sequence-mediated conjunction comprises an HNF4α gene, and one or more, e.g., 2, 3, 4, 5, or other genes other than the HNF4α gene.

In some embodiments, the anchor sequence-mediated conjunction is associated with one or more, e.g., 2, 3, 4, 5, or more, transcriptional control elements. In some embodiments, the HNF4α gene is noncontiguous with one or more of the transcriptional control elements. In some embodiments where the HNF4α gene is non-contiguous with the transcriptional control element, the gene may be separated from one or more transcriptional control elements by about 100 bp to about 500 Mb, about 500 bp to about 200 Mb, about 1 kb to about 100 Mb, about 25 kb to about 50 Mb, about 50 kb to about 1 Mb, about 100 kb to about 750 kb, about 150 kb to about 500 kb, or about 175 kb to about 500 kb. In some embodiments, the gene is separated from the transcriptional control element by about 100 bp, 300 bp, 500 bp, 600 bp, 700 bp, 800 bp, 900 bp, 1 kb, 5 kb, 10 kb, 15 kb, 20 kb, 25 kb, 30 kb, 35 kb, 40 kb, 45 kb, 50 kb, 55 kb, 60 kb, 65 kb, 70 kb, 75 kb, 80 kb, 85 kb, 90 kb, 95 kb, 100 kb, 125 kb, 150 kb, 175 kb, 200 kb, 225 kb, 250 kb, 275 kb, 300 kb, 350 kb, 400 kb, 500 kb, 600 kb, 700 kb, 800 kb, 900 kb, 1 Mb, 2 Mb, 3 Mb, 4 Mb, 5 Mb, 6 Mb, 7 Mb, 8 Mb, 9 Mb, 10 Mb, 15 Mb, 20 Mb, 25 Mb, 50 Mb, 75 Mb, 100 Mb, 200 Mb, 300 Mb, 400 Mb, 500 Mb, or any size therebetween.

In some embodiments, the type of anchor sequence-mediated conjunction may help to determine how to modulate gene expression, e.g., choice of site-specific targeting moiety, by altering the anchor sequence-mediated conjunction. For example, some types of anchor sequence-mediated conjunctions comprise one or more transcription control elements within the anchor sequence-mediated conjunction. Disruption of such an anchor sequence-mediated conjunction by disrupting the formation of the anchor sequence-mediated conjunction, e.g., altering one or more anchor sequences, is likely to decrease transcription of an HNF4α gene within the anchor sequence-mediated conjunction.

In some embodiments, expression of the HNF4α gene is regulated, modulated, or influenced by one or more transcriptional control elements associated with the anchor sequence-mediated conjunction. In some embodiments, the anchor sequence-mediated conjunction comprises an HNF4α gene and one or more transcriptional control elements. For example, the HNF4α gene and one or more transcriptional control sequences are located within, at least partially, an anchor sequence-mediated conjunction, e.g., a Type 1 anchor sequence-mediated conjunction. The anchor sequence-mediated conjunction may also be referred to as a “Type 1, EP subtype.” In some embodiments, the HNF4α gene has a defined state of expression, e.g., in its native state, e.g., in a diseased state. For example, the HNF4α gene may have a high level of expression. By disrupting the anchor sequence-mediated conjunction, expression of the HNF4α gene may be decreased, e.g., decreased transcription due to conformational changes of the DNA previously open to transcription within the anchor sequence-mediated conjunction, e.g., decreased transcription due to conformational changes of the DNA creating additional distance between the HNF4α gene and the enhancing sequences. In one embodiment, both the HNF4α gene associated and one or more transcriptional control sequences, e.g., enhancing sequences, reside inside the anchor sequence-mediated conjunction. Disruption of the anchor sequence-mediated conjunction decreases expression of the HNF4α gene. In one embodiment, the HNF4α gene associated with the anchor sequence-mediated conjunction is accessible to one or more transcriptional control elements that reside inside, at least partially, the anchor sequence-mediated conjunction.

In some embodiments, expression of the HNF4α gene is regulated, modulated, or influenced by one or more transcriptional control elements associated with, but inaccessible due to the anchor sequence-mediated conjunction. For example, the anchor sequence-mediated conjunction associated with an HNF4α gene disrupts the ability of one or more transcriptional control elements to regulate, modulate, or influence expression of the HNF4α gene. The transcriptional control sequences may be separated from the HNF4α gene, e.g., reside on the opposite side, at least partially, e.g., inside or outside, of the anchor sequence-mediated conjunction as the HNF4α gene, e.g., the HNF4α gene is inaccessible to the transcriptional control elements due to proximity of the anchor sequence-mediated conjunction. In some embodiments, one or more enhancing sequences are separated from the HNF4α gene by the anchor sequence-mediated conjunction, e.g., a Type 2 anchor sequence-mediated conjunction.

In some embodiments, the HNF4α gene is inaccessible to one or more transcriptional control elements due to the anchor sequence-mediated conjunction, and disruption of the anchor sequence-mediated conjunction allows the transcriptional control element to regulate, modulate, or influence expression of the HNF4α gene. In one embodiment, the HNF4α gene is inside and outside the anchor sequence-mediated conjunction and inaccessible to the one or more transcriptional control elements. Disruption of the anchor sequence-mediated conjunction increases access of the transcriptional control elements to regulate, modulate, or influence expression of the HNF4α gene, e.g., the transcriptional control elements increase expression of the HNF4α gene. In one embodiment, the HNF4α gene is inside the anchor sequence-mediated conjunction and inaccessible to the one or more transcriptional control elements residing outside, at least partially, the anchor sequence-mediated conjunction. Disruption of the anchor sequence-mediated conjunction increases expression of the HNF4α gene. In one embodiment, the HNF4α gene is outside, at least partially, the anchor sequence-mediated conjunction and inaccessible to the one or more transcriptional control elements residing inside the anchor sequence-mediated conjunction. Disruption of the anchor sequence-mediated conjunction increases expression of the HNF4α gene.

A. HNF4α Site-Specific Targeting Moieties

The site-specific HNF4α targeting moieties of the invention target an HNF4α expression control region and may comprise a polymer or polymeric molecule, such as a polyamide (i.e., a molecule of repeating units linked by amide binds, e.g., a polypeptide), a polymer of nucleotides (such as a guide RNA, a nucleic acid molecule encoding a TALE polypeptide or a zinc finger polypeptides), a peptide nucleic acid (PNA), or a polymer of amino acids, such as a peptide or polypeptide, e.g., a fusion protein, etc. Suitable site-specific HNF4α targeting moieties, compositions, and methods of use of such agents and compositions are described below and in PCT Publication WO 2018/049073, the entire contents of which are expressly incorporated herein by reference.

In one embodiment, a site specific disrupting agent of the invention comprises a site-specific HNF4α targeting moiety comprising a nucleic acid molecule encoding a polypeptide, such as a DNA-binding domain, of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that is engineered to specifically target an HNF4α expression control region to modulate expression of an HNF4α gene.

In another embodiment, a site-specific disrupting agent of the invention comprises a site-specific HNF4α targeting moiety comprising a nucleic acid molecule, such as a guide RNA (or gRNA) or a guide RNA and an effector, or fragment thereof, or nucleic acid molecule encoding an effector, or fragment thereof.

In another embodiment, a site-specific disrupting agent of the invention comprises a site-specific HNF4α targeting moiety comprising a polynucleotide, such as a PNA, e.g., a nucleic acid gRNA linked to an effector polypeptide, or fragment thereof.

In another embodiment, a site-specific disrupting agent of the invention comprises a site-specific HNF4α targeting moiety comprising a fusion molecule, such as a nucleic acid molecule encoding a DNA-binding domain, of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, and an effector.

In one embodiment, such site-specific disrupting agents comprise a second fusion protein, wherein the second fusion protein comprises a second site-specific HNF4α targeting moiety which targets a second HNF4α expression control region and a second effector molecule, wherein the second HNF4α expression control region is different than the HNF4α expression control region.

In another embodiment, a site-specific disrupting agent of the invention comprises a site-specific HNF4α targeting moiety comprising a fusion molecule, such as a nucleic acid molecule encoding a protein comprising a Cas polypeptide and, e.g., an epigenetic recruiter or an epigenetic CpG modifier.

In yet, another embodiment, a site-specific disrupting agent of the invention comprises a site-specific HNF4α targeting moiety comprising a fusion molecule, such as fusion protein comprising a Cas polypeptide and, e.g., an epigenetic recruiter or an epigenetic CpG modifier.

As used herein, in its broadest sense, the term “nucleic acid” refers to any compound and/or substance that is or can be incorporated into an oligonucleotide chain. In some embodiments, a nucleic acid is a compound and/or substance that is or can be incorporated into a polynucleotide chain via a phosphodiester linkage. As will be clear from context, in some embodiments, “nucleic acid” refers to an individual nucleic acid residue (e.g., a nucleotide and/or nucleoside); in some embodiments, “nucleic acid” refers to a polynucleotide chain comprising individual nucleic acid residues. In some embodiments, a “nucleic acid” is or comprises RNA; in some embodiments, a “nucleic acid” is or comprises DNA. In some embodiments, a “nucleic acid” is a “mixmer” comprising locked nucleic acid molecules and deoxynucleic acid molecules. In some embodiments, a nucleic acid is, comprises, or consists of one or more natural nucleic acid residues. In some embodiments, a nucleic acid is, comprises, or consists of one or more nucleic acid analogs. In some embodiments, a nucleic acid analog differs from a nucleic acid in that it does not utilize a phosphodiester backbone. For example, in some embodiments, a nucleic acid is, comprises, or consists of one or more “peptide nucleic acids”, which are known in the art and have peptide bonds instead of phosphodiester bonds in the backbone, are considered within the scope of the present invention. Alternatively or additionally, in some embodiments, a nucleic acid has one or more phosphorothioate and/or 5′-N-phosphoramidite linkages rather than phosphodiester bonds. In some embodiments, a nucleic acid is, comprises, or consists of one or more natural nucleosides (e.g., adenosine, thymidine, guanosine, cytidine, uridine, deoxyadenosine, deoxythymidine, deoxy guanosine, and deoxycytidine). In some embodiments, a nucleic acid is, comprises, or consists of one or more nucleoside analogs (e.g., 2-aminoadenosine, 2-thiothymidine, inosine, pyrrolo-pyrimidine, 3-methyl adenosine, 5-methylcytidine, C-5 propynyl-cytidine, C-5 propynyl-uridine, 2-aminoadenosine, C5-bromouridine, C5-fluorouridine, C5-iodouridine, C5-propynyl-uridine, C5-propynyl-cytidine, C5-methylcytidine, 2-aminoadenosine, 7-deazaadenosine, 7-deazaguanosine, 8-oxoadenosine, 8-oxoguanosine, O(6)-methylguanine, 2-thiocytidine, methylated bases, intercalated bases, and combinations thereof). In some embodiments, a nucleic acid comprises one or more modified sugars (e.g., 2′-fluororibose, ribose, 2′-deoxyribose, arabinose, and hexose) as compared with those in natural nucleic acids. In some embodiments, a nucleic acid has a nucleotide sequence that encodes a functional gene product such as an RNA or protein. In some embodiments, a nucleic acid includes one or more introns. In some embodiments, nucleic acids are prepared by one or more of isolation from a natural source, enzymatic synthesis by polymerization based on a complementary template (in vivo or in vitro), reproduction in a recombinant cell or system, and chemical synthesis. In some embodiments, a nucleic acid is at least 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 20, 225, 250, 275, 300, 325, 350, 375, 400, 425, 450, 475, 500, 600, 700, 800, 900, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 4500, 5000 or more residues long. In some embodiments, a nucleic acid is partly or wholly single stranded; in some embodiments, a nucleic acid is partly or wholly double stranded. In some embodiments a nucleic acid has a nucleotide sequence comprising at least one element that encodes, or is the complement of a sequence that encodes, a polypeptide. In some embodiments, a nucleic acid has enzymatic activity.

As used herein, the terms “peptide,” “polypeptide,” and “protein” refer to a compound comprised of amino acid residues covalently linked by peptide bonds, or by means other than peptide bonds. A protein or peptide must contain at least two amino acids, and no limitation is placed on the maximum number of amino acids that can comprise a protein's or peptide's sequence. Polypeptides include any peptide or protein comprising two or more amino acids joined to each other by peptide bonds or by means other than peptide bonds. As used herein, the term refers to both short chains, which also commonly are referred to in the art as peptides, oligopeptides and oligomers, for example, and to longer chains, which generally are referred to in the art as proteins, of which there are many types.

In certain embodiments, a polypeptide is or may comprise a chimeric or “fusion protein.” As used herein, a “chimeric protein” or “fusion protein” comprises all or part (preferably a biologically active part) of a first protein operably linked to a heterologous second polypeptide (i.e., a polypeptide other than the first protein). Within the fusion protein, the term “operably linked” is intended to indicate that the first protein or segment thereof and the heterologous polypeptide are fused in-frame to each other. The heterologous polypeptide can be fused to the amino-terminus or the carboxyl-terminus of the first protein or segment.

A “polyamide” is a polymeric molecule with repeating units linked by amide binds. Proteins are examples of naturally occurring polyamides. In some embodiments, a polyamide comprises a peptide nucleic acid (PNA).

A “peptide nucleic acid” (“PNA”) is a molecule in which one or more amino acid units in the PNA have an amide containing backbone, e.g., aminoethyl-glycine, similar to a peptide backbone, with a nucleic acid side chain in place of the amino acid side chain. Peptide nucleic acids (PNA) are known to hybridize complementary DNA and RNA with higher affinity than their oligonucleotide counterparts. This character of PNA not only makes them a stable hybrid with the nucleic acid side chains, but at the same time, the neutral backbone and hydrophobic side chains result in a hydrophobic unit within the polypeptide. The nucleic acid side chain includes, but is not limited to, a purine or a pyrimidine side chain such as adenine, cytosine, guanine, thymine and uracil. In one embodiment, the nucleic acid side chain includes a nucleoside analog as described herein.

In one embodiment, a site-specific HNF4α targeting moiety of the invention comprises a polyamide. Suitable polyamides for use in the agents and compositions of the invention are known in the art.

In one embodiment, a site-specific HNF4α targeting moiety of the invention comprises a polynucleotide. In some embodiments, the nucleotide sequence of the polynucleotide encodes an HNF4α gene or an HNF4α expression product. In some embodiments, the nucleotide sequence of the polynucleotide does not include an HNF4α coding sequence or an HNF4α expression product. For example, in some embodiments, a site-specific HNF4α targeting moiety of the invention comprises a polynucleotide that hybridizes to a target expression control region, e.g., a promoter or an anchor sequence. In some embodiments, the nucleotide sequence of the polynucleotide is a complement of a target anchor sequence, or has a sequence that is at least 80%, at least 85%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% identical to a complement of the target sequence.

The polynucleotides of the invention may include deoxynucleotides, ribonucleotides, modified deoxynucleotides, modified ribonucleotides (e.g., chemical modifications, such as modifications that alter the backbone linkages, sugar molecules, and/or nucleic acid bases), and artificial nucleic acids. In some embodiments, the polynucleotide includes, but is not limited to, genomic DNA, cDNA, peptide nucleic acids (PNA) or peptide oligonucleotide conjugates, locked nucleic acids (LNA), bridged nucleic acids (BNA), polyamides, triplex forming oligonucleotides, modified DNA, antisense DNA oligonucleotides, tRNA, mPvNA, rPvNA, modified RNA, miRNA, gRNA, and siRNA or other RNA or DNA molecules.

In some embodiments, the polynucleotides of the invention have a length from about 2 to about 5000 nts, about 10 to about 100 nts, about 50 to about 150 nts, about 100 to about 200 nts, about 150 to about 250 nts, about 200 to about 300 nts, about 250 to about 350 nts, about 300 to about 500 nts, about 10 to about 1000 nts, about 50 to about 1000 nts, about 100 to about 1000 nts, about 1000 to about 2000 nts, about 2000 to about 3000 nts, about 3000 to about 4000 nts, about 4000 to about 5000 nts, or any range therebetween.

The polynucleotides of the invention may include nucleosides, e.g., purines or pyrimidines, e.g., adenine, cytosine, guanine, thymine and uracil. In some embodiments, the polynucleotides includes one or more nucleoside analogs. The nucleoside analog includes, but is not limited to, a nucleoside analog, such as 5-fluorouracil; 5-bromouracil, 5-chlorouracil, 5-iodouracil, hypoxanthine, xanthine, 4-acetylcytosine, 4-methylbenzimidazole, 5-(carboxyhydroxylmethyl) uracil, 5-carboxymethylaminomethyl-2-thiouridine, 5-carboxymethylaminomethyluracil, dihydrouracil, dihydrouridine, beta-D-galactosylqueosine, inosine, N6-isopentenyladenine, 1-methylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-methyladenine, 2-methylguanine, 3-methylcytosine, 5-methylcytosine, N6-adenine, 7-methylguanine, 5-methylaminomethyluracil, 5-methoxyaminomethyl-2-thiouracil, beta-D-mannosylqueosine, 5′-methoxycarboxymethyluracil, 5-methoxyuracil, 2-methylthio-N6-isopentenyladenine, uracil-5-oxyacetic acid (v), wybutoxosine, pseudouracil, queosine, 2-thiocytosine, 5-methyl-2-thiouracil, 2-thiouracil, 4-thiouracil, 5-methyluracil, uracil-5-oxyacetic acid methylester, uracil-5-oxyacetic acid (v), 5-methyl-2-thiouracil, 3-(3-amino-3-N-2-carboxypropyl) uracil, (acp3)w, 2,6-diaminopurine, 3-nitropyrrole, inosine, thiouridine, queuosine, wyosine, diaminopurine, isoguanine, isocytosine, diaminopyrimidine, 2,4-difluorotoluene, isoquinoline, pyrrolo[2,3-]pyridine, and any others that can base pair with a purine or a pyrimidine side chain.

In some embodiments, the site-specific HNF4α targeting moieties of the invention comprise a polynucleotide encoding a polypeptide that comprises a DNA-binding domain (DBD), or fragment thereof, of a zinc finger or TALE, that is engineered to specifically target an HNF4α expression control region to modulate expression of an HNF4α gene.

The design and preparation of such zinc finger polypeptides which specifically bind to a DNA target region of interest, such as an HNF4α expression control region, is well known in the art. For example, zinc finger (ZNF) proteins contain a DNA binding domain that specifically binds a triplet of nucleotides. Thus, to design and prepare the site-specific HNF4α targeting moieties of the invention, a modular assembly process which includes combining separate zinc finger DNA binding domains that can each recognize a specific 3-basepair DNA sequence to generate 3-finger, 4-, 5-, 6-, 7-, or 8-zinc finger polypeptide that recognizes specific target sites ranging from 9 base pairs to 24 base pairs in length may be used. Another suitable method may include 2-finger modules to generate ZNF polynucleotides with up to six individual zinc fingers. See, e.g., Shukla V K, et al., Nature. 459 (7245) 2009: 437-41; Dreier B, et al., JBC. 280 (42) 2005: 35588-97; Dreier B, et al, JBC 276 (31) 2001: 29466-78; Bae K H, et al., Nature Biotechnology. 21 (3) 2003: 275-80.

In some embodiments, a site-specific HNF4α targeting moiety of the invention comprises a polynucleotide encoding a polypeptide that comprises a DNA-binding domain (DBD), or fragment thereof, of a zinc finger, that is engineered to specifically target an HNF4α expression control region to modulate expression of an HNF4α gene. Exemplary amino acid sequences encoding a zinc finger that binds to a nucleotide triplet suitable for use in the present invention are provide in Table 1A below. (See, e.g., Gersbach et al., Synthetic Zinc Finger Proteins: The Advent of Targeted Gene Regulation and Genome Modification Technologies).

TABLE 1A Amino Acid Sequence of Zing Finger DNA Binding Domain Nucleotide SEQ ID (Finger) Triplet NO. RKDALRG TTG 1 TTGALTE CTT 2 QRHHLVE CTC 3 QNSTLTE CTA 4 RNDALTE CTG 5 HKNALQN ATT 6 RRSACRR ATC 7 QKSSLIA ATA 8 RRDELNV ATG 9 TSGSLVR GTT 10 DPGALVR GTC 11 QSSSLVR GTA 12 RSDELVR GTG 13 RLRDIQF TCT 14 RSDERKR TCC 15 RSDHLTT TCA 16 RLRALDR TCG 17 TKNSLTE CCT 18 SKKHLAE CCC 19 TSHSLTE CCA 20 RNDTLTE CCG 21 THLDLIR ACT 22 DKKDLTR ACC 23 SPADLTR ACA 24 RTDTLRD ACG 25 TSGELVR GCT 26 DCRDLAR GCC 27 QSGDLRR GCA 28 RSDDLVR GCG 29 ARGNLRT TAT 30 SRGNLKS TAC 31 QASNLIS TAA 32 REDNLHT TAG 33 TSGNLTE CAT 34 SKKALTE CAC 35 QSGNLTE CAA 36 RADNLTE CAG 37 TTGNLTV AAT 38 DSGNLRV AAC 39 QRANLRA AAA 40 RKDNLKN AAG 41 TSGNLVR GAT 42 DPGNLVR GAC 43 QSSNLVR GAA 44 RSDNLVR GAG 45 APKALGW TGC 46 QAGHLAS TGA 47 RSDHLTT TGG 48 SRRTCRA CGT 49 HTGHLLE CGC 50 QSGHLTE CGA 51 RSDKLTE CGG 52 HRTTLTN AGT 53 ERSHLRE AGC 54 QLAHLRA AGA 55 RSDHLTN AGG 56 TSGHLVR GGT 57 DPGHLVR GGC 58 QRAHLER GGA 59 RSDKLVR GGG 60

A zinc finger DNA binding domain comprises an N-terminal region and a C-terminal region with the “fingers” that bind to the target DNA sequence in between. The N-terminal region generally is 7 amino acids in length. The C-terminal region is generally 6 amino acids in length. Thus, the N-terminal region generally comprises the amino acid sequence of X₁X₂X₃X₄X₅X₆X₇. “X” can be any amino acid. In some embodiments, the N-terminal region comprises the exemplary amino acid sequence of LEPGEKP (SEQ ID NO: 309). “X” can be any amino acid. The C-terminal region generally comprises the amino acid sequence of X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀. In certain embodiments, the C-terminal region comprises the exemplary amino acid sequence of TGKKTS (SEQ ID NO: 310)

Each finger in the DNA binding domain is flanked by a N-terminal backbone located to the N-terminus of the finger and a C-terminal backbone located to the C-terminus of the finger. The N-terminal backbone of the finger generally is 11 amino acids long with two conservative cysteines (C) locate at 3^(rd) and 6^(th) positions. Thus, the N-terminal backbone of the finger generally comprises the amino acid sequence of X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆. “X” can be any amino acid. The C-terminal backbone of the finger generally is 5 amino acids long with two conservative histines (H) located at 1_(st) and 5^(th) positions. Thus, the C-terminal backbone of the finger generally comprises the amino acid sequence of HX₁₇X₁₈X₁₉H. “X” can be any amino acid. In some embodiments, the N-terminal backbone comprises the exemplary amino acid sequence of YKCPECGKSFS (SEQ ID No. 61) and the C-terminal backbone comprises the exemplary amino acid sequence of HQRTH (SEQ ID No. 62). Two “fingers” are linked through a linker. A linker generally is 5 amino acids in length and comprises the amino acid sequence of X₂₀X₂₁X₂₂X₂₃X₂₄ “X” can be any amino acid. In certain embodiments, the linker comprises the exemplary amino acid sequence of TGEKP (SEQ ID No. 63). Thus, the zinc finger of a site specific HNF4α site-specific disrupting agent has a structure as follows: (N-terminal backbone-finger-C-terminal backbone-linker)_(n) and the zinc finger DNA binding domain of a site specific HNF4α site-specific disrupting agent has a structure as follows: [N-terminal region (N-terminal backbone-finger-C-terminal backbone-linker)_(n)-C-terminal region]. “N” represents the number of triplets of nucleotides to which the zinc finger DNA binding domain and, thus, to which the HNF4α site-specific disrupting agent binds.

The “finger” amino acid sequences of four nucleotide triplets are unknown, however, if such a triplet is identified in a target area of interest, two “linker span sequences”—linker span 1 and linker span 2—are useful to circumvent the issue. Linker span 1 is used to skip one base pair if a “finger” amino acid sequence of a triplet is not available. Linker span 2 is used to skip 2 base pairs if a “finger” amino acid sequence of a triplet is not available. Linker span 1 is generally 12 amino acids long. Linker span 2 is generally 16 amino acids long. Thus, linker span 1 generally comprises the amino acid sequence of X₃₁X₃₂X₃₃X₃₄X₃₅X₃₆X₃₇X₃₈X₃₉X₄₀X₄₁X₄₂. Linker span 2 generally comprises the amino acid sequence of X₄₃X₄₄X₄₅X₄₆X₄₇X₄₈X₄₉X₅₀X₅₁X₅₂X₅₃X₅₄X₅₅X₅₆X₅₇X₅₈. In some embodiments, linker span 1 comprises the amino acid sequence of THPRAPIPKPFQ (SEQ ID NO: 311). In certain embodiments, linker span 2 comprises the amino acid sequence of TPNPHRRTDPSHKPFQ (SEQ ID NO: 312). When linker span 1 and/or linker span 2 is used, the finger-linker span 1/span 2-finger comprises the structure as follows: N-terminal back bone-finger-C-terminal backbone-linker span 1/span 2-N-terminal backbone-finger-C-terminal backbone-linker.

Table 1B provides the amino acid sequence structure of exemplary zinc finger DNA binding domains of the disrupting agents comprising a zinc finger DNA binding domain described in the working examples below (see Table 6A). Table 10 also provides the nucleotide sequence of suitable target sequences in the expression control region, the amino acid sequences of exemplary zinc finger DNA binding domains suitable for use in the disrupting agents comprising a zinc finger DNA binding domain of the present invention as well as the amino acid sequence structure of the exemplary zinc finger DNA binding domains suitable for use in the disrupting agents comprising a zinc finger DNA binding domain of the present invention. The “X,” as used in Table 1B, represents any amino acid.

In some embodiments, a zinc finger DNA binding domain suitable for use in the disrupting agents of the invention comprises an amino acid sequence having at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% amino acid identity to the entire amino acid sequence of any one of the zinc finger DNA binding domains provided in any one of Tables 6A and 10.

TABLE 1B Name of Exemplary Zinc SEQ Finger DNA ID Binding Domain Amino Acid Sequence Structure NO: ZF1 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ 313 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVR HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SR RTCRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ RSDKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆RNDTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF2 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ 314 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDL ARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ RNDALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆DKKDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF3 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ 315 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVR HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNL VRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RK DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X61 QAGHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆TSGSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF4 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ 316 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAE HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGAL TEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSG NLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ QSGDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆TSHSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF5 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ 317 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQN HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ RSDKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆DPGHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF6 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ 318 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTE HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHL REHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPG ALVRHXI7X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ TSGHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆RNDTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF7 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ 319 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLAS HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKL TEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSG NLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆Q SSNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ THLDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF8 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ 320 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNV HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADL TRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSD ELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆R SDKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆TTGALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF9 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ 321 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTE HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ QSGHLTEHX₁₇X₁₈X₁₉HX₄₃X₄₄X₄₅X₄₆X₄₇X₄₈X₄₉X₅₀X₅₁X₅₂X₅₃X₅₄X₅₅ X₅₆X₅₇X58X8X9CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈X₁₉HX₂₀ X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF10 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈ 322 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCR DLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ QSGDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆TKNSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF11 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ 323 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHL AEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ DKKDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆SKKHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF12 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ 324 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKN HX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RE DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ DPGHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆QLAHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF13 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ 325 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPG HLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ RNDALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅ X₁₆RSDHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF14 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ 326 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRH X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ QRAHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ZF15 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ 327 X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ QSSNLVRHX₁₇X₁₈X₁₉11X₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀

Similarly, the design and preparation of such TALE polypeptide which specifically bind to a DNA target region of interest, such as an HNF4α expression control region, is well known in the art. For example, the DNA binding domain of TALE contains a repeated highly conserved 33-34 amino acid sequence with divergent 12th and 13th amino acids. These two positions, referred to as the Repeat Variable Diresidue (RVD), are highly variable and show a strong correlation with specific nucleotide recognition. This straightforward relationship between amino acid sequence and DNA recognition has allowed for the engineering of specific DNA-binding domains by selecting a combination of repeat segments containing the appropriate RVDs. See, e.g., Boch J Nature Biotechnology. 29 (2) 2011: 135-6; Boch J, et al., Science. 326 (5959) 2009: 1509-12; Moscou M J & Bogdanove A J Science. 326 (5959) 2009: 1501.

In some embodiments, the site-specific HNF4α targeting moieties of the invention comprising a polynucleotide comprise a guide RNA (or gRNA) or nucleic acid encoding a guide RNA. A gRNA is a short synthetic RNA molecule comprising a “scaffold” sequence necessary for, e.g., directing an effector to an HNF4α expression control element which may, e.g., include an about 20 nucleotide site-specific sequence targeting a genomic target sequence comprising the HNF4α expression control element.

Generally, guide RNA sequences are designed to have a length of between about 17 to about 24 nucleotides (e.g., 19, 20, or 21 nucleotides) and are complementary to the target sequence. Custom gRNA generators and algorithms are available commercially for use in the design of effective guide RNAs. Gene editing has also been achieved using a chimeric “single guide RNA” (“sgRNA”), an engineered (synthetic) single RNA molecule that mimics a naturally occurring crRNA-tracrRNA complex and contains both a tracrRNA (for binding the nuclease) and at least one crRNA (to guide the nuclease to the sequence targeted for editing). Chemically modified sgNAs have also been demonstrated to be effective in genome editing; see, for example, Hendel et al. (2015) Nature Biotechnol., 985-991.

Exemplary site-specific HNF4α promoter 1 targeting moieties are provided in Table 2, below. In some embodiments, the polynucleotide comprises a nucleotide sequence at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% identical to the entire nucleotide sequence of any one of the nucleotide sequences in Table 2.

Exemplary site-specific HNF4α promoter 2 targeting moieties are provided in Table 3, below. In some embodiments, the polynucleotide comprises a nucleotide sequence at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% identical to the entire nucleotide sequence of any one of the nucleotide sequences in Table 3.

Exemplary site-specific HNF4α promoter targeting moieties are also provided in Table 9, below. In some embodiments, the polynucleotide comprises a nucleotide sequence at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% identical to the entire nucleotide sequence of any one of the nucleotide sequences in Table 9.

It will be understood that, although the sequences in Tables 2, 3, 4, and 9 are described as modified (or unmodified), the nucleic acid molecule encompassed by the of the invention, e.g., a site-specific disrupting agent, may comprise any one of the sequences set forth in any one of Tables 2, 3, 4, or 9 that is un-modified or modified differently than described therein. It will also be understood that although some of the sequences in Table 9 have “Ts”, when used as an RNA molecule, such as a guide RNA, in the site-specific targeting moieties of the invention, the “Ts” may be replaced with “Us.”

In some embodiments, a site-specific HNF4α targeting moiety comprising a polynucleotide, e.g., gRNA, comprises a nucleotide sequence complementary to an anchor sequence. In one embodiment, the anchor sequence comprises a CTCF-binding motif or consensus sequence:

(SEQ ID NO: 64) N(T/C/G)N(G/A/T)CC(A/T/G)(C/G)(C/T/A)AG(G/A)(G/T) GG(C/A/T)(G/A)(C/G)(C/T/A)(G/A/C), where N is any nucleotide. A CTCF-binding motif or consensus sequence may also be in the opposite orientation, e.g.,

(SEQ ID NO: 65) (G/A/C)(C/T/A)(C/G)(G/A)(C/A/T)GG(G/T)(G/A)GA (C/T/A)(C/G)(A/T/G)CC(G/A/T)N(T/C/G)N. In some embodiments, the nucleic acid sequence comprises a sequence complementary to a CTCF-binding motif or consensus sequence.

In some embodiments, the polynucleotide comprises a nucleotide sequence at least 75%, at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% complementary to an anchor sequence.

In some embodiments, the polynucleotide comprises a nucleotide sequence at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% complementary to a CTCF-binding motif or consensus sequence. In some embodiments, the polynucleotide is selected from the group consisting of a gRNA, and a sequence complementary or a sequence comprising at least 80%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% complementary sequence to an anchor sequence.

In some embodiments, a site-specific HNF4α targeting moiety comprising a polynucleotide of the invention is an RNAi molecule. RNAi molecules comprise RNA or RNA-like structures typically containing 15-50 base pairs (such as about 18-25 base pairs) and having a nucleobase sequence identical (complementary) or nearly identical (substantially complementary) to a coding sequence in an expressed target gene within the cell. RNAi molecules include, but are not limited to: short interfering RNAs (siRNAs), double-strand RNAs (dsRNA), micro RNAs (miRNAs), short hairpin RNAs (shRNA), meroduplexes, and dicer substrates (U.S. Pat. Nos. 8,084,599, 8,349,809, and 8,513,207). In one embodiment, the invention includes a composition to inhibit expression of a gene encoding a polypeptide described herein, e.g., a conjunction nucleating molecule.

RNAi molecules comprise a sequence substantially complementary, or fully complementary, to all or a fragment of a target gene. RNAi molecules may complement sequences at the boundary between introns and exons to prevent the maturation of newly-generated nuclear RNA transcripts of specific genes into mRNA for transcription. RNAi molecules complementary to specific genes can hybridize with the mRNA for that gene and prevent its translation. The antisense molecule can be DNA, RNA, or a derivative or hybrid thereof. Examples of such derivative molecules include, but are not limited to, peptide nucleic acid (PNA) and phosphorothioate-based molecules such as deoxyribonucleic guanidine (DNG) or ribonucleic guanidine (R G).

RNAi molecules can be provided to the cell as “ready-to-use” RNA synthesized in vitro or as an antisense gene transfected into cells which will yield RNAi molecules upon transcription. Hybridization with mRNA results in degradation of the hybridized molecule by RNAse H and/or inhibition of the formation of translation complexes. Both result in a failure to produce the product of the original gene.

The length of the RNAi molecule that hybridizes to the transcript of interest should be around 10 nucleotides, between about 15 or 30 nucleotides, or about 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 or more nucleotides. The degree of identity of the antisense sequence to the targeted transcript should be at least 75%, at least 80%, at least 85%, at least 90%, or at least 95.

RNAi molecules may also comprise overhangs, i.e. typically unpaired, overhanging nucleotides which are not directly involved in the double helical structure normally formed by the core sequences of the herein defined pair of sense strand and antisense strand. RNAi molecules may contain 3′ and/or 5′ overhangs of about 1-5 bases independently on each of the sense strands and antisense strands. In one embodiment, both the sense strand and the antisense strand contain 3′ and 5′ overhangs. In one embodiment, one or more of the 3′ overhang nucleotides of one strand base pairs with one or more 5′ overhang nucleotides of the other strand. In another embodiment, the one or more of the 3′ overhang nucleotides of one strand base do not pair with the one or more 5′ overhang nucleotides of the other strand. The sense and antisense strands of an RNAi molecule may or may not contain the same number of nucleotide bases. The antisense and sense strands may form a duplex wherein the 5′ end only has a blunt end, the 3′ end only has a blunt end, both the 5′ and 3′ ends are blunt ended, or neither the 5′ end nor the 3′ end are blunt ended. In another embodiment, one or more of the nucleotides in the overhang contains a thiophosphate, phosphorothioate, deoxynucleotide inverted (3′ to 3′ linked) nucleotide or is a modified ribonucleotide or deoxynucleotide.

Small interfering RNA (siRNA) molecules comprise a nucleotide sequence that is identical to about 15 to about 25 contiguous nucleotides of the target mRNA. In some embodiments, the siRNA sequence commences with the dinucleotide AA, comprises a GC-content of about 30-70% (about 50-60%, about 40-60%, or about 45%-55%), and does not have a high percentage identity to any nucleotide sequence other than the target in the genome of the mammal in which it is to be introduced, for example as determined by standard BLAST search.

siRNAs and shRNAs resemble intermediates in the processing pathway of the endogenous microRNA (miRNA) genes (Bartel, Cell 116:281-297, 2004). In some embodiments, siRNAs can function as miRNAs and vice versa (Zeng et al., Mol Cell 9: 1327-1333, 2002; Doench et al., Genes Dev 17:438-442, 2003). MicroRNAs, like siRNAs, use RISC to downregulate target genes, but unlike siRNAs, most animal miRNAs do not cleave the mRNA. Instead, miRNAs reduce protein output through translational suppression or polyA removal and mRNA degradation (Wu et al., Proc Natl Acad Sci USA 103:4034-4039, 2006). Known miRNA binding sites are within mRNA 3′ UTRs; miRNAs seem to target sites with near-perfect complementarity to nucleotides 2-8 from the miRNA's 5′ end (Rajewsky, Nat Genet 38 Suppl: S8-13, 2006; Lim et al, Nature 433:769-773, 2005). This region is known as the seed region. Because siRNAs and miRNAs are interchangeable, exogenous siRNAs downregulate mRNAs with seed complementarity to the siRNA (Birmingham et al., Nat Methods 3: 199-204, 2006. Multiple target sites within a 3′ UTR give stronger downregulation (Doench et al., Genes Dev 17:438-442, 2003).

Lists of known miRNA sequences can be found in databases maintained by research organizations, such as Wellcome Trust Sanger Institute, Perm Center for Bioinformatics, Memorial Sloan Kettering Cancer Center, and European Molecule Biology Laboratory, among others. Known effective siRNA sequences and cognate binding sites are also well represented in the relevant literature. RNAi molecules are readily designed and produced by technologies known in the art. In addition, there are computational tools that increase the chance of finding effective and specific sequence motifs (Pei et al. 2006, Reynolds et al. 2004, Khvorova et al. 2003, Schwarz et al. 2003, Ui-Tei et al. 2004, Heale et al. 2005, Chalk et al. 2004, Amarzguioui et al. 2004).

An RNAi molecule modulates expression of RNA encoded by a gene. Because multiple genes can share some degree of sequence homology with each other, in some embodiments, the RNAi molecule can be designed to target a class of genes with sufficient sequence homology. In some embodiments, the RNAi molecule can contain a sequence that has complementarity to sequences that are shared amongst different gene targets or are unique for a specific gene target. In some embodiments, the RNAi molecule can be designed to target conserved regions of an RNA sequence having homology between several genes thereby targeting several genes in a gene family (e.g., different gene isoforms, splice variants, mutant genes, etc.). In some embodiments, the RNAi molecule can be designed to target a sequence that is unique to a specific RNA sequence of a single gene.

In some embodiments, the RNAi molecule targets a sequence in a conjunction nucleating molecule, e.g., CTCF, cohesin, USF 1, YY1, TATA-box binding protein associated factor 3 (TAF3), ZNF 143, or another polypeptide that promotes the formation of an anchor sequence-mediated conjunction, or an epigenetic modifying agent, e.g., an enzyme involved in post-translational modifications including, but are not limited to, DNA methylases (e.g., DNMT3a, DNMT3b, DNMTL), DNA demethylation (e.g., the TET family enzymes catalyze oxidation of 5-methylcytosine to 5-hydroxymethylcytosine and higher oxidative derivatives), histone methyltransferases, histone deacetylase (e.g., HDAC1, HDAC2, HDAC3), sirtuin 1, 2, 3, 4, 5, 6, or 7, lysine-specific histone demethylase 1 (LSD1), histone-lysine-N-methyltransferase (Setdbl), euchromatic histone-lysine N-methyltransferase 2 (G9a), histone-lysine N-methyltransferase (SUV39H1), enhancer of zeste homolog 2 (EZH2), viral lysine methyltransferase (vSET), histone methyltransferase (SET2), protein-lysine N-methyltransferase (SMYD2), and others. In one embodiment, the RNAi molecule targets a protein deacetylase, e.g., sirtuin 1, 2, 3, 4, 5, 6, or 7. In one embodiment, the invention includes a composition comprising an RNAi that targets a conjunction nucleating molecule, e.g., CTCF.

In some embodiments, the site-specific HNF4α targeting moiety comprises a peptide or protein moiety. In some embodiments, a site-specific disrupting agent comprises a fusion protein. In some embodiments, an effector is ca peptide or protein moiety. The peptide or protein moieties may include, but is not limited to, a peptide ligand, antibody fragment, or targeting aptamer that binds a receptor such as an extracellular receptor, neuropeptide, hormone peptide, peptide drug, toxic peptide, viral or microbial peptide, synthetic peptide, and agonist or antagonist peptide.

Exemplary peptides or protein include a DNA-binding protein, a CRISPR component protein, a conjunction nucleating molecule, a dominant negative conjunction nucleating molecule, an epigenetic modifying agent, or any combination thereof. In some embodiments, the peptide comprises a nuclease, a physical blocker, an epigenetic recruiter, and an epigenetic CpG modifier, and fragments and combinations of any of the foregoing. In some embodiments, the peptide comprises a DNA-binding domain of a protein, such as a helix-turn-helix motif, a leucine zipper, a Zn-finger, a TATA box binding proteins, a transcription factor.

Peptides or proteins may be linear or branched. The peptide or protein moiety may have a length from about 5 to about 200 amino acids, about 15 to about 150 amino acids, about 20 to about 125 amino acids, about 25 to about 100 amino acids, 20-70 amino acids, 20-80 amino acids, 20-90 amino acids, 30-100 amino acids, 30-60 amino acids, 30-80 amino acids, 35-85 amino acids, 40-100 amino acids, or 50-125 amino acids or any range therebetween.

As indicated above, in some embodiments, the site-specific HNF4α targeting moieties of the invention comprise a fusion protein.

In some embodiments, the fusion proteins of the invention include a site-specific HNF4α targeting moiety which targets an HNF4α expression control region and an effector molecule. In other embodiments, a fusion protein of the invention comprises an effector molecule. Exemplary effector molecules include are described below and in some embodiments include, for example, nucleases, physical blockers, epigenetic recruiters, e.g., a transcriptional enhancer or a transcriptional repressor, and epigenetic CpG modifiers, e.g., a DNA methylase, a DNA demethylase, a histone modifying agent, or a histone deacetylase, and combinations of any of the foregoing.

For example, a site-specific targeting moiety may comprise a gRNA and an effector, such as a nuclease, e.g., a Cas9, e.g., a wild type Cas9, a nickase Cas9 (e.g., Cas9 D10A), a dead Cas9 (dCas9), eSpCas9, Cpf1, C2C1, or C2C3, or a nucleic acid encoding such a nuclease. The choice of nuclease and gRNA(s) is determined by whether the targeted mutation is a deletion, substitution, or addition of nucleotides, e.g., a deletion, substitution, or addition of nucleotides to a targeted sequence. Fusions of a catalytically inactive endonuclease e.g., a dead Cas9 (dCas9, e.g., D10A; H840A) tethered with all or a portion of (e.g., biologically active portion of) an (one or more) effector domain create chimeric proteins that can be linked to the polypeptide to guide the composition to specific DNA sites by one or more RNA sequences (e.g., DNA recognition elements including, but not restricted to zinc finger arrays, sgRNA, TAL arrays, peptide nucleic acids described herein) to modulate activity and/or expression of one or more target nucleic acids sequences (e.g., to methylate or demethylate a DNA sequence).

In one embodiment, a fusion protein of the invention may comprise an effector molecule comprising, for example, a CRISPR associated protein (Cas) polypeptide, or fragment thereof, (e.g., a Cas9 polypeptide, or fragment thereof) and an epigenetic recruiter or an epigenetic CpG modifier.

In one embodiment, a suitable Cas polypeptide is an enzymatically inactive Cas polypeptide, e.g., a “dead Cas polypeptide” or “dCas” polypeptide

Exemplary Cas polypeptides that are adaptable to the methods and compositions described herein are described below. Using methods known in the art, a Cas polypeptide can be fused to any of a variety of agents and/or molecules as described herein; such resulting fusion molecules can be useful in various disclosed methods.

In one aspect, the invention includes a composition comprising a protein comprising a domain, e.g., an effector, that acts on DNA (e.g., a nuclease domain, e.g., a Cas9 domain, e.g., a dCas9 domain; a DNA methyltransferase, a demethylase, a deaminase), in combination with at least one guide RNA (gRNA) or antisense DNA oligonucleotide that targets the protein to site-specific target sequence, wherein the composition is effective to alter, in a human cell, the expression of a target gene. In some embodiments, the enzyme domain is a Cas9 or a dCas9. In some embodiments, the protein comprises two enzyme domains, e.g., a dCas9 and a methylase or demethylase domain.

In one aspect, the invention includes a composition comprising a protein comprising a domain, e.g., an effector, that comprises a transcriptional control element (e.g., a nuclease domain, e.g., a Cas9 domain, e.g., a dCas9 domain; a transcriptional enhancer; a transcriptional repressor), in combination with at least one guide RNA (gRNA) or antisense DNA oligonucleotide that targets the protein to a site-specific target sequence, wherein the composition is effective to alter, in a human cell, the expression of a target gene. In some embodiments, the enzyme domain is a Cas9 or a dCas9. In some embodiments, the protein comprises two enzyme domains, e.g., a dCas9 and a transcriptional enhancer or transcriptional repressor domain.

As used herein, a “biologically active portion of an effector domain” is a portion that maintains the function (e.g. completely, partially, minimally) of an effector domain (e.g., a “minimal” or “core” domain).

The chimeric proteins described herein may also comprise a linker, e.g., an amino acid linker. In some aspects, a linker comprises 2 or more amino acids, e.g., one or more GS sequences. In some aspects, fusion of Cas9 (e.g., dCas9) with two or more effector domains (e.g., of a DNA methylase or enzyme with a role in DNA demethylation or protein acetyl transferase or deacetylase) comprises one or more interspersed linkers (e.g., GS linkers) between the domains. In some aspects, dCas9 is fused with 2-5 effector domains with interspersed linkers.

In some embodiments, a site-specific HNF4α targeting moiety comprises a conjunction nucleating molecule, a nucleic acid encoding a conjunction nucleating molecule, or a combination thereof. In some embodiments, an anchor sequence-mediated conjunction is mediated by a first conjunction nucleating molecule bound to the first anchor sequence, a second conjunction nucleating molecule bound to the noncontiguous second anchor sequence, and an association between the first and second conjunction nucleating molecules. In some embodiments, a conjunction nucleating molecule may disrupt, e.g., by competitive binding, the binding of an endogenous conjunction nucleating molecule to its binding site.

The conjunction nucleating molecule may be, e.g., CTCF, cohesin, USF1, YY1, TATA-box binding protein associated factor 3 (TAF3), ZNF143 binding motif, or another polypeptide that promotes the formation of an anchor sequence-mediated conjunction. The conjunction nucleating molecule may be an endogenous polypeptide or other protein, such as a transcription factor, e.g., autoimmune regulator (AIRE), another factor, e.g., X-inactivation specific transcript (XIST), or an engineered polypeptide that is engineered to recognize a specific DNA sequence of interest, e.g., having a zinc finger, leucine zipper or bHLH domain for sequence recognition. The conjunction nucleating molecule may modulate DNA interactions within or around the anchor sequence-mediated conjunction. For example, the conjunction nucleating molecule can recruit other factors to the anchor sequence that alters an anchor sequence-mediated conjunction formation or disruption.

The conjunction nucleating molecule may also have a dimerization domain for homo- or heterodimerization. One or more conjunction nucleating molecules, e.g., endogenous and engineered, may interact to form the anchor sequence-mediated conjunction. In some embodiments, the conjunction nucleating molecule is engineered to further include a stabilization domain, e.g., cohesion interaction domain, to stabilize the anchor sequence-mediated conjunction. In some embodiments, the conjunction nucleating molecule is engineered to bind a target sequence, e.g., target sequence binding affinity is modulated. In some embodiments, the conjunction nucleating molecule is selected or engineered with a selected binding affinity for an anchor sequence within the anchor sequence-mediated conjunction. Conjunction nucleating molecules and their corresponding anchor sequences may be identified through the use of cells that harbor inactivating mutations in CTCF and Chromosome Conformation Capture or 3C-based methods, e.g., Hi-C or high-throughput sequencing, to examine topologically associated domains, e.g., topological interactions between distal DNA regions or loci, in the absence of CTCF. Long-range DNA interactions may also be identified. Additional analyses may include ChlA-PET analysis using a bait, such as Cohesin, YY1 or USF1, ZNF143 binding motif, and MS to identify complexes that are associated with the bait.

B. Effector Molecules

Effector molecules for use in the compositions and methods of the invention include those that modulate a biological activity, for example increasing or decreasing enzymatic activity, gene expression, cell signalling, and cellular or organ function. Preferred effector molecules of the invention are nucleases, physical blockers, epigenetic recruiters, e.g., a transcriptional enhancer or a transcriptional repressor, and epigenetic CpG modifiers, e.g., a DNA methylase, a DNA demethylase, a histone modifying agent, or a histone deacetylase, and combinations of any of the foregoing.

Additional effector effector activities of the effector molecules of the invention may also include binding regulatory proteins to modulate activity of the regulator, such as transcription or translation. Effector molecules also may include activator or inhibitor (or “negative effector”) functions as described herein. For example, the effector molecule may inhibit substrate binding to a receptor and inhibit its activation, e.g., naltrexone and naloxone bind opioid receptors without activating them and block the receptors' ability to bind opioids. Effector molecules may also modulate protein stability/degradation and/or transcript stability/degradation. For example, proteins may be targeted for degradation by the polypeptide co-factor, ubiquitin, onto proteins to mark them for degradation. In another example, an effector molecule inhibits enzymatic activity by blocking the enzyme's active site, e.g., methotrexate is a structural analog of tetrahydrofolate, a coenzyme for the enzyme dihydrofolate reductase that binds to dihydrofolate reductase 1000-fold more tightly than the natural substrate and inhibits nucleotide base synthesis.

In some embodiments, the effector molecule is a chemical, e.g., a chemical that modulates a cytosine (C) or an adenine (A) (e.g., Na bisulfite, ammonium bisulfite). In some embodiments, the effector molecule has enzymatic activity (methyl transferase, demethylase, nuclease (e.g., Cas9), a deaminase). In some embodiments, the effector molecule sterically hinders formation of an anchor sequence-mediated conjunction or binding of an RNA polymerase to a promoter.

The effector molecule with effector activity may be any one of the small molecules, peptides, fusion proteins, nucleic acids, nanoparticle, aptamers, or pharmacoagents with poor PK/PD described herein.

In some embodiments, the effector molecule is an inhibitor or “negative effector molecule”. In the context of a negative effector molecule that modulates formation of an anchor sequence-mediated conjunction, in some embodiments, the negative effector molecule is characterized in that dimerization of an endogenous nucleating polypeptide is reduced when the negative effector molecule is present as compared with when it is absent. For example, in some embodiments, the negative effector molecule is or comprises a variant of the endogenous nucleating polypeptide's dimerization domain, or a dimerizing portion thereof.

For example, in certain embodiments, an anchor sequence-mediated conjunction is altered (e.g., disrupted) by use of a dominant negative effector, e.g., a protein that recognizes and binds an anchor sequence, (e.g., a CTCF binding motif), but with an inactive (e.g., mutated) dimerization domain, e.g., a dimerization domain that is unable to form a functional anchor sequence-mediated conjunction. For example, the Zinc Finger domain of CTCF can be altered so that it binds a specific anchor sequence (by adding zinc fingers that recognize flanking nucleic acids), while the homo-dimerization domain is altered to prevent the interaction between the engineered CTCF and endogenous forms of CTCF.

In some embodiments, the effector molecule comprises a synthetic conjunction nucleating molecule with a selected binding affinity for an anchor sequence within a target anchor sequence-mediated conjunction, (the binding affinity may be at least 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or higher or lower than the affinity of an endogenous conjunction nucleating molecule that associates with the target anchor sequence. The synthetic conjunction nucleating molecule may have between 30-90%, 30-85%, 30-80%, 30-70%, 50-80%, 50-90% amino acid sequence identity to the endogenous conjunction nucleating molecule). The conjunction nucleating molecule may disrupt, such as through competitive binding, the binding of an endogenous conjunction nucleating molecule to its anchor sequence. In some more embodiments, the conjunction nucleating molecule is engineered to bind a novel anchor sequence within the anchor sequence-mediated conjunction.

In some embodiments, a dominant negative effector molecule has a domain that recognizes specific DNA sequences (e.g., an anchor sequence, a CTCF anchor sequence, flanked by sequences that confer sequence specificity), and a second domain that provides a steric presence in the vicinity of the anchoring sequence. The second domain may include a dominant negative conjunction nucleating molecule or fragment thereof, a polypeptide that interferes with conjunction nucleating molecule sequence recognition (e.g., the amino acid backbone of a peptide/nucleic acid or PNA), a nucleic acid sequence ligated to a small molecule that imparts steric interference, or any other combination of DNA recognition elements and a steric blocker.

In some embodiments, the effector molecule is an epigenetic modifying agent. Epigenetic modifying agents useful in the methods and compositions described herein include agents that affect, e.g., DNA methylation, histone acetylation, and RNA-associated silencing. In some embodiments, the effectors sequence-specifically target an epigenetic enzyme (e.g., an enzyme that generates or removes epigenetic marks, e.g., acetylation and/or methylation). Exemplary epigenetic effectors may target an expression control region comprising, e.g., a transcriptional control element or an anchor sequence, by a site-specific disrupting agent comprising a site-specific targeting moiety.

In some embodiments, an effector molecule comprises one or more components of a gene editing system. Components of gene editing systems may be used in a variety of contexts including but not limited to gene editing. For example, such components may be used to target agents that physically modify, genetically modify, and/or epigenetically modify HNF4α sequences.

Exemplary gene editing systems include the clustered regulatory interspaced short palindromic repeat (CRISPR) system, zinc finger nucleases (ZFNs), and Transcription Activator-Like Effector-based Nucleases (TALEN). ZFNs, TALENs, and CRISPR-based methods are described, e.g., in Gaj et al. Trends Biotechnol. 31.7(2013):397-405; CRISPR methods of gene editing are described, e.g., in Guan et al, Application of CRISPR-Cas system in gene therapy: Pre-clinical progress in animal model. DNA Repair 2016 Jul. 30 [Epub ahead of print]; Zheng et al, Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells. BioTechniques, Vol. 57, No. 3, September 2014, pp. 115-124.

CRISPR systems are adaptive defense systems originally discovered in bacteria and archaea. CRISPR systems use RNA-guided nucleases termed CRISPR-associated or “Cas” endonucleases (e.g., Cas9 or Cpf1) to cleave foreign DNA. In a typical CRISPR/Cas system, an endonuclease is directed to a target nucleotide sequence (e.g., a site in the genome that is to be sequence-edited) by sequence-specific, non-coding “guide RNAs” that target single- or double-stranded DNA sequences. Three classes (I-III) of CRISPR systems have been identified. The class II CRISPR systems use a single Cas endonuclease (rather than multiple Cas proteins). One class II CRISPR system includes a type II Cas endonuclease such as Cas9, a CRISPR RNA (“crRNA”), and a trans-activating crRNA (“tracrRNA”). The crRNA contains a “guide RNA”, typically about 20-nucleotide RNA sequence that corresponds to a target DNA sequence. The crRNA also contains a region that binds to the tracrRNA to form a partially double-stranded structure which is cleaved by RNase III, resulting in a crRNA/tracrRNA hybrid. The crRNA/tracrRNA hybrid then directs the Cas9 endonuclease to recognize and cleave the target DNA sequence. The target DNA sequence must generally be adjacent to a “protospacer adjacent motif (“PAM”) that is specific for a given Cas endonuclease; however, PAM sequences appear throughout a given genome. CRISPR endonucleases identified from various prokaryotic species have unique PAM sequence requirements; examples of PAM sequences include 5′-NGG (Streptococcus pyogenes), 5′-NNAGAA (Streptococcus thermophilus CRISPR1), 5′-NGGNG (Streptococcus thermophilus CRISPR3), and 5′-NNNGATT (Neisseria meningiditis). Some endonucleases, e.g., Cas9 endonucleases, are associated with G-rich PAM sites, e.g., 5′-NGG, and perform blunt-end cleaving of the target DNA at a location 3 nucleotides upstream from (5′ from) the PAM site. Another class II CRISPR system includes the type V endonuclease Cpf1, which is smaller than Cas9; examples include AsCpf1 (from Acidaminococcus sp.) and LbCpf1 (from Lachnospiraceae sp.). Cpf 1-associated CRISPR arrays are processed into mature crRNAs without the requirement of a tracrRNA; in other words a Cpf1 system requires only the Cpf1 nuclease and a crRNA to cleave the target DNA sequence. Cpf1 endonucleases, are associated with T-rich PAM sites, e.g., 5′-TTN. Cpf1 can also recognize a 5′-CTA PAM motif. Cpf1 cleaves the target DNA by introducing an offset or staggered double-strand break with a 4- or 5-nucleotide 5′ overhang, for example, cleaving a target DNA with a 5-nucleotide offset or staggered cut located 18 nucleotides downstream from (3′ from) from the PAM site on the coding strand and 23 nucleotides downstream from the PAM site on the complimentary strand; the 5-nucleotide overhang that results from such offset cleavage allows more precise genome editing by DNA insertion by homologous recombination than by insertion at blunt-end cleaved DNA. See, e.g., Zetsche et al. (2015) Cell, 163:759-771.

A variety of CRISPR associated (Cas) genes or proteins can be used in the present invention and the choice of Cas protein will depend upon the particular conditions of the method.

Specific examples of Cas proteins include class II systems including Cas1, Cast, Cas3, Cas4, Cas5, Cas6, Cas7, Cas8, Cas9, Cas10, Cpf1, C2C1, or C2C3. In some embodiments, a Cas protein, e.g., a Cas9 protein, may be from any of a variety of prokaryotic species. In some embodiments a particular Cas protein, e.g., a particular Cas9 protein, is selected to recognize a particular protospacer-adjacent motif (PAM) sequence. In some embodiments, the site-specific targeting moiety includes a sequence targeting polypeptide, such as an enzyme, e.g., Cas9. In certain embodiments a Cas protein, e.g., a Cas9 protein, may be obtained from a bacteria or archaea or synthesized using known methods. In certain embodiments, a Cas protein may be from a gram positive bacteria or a gram negative bacteria. In certain embodiments, a Cas protein may be from a Streptococcus, (e.g., a S. pyogenes, a S. thermophilus) a Crptococcus, a Corynebacterium, a Haemophilus, a Eubacterium, a Pasteurella, a Prevotella, a Veillonella, or a Marinobacter. In some embodiments nucleic acids encoding two or more different Cas proteins, or two or more Cas proteins, may be introduced into a cell, zygote, embryo, or animal, e.g., to allow for recognition and modification of sites comprising the same, similar or different PAM motifs. In some embodiments, the Cas protein is modified to deactivate the nuclease, e.g., nuclease-deficient Cas9, and to recruit transcription activators or repressors, e.g., the co-subunit of the E. coli Pol, VP64, the activation domain of p65, KRAB, or SID4X, to induce epigenetic modifications, e.g., histone acetyltransferase, histone methyltransferase and demethylase, DNA methyltransferase and enzyme with a role in DNA demethylation (e.g., the TET family enzymes catalyze oxidation of 5-methylcytosine to 5-hydroxymethylcytosine and higher oxidative derivatives).

For the purposes of gene editing, CRISPR arrays can be designed to contain one or multiple guide RNA sequences corresponding to a desired target DNA sequence; see, for example, Cong et al. (2013) Science, 339:819-823; Ran et al. (2013) Nature Protocols, 8:2281-2308. At least about 16 or 17 nucleotides of gRNA sequence are required by Cas9 for DNA cleavage to occur; for Cpf1 at least about 16 nucleotides of gRNA sequence is needed to achieve detectable DNA cleavage.

Whereas wild-type Cas9 generates double-strand breaks (DSBs) at specific DNA sequences targeted by a gRNA, a number of CRISPR endonucleases having modified functionalities are available, for example: a “nickase” version of Cas9 generates only a single-strand break; a catalytically inactive Cas9 (“dCas9”) does not cut the target DNA but interferes with transcription by steric hindrance. dCas9 can further be fused with a heterologous effector to repress (CRISPRi) or activate (CRISPRa) expression of a target gene. For example, Cas9 can be fused to a transcriptional silencer (e.g., a KRAB domain) or a transcriptional activator (e.g., a dCas9-VP64 fusion). A catalytically inactive Cas9 (dCas9) fused to FokI nuclease (“dCas9-FokI”) can be used to generate DSBs at target sequences homologous to two gRNAs. See, e.g., the numerous CRISPR/Cas9 plasmids disclosed in and publicly available from the Addgene repository (Addgene, 75 Sidney St., Suite 550A, Cambridge, Mass. 02139; addgene.org/crispr). A “double nickase” Cas9 that introduces two separate double-strand breaks, each directed by a separate guide RNA, is described as achieving more accurate genome editing by Ran et al. (2013) Cell, 154: 1380-1389.

CRISPR technology for editing the genes of eukaryotes is disclosed in US Patent Application Publications 2016/0138008A1 and US2015/0344912A1, and in U.S. Pat. Nos. 8,697,359, 8,771,945, 8,945,839, 8,999,641, 8,993,233, 8,895,308, 8,865,406, 8,889,418, 8,871,445, 8,889,356, 8,932,814, 8,795,965, and 8,906,616. Cpf1 endonuclease and corresponding guide RNAs and PAM sites are disclosed in US Patent Application Publication 2016/0208243 A1.

In some embodiments, an effector comprises one or more components of a CRISPR system described hereinabove.

In some embodiments, suitable effectors for use in the agents, compositions, and methods of the invention include, for example, nucleases, physical blockers, epigenetic recruiters, e.g., a transcriptional enhancer or a transcriptional repressor, and epigenetic CpG modifiers, e.g., a DNA methylase, a DNA demethylase, a histone modifying agent, or a histone deacetylase, and combinations of any of the foregoing.

Suitable effectors include a polypeptide or its variant. The term “variant,” as used herein, refers to a polypeptide that is derived by incorporation of one or more amino acid insertions, substitutions, or deletions in a precursor polypeptide (e.g., “parent” polypeptide). In certain embodiments, a variant polypeptide has at least about 85% amino acid sequence identity, e.g., about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%, amino acid sequence identity to the entire amino acid sequence of a parent polypeptide.

The term “sequence identity,” as used herein, refers to a comparison between pairs of nucleic acid or amino acid molecules, i.e., the relatedness between two amino acid sequences or between two nucleotide sequences. In general, the sequences are aligned so that the highest order match is obtained. Methods for determining sequence identity are known and can be determined by commercially available computer programs that can calculate the percentage of identity between two or more sequences. A typical example of such a computer program is CLUSTAL.

Exemplary effectors include ubiquitin, bicyclic peptides as ubiquitin ligase inhibitors, transcription factors, DNA and protein modification enzymes such as topoisomerases, topoisomerase inhibitors such as topotecan, DNA methyltransferases such as the DNMT family (e.g., DNMT3a, DNMT3b, DNMTL), protein methyltransferases (e.g., viral lysine methyltransferase (vSET), protein-lysine N-methyltransferase (SMYD2), deaminases (e.g., APOBEC, UG1), histone methyltransferases such as enhancer of zeste homolog 2 (EZH2), PRMT1, histone-lysine-N-methyltransferase (Setdbl), histone methyltransferase (SET2), euchromatic histone-lysine N-methyltransferase 2 (G9a), histone-lysine N-methyltransferase (SUV39H1), and G9a), histone deacetylase (e.g., HDAC1, HDAC2, HDAC3), enzymes with a role in DNA demethylation (e.g., the TET family enzymes catalyze oxidation of 5-methylcytosine to 5-hydroxymethylcytosine and higher oxidative derivatives), protein demethylases such as KDMIA and lysine-specific histone demethylase 1 (LSD1), helicases such as DHX9, acetyltransferases, deacetylases (e.g., sirtuin 1, 2, 3, 4, 5, 6, or 7), kinases, phosphatases, DNA-intercalating agents such as ethidium bromide, sybr green, and proflavine, efflux pump inhibitors such as peptidomimetics like phenylalanine arginyl-naphthylamide or quinoline derivatives, nuclear receptor activators and inhibitors, proteasome inhibitors, competitive inhibitors for enzymes such as those involved in lysosomal storage diseases, zinc finger proteins, TALENs, specific domains from proteins, such as a KRAB domain, a VP64 domain, a p300 domain (e.g., p300 core domain), an MeCP2 domain, an MQ1 domain, a DNMT3a-3L domain a TET1 domain, and a TET2 domain, protein synthesis inhibitors, nucleases (e.g., Cpf1, Cas9, zinc finger nuclease), fusions of one or more thereof (e.g., dCas9-DNMT, dCas9-APOBEC, dCas9-UG1, dCas9-VP64, dCas9-p300 core, dCas9-KRAB, dCas9-KRAB-MeCP2, dCas9-MQ1, dCas9-DNMT3a-3L, dCAS9-TET1, dCAS9-TET2, and dCas9-MC/MN).

In some embodiments, a suitable nuclease for use in the agent, compositions, and methods of the invention comprises a Cas9 polypeptide, or enzymatically active portion thereof. In one embodiment, the Cas9 polypeptide, or enzymatically active portion thereof, further comprises a catalytically active domain of human exonuclease 1 (hEXO1), e.g., 5′ to 3′ exonuclease activity and/or an RNase H activity. In other embodiments, a suitable nuclease comprises a transcription activator like effector nucleases (TALEN). In yet other embodiments, a suitable nuclease comprises a zinc finger protein.

The term TALEN, as used herein, is broad and includes a monomeric TALEN that can cleave double stranded DNA without assistance from another TALEN. The term TALEN is also used to refer to one or both members of a pair of TALENs that are engineered to work together to cleave DNA at the same site. TALENs that work together may be referred to as a left-TALEN and a right-TALEN, which references the handedness of DNA. See U.S. Ser. No. 12/965,590; U.S. Ser. No. 13/426,991 (U.S. Pat. No. 8,450,471); U.S. Ser. No. 13/427,040 (U.S. Pat. No. 8,440,431); U.S. Ser. No. 13/427,137 (U.S. Pat. No. 8,440,432); and U.S. Ser. No. 13/738,381, all of which are incorporated by reference herein in their entirety.

TAL effectors are proteins secreted by Xanthomonas bacteria. The DNA binding domain contains a highly conserved 33-34 amino acid sequence with the exception of the 12th and 13th amino acids. These two locations are highly variable (Repeat Variable Diresidue (RVD)) and show a strong correlation with specific nucleotide recognition. This simple relationship between amino acid sequence and DNA recognition has allowed for the engineering of specific DNA binding domains by selecting a combination of repeat segments containing the appropriate RVDs.

The non-specific DNA cleavage domain from the end of the FokI endonuclease can be used to construct hybrid nucleases that are active in a yeast assay. These reagents are also active in plant cells and in animal cells. Initial TALEN studies used the wild-type FokI cleavage domain, but some subsequent TALEN studies also used FokI cleavage domain variants with mutations designed to improve cleavage specificity and cleavage activity. The FokI domain functions as a dimer, requiring two constructs with unique DNA binding domains for sites in the target genome with proper orientation and spacing. Both the number of amino acid residues between the TALEN DNA binding domain and the Fold cleavage domain and the number of bases between the two individual TALEN binding sites are parameters for achieving high levels of activity. The number of amino acid residues between the TALEN DNA binding domain and the Fold cleavage domain may be modified by introduction of a spacer (distinct from the spacer sequence) between the plurality of TAL effector repeat sequences and the Fold endonuclease domain. The spacer sequence may be 12 to 30 nucleotides.

The relationship between amino acid sequence and DNA recognition of the TALEN binding domain allows for designable proteins. In this case artificial gene synthesis is problematic because of improper annealing of the repetitive sequence found in the TALE binding domain. One solution to this is to use a publicly available software program (DNAWorks) to calculate oligonucleotides suitable for assembly in a two step PCR; oligonucleotide assembly followed by whole gene amplification. A number of modular assembly schemes for generating engineered TALE constructs have also been reported. Both methods offer a systematic approach to engineering DNA binding domains that is conceptually similar to the modular assembly method for generating zinc finger DNA recognition domains.

Once the TALEN genes have been assembled they are inserted into plasmids; the plasmids are then used to transfect the target cell where the gene products are expressed and enter the nucleus to access the genome. TALENs can be used to edit genomes by inducing double-strand breaks (DSB), which cells respond to with repair mechanisms. In this manner, they can be used to correct mutations in the genome which, for example, cause disease.

As used herein, a “zinc finger polypeptide” or “zinc finger protein” is a protein that binds to DNA, RNA and/or protein, in a sequence-specific manner, by virtue of a metal stabilized domain known as a zinc finger. Zinc finger proteins are nucleases having a DNA cleavage domain and a DNA binding zinc finger domain. Zinc finger polypeptides may be made by fusing the nonspecific DNA. cleavage domain of an endonuclease with site-specific DNA binding zinc finger domains. Such nucleases are powerful tools for gene editing and can be assembled to induce double strand breaks (DSBs) site-specifically into genomic DNA. ZFNs allow specific gene disruption as during DNA repair, the targeted genes can be disrupted via mutagenic non-homologous end joint (NHEJ) or modified via homologous recombination (HR) if a closely related DNA template is supplied.

Zinc finger nucleases are chimeric enzymes made by fusing the nonspecific DNA. cleavage domain of the endonuclease FokI with site-specific DNA binding zinc finger domains. Due to the flexible nature of zinc finger proteins (ZFPs), ZFNs can be assembled that induce double strand breaks (DSBs) site-specifically into genomic DNA. ZFNs allow specific gene disruption as during DNA repair, the targeted genes can be disrupted via mutagenic non-homologous end joint (NHEJ) or modified via homologous recombination (HR) if a closely related DNA template is supplied.

In some embodiments, a suitable physical blocker for use in the agent, compositions, and methods of the invention comprises a gRNA, antisense DNA, or triplex forming oligonucleotide (which may target an expression control unit) steric block a transcriptional control element or anchoring sequence. The gRNA recognizes specific DNA sequences and further includes sequences that interfere with, e.g., a conjunction nucleating molecule sequence to act as a steric blocker. In some embodiments, the gRNA is combined with one or more peptides, e.g., S-adenosyl methionine (SAM), that acts as a steric presence. In other embodiments, a physical blocker comprises an enzymatically inactive Cas9 polypeptide, or fragment thereof (e.g., dCas9).

In one embodiment, an epigenetic recruiter activates or enhances transcription of a target gene. In some embodiments, a suitable epigenetic recruiter for use in the agent, compositions, and methods of the invention comprises a VP64 domain or a p300 core domain.

In one embodiment, an epigenetic recruiter silences or represses transcription of a target gene. In some embodiments, a suitable epigenetic recruiter for use in the agent, compositions, and methods of the invention comprises a KRAB domain, or an MeCP2 domain.

In one embodiment, a suitable epigenetic recruiter for use in the agent, compositions, and methods of the invention comprises dCas9-VP64 fusion, a dCas9-p300 core fusion, a dCas9-KRAB fusion, or a dCas9-KRAB-MeCP2 fusion.

As used herein, “VP64” is a transcriptional activator composed of four tandem copies of VP16 (Herpes Simplex Viral Protein 16, amino acids 437-447*: DALDDFDLDML (SEQ ID NO: 328) connected with glycine-serine (GS) linkers. In one embodiment, the VP64 further comprises the transcription factors p65 (RelA) and Rta at the C terminus. An effector that comprises VP64, p65 and Rta is referred to as “VPR.” The GenBank Accession number of VP64 is ADD60007.1, the GenBank Accession number of p65 is NP_001138610.1, and the GenBank Accession number of Rta is AAA66528.1.

An exemplary amino acid sequence of a VPR is as follows:

(SEQ ID NO.: 66) DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDML SGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDP RPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQIS QASALAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPP APKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEF QQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLP NGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVF EGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPV PQPLDPAPAVTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICG QMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECL LHAMHISTGLSIFDTSLF

As used herein, “p300 core domain” refers to the catalytic core of the human acetyltransferase p300. The GenBank Accession number for the protein comprising p300 is NP_001420.2.

An exemplary amino acid sequence of a p300 is as follows:

(SEQ ID NO.: 67)  IFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYEDIVKSPM DLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCSKLSE VFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNR YHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVEC TECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTR LGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSG EMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISY LDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYI FHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTS AKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKN AKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFV IRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRA QWSTMCMLVELHTQSQD.

As used herein, “KRAB” refers to a Krüppel associated box (KRAB) transcriptional repression domain present in human zinc finger protein-based transcription factors (KRAB zinc finger proteins).

As used herein, “MeCp2” refers to methyl CpG binding protein 2 which represses transcription, e.g., by binding to a promoter comprising methylated DNA.

In one embodiment, an epigenetic CpG modifier methylates DNA and inactivates or represses transcription. In some embodiments, a suitable epigenetic CpG modifier for use in the agent, compositions, and methods of the invention comprises a MQ1 domain or a DNMT3a-3L domain.

In one embodiment, an epigenetic CpG modifier demethylates DNA and activates or stimulates transcription. In some embodiments, a suitable epigenetic recruiter for use in the agent, compositions, and methods of the invention comprises a TET1 or TET2 domain.

As used herein “TET1” refers to “ten-eleven translocation methylcytosine dioxygenase 1,” a member of the TET family of enzymes, encoded by the TET1 gene. TET1 is a dioxygenase that catalyzes the conversion of the modified DNA base 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) by oxidation of 5-mC in an iron and alpha-ketoglutarate dependent manner, the initial step of active DNA demethylation in mammals. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, plays a more general role in chromatin regulation. Preferentially binds to CpG-rich sequences at promoters of both transcriptionally active and Polycomb-repressed genes. Involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.

As used herein, “TET2” refers to “ten-eleven translocation 2 (TET2),” a member of the TET family of enzymes, encoded by the TET1 gene. Similarly to TET1, TET2 is a dioxygenase that catalyzes the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) and plays a key role in active DNA demethylation. TET2 a preference for 5-hydroxymethylcytosine in CpG motifs. TET2 also mediates subsequent conversion of 5hmC into 5-formylcytosine (5fC), and conversion of 5fC to 5-carboxylcytosine (5caC). The conversion of 5mC into 5hmC, 5fC and 5caC probably constitutes the first step in cytosine demethylation. Methylation at the C5 position of cytosine bases is an epigenetic modification of the mammalian genome which plays an important role in transcriptional regulation. In addition to its role in DNA demethylation, also involved in the recruitment of the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, thereby promoting histone H2B GlcNAcylation by OGT.

As used herein “DNMT3a-3L” refers to a fusion of a DNA methyltransferase, Dnmt3a and a Dnmt3L which is catalytically inactive, but directly interacts with the catalytic domains of Dnmt3a.

In some embodiments, a suitable epigenetic recruiter for use in the agent, compositions, and methods of the invention comprises a MQ1 domain, a DNMT3a-3L domain, a TET1 domain, or a TET2 domain. In one embodiment, a suitable epigenetic recruiter for use in the agent, compositions, and methods of the invention comprises a dCas9-MQ1 fusion, a dCas9-DNMT3a-3L fusion, a dCas9-TET1 fusion or a dCAS9-TET2 fusion.

III. Delivery of a Site-Specific HNF4α Disrupting Agent of the Invention and Compositions Comprising a Site-Specific an HNF4α Disrupting Agents of the Invention

The delivery of the disrupting agents of the invention to a cell e.g., a cell within a subject, such as a human subject (e.g., a subject in need thereof, such as a subject having an HNF4α-associated disorder, e.g., cirrhosis) may be achieved in a number of different ways. For example, delivery may be performed by contacting a cell with a disrupting agent of the invention either in vitro, ex vivo, or in vivo. In vivo delivery may be performed directly by administering a composition, such as a lipid composition, comprising a disrupting agent to a subject. Alternatively, in vivo delivery may be performed indirectly by administering one or more vectors that encode and direct the expression of the disrupting agent. These alternatives are discussed further below.

In some embodiments, the disrupting agent comprises a nucleic acid molecule encoding a fusion protein, the fusion protein comprising a site-specific HNF4α targeting moiety, such as a polynucleotide encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically targets and binds to the HNF4α expression control region and an effector molecule, such as a VPR.

In other embodiments, the disrupting agent comprises a guide RNA and an mRNA encoding an effector molecule. The ratio of guide RNA to mRNA may be about 100:1 to about 1:100 (wt:wt).

In general, any method of delivery of a site-specific HNF4α disrupting agent of the invention (in vitro, ex vivo, or in vivo) may be adapted for use with the disrupting agents of the invention (see e.g., Akhtar S. and Julian R L., (1992) Trends Cell. Biol. 2(5):139-144 and WO94/02595, which are incorporated herein by reference in their entireties). For in vivo delivery, factors to be considered for delivering a site-specific HNF4α disrupting agent of the invention include, for example, biological stability of the disrupting agent, prevention of non-specific effects, and accumulation of the disrupting agent in the target tissue. The non-specific effects of a disrupting agent can be minimized by local administration, for example, by direct injection or implantation into a tissue or topically administering a composition comprising the disrupting agent. Local administration to a treatment site maximizes local concentration of the disrupting agent, limits the exposure of the disrupting agent to systemic tissues that can otherwise be harmed by the disrupting agent or that can degrade the disrupting agent, and permits a lower total dose of the disrupting agent to be administered.

For administering a site-specific HNF4α disrupting agent systemically for the treatment of a disease, such as an HNF4α-associate disease, the disrupting agent, e.g., a disrupting agent comprising a site-specific targeting moiety comprising a nucleic acid molecule, can be modified or alternatively delivered using a drug delivery system; both methods act to prevent the rapid degradation of a site-specific targeting moiety comprising a nucleic acid molecule by endo- and exo-nucleases in vivo. Modification of a disrupting agent comprising a site-specific targeting moiety comprising a nucleic acid molecule or a pharmaceutical carrier also permits targeting of the disrupting agent to a target tissue and avoidance of undesirable off-target effects. For example, a disrupting agent of the invention may be modified by chemical conjugation to lipophilic groups such as cholesterol to enhance cellular uptake and prevent degradation.

Alternatively, a disrupting agent of the invention may be delivered using a drug delivery system such as a nanoparticle, a dendrimer, a polymer, a liposome, or a cationic delivery system. Positively charged cationic delivery systems facilitate binding of disrupting agent (e.g., negatively charged molecule) and also enhance interactions at the negatively charged cell membrane to permit efficient uptake of a disrupting agent by the cell. Cationic lipids, dendrimers, or polymers can either be bound to a disrupting agent, or induced to form a vesicle or micelle (see e.g., Kim S H. et al., (2008) Journal of Controlled Release 129(2):107-116) that encases the disrupting agent. The formation of vesicles or micelles further prevents degradation of the disrupting agent when administered systemically. Methods for making and administering cationic complexes are well within the abilities of one skilled in the art (see e.g., Sorensen, D R., et al. (2003) J. Mol. Biol 327:761-766; Verma, U N. et al., (2003) Clin. Cancer Res. 9:1291-1300; Arnold, A S et al. (2007) J. Hypertens. 25:197-205, which are incorporated herein by reference in their entirety). Some non-limiting examples of drug delivery systems useful for systemic delivery of a distrupting agent of the invention include DOTAP (Sorensen, D R., et al (2003), supra; Verma, U N. et al., (2003), supra), Oligofectamine, “solid nucleic acid lipid particles” (Zimmermann, T S. et al., (2006) Nature 441:111-114), cardiolipin (Chien, P Y. et al., (2005) Cancer Gene Ther. 12:321-328; Pal, A. et al., (2005) Int J. Oncol. 26:1087-1091), polyethyleneimine (Bonnet M E. et al., (2008) Pharm. Res. August 16 Epub ahead of print; Aigner, A. (2006) J. Biomed. Biotechnol. 71659), Arg-Gly-Asp (RGD) peptides (Liu, S. (2006) Mol. Pharm. 3:472-487), and polyamidoamines (Tomalia, D A. et al., (2007) Biochem. Soc. Trans. 35:61-67; Yoo, H. et al., (1999) Pharm. Res. 16:1799-1804). In some embodiments, a disrupting agent (e.g., gRNA, or mRNA) forms a complex with cyclodextrin for systemic administration. Methods for administration and pharmaceutical compositions comprising cyclodextrins may be found in U.S. Pat. No. 7,427,605, the entire contents of which are incorporated herein by reference.

The disrupting agents of the invention may be incorporated into pharmaceutical compositions suitable for administration. Such compositions typically include one or more species of disrupting agent and a pharmaceutically acceptable carrier. As used herein the language “pharmaceutically acceptable carrier” is intended to include any and all solvents, dispersion media, coatings, antibacterial and antifungal agents, isotonic and absorption delaying agents, and the like, compatible with pharmaceutical administration. The use of such media and agents for pharmaceutically active substances is well known in the art. Except insofar as any conventional media or agent is incompatible with the active compound, use thereof in the compositions is contemplated. Supplementary active compounds can also be incorporated into the compositions.

The pharmaceutical compositions of the present invention may be administered in a number of ways depending upon whether local or systemic treatment is desired and upon the area to be treated. Administration may be topical (including ophthalmic, vaginal, rectal, intranasal, transdermal), oral, or parenteral. Parenteral administration includes intravenous drip, subcutaneous, intraperitoneal or intramuscular injection, or intrathecal or intraventricular administration.

The route and site of administration may be chosen to enhance delivery or targeting of the disrupting agent comprising a site-specific targeting moiety to a particular location. For example, to target liver cells, intravenous injection may be used. Lung cells may be targeted by administering the disrupting agent in aerosol form. Jejunum cells may be targeted by anal administration.

Formulations for topical administration may include transdermal patches, ointments, lotions, creams, gels, drops, suppositories, sprays, liquids, and powders. Conventional pharmaceutical carriers, aqueous, powder or oily bases, thickeners and the like may be necessary or desirable. Coated condoms, gloves and the like may also be useful.

Compositions for oral administration include powders or granules, suspensions or solutions in water, syrups, elixirs or non-aqueous media, tablets, capsules, lozenges, or troches. In the case of tablets, carriers that can be used include lactose, sodium citrate and salts of phosphoric acid. Various disintegrants such as starch, and lubricating agents such as magnesium stearate, sodium lauryl sulfate and talc, are commonly used in tablets. For oral administration in capsule form, useful diluents are lactose and high molecular weight polyethylene glycols. When aqueous suspensions are required for oral use, the nucleic acid compositions can be combined with emulsifying and suspending agents. If desired, certain sweetening or flavoring agents can be added.

Compositions for intravenous administration may include sterile aqueous solutions which may also contain buffers, diluents, and other suitable additives.

Formulations for parenteral administration may include sterile aqueous solutions which may also contain buffers, diluents, and other suitable additives. For intravenous use, the total concentration of solutes may be controlled to render the preparation isotonic.

In one embodiment, the administration of a disrupting agent composition of the invention is parenteral, e.g., intravenous (e.g., as a bolus or as a diffusible infusion), intradermal, intraperitoneal, intramuscular, intrathecal, intraventricular, intracranial, subcutaneous, transmucosal, buccal, sublingual, endoscopic, rectal, oral, vaginal, topical, pulmonary, intranasal, urethral, or ocular. Administration can be provided by the subject or by another person, e.g., a health care provider. The composition may be provided in measured doses or in a dispenser which delivers a metered dose. Selected modes of delivery are discussed in more detail below.

In certain embodiments, the disrupting agents of the invention are polynucleotides, such as mRNAs, and are formulated in lipid nanoparticles (LNPs).

A. Compositions Comprising a Site-Specific an HNF4α Disrupting Agent of the Invention

The site-specific HNF4α disrupting agents of the invention may be formulated into compositions, such as pharmaceutical compositions, using one or more excipients to: (1) increase stability; (2) increase cell transfection; (3) permit sustained or delayed release (e.g., from a depot formulation); (4) alter the biodistribution (e.g., target the disrupting agent to specific tissues or cell types); (5) increase the translation of an encoded protein in vivo; and/or (6) alter the release profile of an encoded protein in vivo. In addition to traditional excipients, such as any and all solvents, dispersion media, diluents, or other liquid vehicles, dispersion or suspension aids, surface active agents, isotonic agents, thickening or emulsifying agents, preservatives, excipients for use in the compositions of the invention may include, without limitation, lipidoids, liposomes, lipid nanoparticles, polymers, lipoplexes, core-shell nanoparticles, peptides, proteins, cells transfected with nucleic acid molecules, modified nucleic acid molecules, or RNA (e.g., for transplantation into a subject), hyaluronidase, nanoparticle mimics and combinations thereof. Accordingly, the pharmaceutical compositions of the invention can include one or more excipients, each in an amount that together increases the stability of the disrupting agent, increases cell transfection by the disrupting agent, increases the expression of modified nucleic acid, or mRNA encoded protein, and/or alters the release profile of a disrupting agent. Further, the disrupting agents of the present invention may be formulated using self-assembled nucleic acid nanoparticles (see, e.g., U.S. Patent Publication No. 2016/0038612A1, which is incorporated herein by reference in its entirety).

i. Lipidoid

The synthesis of lipidoids has been extensively described and formulations containing these compounds are particularly suited for delivery of a disrupting agent of the invention, such as a disrupting agent comprising a site-specific HNF4α targeting moiety comprising a nucleic acid molecule, e.g., comprising modified nucleic acid molecules or mRNA (see Mahon et al., Bioconjug Chem. 2010 21:1448-1454; Schroeder et al., J Intern Med. 2010 267:9-21; Akinc et al., Nat Biotechnol. 2008 26:561-569; Love et al., Proc Natl Acad Sci USA. 2010 107: 1864-1869; Siegwart et al., Proc Natl Acad Sci USA. 2011108:12996-3001; the contents of all of which are incorporated herein in their entireties).

For example, lipidoids have been used to effectively deliver double stranded small interfering RNA molecules, single stranded nucleic acid molecules, modified nucleic acid molecules or modified mRNA. (See, e.g., US Patent Publication 2016/0038612A1). Complexes, micelles, liposomes or particles can be prepared containing these lipidoids and, therefore, provide effective delivery of a site-specific HNF4α targeting moiety comprising a nucleic acid molecule, as judged by the production of an encoded protein, following the administration of a lipidoid formulation, e.g., via localized and/or systemic administration. Lipidoid complexes of can be administered by various means including, but not limited to, intravenous, intramuscular, intradermal, intraperitoneal or subcutaneous routes.

In vivo delivery of a site-specific HNF4α targeting moiety comprising, e.g., a nucleic acid molecule, may be affected by many parameters, including, but not limited to, the formulation composition, nature of particle PEGylation, degree of loading, polynucleotide to lipid ratio, and biophysical parameters such as, but not limited to, particle size (Akinc et al., Mol Ther. 2009 17:872-879; herein incorporated by reference in its entirety). As an example, small changes in the anchor chain length of poly(ethylene glycol) (PEG) lipids may result in significant effects on in vivo efficacy. Formulations with different lipidoids, including, but not limited to penta[3-(1-laurylaminopropionyl)]-triethylenetetramine hydrochloride (TETA-SLAP; aka 98NI2-5, see Murugaiah et al., Analytical Biochemistry, 401:61 (2010); the contents of which are herein incorporated by reference in their entirety), C12-200 (including derivatives and variants), and MDI, may be used.

In one embodiment, a disrupting agent comprising a site-specific HNF4α targeting moiety comprising, e.g., a nucleic acid molecule, is formulated with a lipidoid for systemic intravenous administration to target cells of the liver. For example, a final optimized intravenous formulation comprising a disrupting agent comprising a site-specific HNF4α targeting moiety comprising a nucleic acid molecule, and a lipid molar composition of 42% 98NI2-5, 48% cholesterol, and 10% PEG-lipid with a final weight ratio of about 7.5 to 1 total lipid to nucleic acid molecule, and a C14 alkyl chain length on the PEG lipid, with a mean particle size of roughly 50-60 nm, can result in the distribution of the formulation to be greater than 90% to the liver (see, Akinc et al., Mol Ther. 2009 17:872-879; the contents of which is herein incorporated by reference in its entirety). In another example, an intravenous formulation using a C12-200 lipidoid (see, e.g., PCT Publication No. WO 2010/129709, which is herein incorporated by reference in its entirety) having a molar ratio of 50/10/38.5/1.5 of C12-200/disteroylphosphatidyl choline/cholesterol/PEG-DMG, with a weight ratio of 7 to 1 total lipid to nucleic acid molecule, and a mean particle size of 80 nm may be used to deliver a disrupting agent comprising a site-specific HNF4α targeting moiety comprising a nucleic acid molecule, to hepatocytes (see, Love et al., Proc Natl Acad Sci USA. 2010 107:1864-1869; the contents of which are herein incorporated by reference in their entirety). In another embodiment, an MDI lipidoid-containing formulation may be used to effectively deliver a disrupting agent comprising a site-specific HNF4α targeting moiety comprising a nucleic acid molecule, to hepatocytes in vivo. The characteristics of optimized lipidoid formulations for intramuscular or subcutaneous routes may vary significantly depending on the target cell type and the ability of formulations to diffuse through the extracellular matrix into the blood stream. While a particle size of less than 150 nm may be desired for effective hepatocyte delivery due to the size of the endothelial fenestrae (see, Akinc et al., Mol Ther. 2009 17:872-879; the contents of which are herein incorporated by reference in their entirety), use of lipidoid-formulated nucleic acid molecules to deliver the formulation to other cells types including, but not limited to, endothelial cells, myeloid cells, and muscle cells may not be similarly size-limited. Use of lipidoid formulations to deliver siRNA in vivo to other non-hepatocyte cells such as myeloid cells and endothelium has been reported (see Akinc et al., Nat Biotechnol. 200826:561-569; Leuschner et al., Nat Biotechnol. 2011 29: 1005-1010; Cho et al. Adv. Funct. Mater. 2009 19:3112-3118; 8th International Judah Folkman Conference, Cambridge, Mass. Oct. 8-9, 2010; the contents of each of which are herein incorporated by reference in their entirety). For delivery to myeloid cells, such as monocytes, lipidoid formulations may have a similar component molar ratio. Different ratios of lipidoids and other components including, but not limited to, disteroylphosphatidyl choline, cholesterol and PEG-DMG, may be used to optimize the formulation for delivery to different cell types including, but not limited to, hepatocytes, myeloid cells, muscle cells, etc. For example, the component molar ratio may include, but is not limited to, 50% CI2-200, 10% disteroylphosphatidyl choline, 38.5% cholesterol, and 1.5% PEG-DMG (see Leuschner et al., Nat Biotechnol 2011 29: 1005-1010; the contents of which are herein incorporated by reference in its entirety). The use of lipidoid formulations for the localized delivery to cells (such as, but not limited to, adipose cells and muscle cells) via either subcutaneous, intradermal or intramuscular delivery, may not require all of the formulation components desired for systemic delivery and, as such, may comprise only the lipidoid and a disrupting agent comprising comprising a site-specific HNF4α targeting moiety comprising, e.g., a nucleic acid molecule, as described herein.

Combinations of different lipidoids may be used to improve the efficacy of the formualtions by increasing cell transfection and/or increasing the translation of encoded protein contained therein (see Whitehead et al., Mol. Ther. 2011, 19:1688-1694, the contents of which are herein incorporated by reference in their entirety).

In one embodiment, the lipidoid may be prepared from the conjugate addition of alklamines to acrylates. As a non-limiting example, a lipidoid may be prepared by the methods described in PCT Patent Publication No. WO 2014/028487, the contents of which are herein incorporated by reference in its entirety. In one embodiment, the lipidoid may comprise a compound having formula (I), formula (II), formula (III), formula (IV) or formula (V) as described in PCT Patent Publication No. WO 2014/028487, the contents of which are herein incorporated by reference in their entirety. In one embodiment, the lipidoid may be biodegradable.

ii. Liposomes, Lipoplexes, and Lipid Nanoparticles

A disrupting agent of the invention may be formulated using one or more liposomes, lipoplexes, or lipid nanoparticles. In one embodiment, pharmaceutical compositions of the invention include liposomes. Liposomes are artificially-prepared vesicles which are primarily composed of a lipid bilayer and may be used as a delivery vehicle for the administration of nutrients and pharmaceutical formulations. Liposomes may be of different sizes such as, but not limited to, a multilamellar vesicle (MLV) which may be hundreds of nanometers in diameter and may contain a series of concentric bilayers separated by narrow aqueous compartments, a small unicellular vesicle (SUV) which may be smaller than 50 nm in diameter, and a large unilamellar vesicle (LUV) which may be between 50 and 500 nm in diameter. Liposome design may include, but is not limited to, opsonins or ligands in order to improve the attachment of liposomes to unhealthy tissue or to activate events such as, but not limited to, endocytosis. Liposomes may contain a low or a high pH in order to improve the delivery of the pharmaceutical formulations. The formation of liposomes may depend on the physicochemical characteristics such as, but not limited to, the pharmaceutical formulation entrapped and the liposomal ingredients, the nature of the medium in which the lipid vesicles are dispersed, the effective concentration of the entrapped substance and its potential toxicity, any additional processes involved during the application and/or delivery of the vesicles, the optimization size, polydispersity and the shelf-life of the vesicles for the intended application, and the batch-to-batch reproducibility and possibility of large-scale production of safe and efficient liposomal products.

As a non-limiting example, liposomes, such as synthetic membrane vesicles, may be prepared by the methods, apparatus and devices described in U.S. Patent Publication Nos. 2013/0177638, 2013/0177637, 2013/0177636, 201/30177635, 2013/0177634, 2013/0177633, 2013/0183375, 2013/0183373, 2013/0183372 and 2016/0038612) and PCT Patent Publication No WO 2008/042973, the contents of each of which are herein incorporated by reference in their entirety.

In one embodiment, a pharmaceutical composition described herein may include, without limitation, liposomes such as those formed from 1,2-dioleyloxy-N,N-dimethyl aminopropane (DODMA) liposomes, DiLa2 liposomes from Marina Biotech (Bothell, Wash.), 1,2-dilinoleyloxy-3-dimethylaminopropane (DLin-DMA), 2,2-dilinoleyl-4-(2-dimethylaminoethyl)-[1,3]-dioxolane (DLin-KC2-DMA), and MC3 (US20100324120; herein incorporated by reference in its entirety) and liposomes which may deliver small molecule drugs such as, but not limited to, DOXIL® from Janssen Biotech, Inc. (Horsham, Pa.). In one embodiment, a pharmaceutical composition described herein may include, without limitation, liposomes such as those formed from the synthesis of stabilized plasmid-lipid particles (SPLP) or stabilized nucleic acid lipid particle (SNALP) that have been previously described and shown to be suitable for oligonucleotide delivery in vitro and in vivo (see Wheeler et al. Gene Therapy. 1999 6:271-281; Zhang et al. Gene Therapy. 19996:1438-1447; Jeffs et al. Pharm Res. 2005 22:362-372; Morrissey et al., Nat Biotechnol. 2005 2:1002-1007; Zimmermann et al., Nature. 2006 441:111-114; Heyes et al. J Contr Rel. 2005 107:276-287; Semple et al. Nature Biotech. 2010 28:172-176; Judge et al. J Clin Invest. 2009 119:661-673; deFougerolles Hum Gene Ther. 2008 19:125-132; U.S. Patent Publication Nos 2013/0122104, 2013/0303587, and 2016/0038612; the contents of each of which are incorporated herein in their entireties). The original manufacturing method of Wheeler et al. was a detergent dialysis method, which was later improved by Jeffs et al. and is referred to as the spontaneous vesicle formation method. The liposome formulations of the invention may be composed of 3 to 4 lipid components in addition a disrupting agent comprising a site-specific HNF4α targeting moiety. As an example a liposome of the invention can contain, but is not limited to, 55% cholesterol, 20% disteroylphosphatidyl choline (DSPC), 10% PEG-SDSG, and 15% 1,2-dioleyloxy-N,N-dimethylaminopropane (DODMA), as described by Jeffs et al. As another example, liposome formulationsof the invention may contain, but are not limited to, 48% cholesterol, 20% DSPC, 2% PEG-c-DMA, and 30% cationic lipid, where the cationic lipid can be 1,2-distearloxy-N,N-dimethylaminopropane (DSDMA), DODMA, DLin-DMA, or 1,2-dilinolenyloxy-3-dimethylaminopropane (DLenDMA), as described by Heyes et al. In some embodiments, liposome formulations may comprise from about 25.0% cholesterol to about 40.0% cholesterol, from about 30.0% cholesterol to about 45.0% cholesterol, from about 35.0% cholesterol to about 50.0% cholesterol and/or from about 48.5% cholesterol to about 60% cholesterol. In another embodiment, formulations of the invention may comprise a percentage of cholesterol selected from the group consisting of 28.5%, 31.5%, 33.5%, 36.5%, 37.0%, 38.5%, 39.0% and 43.5%. In some embodiments, liposome formulations of the invention may comprise from about 5.0% to about 10.0% DSPC and/or from about 7.0% to about 15.0% DSPC.

In one embodiment, a pharmaceutical composition may include liposomes which may be formed to deliver a disrupting agent of the invention. The disrupting agent comprising a site-specific HNF4α targeting moiety comprising may be encapsulated by the liposome and/or it may be contained in an aqueous core which may then be encapsulated by the liposome (see, e.g., PCT Patent Publication Nos. WO 2012/031046, WO 2012/031043, WO 2012/030901 and WO 2012/006378 and U.S. Patent Publication Nos. 2013/0189351, 2013/0195969 and 201/30202684, the contents of each of which are herein incorporated by reference in their entirety).

In another embodiment, liposomes for use in the present invention may be formulated for targeted delivery. As a non-limiting example, the liposome may be formulated for targeted delivery to the liver. Such a liposome may include, but is not limited to, a liposome described in U.S. Patent Publication No. 2013/0195967, the contents of which are herein incorporated by reference in their entirety.

In one embodiment, formulations comprising liposomes and a disrupting agent may be administered intramuscularly, intrademrally, or intravenously.

In another embodiment, a lipid formulation of the invention may include at least one cationic lipid, a lipid which enhances transfection and a least one lipid which contains a hydrophilic head group linked to a lipid moiety (International Pub. No. WO2011076807 and U.S. Pub. No. 20110200582; the contents of each of which is herein incorporated by reference in their entirety). In another embodiment, a lipdid formulation of the invention is a lipid vesicle which may have crosslinks between functionalized lipid bilayers (see U.S Patent Publication No. 2012/0177724, the contents of which are herein incorporated by reference in their entirety).

In one embodiment, a formulation comprising a disrupting agent is a lipid nanoparticle (LNP) which may comprise at least one lipid. The lipid may be selected from, but is not limited to, DLin-DMA, DLin-K-DMA, 98NI2-5, CI2-200, DLin-MC3-DMA, DLin-KC2-DMA, DODMA, PLGA, PEG, PEG-DMG, PEGylated lipids and amino alcohol lipids. In another aspect, the lipid may be a cationic lipid such as, but not limited to, DLin-DMA, DLin-D-DMA, DLin-MC3-DMA, DLin-KC2-DMA, DODMA and amino alcohol lipids. The amino alcohol cationic lipid may be the lipids described in and/or made by the methods described in U.S. Patent Publication No. 2013/0150625.

In one embodiment, the cationic lipid may be selected from, but not limited to, a cationic lipid described in PCT Publication Nos. WO 2012/040184, WO 2011/153120, WO 2011/149733, WO 2011/090965, WO 2011/043913, WO 2011/022460, WO 2012/061259, WO 2012/054365, WO 2012/044638, WO 2010/080724, WO 2010/21865, WO 2008/103276, WO 2013/086373 and WO 2013/086354, U.S. Pat. Nos. 7,893,302, 7,404,969, 8,283, 333, 8,466,122 and 8,569,256, and U.S. Patent Publication Nos. 2010/0036115, 2012/0202871, 2013/0064894, 2013/0129785, 2013/0150625, 2013/0178541, 2013/0225836 and 2014/0039032; the contents of each of which are herein incorporated by reference in their entirety. In another embodiment, the cationic lipid may be selected from, but not limited to, formula A described in PCT Publication Nos. WO 2012/040184, WO 0111/53120, WO 2011/149733, WO 2011/090965, WO 2011/043913, WO 2011/022460, WO 2012/061259, WO 2012/054365, WO 2012/044638 and WO 2013/116126 or U.S. Patent Publication Nos. 2013/0178541 and 2013/0225836; the contents of each of which is herein incorporated by reference in their entirety. In yet another embodiment, the cationic lipid may be selected from, but not limited to, formula CLI-CLXXIX of PCT Publication No. WO 2008/103276, formula CLICLXXIX of U.S. Pat. No. 7,893,302, formula CLICLXXXXII of U.S. Pat. No. 7,404,969 and formula I-VI of us Patent Publication No. 2010/0036115, formula I of U.S. Patent Publication No 2013/0123338; each of which is herein incorporated by reference in their entirety.

In one embodiment, the cationic lipid may be synthesized by methods known in the art and/or as described in PCT Publication Nos. WO 2012/040184 WO 2011/153120, WO 2011/149733, WO 2011/090965: WO 2011/043913, WO 2011/022460, WO 2012/061259, WO 2012/054365, WO 2012/044638, WO 2010/080724, WO 2010/21865, WO 2013/126803, WO 2013/086373, and WO 2013/086354; the contents of each of which are herein incorporated by reference in their entirety.

In one embodiment, the lipids which may be used in the formulations and/or for delivery of the disrupting agents described herein may be a cleavable lipid. As a non-limiting example, a cleavable lipid and/or pharmaceutical compositions comprising cleavable lipids include those described in PCT Patent Publication No. WO 2012/170889, the contents of which are herein incorporated by reference in their entirety. As another non-limiting example, the cleavable lipid may be HGT4001, HGT4002, HGT4003, HGT4004 and/or HGT4005 as described in PCT Patent Publication No. WO 2012/170889, the contents of which are herein incorporated by reference in their entirety.

In one embodiment, polymers which may be used in the formulation and/or delivery of the disrupting agents described herein may include, but is not limited to, poly(ethylene) glycol (PEG), polyethylenimine (PEI), dithiobis(succinimidylpropionate) (DSP), Dimethyl-3,3′-dithiobispropionimidate (DTBP), poly(ethylene imine) biscarbamate (PEIC), poly(L-lysine) (PLL), histidine modified PLL, poly(N-vinylpyrrohdone) (PVP), poly(propylenimine (PPI), poly(amidoamine) (PAMAM), poly(amido ethylenimine) (SS-PAEI), triehtylenetetramine (TETA), poly(β-aminoester), poly(4-hydroxy-L-proine ester) (PHP), poly(allylamine), poly(α-[4-aminobutyl]-L-glycolic acid (PAGA), Poly(D,L-lactic-coglycolid acid (PLGA), Poly(N-ethyl-4-vinylpyridinium bromide), poly(phosphazene)s (PPZ), poly(phosphoester)s (PPE), poly(phosphoramidate)s (PPA), poly(N-2-hydroxypropylmethacrylamide) (pHPMA), poly(2-(dimethylamino)ethyl methacrylate) (pDMAEMA), poly(2-aminoethyl propylene phosphate) PPE_EA), Chitosan, galactosylated chitosan, N-dodecylated chitosan, histone, collagen and dextran-spermine. In one embodiment, the polymer may be an inert polymer such as, but not limited to, PEG.

In one embodiment, the polymer may be a cationic polymer such as, but not limited to, PEL PLL, TETA, poly(allylamine), Poly(N-ethyl-4-vinylpyridinium bromide), pHPMA and pDMAEMA. In one embodiment, the polymer may be a biodegradable PEI such as, but not limited to, DSP, DTBP and PEIC. In one embodiment, the polymer may be biodegradable such as, but not limited to, histine modified PLL SSPAEI, poly(β-aminoester), PHP, PAGA, PLGA, PPZ, PPE, PPA and PPE-EA. In one embodiment, an LNP formulation of the invention may be prepared according to the methods described in PCT Publication Nos. WO 2011/127255 or WO 2008/103276, the contents of each of which are herein incorporated by reference in their entirety. As a non-limiting example, a disrupting agent comprising a site-specific HNF4α targeting moiety may be encapsulated in an LNP formulation as described in PCT Publication Nos. WO 2011/127255 and/or WO 2008/103276; the contents of each of which are herein incorporated by reference in their entirety. As another non-limiting example, a disrupting agent comprising a site-specific HNF4α targeting moiety as described herein, may be formulated in a nanoparticle to be delivered by a parenteral route as described in U.S. Patent Publication No. 2012/0207845 and PCT Publication No. WO 2014/008334; the contents of each of which are herein incorporated by reference in their entirety.

In one embodiment, LNP formulations described herein may be administered intramusculary. The LNP formulation may comprise a cationic lipid described herein, such as, but not limited to, DLin-DMA, DLin-KC2-DMA, DLin-MC3-DMA, DODMA and C12-200.

In one embodiment, LNP formulations described herein comprising a disrupting agent as described herein, may be administered intradermally. The LNP formulation may comprise a cationic lipid described herein, such as, but not limited to, DLin-DMA, DLin-KC2-DMA, DLin-MC3-DMA, DODMA and C12-200.

The nanoparticle formulations may comprise conjugate, such as a phosphate conjugate, a polymer conjugates, a conjugate that enhances the delivery of nanoparticle as described in US Patent Publication No. US20160038612 A1.

In one embodiment, the lipid nanoparticle formulation comprises DLin-MC3-DMA as described in US Patent Publication No. US20100324120.

In one embodiment, the lipid nanoparticle comprises a lipid compound, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, or a lipid nanoparticle formulation, as described in U.S. Pat. No. 10,723,692B2, US Patent Publication Nos. US20200172472A1, US20200163878A1, US20200046838A1, US20190359556A1, US20190314524A1, US20190274968A1, US20190022247A1, US20180303925A1, US20180185516A1, US20160317676A1, International Patent Publication No.: WO20200146805A1, WO2020081938A1, WO2019089828A1, WO2019036030A1, WO2019036028A1, WO2019036008A1, WO 2018200943A1, WO2018191719A1, WO2018107026A1, WO2018081480A1, the contents of each of which are herein incorporated by reference in their entirety (Acuitas Therapeutics, Inc.).

In one embodiment, the lipid nanoparticle comprises an amino lipid, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, or a lipid nanoparticle formulation, described by Tekmira Pharmaceuticals Corp. in U.S. Pat. No. 9,139,554B2, U.S. Pat. No. 9,051,567B2, U.S. Pat. No. 8,883,203B2, US Patent Publication US20110117125A1, the contents of each of which are herein incorporated by reference in their entirety. In one particular example, the compound described in U.S. Pat. No. 9,139,554B2 is DLin-kC2-DMA.

In one embodiment, the lipid nanoparticle comprises an amino lipid, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, or a lipid nanoparticle formulation, described by Arbutus Biopharma Corp. in U.S. Ser. No. 10/561,732B2, U.S. Pat. No. 9,938,236B2, U.S. Pat. No. 9,687,550B2, US Patent Publication US20190240354A1, US20170027658A1, WO2020097493A1, WO2020097520A1, WO2020097540A1, WO2020097548A1, the contents of each of which are herein incorporated by reference in their entirety.

Lipid nanoparticles may be engineered to alter the surface properties of particles so the lipid nanoparticles may penetrate the mucosal barrier. Mucus is located on mucosal tissue such as, but not limited to, oral (e.g., the buccal and esophageal membranes and tonsil tissue), ophthalmic, gastrointestinal (e.g., stomach, small intestine, large intestine, colon, rectum), nasal, respiratory (e.g., nasal, pharyngeal, tracheal and bronchial membranes), genital (e.g., vaginal, cervical and urethral membranes). Nanoparticles larger than 10-200 nm which are preferred for higher drug encapsulation efficiency and the ability to provide the sustained delivery of a wide array of drugs have been thought to be too large to rapidly diffuse through mucosal barriers. Mucus is continuously secreted, shed, discarded or digested and recycled so most of the trapped particles may be removed from the mucosla tissue within seconds or within a few hours. Large polymeric nanoparticles (200 nm-500 nm in diameter) which have been coated densely with a low molecular weight polyethylene glycol (PEG) diffused through mucus only 4 to 6-fold lower than the same particles diffusing in water (Lai et al. PNAS 2007 104(5): 1482-487; Lai et al. Adv Drug Deliv Rev. 200961(2): 158-171; the contents of each of which are herein incorporated by reference in their entirety). The transport of nanoparticles may be determined using rates of permeation and/or fluorescent microscopy techniques including, but not limited to, fluorescence recovery after photobleaching (FRAP) and high resolution multiple particle tracking (MPT). As a non-limiting example, compositions which can penetrate a mucosal barrier may be made as described in U.S. Pat. No. 8,241,670 or International Patent Publication No. WO2013110028, the contents of each of which are herein incorporated by reference in their entirety.

In one embodiment, a disrupting agent comprising a site-specific HNF4α targeting moiety as described herein, is formulated as a lipoplex, such as, without limitation, the ATUPLEX™ system, the DACC system, the DBTC system and other siRNAlipoplex technology from Silence Therapeutics (London, United Kingdom), STEMFECFM from STEMGENT® (Cambridge, Mass.), and polyethylenimine (PEI) or protamine-based targeted and non-targeted delivery of nucleic acids acids (Aleku et al. Cancer Res. 2008 68:9788-9798; Strumberg et al. Int J Clin Pharmacol Ther 2012 50:76-78; Santel et al., Gene Ther 2006 13:1222-1234; Santel et al., Gene Ther 200613:1360-1370; Gutbier et al., PulmPharmacol. Ther. 201023:334-344; Kaufmann et al. Microvasc Res 2010 80:286-293; Weide et al. J Immunother. 2009 32:498-507; Weide et al. J Immnnother. 2008 31:180-188; Pascolo Expert Opin. Biol. Ther. 4:1285-1294; Fotin-Mleczek et al., 2011 J. Immunother. 34: 1-15; Song et al., Nature Biotechnol. 2005, 23:709-717; Peer et al., Proc NatlAcad Sci USA. 2007 6; 104:4095-4100; deFougerolles Hum Gene Ther. 2008 19: 125-132; all of which are incorporated herein by reference in their entirety).

In one embodiment such formulations may also be constructed or compositions altered such that they passively or actively are directed to different cell types in vivo, including but not limited to hepatocytes, immune cells, tumor cells, endothelial cells, antigen presenting cells, and leukocytes (Akinc et al. Mol Ther. 2010 18:1357-1364; Song et al., Nat Biotechnol. 2005 23:709-717; Judge et al., J Clin Invest. 2009 119:661-673; Kaufmann et al., Microvasc Res 2010 80:286-293; Santel et al., Gene Ther 200613:1222-1234; Santel et al., Gene Ther 2006 13: 1360-1370; Gutbier et al., Pulm Pharmacol. Ther. 2010 23:334-344; Basha et al., Mol. Ther. 2011 19:2186-2200; Fenske and Cullis, Expert Opin Drug Deliv. 20085:25-44; Peer et al., Science. 2008 319:627-630; Peer and Lieberman, Gene Ther. 2011 18: 1127-1133; all of which are incorporated herein by reference in its entirety). One example of passive targeting of formulations to liver cells includes the DLin-DMA, DLin-KC2-DMA and DLin-MC3-DMA-based lipid nanoparticle formulations which have been shown to bind to apolipoprotein E and promote binding and uptake of these formulations into hepatocytes in vivo (Akinc et al. Mol Ther. 2010 18: 1357-1364; the contents of which are herein incorporated by reference in its entirety). Formulations can also be selectively targeted through expression of different ligands on their surface as exemplified by, but not limited by, folate, transferrin, N-acetylgalactosamine (GalNAc), and antibody targeted approaches (Kolhatkar et al., Curr Drug Discov Technol. 2011 8: 197-206; Musacchio and Torchilin, Front Biosci. 201116: 1388-1412; Yu et al., Mol Membr Biol. 2010 27:286-298; Patil et al., Crit Rev Ther Drug Carrier Syst. 2008 25: 1-61; Benoit et al., Biomacromolecules. 2011 12:2708-2714; Zhao et al., Expert Opin Drug Deliv. 2008 5:309-319; Akinc et al., Mol Ther. 2010 18:1357-1364; Srinivasan et al., Methods Mol Biol. 2012 820: 105-116; Ben-Arie et al., Methods Mol Biol. 2012 757:497-507; Peer 2010 J Control Release. 20:63-68; Peer et al., Proc Natl Acad Sci USA. 2007 104:4095-4100; Kim et al., Methods Mol Biol. 2011 721:339-353; Subramanya et aL, Mol Ther. 2010 18:2028-2037; Song et aL, Nat Biotechnol. 2005 23:709-717; Peer et al., Science. 2008 319:627-630; Peer and Lieberman, Gene Ther. 2011 18:1127-1133; the contents of all of which are incorporated herein by reference in its entirety).

In one embodiment, a disrupting agent comprising a site-specific HNF4α targeting moiety of the invention, may be formulated as a solid lipid nanoparticle. A solid lipid nanoparticle (SLN) may be spherical with an average diameter between 10 to 1000 nm. SLN possess a solid lipid core matrix that can solubilize lipophilic molecules and may be stabilized with surfactants and/or emulsifiers. In a further embodiment, the lipid nanoparticle may be a self-assembly lipid-polymer nanoparticle (see Zhang et al., ACS Nano, 2008, 2 (8), pp 1696-1702; herein incorporated by reference in its entirety). As a non-limiting example, the SLN may be the SLN described in PCT Publication No. WO2013/105101, the contents of which are herein incorporated by reference in their entirety. As another non-limiting example, the SLN may be made by the methods or processes described in PCT Publication No. WO 2013/105101, the contents of which are herein incorporated by reference in their entirety.

Liposomes, lipoplexes, or lipid nanoparticles may be used to improve the efficacy of a disrupting agent comprising a site-specific HNF4α targeting moiety comprising, e.g., a nucleic acid molecule, to direct protein production as these formulations may be able to increase cell transfection by a nucleic acid molecule; and/or increase the translation of encoded protein (e.g., an effector of the invention). One such example involves the use of lipid encapsulation to enable the effective systemic delivery of polyplex plasmid DNA (Heyes et al., Mol Ther. 2007 15:713-720; the contents of which are herein incorporated by reference in its entirety). The liposomes, lipoplexes, or lipid nanoparticles of the invention may also increase the stability of a a disrupting agent comprising a site-specific HNF4α targeting moiety comprising, e.g., a nucleic acid molecule. Liposomes, lipoplexes, or lipid nanoparticles are described in U.S. Patent Publication No. 2016/0038612, the contents of which are incorporated herein by reference in their entirety.

In one embodiment, a disrupting agent comprising a site-specific HNF4α targeting moiety comprising may be formulated for controlled release and/or targeted delivery. As used herein, “controlled release” refers to a pharmaceutical composition or compound release profile that conforms to a particular pattern of release to effect a therapeutic outcome. In one embodiment, a disrupting agent comprising a site-specific HNF4α targeting moiety, as described herein, may be encapsulated into a delivery agent described herein and/or known in the art for controlled release and/or targeted delivery. As used herein, the term “encapsulate” means to enclose, surround or encase. As it relates to the formulation of the compounds of the invention, encapsulation may be substantial, complete or partial. The term “substantially encapsulated” means that at least greater than 50, 60, 70, 80, 85, 90, 95, 96, 97, 98, 99, 99.9, 99.9 or greater than 99.999% of the pharmaceutical composition or disrupting agent of the invention may be enclosed, surrounded or encased within the delivery agent. “Partial encapsulation” or “partially encapsulated” means that less than 10, 10, 20, 30, 40 50 or less of the pharmaceutical composition or disrupting agent of the invention may be enclosed, surrounded or encased within the delivery agent. Advantageously, encapsulation may be determined by measuring the escape or the activity of the pharmaceutical composition or compound of the invention using fluorescence and/or electron micrograph. For example, at least 1, 5, 10, 20, 30, 40, 50, 60, 70, 80, 85, 90, 95, 96, 97, 98, 99, 99.9, 99.99 or greater than 99.99% of the pharmaceutical composition or disrupting agent of the invention are encapsulated in the delivery agent.

In one embodiment, a disrupting agent comprising a site-specific HNF4α targeting moiety comprising as described herein, may be encapsulated in a therapeutic nanoparticle (e.g., a therapeutic nanoparticle from BIND Therapeutics). Therapeutic nanoparticles may be formulated by methods described herein and known in the art such as, but not limited to, PCT Publication Nos. WO 2010/005740, WO 2010/030763, WO 2010/005721, WO 2010/005723, WO 2012/054923, U.S. Patent Publication Nos. 2201/10262491, 2010/0104645, 2010/0087337, 2010/0068285, 2011/0274759, 2010/0068286, 2012/0288541, 2013/0123351, 2013/0230567, 2013/0236500, 2013/0302433, 2013/0302432, 1013/0280339 and 2013/0251757, and U.S. Pat. Nos. 8,206,747, 8,293,276 8,318,208, 8,318,211, 8,623,417, 8,617,608, 8,613,954, 8,613,951, 8,609,142, 8,603,534 and 8,563,041; the contents of each of which is herein incorporated by reference in their entirety. In another embodiment, therapeutic polymer nanoparticles may be prepared by the methods described in U.S. Patent Publication No. 2012/0140790, herein incorporated by reference in its entirety. As a non-limiting example, the therapeutic nanoparticle may comprise about 4 to about 25 weight percent of a disrupting agent and about 10 to about 99 weight percent of a diblock poly (lactic) acid-poly (ethylene)glycol copolymer comprising poly(lactic) acid as described in US Patent Publication No. 2013/0236500 (Bind), the contents of which are herein incorporated by reference in its entirety. As another non-limiting example, the nanoparticle may comprise about 0.2 to about 35 weight percent of a disrupting agent and about 10 to about 99 weight percent of a diblock poly(lactic) acid-poly(ethylene)glycol copolymer as described in U.S. Patent Publication Nos. 2013/0280339 (Bind) and 2010251757 and U.S. Pat. No. 8,652,528, the contents of each of which are herein incorporated by reference in their entirety.

In one embodiment, a disrupting agent formulated in therapeutic nanoparticles may be administered intramuscularly, intrademrally, or intravenously.

In one embodiment, a disrupting agent formulated in ACCURINS™ nanoparticles may be administered intramuscularly, intrademrally, or intravenously.

In one embodiment, a disrupting agent may be delivered in therapeutic nanoparticles having a high glass transition temperature such as, but not limited to, the nanoparticles described in US Patent Publication Nos. 2014/0030351 and 2011/0294717, the entire contents of each of which are incorporated herein by reference.

In one embodiment, the therapeutic nanoparticle may be formulated for sustained release. As used herein, “sustained release” refers to a pharmaceutical composition or compound that conforms to a release rate over a specific period of time. The period of time may include, but is not limited to, hours, days, weeks, months and years. As a nonlimiting example, the sustained release nanoparticle may comprise a polymer and a disrupting agent of the present invention (see PCT Publication No. WO2010075072 and U.S. Patent Publication Nos. 2010/0216804, 2011/0217377, 2012/0201859, 2013/0243848 and 2013/0243827, each of which is herein incorporated by reference in their entirety).

In one embodiment, a disrupting agent of the invention may be encapsulated in, linked to and/or associated with synthetic nanocarriers. Synthetic nanocarriers include, but are not limited to, those described in PCT Publication Nos. WO 2010/005740, WO 2010/030763, WO 2012/13501, WO 2012/149252, WO 2012149255, WO 2012149259, WO 2012149265, WO 2012149268, WO 2012149282, WO 2012149301, WO 2012149393, WO 2012149405, WO 2012149411 and WO 2012149454 and US Patent Publication Nos. 20110262491, 20100104645, 20100087337, 20120244222 and US20130236533, and U.S. Pat. No. 8,652,487, the contents of each of which is herein incorporated by reference in their entirety. The synthetic nanocarriers may be formulated using methods known in the art and/or described herein. As a nonlimiting example, the synthetic nanocarriers may be formulated by the methods described in PCT Publication Nos. WO 2010005740, WO 2010030763 and WO 201213501 and US Patent Publication Nos. 20110262491, 20100104645, 20100087337 and 20120244222, each of which is herein incorporated by reference in their entirety. In another embodiment, the synthetic nanocarrier formulations may be lyophilized by methods described in PCT Publication No. WO 2011072218 and U.S. Pat. No. 8,211,473; each of which is herein incorporated by reference in their entirety. In yet another embodiment, formulations of the present invention, including, but not limited to, synthetic nanocarriers, may be lyophilized or reconstituted by the methods described in US Patent Publication No. 20130230568, the contents of which are herein incorporated by reference in its entirety.

In one embodiment, synthetic nanocarriers comprising a disrupting agent may be administered intramuscularly, intrademrally, or intravenously.

In some embodiments, a disrupting agent may be formulated for delivery using smaller LNPs. Such particles may comprise a diameter from below 0.1 μm up to 1000 μm such as, but not limited to, less than 0.1 μm, less than 1.0 μm, less than 5 μm, less than 10 μm, less than 15 μm, less than 20 μm, less than 25 μm, less than 30 μm, less than 35 μm, less than 40 μm, less than 50 μm, less than 55 μm, less than 60 μm, less than 65 μm, less than 70 μm, less than 75 μm, less than 80 μm, less than 85 μm, less than 90 μm, less than 95 μm, less than 100 μm, less than 125 μm, less than 150 μm, less than 175 μm, less than 200 μm, less than 225 μm, less than 250 μm, less than 275 μm, less than 300 μm, less than 325 μm, less than 350 μm, less than 375 μm, less than 400 μm, less than 425 μm, less than 450 μm, less than 475 μm, less than 500 μm, less than 525 μm, less than 550 μm, less than 575 μm, less than 600 μm, less than 625 μm, less than 650 μm, less than 675 μm, less than 700 μm, less than 725 μm, less than 750 μm, less than 775 μm, less than 800 μm, less than 825 μm, less than 850 μm, less than 875 μm, less than 900 μm, less than 925 μm, less than 950 μm, less than 975 μm.

In another embodiment, a disrupting agent may be formulated for delivery using smaller LNPs which may comprise a diameter from about 1 nm to about 100 nm, from about 1 nm to about 10 nm, about 1 nm to about 20 nm, from about 1 nm to about 30 nm, from about 1 nm to about 40 nm, from about 1 nm to about 50 nm, from about 1 nm to about 60 nm, from about 1 nm to about 70 nm, from about 1 nm to about 80 nm, from about 1 nm to about 90 nm, from about 5 nm to about from 100 nm, from about 5 nm to about 10 nm, about 5 nm to about 20 nm, from about 5 nm to about 30 nm, from about 5 nm to about 40 nm, from about 5 nm to about 50 nm, from about 5 nm to about 60 nm, from about 5 nm to about 70 nm, from about 5 nm to about 80 nm, from about 5 nm to about 90 nm, about 10 to about 50 nm, from about 20 to about 50 nm, from about 30 to about 50 nm, from about 40 to about 50 nm, from about 20 to about 60 nm, from about 30 to about 60 nm, from about 40 to about 60 nm, from about 20 to about 70 nm, from about 30 to about 70 nm, from about 40 to about 70 nm, from about 50 to about 70 nm, from about 60 to about 70 nm, from about 20 to about 80 nm, from about 30 to about 80 nm, from about 40 to about 80 nm, from about 50 to about 80 nm, from about 60 to about 80 nm, from about 20 to about 90 nm, from about 30 to about 90 nm, from about 40 to about 90 nm, from about 50 to about 90 nm, from about 60 to about 90 nm and/or from about 70 to about 90 nm.

In one embodiment, a disrupting agent may be formulated in smaller LNPs and may be administered intramuscularly, intrademrally, or intravenously.

In one embodiment, a disrupting agent may be formulated for delivery using the drug encapsulating microspheres described in PCT Patent Publication No. WO 2013063468 or U.S. Pat. No. 8,440,614, each of which is herein incorporated by reference in its entirety. In another aspect, the amino acid, peptide, polypeptide, lipids (APPL) are useful in delivering the disrupting agents of the invention to cells (see PCT Patent Publication No. WO 2013063468, herein incorporated by reference in its entirety).

In one aspect, the lipid nanoparticle may be a limit size lipid nanoparticle described in PCT Patent Publication No. WO 2013059922, herein incorporated by reference in its entirety. The limit size lipid nanoparticle may comprise a lipid bilayer surrounding an aqueous core or a hydrophobic core; where the lipid bilayer may comprise a phospholipid such as, but not limited to, diacylphosphatidylcholine, a diacylphosphatidylethanolamine, a ceramide, a sphingomyelin, a dihydrosphingomyelin, a cephalin, a cerebroside, a C8-C20 fatty acid diacylphophatidylcholine, and I-palmitoyl-2-oleoyl phosphatidylcholine (POPC). In another aspect the limit size lipid nanoparticle may comprise a polyethylene glycol-lipid such as, but not limited to, DLPEPEG, DMPE-PEG, DPPC-PEG and DSPE-PEG.

In one embodiment, a disrupting agent of the invention may be delivered, localized and/or concentrated in a specific location using the delivery methods described in PCT Patent Publication No. WO 2013063530, the contents of which are herein incorporated by reference in its entirety. As a non-limiting example, a subject may be administered an empty polymeric particle prior to, simultaneously with or after delivering the disrupting agent to the subject. The empty polymeric particle undergoes a change in volume once in contact with the subject and becomes lodged, embedded, immobilized or entrapped at a specific location in the subject.

In one embodiment, a disrupting agent may be formulated in an active substance release system (See e.g., US Patent Publication No. 20130102545, herein incorporated by reference in its entirety). The active substance release system may comprise 1) at least one nanoparticle bonded to an oligonucleotide inhibitor strand which is hybridized with a catalytically active nucleic acid and 2) a compound bonded to at least one substrate molecule bonded to a therapeutically active substance (e.g., a disrupting agent of the invention), where the therapeutically active substance is released by the cleavage of the substrate molecule by the catalytically active nucleic acid.

In one embodiment, the nanoparticles of the present invention may be water soluble nanoparticles such as, but not limited to, those described in PCT Publication No. WO 2013090601, the contents of which are herein incorporated by reference in its entirety. The nanoparticles may be inorganic nanoparticles which have a compact and zwitterionic ligand in order to exhibit good water solubility. The nanoparticles may also have small hydrodynamic diameters (HD), stability with respect to time, pH, and salinity and a low level of non-specific protein binding.

In one embodiment, the nanoparticles of the present invention are stealth nanoparticles or target-specific stealth nanoparticles such as, but not limited to, those described in U.S. Patent Publication Nos. 20130172406 (Bind), US20130251817 (Bind), 2013251816 (Bind) and 20130251766 (Bind), the contents of each of which are herein incorporated by reference in its entirety. The stealth nanoparticles may comprise a diblock copolymer and a chemotherapeutic agent. These stealth nanoparticles may be made by the methods described in us Patent Publication Nos. 20130172406, 20130251817, 2013251816 and 20130251766, the contents of each of which are herein incorporated by reference in its entirety. As a non-limiting example, the stealth nanoparticles may target cancer cells such as the nanoparticles described in US Patent Publication Nos. 20130172406, 20130251817, 2013251816 and 20130251766, the contents of each of which are herein incorporated by reference in its entirety.

In one embodiment, stealth nanoparticles comprising a disrupting agent of the invention may be administered intramuscularly, intradermally, or intravenously.

In one embodiment, a disrupting agent of the invention may be formulated in and/or delivered in a lipid nanoparticle comprising a plurality of cationic lipids such as, but not limited to, the lipid nanoparticles described in US Patent Publication No. 20130017223, the contents of which are herein incorporated by reference in its entirety. As a non-limiting example, the LNP formulation may comprise a first cationic lipid and a second cationic lipid. As another non-limiting example, the LNP formulation may comprise DLin-MC2-DMA and DLinMC4-DMA. As yet another non-limiting example, the LNP formulation may comprise DLin-MC3-DMA and CI2-200. In one embodiment, the LNP formulations comprising a plurality of cationic lipids (such as, but not limited to, those described in US Patent Publication No. US20130017223, the contents of which are herein incorporated by reference in its entirety) and may be administered intramuscularly, intradermally, or intravenously.

In one embodiment, a disrupting agent as described herein, may be formulated in and/or delivered in a lipid nanoparticle comprising the cationic lipid DLin-MC3-DMA and the neutral lipid DOPE. The lipid nanoparticle may also comprise a PEG based lipid and a cholesterol or antioxidant. These lipid nanoparticle formulations comprising DLin-MC3-DMA and DOPE and a disrupting agent may be administered intramuscularly, intradermally, or intravenously.

In one embodiment, the lipid nanoparticle comprising DLin-MC3-DMA and DOPE may comprise a PEG lipid such as, but not limited to, pentaerythritol PEG ester tetrasuccinimidyl and pentaerythritol PEG ether tetra-thiol, PEGc-DOMG, PEG-DMG (1,2-Dimyristoyl-sn-glycerol, methoxypolyethylene Glycol), PEG-DSG (1,2-Distearoyl-snglycerol, methoxypolyethylene Glycol), PEG-DPG (1,2-Dipalmitoyl-sn-glycerol, methoxypolyethylene glycol), PEG-DSA (PEG coupled to 1,2-distearyloxypropyl-3-amine), PEG-DMA (PEG coupled to 1,2-dimyristyloxypropyl-3-amine, PEG-c-DNA, PEG-c-DMA, PEG-S-DSG, PEG-c-DMA, PEG-DPG, PEG-DMG 2000 and those described herein and/or known in the art.

In one embodiment, the lipid nanoparticle comprising DLin-MC3-DMA and DOPE may include 0.5% to about 3.0%, from about 1.0% to about 3.5%, from about 1.5% to about 4.0%, from about 2.0% to about 4.5%, from about 2.5% to about 5.0% and/or from about 3.0% to about 6.0% of the lipid molar ratio of a PEG lipid.

In one embodiment, the lipid nanoparticle comprising DLin-MC3-DMA and DOPE may include 25.0% cholesterol to about 50.0% cholesterol, from about 30.0% cholesterol to about 45.0% cholesterol, from about 35.0% cholesterol to about 50.0% cholesterol and/or from about 48.5% cholesterol to about 60% cholesterol. In one embodiment, formulations may comprise a percentage of cholesterol selected from the group consisting of 28.5%, 31.5%, 33.5%, 36.5%, 37.0%, 38.5%, 39.0%, 43.5% and 48.5%.

In one embodiment, the lipid nanoparticle comprising DLin-MC3-DMA and DOPE may include 25.0% antioxidant to about 50.0% antioxidant, from about 30.0% antioxidant to about 45.0% antioxidant, from about 35.0% antioxidant to about 50.0% antioxidant and/or from about 48.5% antioxidant to about 60% antioxidant. In one embodiment, formulations may comprise a percentage of antioxidant selected from the group consisting of 28.5%, 31.5%, 33.5%, 36.5%, 37.0%, 38.5%, 39.0%, 43.5% and 48.5%.

The disrupting agent of the invention can be formulated using natural and/or synthetic polymers. Non-limiting examples of polymers which may be used for delivery include, but are not limited to, DYNAMIC POLYCONJUGATE (Arrowhead Research Corp., Pasadena, Calif.) formulations from MIRUS® Bio (Madison, Wis.) and Roche Madison (Madison, Wis.), PHASERX™ polymer formulations such as, without limitation, SMARTT POLYMER TECHNOLOGY™ (Seattle, Wash.), DMRIIDOPE, poloxamer, VAXFECTIN® adjuvant from Vical (San Diego, Calif.), chitosan, cyclodextrin from Calando Pharmaceuticals (Pasadena, Calif.), dendrimers and polylactic-co-glycolic acid) (PLGA) polymers, RONDEL™ (RNAVOligonucleotide Nanoparticle Delivery) polymers (Arrowhead Research Corporation, Pasadena, Calif.) and pH responsive co-block polymers such as, but not limited to, PHASERX™ (Seattle, Wash.).

The polymer formulations may permit the sustained or delayed release of a disrupting agent (e.g., following intramuscular, intradermal or subcutaneous injection). The altered release profile of the disrupting agent can result in, for example, translation of an encoded protein over an extended period of time. The polymer formulation may also be used to increase the stability of the disrupting agent. For example, biodegradable polymers have been previously used to protect nucleic acids other than modified mRNA from degradation and been shown to result in sustained release of payloads in vivo (Rozema et al., Proc Natl Acad Sci USA. 2007 104:12982-12887; Sullivan et al., Expert Opin Drug Deliv. 2010 7:1433-1446; Convertine et al., Biomacromolecules. 2010 Oct. 1; Chu et al., Acc Chern Res. 2012 Jan. 13; Manganiello et al et al., Biomaterials. 2012 33:2301-2309; Benoit et al., Biomacromolecules. 2011 12:2708-2714; Singha et al., Nucleic Acid Ther. 2011 2: 133-147; deFougerolles Hum Gene Ther. 2008 19:125-132; Schaffert and Wagner, Gene Ther. 2008 16:1131-1138; Chaturvedi et al., Expert Opin Drug Deliv. 2011 8: 1455-1468; Davis, Mol Pharm. 2009 6:659-668; Davis, Nature 201 0464: 1067-1070; each of which is herein incorporated by reference in its entirety).

In one embodiment, the pharmaceutical compositions may be sustained release formulations. In a further embodiment, the sustained release formulations may be for subcutaneous delivery. Sustained release formulations may include, but are not limited to, PLGA microspheres, ethylene vinyl acetate (EVAc), poloxamer, GELSITE® (Nanotherapeutics, Inc. Alachua, Fla.), HYLENEX® (Halozyme Therapeutics, San Diego Calif.), surgical sealants such as fibrinogen polymers (Ethic on Inc. Cornelia, Ga.), TISSELL® (Baxter International, Inc Deerfield, Ill.), PEG-based sealants, and COSEAL® (Baxter International, Inc Deerfield, Ill.).

B. Vector Encoded Site-Specific HNF4α Disrupting Agents of the Invention

Disrupting agents comprising a site-specific HNF4α targeting moiety, e.g., comprising a nucleic acid molecule, may be expressed from transcription units inserted into DNA or RNA vectors (see, e.g., Couture, A, et al., TIG. (1996), 12:5-10; WO 00/22113, WO 00/22114, and U.S. Pat. No. 6,054,299). In some embodiment, expression is sustained (months or longer), depending upon the specific construct used and the target tissue or cell type. These transgenes can be introduced as a linear construct, a circular plasmid, or a viral vector, which can be an integrating or non-integrating vector. The transgene can also be constructed to permit it to be inherited as an extrachromosomal plasmid (Gassmann, et al., (1995) Proc. Natl. Acad. Sci. USA 92:1292). Different components of the disrupting agent, e.g., gRNA and effector, can be located on separate expression vectors that can be co-introduced (e.g., by transfection or infection) into a target cell. Alternatively, each individual component can be transcribed by promoters both of which are located on the same expression plasmid.

Delivery of a disrupting agent expressing vector can be systemic, such as by intravenous or intramuscular administration, by administration to target cells ex-planted from the patient followed by reintroduction into the patient, or by any other means that allows for introduction into a desired target cell.

In certain embodiment, the nucleic acids described herein or the nucleic acids encoding a protein described herein, e.g., an effector, are incorporated into a vector, e.g., a viral vector.

The individual strand or strands of a disrupting agent comprising a site-specific HNF4α targeting moiety comprising a nucleic acid molecule can be transcribed from a promoter in an expression vector. Where two separate strands are to be expressed to generate, for example, a dsRNA, two separate expression vectors can be co-introduced (e.g., by transfection or infection) into a target cell. Alternatively, each individual strand of a nucleic acid molecule can be transcribed by promoters both of which are located on the same expression plasmid. In one embodiment, a nucleic acid molecule is expressed as inverted repeat polynucleotides joined by a linker polynucleotide sequence such that the nucleic acid molecule has a stem and loop structure.

Expression vectors are generally DNA plasmids or viral vectors. Expression vectors compatible with eukaryotic cells, preferably those compatible with vertebrate cells, can be used to produce recombinant constructs for the expression of a disrupting agent as described herein.

Constructs for the recombinant expression of a disrupting agent will generally require regulatory elements, e.g., promoters, enhancers, etc., to ensure the expression of the disrupting agent in target cells.

Expression of natural or synthetic nucleic acids is typically achieved by operably linking a nucleic acid encoding the nucleic acid of interest to a regulatory region, such as a promoter, and incorporating the construct into an expression vector. The vectors can be suitable for replication and integration in eukaryotes.

Regulatory regions, such as a promoter, suitable for operable linking to a nucleic acid molecules can be operably linked to a regulatory region such as a promoter. can be from any species. Any type of promoter can be operably linked to a nucleic acid sequence. Examples of promoters include, without limitation, tissue-specific promoters, constitutive promoters, and promoters responsive or unresponsive to a particular stimulus (e.g., inducible promoters). Additional promoter elements, e.g., enhancing sequences, regulate the frequency of transcriptional initiation. Typically, these are located in the region 30-110 bp upstream of the start site, although a number of promoters have recently been shown to contain functional elements downstream of the start site as well. The spacing between promoter elements frequently is flexible, so that promoter function is preserved when elements are inverted or moved relative to one another. In the thymidine kinase (tk) promoter, the spacing between promoter elements can be increased to 50 bp apart before activity begins to decline. Depending on the promoter, individual elements can function either cooperatively or independently to activate transcription.

One example of a suitable promoter is the immediate early cytomegalovirus (CMV) promoter sequence. This promoter sequence is a strong constitutive promoter sequence capable of driving high levels of expression of any polynucleotide sequence operatively linked thereto. Another example of a suitable promoter is Elongation Growth Factor-1a (EF-1a). However, other constitutive promoter sequences may also be used, including, but not limited to the simian virus 40 (SV40) early promoter, mouse mammary tumor virus (MMTV), human immunodeficiency virus (HIV) long terminal repeat (LTR) promoter, MoMuLV promoter, an avian leukemia virus promoter, an Epstein-Barr virus immediate early promoter, a Rous sarcoma virus promoter, as well as human gene promoters such as, but not limited to, the actin promoter, the myosin promoter, the hemoglobin promoter, and the creatine kinase promoter.

Further, the present invention should not be limited to the use of constitutive promoters. Inducible promoters are also contemplated as part of the invention. The use of an inducible promoter provides a molecular switch capable of turning on expression of the polynucleotide sequence which it is operatively linked when such expression is desired, or turning off the expression when expression is not desired. Examples of inducible promoters include, but are not limited to a metallothionine promoter, a glucocorticoid promoter, a progesterone promoter, and a tetracycline promoter.

Additional regulatory regions that may be useful in nucleic acid constructs, include, but are not limited to, transcription and translation terminators, initiation sequences, polyadenylation sequences, translation control sequences (e.g., an internal ribosome entry segment, IRES), enhancers, inducible elements, or introns. Such regulatory regions may not be necessary, although they may increase expression by affecting transcription, stability of the mRNA, translational efficiency, or the like. Such regulatory regions can be included in a nucleic acid construct as desired to obtain optimal expression of the nucleic acids in the cell(s). Sufficient expression, however, can sometimes be obtained without such additional elements.

The expression vector to be introduced can also contain either a selectable marker gene or a reporter gene or both to facilitate identification and selection of expressing cells from the population of cells sought to be transfected or infected through viral vectors. In other aspects, the selectable marker may be carried on a separate piece of DNA and used in a co-transfection procedure. Both selectable markers and reporter genes may be flanked with appropriate transcriptional control sequences to enable expression in the host cells. Useful selectable markers include, for example, antibiotic-resistance genes, such as neo and the like. Non-limiting examples of selectable markers include puromycin, ganciclovir, adenosine deaminase (ADA), aminoglycoside phosphotransferase (neo, G418, APH), dihydrofolate reductase (DHFR), hygromycin-B-phosphtransferase, thymidine kinase (TK), and xanthin-guanine phosphoribosyltransferase (XGPRT). Such markers are useful for selecting stable transformants in culture. Other selectable markers include fluorescent polypeptides, such as green fluorescent protein or yellow fluorescent protein.

Signal peptides may also be included and can be used such that an encoded polypeptide is directed to a particular cellular location (e.g., the cell surface).

Reporter genes may be used for identifying potentially transfected cells and for evaluating the functionality of transcriptional control sequences. In general, a reporter gene is a gene that is not present in or expressed by the recipient source and that encodes a polypeptide whose expression is manifested by some easily detectable property, e.g., enzymatic activity. Expression of the reporter gene is assayed at a suitable time after the DNA has been introduced into the recipient cells. Suitable reporter genes may include genes encoding luciferase, beta-galactosidase, chloramphenicol acetyl transferase, secreted alkaline phosphatase, or the green fluorescent protein gene (e.g., Ui-Tei et al., 2000 FEBS Letters 479: 79-82). Suitable expression systems are well known and may be prepared using known techniques or obtained commercially. In general, the construct with the minimal 5′ flanking region showing the highest level of expression of reporter gene is identified as the promoter. Such promoter regions may be linked to a reporter gene and used to evaluate agents for the ability to modulate promoter-driven transcription.

Other aspects to consider for vectors and constructs are known in the art.

In some embodiments, a vector, e.g., a viral vector comprises a disrupting agent comprising a site-specific HNF4α targeting moiety comprising a nucleic acid molecule.

Viral vector systems which can be utilized with the methods and compositions described herein include, but are not limited to, (a) adenovirus vectors (e.g., an Ad5/F35 vector); (b) retrovirus vectors, including but not limited to lentiviral vectors (including integration competent or integration-defective lentiviral vectors), moloney murine leukemia virus, etc.; (c) adeno-associated virus vectors; (d) herpes simplex virus vectors; (e) SV 40 vectors; (f) polyoma virus vectors; (g) papilloma virus vectors; (h) picornavirus vectors; (i) pox virus vectors such as an orthopox, e.g., vaccinia virus vectors or avipox, e.g. canary pox or fowl pox; and (j) a helper-dependent or gutless adenovirus. Replication-defective viruses can also be advantageous. Different vectors will or will not become incorporated into the cells' genome. The constructs can include viral sequences for transfection, if desired. Alternatively, the construct can be incorporated into vectors capable of episomal replication, e.g. EPV and EBV vectors. See, e.g., U.S. Pat. Nos. 6,534,261; 6,607,882; 6,824,978; 6,933,113; 6,979,539; 7,013,219; and 7,163,824, the entire contents of each of which is incorporated by reference herein.

Vectors, including those derived from retroviruses such as adenoviruses and adeno-associated viruses and lentiviruses, are suitable tools to achieve long-term gene transfer since they allow long-term, stable integration of a transgene and its propagation in daughter cells. Examples of vectors include expression vectors, replication vectors, probe generation vectors, and sequencing vectors. The expression vector may be provided to a cell in the form of a viral vector. Viral vector technology is well known in the art, and described in a variety of virology and molecular biology manuals.

In one embodiment, a suitable viral vector for use in the present invention is an adeno-associated viral vector, such as a recombinant adeno-associate viral vector.

Recombinant adeno-associated virus vectors (rAAV) are gene delivery systems based on the defective and nonpathogenic parvovirus adeno-associated type 2 virus. All vectors are derived from a plasmid that retains only the AAV 145 bp inverted terminal repeats flanking the transgene expression cassette. Efficient gene transfer and stable transgene delivery due to integration into the genomes of the transduced cell are key features for this vector system. (Wagner et al., Lancet 351:9117 1702-3 (1998), Kearns et al., Gene Ther. 9:748-55 (1996)). AAV serotypes, including AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV7, AAV8 and AAV9, can be used in accordance with the present invention.

Replication-deficient recombinant adenoviral vectors (Ad) can be produced at high titer and readily infect a number of different cell types. Most adenovirus vectors are engineered such that a transgene replaces the Ad E1a, E1b, and/or E3 genes; subsequently the replication defective vector is propagated in human 293 cells that supply deleted gene function in trans. Ad vectors can transduce multiple types of tissues in vivo, including nondividing, differentiated cells such as those found in liver, kidney and muscle. Conventional Ad vectors have a large carrying capacity. An example of the use of an Ad vector in a clinical trial involved polynucleotide therapy for antitumor immunization with intramuscular injection (Sterman et al., Hum. Gene Ther. 7:1083-9 (1998)). Additional examples of the use of adenovirus vectors for gene transfer in clinical trials include Rosenecker et al., Infection 24:1 5-10 (1996); Sterman et al., Hum. Gene Ther. 9:7 1083-1089 (1998); Welsh et al., Hum. Gene Ther. 2:205-18 (1995); Alvarez et al., Hum. Gene Ther. 5:597-613 (1997); Topf et al., Gene Ther. 5:507-513 (1998); Sterman et al., Hum. Gene Ther. 7:1083-1089 (1998).

Packaging cells are used to form virus particles that are capable of infecting a host cell. Such cells include 293 cells, which package adenovirus, and ψ2 cells or PA317 cells, which package retrovirus. Viral vectors used in gene therapy are usually generated by a producer cell line that packages a nucleic acid vector into a viral particle. The vectors typically contain the minimal viral sequences required for packaging and subsequent integration into a host (if applicable), other viral sequences being replaced by an expression cassette encoding the protein to be expressed. The missing viral functions are supplied in trans by the packaging cell line. For example, AAV vectors used in gene therapy typically only possess inverted terminal repeat (ITR) sequences from the AAV genome which are required for packaging and integration into the host genome. Viral DNA is packaged in a cell line, which contains a helper plasmid encoding the other AAV genes, namely rep and cap, but lacking ITR sequences. The cell line is also infected with adenovirus as a helper. The helper virus promotes replication of the AAV vector and expression of AAV genes from the helper plasmid. The helper plasmid is not packaged in significant amounts due to a lack of ITR sequences. Contamination with adenovirus can be reduced by, e.g., heat treatment to which adenovirus is more sensitive than AAV

IV. Methods of the Invention

The present invention also provides methods of use of the agents and compositions described herein to modulate expression of hepatocyte nuclear factor 4 alpha- (HNF4α) in a cell. The methods include contacting the cell with a site-specific HNF4α disrupting agent, the disrupting agent comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, and an effector molecule, thereby modulating expression of HNF4α in the cell. The site-specific disrupting agent, the effector, or both the site-specific disrupting agent and the effector may be present in a composition, such as a composition described above. In some embodiments, the site-specific disrupting agent and the effector are present in the same compositions. In other embodiments, the site-specific disrupting agent and the effector are present in different compositions. In some embodiments, the methods of the invention include contacting a cell with two site-specific HNF4α disrupting agents (a first and a second agent). The two site specific HNF4α disrupting agents may be present in the same composition, e.g., pharmaceutical composition, e.g., pharmaceutical composition comprising an LNP, or in seprate compositions, e.g., pharmaceutical composition, e.g., pharmaceutical composition comprising an LNP. The cell may be contacted with the first site specific HNF4α disrupting agent at one time and contacted with the second site specific HNF4α disrupting agent at a second time, or the cell may be contacted with both agents at the same time.

As indicated above, in fibrotic liver disease, HNF4α is dysregulated and, as a result, gene expression in its network declines significantly or stops. As reported by Guzman-Lepe (Guzman-Lepe J, et al. Liver-enriched transcription factor expression relates to chronic hepatic failure in humans. Hepatol Commun. 2018; 2(5):582-594. doi:10.1002/hep4.1172), HNF4α expression was down-regulated and correlated well with the extent of liver dysfunction (P=0.001), stage of fibrosis (P=0.0005), and serum levels of total bilirubin (P=0.009; r=0.35), albumin (P<0.001; r=0.52), and prothrombin time activity (P=0.002; r=0.41). HNF4α expression also correlated with CYP3A4, ornithine transcarbamylase (OTC), and F7 as well as CDH1 RNA levels. This dysregulation of the network contributes to the pathology of liver failure in the organ itself, and to co-morbidities throughout the patient. In addition to a repression of proteins associated with healthy liver (e.g. albumin and CYP3A enzyme production), proteins that contribute to the production of fibrosis are activated, including COL1a1 and αSMA.

Proof of principle that increased expression of HNF4α can revert senescent and irreversibly dysfunctional hepatocytes from terminal rodent livers to normal function has been established in several studies (Nishikawa, supra; Scholten D, Trebicka J, Liedtke C, Weiskirchen R. The carbon tetrachloride model in mice. Lab Anim 2015; 49(1 Suppl):4-11. doi:10.1177/0023677215571192; Varga J, Brenner D A, Phan S H, eds. Fibrosis Research: Methods and Protocols. Humana Press; 2005. doi:10.1385/1592599400). Interestingly, as reported by Nishikawa et al. (Nishikawa, supra), reversal of the distorted extracellular matrix is not absolutely required to reverse hepatic failure in degenerative liver disease, as only minimal resolution of fibrosis was found by histology two weeks after forced re-expression of HNF4α, well after improvement in hepatic function was documented. Significant improvement in histology, however, was observed at 100 days. In addition, long-term correction took place despite that forced re-expression generated only 0.01% of the endogenous level of HNF4α. Thus, improvement in hepatic function may only require increasing expression of HNF4α in a relatively modest number of hepatocytes in end-stage degenerative disease.

Recently, Huang et al. (Huang K-W, et al. Liver Activation of Hepatocellular Nuclear Factor-4a by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile. Mol Ther Nucleic Acids. 2019; 19:361-370. doi:10.1016/j.omtn.2019.10.044) also observed that stimulating HNF4α expression with a small-activating RNA in a rat model of non-alcoholic fatty liver disease (NAFLD) restored metabolic regulation and improved lipid profile.

As demonstrated in the examples below, one embodiment of the invention is to increase the expression of the HNF4α gene by delivering an engineered transcription factor to the gene that is pathologically dysregulated. The transcriptional activator, VPR (Chavez A, et al. Highly efficient Cas9-mediated transcriptional programming Nat Methods. 2015; 12(4):326-328. doi:10.1038/nmeth.3312), is a concatemer of the HSV transcriptional activator VP16, nuclear factor NF-kappa-B p65 subunit, and the EBV R transactivator. Each of these transcription factors is capable, individually, of attracting the cellular machinery of transcription, resulting in an upregulation of RNA production from the target locus. As a group, their synergistic cooperation results in physiologic or supra-physiologic expression of a target gene.

Expression of HNF4α may be enhanced or reduced as compared to, for example, a cell that was not contacted with the site-specific HNF4α disrupting agent. Modulation in gene expression can be assessed by any methods known in the art. For example, a modulation in the expression may be determined by determining the mRNA expression level of a gene, e.g., in a cell, a plurality of cells, and/or a tissue sample, using methods routine to one of ordinary skill in the art, e.g., northern blotting, qRT-PCR; by determining the protein level of a gene using methods routine to one of ordinary skill in the art, such as western blotting, immunological techniques.

The term “reduced” in the context of the level of HNF4α gene expression or HNF4α protein production in a subject, or a disease marker or symptom refers to a statistically significant decrease in such level. The decrease can be, for example, at least 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95%, or below the level of detection for the detection method. In certain embodiments, the expression of the target is normalized, i.e., decreased towards or to a level accepted as within the range of normal for an individual without such disorder. As used here, “lower” in a subject can refer to lowering of gene expression or protein production in a cell in a subject does not require lowering of expression in all cells or tissues of a subject. For example, as used herein, lowering in a subject can include lowering of gene expression or protein production in the liver of a subject.

The term “reduced” can also be used in association with normalizing a symptom of a disease or condition, i.e. decreasing the difference between a level in a subject suffering from an HNF4α-associated disease towards or to a level in a normal subject not suffering from an HNF4α-associated disease. As used herein, if a disease is associated with an elevated value for a symptom, “normal” is considered to be the upper limit of normal. If a disease is associated with a decreased value for a symptom, “normal” is considered to be the lower limit of normal.

The term “enhanced” in the context of the level of HNF4α gene expression or HNF4α protein production in a subject, or a disease marker or symptom refers to a statistically significant increase in such level. The increase can be, for example, at least 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95%, or above the level of detection for the detection method. In certain embodiments, the expression of the target is normalized, i.e., increase towards or to a level accepted as within the range of normal for an individual without such disorder. As used here, “higher” in a subject can refer to increasing gene expression or protein production in a cell in a subject does not require increasing expression in all cells or tissues of a subject. For example, as used herein, increasing in a subject can include increasing gene expression or protein production in the liver of a subject.

The term “enhanced” can also be used in association with normalizing a symptom of a disease or condition, i.e. increasing the difference between a level in a subject suffering from an HNF4α-associated disease towards or to a level in a normal subject not suffering from an HNF4α-associated disease. As used herein, if a disease is associated with an elevated value for a symptom, “normal” is considered to be the upper limit of normal. If a disease is associated with a decreased value for a symptom, “normal” is considered to be the lower limit of normal.

In some embodiments, a suitable cell for use in the methods of the invention is a mammalian cell. In some embodiments, the cell is a somatic cell. In some embodiments, the cell is a primary cell. For example, in some embodiments, the cell is a mammalian somatic cell. In some embodiments, the mammalian somatic cell is a primary cell. In some embodiments, the mammalian somatic cell is a non-embryonic cell.

The step of contacting may be performed in vitro, in vivo (i.e., the cell may be within a subject), or ex vivo. In some embodiments, contacting a cell is performed ex vivo and the methods further include, prior to the step of contacting, a step of removing the cell (e.g., a mammalian cell) from a subject. In some embodiments, the methods further comprise, after the step of contacting, a step of (b) administering the cell (e.g., mammalian cells) to a subject.

The in vivo methods of the invention may include administering to a subject an agent or composition of the invention.

The term “subject,” as used herein refers to an organism, for example, a mammal (e.g., a human, a non-human mammal, a non-human primate, a primate, a laboratory animal, a mouse, a rat, a hamster, a gerbil, a cat, or a a dog). In some embodiments a human subject is an adult, adolescent, or pediatric subject. In some embodiments, a subject had a disease or a condition. In some embodiments, the subject is suffering from a disease, disorder or condition, e.g., a disease, disorder or condition that can be treated as provided herein. In some embodiments, a subject is susceptible to a disease, disorder, or condition; in some embodiments, a susceptible subject is predisposed to and/or shows an increased risk (as compared to the average risk observed in a reference subject or population) of developing the disease, disorder or condition. In some embodiments, a subject displays one or more symptoms of a disease, disorder or condition. In some embodiments, a subject does not display a particular symptom (e.g., clinical manifestation of disease) or characteristic of a disease, disorder, or condition. In some embodiments, a subject does not display any symptom or characteristic of a disease, disorder, or condition. In some embodiments, a subject is a patient. In some embodiments, a subject is an individual to whom diagnosis and/or therapy is and/or has been administered.

Subjects that would benefit from the methods of the invention include subjects having an “HNF4α-associated disease” or a subject at risk of an “HNF4α-associated disease.”

Thus, the present invention further provides methods of treatment of a subject in need thereof. The treatment methods of the invention include administering an agent or composition of the invention to a subject, e.g., a subject that would benefit from a modulation of HNF4α expression, such as a subject having an HNF4α-associated disease, in a therapeutically effective amount. In some embodiments, the methods of the invention include the subject may be administered two site-specific HNF4α disrupting agents (a first and a second agent). The two site specific HNF4α disrupting agents may be present in the same composition, e.g., pharmaceutical composition, e.g., pharmaceutical composition comprising an LNP, or in seprate compositions, e.g., pharmaceutical composition, e.g., pharmaceutical composition comprising an LNP. The subject may be administered the first site specific HNF4α disrupting agent at one time and administered the second site specific HNF4α disrupting agent at a second time, or the subject may be administered both agents at the same time.

In addition, the present invention provides methods for preventing at least one symptom in a subject that would benefit from a modulation of HNF4α expression, such as a subject having an HNF4α-associated disease, by administering to the subject an agent or composition of the invention in a prophylactically effective amount.

“Therapeutically effective amount,” as used herein, is intended to include the amount of an agent or composition that, when administered to a patient for treating a subject having a HNF4α-associated disease, is sufficient to effect treatment of the disease (e.g., by diminishing, ameliorating, or maintaining the existing disease or one or more symptoms of disease or its related comorbidities). The “therapeutically effective amount” may vary depending on the agent or composition, how it is administered, the disease and its severity and the history, age, weight, family history, genetic makeup, stage of pathological processes mediated by HNF4α gene expression, the types of preceding or concomitant treatments, if any, and other individual characteristics of the patient to be treated.

“Prophylactically effective amount,” as used herein, is intended to include the amount of an agent or composition that, when administered to a subject who does not yet experience or display symptoms of an HNF4α-associated disease, but who may be predisposed to an HNF4α-associated disease, is sufficient to prevent or delay the development or progression of the disease or one or more symptoms of the disease for a clinically significant period of time. The “prophylactically effective amount” may vary depending on the agent or composition, how it is administered, the degree of risk of disease, and the history, age, weight, family history, genetic makeup, the types of preceding or concomitant treatments, if any, and other individual characteristics of the patient to be treated.

As used herein, “prevention” or “preventing,” when used in reference to a disease, disorder or condition thereof, that would benefit from a reduction in expression of an HNF4α gene or production of HNF4α protein, refers to a reduction in the likelihood that a subject will develop a symptom associated with such a disease, disorder, or condition, e.g., a sign or symptom of HNF4α gene expression or HNF4α activity.

A “therapeutically-effective amount” or “prophylactically effective amount” also includes an amount of an agent or composition that produces some desired local or systemic effect at a reasonable benefit/risk ratio applicable to any treatment. Agents and compositions employed in the methods of the present invention may be administered in a sufficient amount to produce a reasonable benefit/risk ratio applicable to such treatment. In some embodiments, a therapeutically effective amount or prophylactically effect amount tis administered in a single dose; in some embodiments, multiple unit doses are required to deliver a therapeutically or prophylactically effective amount.

As used herein, the phrase “symptoms are reduced” may be used when one or more symptoms of a particular disease, disorder or condition is reduced in magnitude (e.g., intensity, severity, etc.) and/or frequency. In some embodiments, a delay in the onset of a particular symptom is considered one form of reducing the frequency of that symptom.

When the subject to be treated is a mammal such as a human, the composition can be administered by any means known in the art including, but not limited to oral, intraperitoneal, or parenteral routes, including intracranial (e.g., intraventricular, intraparenchymal, and intrathecal), intravenous, intramuscular, subcutaneous, transdermal, airway (aerosol), nasal, rectal, and topical (including buccal and sublingual) administration. In certain embodiments, the compositions are administered by intravenous infusion or injection. In certain embodiments, the compositions are administered by subcutaneous injection.

As used herein, the term “HNF4α-associated disease,” is a disease or disorder that is caused by, or associated with HNF4α gene expression or HNF4α protein production. The term “HNF4α-associated disease” includes a disease, disorder or condition that would benefit from a decrease in HNF4α gene expression, replication, or protein activity. Non-limiting examples of HNF4α-associated diseases include, for example, liver disease (e.g., fatty liver, steatohepatitis including non-alcoholic steatohepatitis (NASH)), inflammatory bowel disease (IBD), hepatocellular carcinoma, MODY I, polycystic kidney disease, dyslipidemia (e.g., hyperlipidemia, high LDL cholesterol, low HDL cholesterol, hypertriglyceridemia, postprandial hypertriglyceridemia), disorders of glycemic control (e.g., insulin resistance not related to immune response to insulin, type 2 diabetes), cardiovascular disease (e.g., hypertension, endothelial cell dysfunction), kidney disease (e.g., acute kidney disorder, tubular dysfunction, proinflammatory changes to the proximal tubules, chronic kidney disease), metabolic syndrome, disease of lipid deposition or dysfunction (e.g., adipocyte dysfunction, visceral adipose deposition, obesity), disease of elevated uric acid (e.g., hyperuricemia, gout), and eating disorders such as excessive sugar craving. Details regarding signs and symptoms of the various diseases or conditions are well known in the art.

In one embodiment, the HNF4α-associated disease is selected from the group consisting of fatty liver (steatosis), nonalcoholic steatohepatitis (NASH), cirrhosis of the liver, accumulation of fat in the liver, inflammation of the liver, hepatocellular necrosis, liver fibrosis, and nonalcoholic fatty liver disease (NAFLD), polycystic kidney disease, inflammatory bowel disease (IBD), and MODY I.

Administration of the agents or compositions according to the methods of the invention may result in a reduction of the severity, signs, symptoms, or markers of an HNF4α-associated disease or disorder in a patient with an HNF4α-associated disease or disorder. By “reduction” in this context is meant a statistically significant decrease in such level. The reduction (absolute reduction or reduction of the difference between the elevated level in the subject and a normal level) can be, for example, at least about 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, or 95%, or to below the level of detection of the assay used.

Administration of the agents or compositions according to the methods of the invention may stably or transiently modulating expression of a target gene. In some embodiments, a modulation of expression persists for at least about 1 hr to about 30 days, or at least about 2 hrs, 6 hrs, 12 hrs, 18 hrs, 24 hrs, 2 days, 3, days, 4 days, 5 days, 6 days, 7 days, 8 days, 9 days, 10 days, 11 days, 12 days, 13 days, 14 days, 15 days, 16 days, 17 days, 18 days, 19 days, 20 days, 21 days, 22 days, 23 days, 24 days, 25 days, 26 days, 27 days, 28 days, 29 days, 30 days, or longer or any time therebetween. In some other embodiments, a modulation of expression persists for no more than about 30 mins to about 7 days, or no more than about 1 hr, 2 hrs, 3 hrs, 4 hrs, 5 hrs, 6 hrs, 7 hrs, 8 hrs, 9 hrs, 10 hrs, 11 hrs, 12 hrs, 13 hrs, 14 hrs, 15 hrs, 16 hrs, 17 hrs, 18 hrs, 19 hrs, 20 hrs, 21 hrs, 22 hrs, 24 hrs, 36 hrs, 48 hrs, 60 hrs, 72 hrs, 4 days, 5 days, 6 days, 7 days, or any time therebetween.

The agents or compositions may be administered once to the subject or, alternatively, multiple administrations may be performed over a period of time. For example, two, three, four, five, or more administrations may be given to the subject during one treatment or over a period of time. In some embodiments, six, eight, ten, 12, 15 or 20 or more administrations may be given to the subject during one treatment or over a period of time as a treatment regimen.

In some embodiments, administrations may be given as needed, e.g., for as long as symptoms associated with the disease, disorder or condition persist. In some embodiments, repeated administrations may be indicated for the remainder of the subject's life. Treatment periods may vary and could be, e.g., one day, two days, three days, one week, two weeks, one month, two months, three months, six months, a year, or longer.

Efficacy of treatment or prevention of disease can be assessed, for example by measuring disease progression, disease remission, symptom severity, reduction in pain, quality of life, dose of a medication required to sustain a treatment effect, level of a disease marker, or any other measurable parameter appropriate for a given disease being treated or targeted for prevention. It is well within the ability of one skilled in the art to monitor efficacy of treatment or prevention by measuring any one of such parameters, or any combination of parameters. As discussed herein, the specific parameters to be measured depend on the HNF4α-associated disease that the subject is suffering from.

Comparisons of the later readings with the initial readings provide a physician an indication of whether the treatment is effective. It is well within the ability of one skilled in the art to monitor efficacy of treatment or prevention by measuring any one of such parameters, or any combination of parameters. In connection with the administration of an agent or composition, “effective against” a HNF4α-associated disorder indicates that administration in a clinically appropriate manner results in a beneficial effect for at least a statistically significant fraction of patients, such as a improvement of symptoms, a cure, a reduction in disease, extension of life, improvement in quality of life, or other effect generally recognized as positive by medical doctors familiar with treating HNF4α-associated disorders.

A treatment or preventive effect is evident when there is a statistically significant improvement in one or more parameters of disease status, or by a failure to worsen or to develop symptoms where they would otherwise be anticipated. As an example, a favorable change of at least 10% in a measurable parameter of disease, and preferably at least 20%, 30%, 40%, 50% or more can be indicative of effective treatment. Efficacy for a given agent or composition can also be judged using an experimental animal model for the given disease as known in the art. When using an experimental animal model, efficacy of treatment is evidenced when a statistically significant reduction in a marker or symptom is observed.

Alternatively, the efficacy can be measured by a reduction in the severity of disease as determined by one skilled in the art of diagnosis based on a clinically accepted disease severity grading scale. Any positive change resulting in e.g., lessening of severity of disease measured using the appropriate scale, represents adequate treatment using an agent or composition as described herein.

As used herein, the terms “treating” or “treatment” refer to a beneficial or desired result including, but not limited to, alleviation or amelioration of one or more signs or symptoms associated with HNF4α gene expression or HNF4α protein production. “Treatment” can also mean prolonging survival as compared to expected survival in the absence of treatment.

The present invention is next described by means of the following examples. However, the use of these and other examples anywhere in the specification is illustrative only, and in no way limits the scope and meaning of the invention or of any exemplified form. The invention is not limited to any particular preferred embodiments described herein. Many modifications and variations of the invention may be apparent to those skilled in the art and can be made without departing from its spirit and scope. The contents of all references, patents and published patent applications cited throughout this application, including the figures and informal sequence listing, are incorporated herein by reference.

EXAMPLES Example 1. Modulation of HNF4α Expression

This example describes silencing of HNF4α expression with a site-specific HNF4α disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, i.e., a guide RNA, and an effector comprising a fusion molecule comprising dCAS9 and KRAB.

Guide RNAs were designed to site-specifically target the transcriptional control region comprising promoter 1 (near the transcriptional start site) of the HNF4α gene (see, e.g., FIG. 1) and synthesized according to standard methods for oligonucleotide synthesis. The nucleotide sequences of the guide RNAs are provided in Table 2, below. Exemplary guide RNAs designed to site-specifically target the transcriptional control region comprising promoter 2 (near the transcriptional start site) of the HNF4α gene were also designed and are provided in Table 3, below. Additional exemplary guide RNAs designed to site-specifically target the transcriptional control region comprising promoter 2 (near the transcriptional start site) of the HNF4α gene were also designed and are provided in Table 9, below. Table 4, below, includes the unmodified nucleotide sequences, reverse complement nucleotide sequences, and chromosomal coordinates of the targeting portion of the guide RNAs in Tables 2 and 3.

HepG2 cells were seeded in 96-well plate (at a density of 3×10E4 cells/well) in appropriate media 24 hours prior to transfection. Cells were transfected with SSOP Lipid Nano-Particles (LNPs) containing mRNA encoding fusion proteins for dCAS9-KRAB (MR_28122) and guide RNAs (sgRNA) according to standard methods (see, e.g., Akita, et al. (Advanced Healthcare Materials (2013) 2:8.:1120-1125).

LNP formulations prepared using individual sgRNAs or Pools of sgRNAs (see, FIG. 1), were added to the cells for a final concentration of 5.0, 2.5, 1.25, or 0.625 μg/ml. The experiment was ended after 72 hours by lysing/freezing in RLT buffer for downstream mRNA purification or treatment with the Cell Titer Glo 2 reagent to quantify final cell number. qPCR was performed using HNF4α and ACTB probes to quantify relative HNF4α RNA transcription.

FIG. 2 demonstrates that Pool 1 or Pool 2 guides in combination with the effector dCAS-KRAB inhibited HNF4α expression in a dose dependent manner relative to dCAS alone, SH-KRAB, and untreated. dCAS alone does affect transcription in some cases, and without wishing to be bound by theory, the inhibition may be the result of dCAS interference with polymerase binding.

In addition, and as demonstrated in FIG. 3, Pool 1 at the highest concentration has the strongest silencing activity and guide RNAs GD-28432 and GD-28433 each have strong silencing activity alone, even at the lowest concentration.

Example 2. Modulation of HNF4α Expression

This example describes activation of HNF4α expression with a site-specific HNF4α disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, i.e., a guide RNA, and an effector comprising a fusion molecule comprising dCAS9 (a non-editing Cas9 protein) and VPR.

Guide RNAs were designed to site-specifically target the transcriptional control region comprising promoter 1 (near the transcriptional start site) of the HNF4α gene (see, e.g., FIG. 1) and were synthesized according to standard methods for oligonucleotide synthesis. The nucleotide sequences of the guide RNAs are provided in Table 2, below. Exemplary guide RNAs designed to site-specifically target the transcriptional control region comprising promoter 2 (near the transcriptional start site) of the HNF4α gene were also designed and are provided in Table 3, below. Additional exemplary guide RNAs designed to site-specifically target the transcriptional control region comprising promoter 2 (near the transcriptional start site) of the HNF4α gene were also designed and are provided in Table 9, below. Table 4, below, includes the unmodified nucleotide sequences, reverse complement nucleotide sequences, and chromosomal coordinates of the guide RNAs in Tables 2 and 3.

LX-2, A549, and HepG2 cells were seeded in 96-well plates (at a density of 1×10E4 cells/well) in appropriate media 24 hours prior to transfection. LX-2 cells normally do not express HNF4α; HepG2 cells, liver cancer cell line cells, normally express more HNF4α that normal non-cancerous liver cells.

Cells were transfected with mRNA encoding fusion proteins for dCAS9-VPR (MR_28196) and guide RNAs (sgRNA). Individual sgRNAs or pools of sgRNAs were prepared using the Lipofectamine MessengerMAX Transfection protocol as described by the manufacturer. Untreated HepG2 cells were also included in the experiment as an internal control (comparator).

Briefly, 2.5 μl lipofectamine per μg of RNA was mixed with OptiMEM media and incubated for 10 minutes at room temperature (RT), and then added to cells in a 1:10 ratio of the media volume to the cells. Lipofectmine media mix was combined with RNA for a total volume of 120 μl at a final concentration of 100 μg/ml. This mix was incubated at RT for 5 minutes and added to the cells for a final concentration of 5.0, 2.5, 1.25, 0.625 μg/ml.

The experiment was ended after 48 hours by lysing/freezing in RLT buffer for downstream mRNA purification or treatment with the Cell Titer Glo 2 reagent to quantify final cell number. Briefly, the plate for RNA extraction was washed three times with PBS, following which 150 μL RLT buffer was added to each well. The plate was then frozen at −80° C. for later RNA processing. RNA was extracted following thawing of the plates, using the Qiagen RNeasy 96-well kit. RNA was quantified using Ribogreen. Reverse transcription and qPCR were carried out following the protocol for Absolute Quantitation for mRNA Expression by RT-qPCR.

The standard curves for HNF4α and β-actin (ACTB) were prepared as follows: HNF4α and ACTB gene block stocks (a synthesized reference copy of target cDNA) were prepared in nuclease-free water to a concentration of 10 mg/mL. A mixture 0.5 mg/mL of each gene block stock was prepared by combining 5 μL of each individual gene block stock and 40 μL H2O to a final volume of 50 uL. This mixture was then serially diluted (10-fold dilutions) 8 times. Two microliter (2 μL) of each standard curve dilution was used as the cDNA for the standard curve to which was added 8 μL of Taqman Master Mix with probes. The standard curve was set up in duplicate Wells were analyzed in technical triplicates.

RNA was extracted and HNF4α mRNA levels were determined by qPCR.

qPCR was performed using HNF4α and ACTB probes to quantify relative HNF4α RNA transcription. HepG2 HNF4α RNA expression was measured as a positive control.

FIGS. 4A and 4B demonstrate that Pool 1 guides in combination with the effector dCAS-VPR show strong activation of HNF4α expression in both A549 cells and LX-2 cells in a dose dependent manner relative to SH-VPR, and untreated.

Delivering dCAS9-P300 using Lipofectamine MessengerMAX Transfection also upregulates HNF4α, but significantly less than dCAS-VPR (data not shown).

Similar experiments were conducted to evaluate the effect of dCas9 fusion proteins comprising dCas9-VPR and guides targeting the promoter region of HNF4α using Dlin-MC3-DMA (MC3), an LNP formulated for in vivo delivery. Using MC3-LNP, mRNA for dCas9-VPR and individual and pooled sgRNAs (Pool 1) were delivered to cells in culture. RNA was extracted and HNF4α mRNA levels were determined by qPCR as described above. Untreated HepG2 cells were included in the experiment as an internal control (comparitor).

FIG. 5 demonstrates that, in this experiment, the MC3 LNPs are more efficient at transfecting LX-2 cells than Messanger Max in comparison to HNF4α levels to HepG2 (internal control). The individual sgRNAs targeting the HNF4α promoter show upregulation but significantly less than the pooled guides.

Activation of HNF4α in HepG2 Cells using MC3-LNP mediated delivery was also evaluated. HepG2 cells express a basal level of HNF4α that is higher than normal cells. Supraphysiological expression may facilitate greater durability of efficacy.

Using MC3-LNP, mRNA for dCas9-VPR and pooled sgRNAs were delivered to HepG2 cells in culture. A dCas9-VPR control with a control, SH (safe harbor non-targeting control) guide, was also included. HNF4α mRNA levels were determined by qPCR.

FIG. 6 demonstrates that MC3-LNP formulations induced over-expression of HNF4α in HepG2 cells. Expression levels of up to about 200% of control levels were observed. Such expression level were tolerated in cells in culture. The result of the SH control demonstrates that upregulation of HNF4α is specifically due to the promoter targeted delivery of the activating effector.

To investigate whether the HNF4α protein induced by dCas9-VPR Pool 1 was localized to the nucleus of the cell, LX-2 cells were transfected with mRNA for dCas9-VPR and and pooled sgRNAs (Pool 1). In order to visualize cells, treated LX-2 cells were fixed and permeabilized. Cells were grown in 96 well plates with black walls and a clear bottom. Media was removed. All incubations were at room temperature (RT) and stationary. All solutions were made with 10×PBS stock solution. Media was removed and cells were washed 2 times with 1×PBS. To wash the cells, 100 μl of 1×PBS was added, and removed. The wash was repeated twice. One hundred microliter (100 μl) of 4% PFA in 1×PBS was added and incubated for 15 minutes at RT. Cells were washed 3 times with 1×PBS, with 5 minutes incubation between each wash. Cells were then incubaded in 100 μl of 0.1% Triton X 100 in 1×PBS for 15 minutes at RT. One hundred microliter (100 μl) of 10% normal goat serum in 1×PBS with 0.1% Triton X 100 was added and kept at 4 C until further use.

The fixed and permeabilized cells were stained with anti-HNF4α antibody and DAPI. FIG. 7 shows that the HNF4α protein induced by dCas9-VPR Pool 1 can be detected and travels to the nucleus.

TABLE 2 Site-Specific HNF4α Promoter 1 Targeting Moieties (sgRNA)- The first 20 nucleotides in each moiety below comprise the targeting portion of the moiety. SEQ ID Identifier NO. Modified Nucleotide Sequence 5′ to 3′ GD-28431 68 mAs; mUs; mUs; rG; rA; rA; rU; rU; rA; rG; rG; rG; rG; rA; rU; rC; rU; rC; rG; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28432 69 mGs; mAs; mCs; rU; rU; rG; rG; rG; rG; rU; rG; rA; rC; rA; rA; rU; rG; rG; rC; rU; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28433 70 mAs; mAs; mCs; rU; rG; rA; rA; rC; rA; rU; rC; rG; rG; rU; rG; rA; rG; rU; rU; rA; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28434 71 mUs; mGs; mGs; rU; rU; rU; rC; rU; rG; rG; rC; rU; rG; rA; rC; rA; rC; rC; rC; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28435 72 mAs; mUs; mGs; rG; rU; rU; rA; rA; rU; rC; rG; rG; rU; rC; rC; rC; rC; rC; rG; rC; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC;  rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28436 73 mGs; mUs; mCs; rC; rU; rC; rU; rG; rG; rG; rA; rA; rG; rA; rU; rC; rU; rG; rC; rU; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28437 74 mGs; mGs; mUs; rU; rU; rG; rA; rA; rA; rG; rG; rA; rA; rG; rG; rC; rA; rG; rA; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28438 75 mAs; mCs; mCs; rC; rU; rG; rG; rG; rC; rG; rC; rC; rC; rA; rC; rC; rC; rC; rG; rA; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD-28439 76 mUs; mUs; mCs; rU; rC; rC; rC; rU; rG; rC; rC; rU; rC; rC; rA; rC; rG; rC; rC; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU

TABLE 3 Site-Specific HNF4α Promoter 2 Targeting Moieties (sgRNA) - The first 20 nucleotides in each moiety below comprise the targeting portion of the moiety. SEQ ID Identifier NO. Modified Nucleotide Sequence 5′ to 3′ GD28427 77 mAs; mUs; mGs; rC; rC; rC; rC; rC; rA; rG; rC; rU; rC; rU; rC; rC; rG; rG; rC; rU; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD28428 78 mCs; mAs; mGs; rC; rG; rU; rG; rA; rA; rC; rG; rC; rG; rC; rC; rC; rC; rU; rC; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD28429 79 mCs; mUs; mUs; rA; rC; rG; rG; rU; rA; rA; rG; rU; rG; rG; rG; rG; rC; rU; rG; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD28430 80 mCs; mCs; mCs; rG; rU; rA; rA; rG; rA; rA; rA; rC; rA; rC; rA; rC; rG; rG; rG; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU GD28431 68 mAs; mUs; mUs; rG; rA; rA; rU; rU; rA; rG; rG; rG; rG; rA; rU; rC; rU; rC; rG; rG; rG; rU; rU; rU; rU; rA; rG; rA; rG; rC; rU; rA; rG; rA; rA; rA; rU; rA; rG; rC; rA; rA; rG; rU; rU; rA; rA; rA; rA; rU; rA; rA; rG; rG; rC; rU; rA; rG; rU; rC; rC; rG; rU; rU; rA; rU; rC; rA; rA; rC; rU; rU; rG; rA; rA; rA; rA; rA; rG; rU; rG; rG; rC; rA; rC; rC; rG; rA; rG; rU; rC; rG; rG; rU; rG; rC; rUs; mUs; mUs; mU

TABLE 4 Unmodified Nucleotide Sequences of the Targeting Portion of the Site-Specific HNF4α Targeting Moieties in Tables 2 and 3. SEQ SEQ ID Unmodified Nucleotide Sequence ID Reverse Complement Nucleotide Chromosomal Identifier NO. 5′ to 3′ NO. Sequence 5′ to 3′ Coordinates GD-28427 329 ATGCCCCCAGCTCTCCGGCT 335 AGCCGGAGAGCTGGGGGCAT chr20: 42984411- 42984433 GD-28428 330 CAGCGTGAACGCGCCCCTCG 336 CGAGGGGCGCGTTCACGCTG chr20: 42984450- 42984472 GD-28429 331 CTTACGGTAAGTGGGGCTGG 337 CCAGCCCCACTTACCGTAAG chr20: 42984488- 42984510 GD-28430 332 CCCGTAAGAAACACACGGGG 338 CCCCGTGTGTTTCTTACGGG chr20: 42984560- 42984582 GD-28431 333 ATTGAATTAGGGGATCTCGG 339 CCGAGATCCCCTAATTCAAT chr20: 43029535- 43029557 GD-28432 334 GACTTGGGGTGACAATGGCT 340 AGCCATTGTCACCCCAAGTC chr20: 43029596- 43029618 GD-28433 81 AACTGAACATCGGTGAGTTA 82 TAACTCACCGATGTTCAGTT chr20: 43029685- 43029707 GD-28434 83 TGGTTTCTGGCTGACACCCG 84 CGGGTGTCAGCCAGAAACCA chr20: 43029729- 43029751 GD-28435 85 ATGGTTAATCGGTCCCCCGC 86 GCGGGGGACCGATTAACCAT chr20: 43029792- 43029814 GD-28436 87 GTCCTCTGGGAAGATCTGCT 88 AGCAGATCTTCCCAGAGGAC chr20: 43029873- 43029895 GD-28437 89 GGTTTGAAAGGAAGGCAGAG 90 CTCTGCCTTCCTTTCAAACC chr20: 43029896- 43029918 GD-28438 91 ACCCTGGGCGCCCACCCCGA 92 TCGGGGTGGGCGCCCAGGGT chr20: 43029957- 43029979 GD-28439 93 TTCTCCCTGCCTCCACGCCG 94 CGGCGTGGAGGCAGGGAGAA chr20: 43029991- 43030013

TABLE 5 Abbreviations of nucleotide monomers used in nucleic acid sequence representation. It will be understood that these monomers, when present in an oligonucleotide, are mutually linked by 5′-3′- phosphodiester bonds. Abbreviation Nucleotide(s) A Adenosine-3′-phosphate As adenosine-3′-phosphorothioate C cytidine-3′-phosphate Cs cytidine-3′-phosphorothioate G guanosine-3′-phosphate Gs guanosine-3′-phosphorothioate U Uridine-3′-phosphate Us uridine-3′-phosphorothioate N any nucleotide, modified or unmodified mA 2′-O-methyladenosine-3′-phosphate mAs 2′-O-methyladenosine-3′-phosphorothioate mC 2′-O-methylcytidine-3′-phosphate mCs 2′-O-methylcytidine-3′- phosphorothioate mG 2′-O-methylguanosine-3′-phosphate mGs 2′-O-methylguanosine-3′- phosphorothioate mU 2′-O-methyluridine-3′-phosphate mUs 2′-O-methyluridine-3′-phosphorothioate s phosphorothioate linkage r ribonucleotide

Example 3. Design of Zinc Finger DNA Binding Domain and TALE Fusion Protein

As described in Examples 1 and 2, the sites of effective activation of HNF4α gene expression were identified using dCas9 fusion proteins and guides directed to specific nucleotide regions 5′ of promoter 1 of the HNF4α gene. Based on these data, Zinc Finger DNA binding domain polypeptides (ZF) and TALE polypeptides were designed to target the same or similar sequence regions 5′ of promoter 1 of the HNF4α gene. FIG. 9 depicts the target areas for design of the exemplary ZF proteins and TALE proteins of the inventions.

FIG. 10 depicts the structure of the exemplary site-specific HNF4α disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, e.g., a zing finger (ZF) or a TALE, and an effector comprising, e.g., VPR (e.g., ZF-VPR or TALE-VPR fusion proteins) of the invention. As shown in FIG. 10, an exemplary ZF-VPR protein may include one or more nuclear localization signals (NLS), such as SV40 NLS or nucleoplasmin NLS. In some embodiments, the NLSs are located at the N-terminus, between the VP64 and RelA (p65) activation domain (VPR), and at the C-terminus.

In some embodiments, the mRNAs encoding the ZF fusion protein or the TAL fusion proteins, may contain a “natural cap” structure at the 5′-terminus, e.g., the mRNAs may be cap0 (no methyl), cap1 (methyl on first ribose), cap2 (methyl on second ribose).

Downstream of the cap is a 5′ untranslated region (UTR), a sequence which is designed to promote high levels of protein translation. Downstream of the 5′ UTR is the coding sequence, 3′ UTR and the polyA tail.

An exemplary nucleotide sequence of a 5′ UTR for use in the constructs is

(SEQ ID NO.: 341) AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACC.

An exemplary nucleotide sequence of a 3′ UTR for use in the constructs is

(SEQ ID NO.: 342) CUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGA AGUCUAG

An exemplary nucleotide sequence of a poly-A tail for use in the constructs is

(SEQ ID NO.: 343) AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAA

The mRNAs encoding the ZF fusion proteins or the TALE fusion proteins may be complexed with a lipid nanoparticle (e.g., MC3). The ZF domains of the fusion proteins are targeted to P1 of HNF4α, which controls the transcription of the isoforms of HNF4α expressed primarily in the liver.

Tables 6A and 6B below provide the amino acid sequences of various exemplary fusion protein constructs, the corresponding encoding mRNA sequences, the target genomic sequences thereof, and the amino acid sequences of the DNA binding domains for use in the disrupting agents of the constructs.

TABLE 6A Column 6 Column 7 Column 4 Column 5 Nucleotide Genomic Coordinates of Sequence of Amino Acid Sequence the Target Site in the Column 1 Column 2 Column 3 Target Sequence of the of the HNF4α Expression Exemplary HNF4α Amino Acid Nucleotide Site in HNF4α DNA Binding DNA Binding Control Region Disrupting Agents Sequence of the Sequence of Expression Control Domain of the Domain of the (Genome Reference Comprising a Zinc Disrupting the Disrupting Region Targeted by Disrupting Disrupting Consortium Finger DNA Binding Agent in Agents in the Disrupting Agent in Agent in Human Build Domain and an Effector Column 1 Column 1 Agents in Column 1 Column 1 Column 1 37 (GRCh37): Name (SEQ ID NO:) (SEQ ID NO). (SEQ ID NO.) (SEQ ID NO.) (SEQ ID NO.) Chromosome 20) ZF1-VPR 100 101 102 103 211 GrCh37: chr20:43029991- 43030011 ZF2-VPR 104 105 106 107 212 GrCh37: chr20:43029959- 43029979 ZF3-VPR 108 109 110 111 213 GrCh37: chr20:43029897- 43029917 ZF4-VPR 112 113 114 115 214 GrCh37: chr20:43029874- 43029894 ZF5-VPR 116 117 118 119 215 GRCh37: chr20:43029794- 43029814 ZF6-VPR 120 121 122 123 216 CRCh37: chr20:43029731- 43029751 ZF7-VPR 124 125 126 127 217 GRCh37: chr20:43029686- 43029706 ZF8-VPR 128 129 130 131 218 GrCh37: chr20:43029598- 43029618 ZF9-VPR 132 133 134 135 219 GrCh37: chr20:43029536- 43029558 ZF10-VPR 136 137 138 139 220 GrCh37: chr20:43029767- 43029787 ZF11-VPR 140 141 142 143 221 GrCh37: chr20:43029820- 43029840 ZF12-VPR 144 145 146 147 222 GrCh37: chr20:43029855- 43029875 ZF13-VPR 148 149 150 151 223 GrCh37: chr20:43029766- 43029786 ZF14-VPR 152 153 154 155 224 GRCh37: chr20:43029810- 43029830 ZF15-VPR 156 157 158 159 225 GRCh37: chr20:43029832- 43029852 ZF5-VPR ATUM Opt_1 116 160 118 119 226 GRCh37: chr20:43029794- (ZF5.1-VPR) 43029814 ZF5-VPR ATUM Opt_2 116 161 118 119 227 GRCh37: chr20:43029794- (ZF5.2-VPR) 43029814 ZF5-VPR ATUM Opt_3 116 162 118 119 228 GRCh37: chr20:43029794- (ZF5.3-VPR) 43029814 ZF5-VPR ATUM Opt_4 116 163 118 119 229 GRCh37: chr20:43029794- (ZF5.4-VPR) 43029814 ZF5-VPR ATUM Opt_5 116 164 118 119 230 GRCh37: chr20:43029794- (ZF5.5-VPR) 43029814 ZF5-VPR ATUM Opt_6 116 165 118 119 231 GRCh37: chr20:43029794- (ZF5.6-VPR) 43029814 ZF5-P300 166 167 118 119 232 GRCh37: chr20:43029794- 43029814 ZF5-VPR + ZF7-VPR 116 + 124 117 + 125 118 + 126 119 + 127 215 + 217 GRCh37: chr20:43029794- 43029814 GRCh37: chr20:43029686- 43029706 ZF5-VPR ATUMOpt_3 + 116 + 124 162 + 125 118 + 126 119 + 127 228 + 217 GRCh37: chr20:43029794- ZF7-VPR 43029814 GRCh37: chr20:43029686- 43029706 ZF7-P300 168 169 126 127 233 GRCh37: chr20:43029686- 43029706 ZF5.3-VPR3 170 171 118 119 234 GRCh37: chr20:43029794- 43029814 ZF5-no effector 174 175 118 119 235 GRCh37: chr20:43029794- 43029814 ZF5.3-VPR-tPT2a-ZF7- 176 177 118 + 126 119 + 127 236 + 237 GRCh37: chr20:43029794- VPR 43029814 GRCh37: chr20:43029686- 43029706 ZF7-VPR-tPT2a-ZF5.3- 178 179 126 + 118 127 + 119 238 + 239 GRCh37: chr20:43029686- VPR 43029706 GRCh37: chr20:43029794- 43029814 ZF5.3-VPR-tPT2a-ZF7- 180 181 118 + 126 119 + 127 240 + 241 GRCh37: chr20:43029794- p300 43029814 GRCh37: chr20:43029686- 43029706 ZF7-p300-tPT2a-ZF5.3- 182 183 126 + 118 127 + 119 242 + 243 GRCh37: chr20:43029686- VPR 43029706 GRCh37: chr20:43029794- 43029814 TAL1-VPR 184 185 102 186 244 GrCh37: chr20:43029991- 43030011 TAL2-VPR 187 188 106 189 245 GrCh37: chr20:43029959- 43029979 TAL3-VPR 190 191 110 192 246 GrCh37: chr20:43029897- 43029917 TAL4-VPR 193 194 114 195 247 GrCh37: chr20:43029874- 43029894 TAL5-VPR 196 197 118 198 248 GRCh37: chr20:43029794- 43029814 TAL6-VPR 199 200 122 201 249 CRCh37: chr20:43029731- 43029751 TAL7-VPR 202 203 126 204 250 GRCh37: chr20:43029686- 43029706 TAL8-VPR 205 206 130 207 251 GrCh37: chr20:43029598- 43029618 TAL9-VPR 208 209 134 210 252 GrCh37: chr20:43029536- 43029558

TABLE 6B Column 1 Column 4 Exemplary Effector Column 2 Column 3 Amino acid Sequence of Fusion Protein of Amino acid sequence of Nucleotide sequence of DNA Binding Domain Exemplary HNF4α the Effector Fusion the Effector Fusion of the Effector Fusion Disrupting Agents Protein in Column 1 Protein in Column 1 Protein in Column 1 Name (SEQ ID NO:) (SEQ ID NO:) (SEQ ID NO:) dCas9-VPR 95 96 97 dCas9-P300 98 99 97 dCas9-VPR3 172 173 97

Example 4. Modulation of HNF4α Expression by ZF-Fusion Proteins

In order to test a single mRNA encoding a site-specific HNF4α disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, e.g., a zing finger (ZF), and an effector comprising, e.g., VPR, (ZF-VPR fusion proteins), rather than dCas9-effector fusions with pooled sgRNAs, Zinc Finger DNA Binding Domain (DBD)-VPR (ZF-VPR) fusion proteins were designed as described above. Such fusion proteins which bind sites similar to or identical to the P1 targeting guide RNAs described in Examples 1 and 2 were evaluated for their ability to effect expression of HNF4α in vitro.

Several mRNAs encoding fusion proteins comprising a ZF DBD and a VPR domain were constructed (see Table 6A). Individual and pooled fusion protein encoding mRNAs were delivered to LX-2 cells as MC3 LNP formulations as described above. Expression of HNF4α was measured by qPCR as described above. Untreated HepG2 and dCas9-VPR-Pool 1 were included as positive controls.

As shown in FIG. 11, it was found that ZF005-VPR (also referred to as ZF5-VPR) showed robust upregulation of HNF4α. ZF007-VPR (also referred to as ZF7-VPR) also showed a quantifiable upregulation.

Example 5. Modulation of HNF4α Expression by TALE-Fusion Proteins

In a further effort to use a single mRNA coding a site-specific HNF4α disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, e.g., a Talen based DNA Binding Domain (DBD), and an effector comprising, e.g., VPR, (TAL-VPR fusion proteins), were designed. Such fusion proteins which bind sites similar to or identical to the P1 targeting guide RNAs described in Examples 1 and 2 were evaluated for their ability to effect expression of HNF4α in vitro.

Several mRNAs encoding fusion proteins of a TALEN DBD with a VPR domain were constructed (see Table 6A). Individual and pooled fusion protein encoding mRNAs were delivered to LX-2 cells as MC3 LNP formulations as described above. Expression of HNF4α was measured by qPCR as described above. Untreated HepG2 and dCas9-VPR-Pool 1 were included a positive controls. ZF5-VPR and ZF7-VPR were also included in the study as comparators.

Table 7 below shows the experiment design for the pooled TAL-VPR experiments.

TABLE 7 TAL1-VPR Pool X Pools are made by mixing 1:1:1 TAL2-VPR of each TAL fusion protein. TAL3-VPR TAL4-VPR Pool Y TAL5-VPR TAL6-VPR TAL7-VPR Pool Z TAL8-VPR Unrelated domain-VPR

As shown in FIG. 12, it was found that pooled TALE based-VPR fusion proteins showed strong up-regulation of HNF4α expression Individually, each TAL-VPR fusion protein did not have significant activity to up-regulate the expression of HNF4α (data not shown). This Figure also demonstrates that the results described above for ZF5-VPR and Z7-VPR were reproducible.

Example 6. Modulation of HNF4α Expression with Codon Optimized ZF5-VPR and Synergy of the Combination of ZF5-VPR and ZF7-VPR in LX-2 Cells

In this example, activation of HNF4α in LX-2 cells with codon optimized ZF5-VPR fusion proteins was evaluated. The objective was to analyze whether codon optimization of ZF5-VPR would improve activity of the ZF5-VPR fusion proteins at the HNF4α promoter. Another objective was to analyze whether the combination of ZF5-VPR and ZF7-VPR fusion proteins was synergistic in activating HNF4α expression.

The sequence for ZF5-VPR fusion proteins were sent to ATUM for codon optimization, a process that uses al algorithm to re-design ideal codon frequency and context to optimize translational efficiency. ATUM returned 6 new variants which all encode the same protein, each with different RNA sequences. (see Table 6A).

mRNAs for all five ATUM codon optimized ZF5-VPR, unaltered ZF5-VPR and ZF7-VPR were transfected into LX-2 cells as MC3 LNPs. Expression of HNF4α was measured by qPCR 48 hours after transfection.

As shown in FIG. 13, ZF-5-VPR ATUM codon otpimized variant 3 (ZF5.3-VPR) showed stronger upregulation of HNF4α expression as compared to the other codon-optimized variants. Co-transfecting ZF5-VPR and ZF7-VPR led to a supraphysiological (>200%) increase in expression of HNF4α, demonstrating synergy of the combination of these two fusion proteins. (In FIG. 13, Pool 1 is dCas9-VPR+GD-28431+GD-28432+GD-28433; Pool 2 is dCas9-VPR+GD-28434+GD-28435+GD-28436).

Example 7. Durability of Modulation of HNF4α Expression in K562 Cells

This example identified the effectors (VPR and/or P300) that was able to induce the longest lasting up-regulation of HNF4α expression. The example also measures how long the up-regulation of HNF4α in K562 could last when treated with various ZF-effector fusion proteins and various combinations of ZF-effector fusion proteins.

Various individual mRNAs encoding ZF-effector fusion proteins and combinations of the mRNAs were transfected into K562 cells and allowed to grow for 10 days in culture.

The following individual fusion proteins and combinations were tested in K562 cells, transfected with MC3 LNPs: ZF5-VPR, ZF5-P300, a combination of ZF5-VPR and ZF5-P300, or a combination of ZF5-VPR and ZF7-VPR (see Table 6A).

Transfections and quantifications were performed as described above. Briefly, untreated K562 cells were included as an assay control. K562 cells were treated with individual and different combination of effectors (2.5 μg/mL) in triplicate. Data points were collected over a period of 10 days. qPCR readout was used to measure mRNA expression. K562 cells were seeded at 100 k/well in triplicates: Time points were collected every 2 days for a total of 10 days. Three wells of untreated K562 were included as a control. RT qPCR for HNF4α was performed to measure the expression of HNF4α at each time point for similarly treated LX-2 cells.

As shown in FIGS. 14 and 15, HNF4α expression upregulation was observed in K562 cell until day 6 when any of the single fusion proteins or combinations of the fusion proteins were transfected. Co-transfection with mRNAs encoding ZF5-VPR and ZF7-VPR led to the highest and most durable increase of HNF4α expression in cultured cells, with detectable expression out to 10 days.

In another experiment, the durability of up-regulation of HNF4α expression in K562 when treated with ZF-5-VPR, ZF-5-P300, a combination of ZF5-VPR-ATUM 3 and ZF7-VPR (also referred to as ZF (5.3+7) or a combination of ZF5-PR and ZF7-VPR (also referred to as ZF-(5+7)-VPR) was determined.

K562 cells were treated with individual and different combination of effectors (2.5 ug/mL) in triplicate. Time points were collected over a period of 10 days. qPCR readout was used to measure mRNA expression. K562 cells were seeded at 100 k/well in triplicates: Time points were collected every 2 days for a total of 10 days. Three wells of untreated K562 were included as a control. RT qPCR was performed to measure the expression of HNF4α at each time point. Fusion protein were formulated in MC3 LNPs.

As shown in FIG. 16, HNF4α upregulation was observed in K562 cell until day 6 using both combinations of ZF5-VPR and ZF7-VPR and ZF5.3-VPR and ZF7-VPR. Both combinations of ZF5-VPR and ZF7-VPR and ZF5.3-VPR and ZF7-VPR showed slight upregulation at day 8 and 10.

Example 8. Modulation of Biomarker Genes Expression Following Activation of HNF4α in LX-2 Cells

The first experiment of this example demonstrates the change in expression level of downstream biomarker genes following activation of HNF4α in LX-2 Cells. The objective of this experiment was to demonstrate that the HNF4α induced by dCas9-VPR in LX-2 cells is an active transcription factor by examining the effect of upregulating HNF4α expression on the expression of two downstream gene Cola1 and aSMA. Collagen 1a1 (Col1a1), and alpha-Smooth Muscle Actin (aSMA) are 2 proteins highly expressed in damaged liver cells and are key drivers of fibrosis in end-stage liver disease. Both of these genes are negatively-regulated by HNF4α.

LX-2 cells, which highly express Col1a1 and aSMA, were transfected with dCas-VPR-Pool 1 as described above, followed by qPCR measurement of HNF4A, Col1a1, and aSMA.

As shown in FIG. 17, upregulation of HNF4α significantly down-regulated expression of Col1a1 and aSMA.

The second experiment of this example demonstrates that the ZF-VPR fusion proteins also down-regulate expression of Col1a1 and aSMA, biomarkers of fibrotic liver disease.

As shown in FIG. 18, biomarkers of fibrotic liver disease. Cola1 and aSMA, were down-regulated in LX-2 cells following up-regulation of HNF4α with ZF5.3-VPR, a combination of ZF5-VPR and ZF7-VPR or a combination of ZF5.3-VPR and ZF7-VPR.

Example 9. Screening of Additional ZF-VPR Fusion Proteins and Combinations Thereof and Assessment of dCas9-VPR3

This example demonstrates that, in addition to the nine ZF-VPR proteins tested in Example 4, other ZF-VPR fusion proteins and various combinations thereof can upregulate the expression of HNF4α in LX-2 cells.

In the first experiment, fusion proteins were screened in LX-2 cells. Untreated Hep G2 cells were included as an assay control. LX-2 cells was treated with a single concentration of effector (2.5 μg/mL) in triplicate and incubated for 48 hours. ZF-5-VPR was used as a positive control for qPCR readout. LX-2 cells were transfected as described above using MC3-LNP formulations. The mRNAs encoding the following ZF-VPR fusion proteins and various combinations were transferred: ZF5-VPR, ZF5-VPR-ATUM3 (ZF5.3-VPR), ZF-7-VPR, ZF-11-VPR, ZF-13-VPR, and ZF-15-VPR, or combinations thereof.

As shown in FIG. 19, stronger upregulation was observed when ZF5-VPR or ZF5.3-VPR were combined with ZF7-VPR. ZF7-VPR alone upregulated HNF4α in LX-2 cells to a low level.

In the second experiment, activation of HNF4α using dCas9-VPR3-Pool 1 or ZF-VPR fusion protein combinations was assessed. The objective was to evaluate the effects of various ZF-VPR fusion proteins in combinations in LX-2 Cells and test the new effector dCas9-VPR3 on LX-2 cells. VPR3 is a dCas9 DNA binding domain fused to 3 consecutive VPR domains in a row, expressed as a single protein. The combinations of ZF5.3-VPR and other ZF-VPRs that slightly upregulated the expression of HNF4α in LX-2 cells were tested for possible synergy. LX-2 cells were treated with a single concentration of effectors (2.5 ag/mL) in MC3 LNP formulations in triplicate for 48 hours. ZF-5-VPR was used as a positive control qPCR readout was used. The following combinations were tested: ZF5.3-VPR and ZF10-VPR, ZF5.3-VPR and ZF14-VPR, and ZF5.3-VPR and ZF15-VPR.

As shown in FIG. 20, dCas9-VPR3 Pool 1 upregulates HNF4α in LX-2 cells. ZF14-VPR and ZF15-VPR caused low upregulation of HNF4α when transfected individually. A strong synergistic upregulation (similar to the synergistic upregulation observed with ZF5.3-VPR+ZF7-VPR) was observed when ZF14-VPR or ZF15-VPR were in combination with ZF5.3-VPR.

Example 10. HNF4α Activation in FRG-KO Mouse Liver Humanized Hepatocytes (Yecuris Human Hepatocytes)

Yecuris human hepatocytes are primary human hepatocytes ex-planted into an immunocompromised mouse, allowed to proliferate, and then harvested for in vitro tissue culture. Yecuris hepatocytes were obtained as a cell suspension and plated in 96-well format at 40K cells/well. Cells were treated with ZF fusion protein-MC3 LNPs for 24 hrs at two concentrations, 2.5 μg/ml and 1.25 μg/ml. HNF4α gene expression was measured at 48 hrs post treatment. ZF7.4-VPR was used instead of ZF7-VPR.

Yecuris cells were transfected with mRNAs encoding ZF5-VPR, ZF5.3-VPR, ZF7.4-VPR, ZF5.3-VPR3 (a ZF5.3 protein fused to 3 consecutive VPR domains in a row, expressed as a single protein), ZF7.4-VPR3, and ZF5-alone (with no VPR fused to ZF5).

As shown in FIG. 21, ZF5.3-VPR3 does not increase HNF4α gene expression compared to ZF5.3-VPR. An increase in HNF4α gene expression was observed with ZF7-VPR3 as compared to ZF7.4-VPR. As compared to the LX-2 cells, the ZF7-VPR constructs upregulate HNF4α to a greater level.

Example 11. Activation of LX-2 Cells with Bicistronic ZF5.3-VPR and ZF7-VPR

This example evaluates whether ZF5.3-VPR (ZF5-VPR ATUM variant 3) and ZF7-VPR bicistronic constructs upregulate HNF4α in LX-2 cells to the same level as ZF5.3-VPR and ZF7-VPR when individually combined.

Untreated Hep G2 cells were included as an assay control. LX-2 cells were treated with a single concentration of the mRNAs encoding the fusion proteins (2.5 μg/mL) in triplicate. The combination of ZF5.3-VPR and ZF7-VPR was used as a positive control. qPCR readout was used to measure mRNA expression.

The following bicistronic mRNA constructs were tested: ZF5.3-VPR-tPT2A-ZF7-VPR, ZF7-ZF5.3-VPR-tPT2A-ZF7-p300, and ZF7-p300-tPT2A-ZF5.3-VPR (see Table 6A). tPT2A is a linker that covalently links a first fusion protein to a second fusion protein to generate a bicistronic fusion protein.

As shown in FIG. 22, the bicistronic mRNA ZF5.3-VPR-tPT2A-ZF7-VPR induced stronger upregulation of HNF4α in LX-2 cells than the other 3 bicistronic mRNAs tested.

Example 12. Effect of Repeat Dosing of Yecuris Hepatocytes with VPR and p300 on HNF4α Gene Expression

This example describes the effect of delivering multiple doses of mRNA encoding ZF-effector fusion proteins to cells. The objective was to evaluate whether additive or synergistic upregulation of HNF4α can be achieved by multiple dosing.

Yecuris hepatocytes were plated at 64K cells/well. Cells were treated with the combination of ZF5.3-VPR and ZF7-VPR or ZF7-p300 via MC3 LNP formulations at a final concentration of 1.25 μg/ml. Bicistronic mRNAs ZF5.3-VPR-tPT2A-ZF7-VPR, ZF7-VPR-tPT2A-ZF5.3-VPR, ZF5.3-VPR-tPT2A-ZF7-p300, ZF7-p300-tPT2A-ZF5.3-VPR in MC3 LNP formulations were used to treat cells at a final concentration of 1.25 μg/ml.

The expression level of the HNF4α was measured at 48 hrs post last dose. The dosing and harvesting schedule followed in this experiment is provided in Table 8, below.

TABLE 8 Dose Harvest Day 0 Dose 1 Day 1 Media change Day 2 Harvest Day 3 Dose 2 Day 4 Media change Day 5 Harvest Day 6 Dose 3 Day 7 Media change Day 8 Harvest

As shown in FIG. 23, repeated dosing of cells with MC3 LNP formulations containing mRNAs encoding ZF-effector fusion proteins resulted in an additive increase of expression of HNF4α. The combination of ZF5.3-VPR and ZF7-VPR was stronger than ZF7-p300 in its activation potential. In addition, and as shown in FIG. 24, bicistronic constructs increased HNF4α in Yecuris hepatocytes, with ZF7-p300-tPT2A-ZF5.3-VPR providing the strongest upregulation.

Example 13: Activation of HNF4α in K562 Cells with Bi-Cistronic mRNA-10 Day Durability Study

This example describes the durability of the bicistronic constructs in K562 cells. K562 cells were treated with a single concentration of mRNAs encoding the fusion proteins in MC3 LNPs (2.5 μg/mL) in triplicate as described above.

The bicistronic mRNAs encoding the following constructs were tested: ZF5.3-VPR-tPT2A-ZF7-VPR, ZF7-VPR-tPT2A-ZF5.3-VPR, ZF5.3-VPR-tPT2A-ZF7-p300, ZF7-p300-tPT2A-ZF5.3-VPR.

As shown in FIG. 25, ZF7-p300-tPT2A-ZF5 (v3)-VPR showed better durability in K562 at later days as compared to other bicistronic constructs.

Table 9 below provides exemplary target nucleotide sequences and corresponding sgRNA nucleotide sequences suitable for use in the present invention.

TABLE 9 Genomic Coordinates of the Target Start Site in Genome Reference Consortium  Human Build 37 (GRCh37): sgRNA sequence Chromosome 20) Strand Target sequence SEQ ID NO PAM [PLEASE ADVISE, NO “Us”] SEQ ID NO 43029193 −1 CCCTCACCCCCACCCCCTCC 344 CGG CCCTCACCCCCACCCCCTCCGTTTTAGAGCTAGAAATAGCAAGTTA 596 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029203 1 TCCGGGAGGGGGTGGGGGTG 345 AGG TCCGGGAGGGGGTGGGGGTGGTTTTAGAGCTAGAAATAGCAAGTTA 597 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029204 1 CCGGGAGGGGGTGGG 346 GGG CCGGGAGGGGGTGGGGGTGAGTTTTAGAGCTAGAAATAGCAAGTTA 598 GGTGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029211 1 GGGGTGGGGGTGAGG 347 AGG GGGGTGGGGGTGAGGGAAACGTTTTAGAGCTAGAAATAGCAAGTTA 599 GAAAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029223 1 AGGGAAACAGGAGAA 348 TGG AGGGAAACAGGAGAATGTGAGTTTTAGAGCTAGAAATAGCAAGTTA 600 TGTGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029224 1 GGGAAACAGGAGAAT 349 GGG GGGAAACAGGAGAATGTGATGTTTTAGAGCTAGAAATAGCAAGTTA 601 GTGAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029238 1 TGTGATGGGAAAATC 350 TGG TGTGATGGGAAAATCCGAGAGTTTTAGAGCTAGAAATAGCAAGTTA 602 CGAGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029241 −1 GGCCCAGGCTGGCTC 351 CGG GGCCCAGGCTGGCTCCATCTGTTTTAGAGCTAGAAATAGCAAGTTA 603 CATCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029249 1 AATCCGAGATGGAGC 352 TGG AATCCGAGATGGAGCCAGCCGTTTTAGAGCTAGAAATAGCAAGTTA 604 CAGCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029250 1 ATCCGAGATGGAGCC 353 GGG ATCCGAGATGGAGCCAGCCTGTTTTAGAGCTAGAAATAGCAAGTTA 605 AGCCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029252 −1 CCAGTGTTTCTGGCC 354 TGG CCAGTGTTTCTGGCCCAGGCGTTTTAGAGCTAGAAATAGCAAGTTA 606 CAGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029256 −1 GCTCCCAGTGTTTCT 355 AGG GCTCCCAGTGTTTCTGGCCCGTTTTAGAGCTAGAAATAGCAAGTTA 607 GGCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029262 −1 CCCACAGCTCCCAGT 356 TGG CCCACAGCTCCCAGTGTTTCGTTTTAGAGCTAGAAATAGCAAGTTA 608 GTTTC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029263 1 CCAGCCTGGGCCAGA 357 TGG CCAGCCTGGGCCAGAAACACGTTTTAGAGCTAGAAATAGCAAGTTA 609 AACAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029264 1 CAGCCTGGGCCAGAA 358 GGG CAGCCTGGGCCAGAAACACTGTTTTAGAGCTAGAAATAGCAAGTTA 610 ACACT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029272 1 GCCAGAAACACTGGG 359 TGG GCCAGAAACACTGGGAGCTGGTTTTAGAGCTAGAAATAGCAAGTTA 611 AGCTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029273 1 CCAGAAACACTGGGA 360 GGG CCAGAAACACTGGGAGCTGTGTTTTAGAGCTAGAAATAGCAAGTTA 612 GCTGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029279 1 ACACTGGGAGCTGTGGGAGA 361 CGG ACACTGGGAGCTGTGGGAGAGTTTTAGAGCTAGAAATAGCAAGTTA 613 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029284 1 GGGAGCTGTGGGAGA 362 AGG GGGAGCTGTGGGAGACGGAGGTTTTAGAGCTAGAAATAGCAAGTTA 614 CGGAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029285 1 GGAGCTGTGGGAGAC 363 GGG GGAGCTGTGGGAGACGGAGAGTTTTAGAGCTAGAAATAGCAAGTTA 615 GGAGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029286 1 GAGCTGTGGGAGACG 364 GGG GAGCTGTGGGAGACGGAGAGGTTTTAGAGCTAGAAATAGCAAGTTA 616 GAGAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029290 1 TGTGGGAGACGGAGA 365 AGG TGTGGGAGACGGAGAGGGGCGTTTTAGAGCTAGAAATAGCAAGTTA 617 GGGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029291 1 GTGGGAGACGGAGAG 366 GGG GTGGGAGACGGAGAGGGGCAGTTTTAGAGCTAGAAATAGCAAGTTA 618 GGGCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029294 1 GGAGACGGAGAGGGG 367 TGG GGAGACGGAGAGGGGCAGGGGTTTTAGAGCTAGAAATAGCAAGTTA 619 CAGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029295 1 GAGACGGAGAGGGGC 368 GGG GAGACGGAGAGGGGCAGGGTGTTTTAGAGCTAGAAATAGCAAGTTA 620 AGGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029303 1 GAGGGGCAGGGTGGG 369 AGG GAGGGGCAGGGTGGGATCACGTTTTAGAGCTAGAAATAGCAAGTTA 621 ATCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029304 1 AGGGGCAGGGTGGGA 370 GGG AGGGGCAGGGTGGGATCACAGTTTTAGAGCTAGAAATAGCAAGTTA 622 TCACA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029310 1 AGGGTGGGATCACAGGGAGC 371 AGG AGGGTGGGATCACAGGGAGCGTTTTAGAGCTAGAAATAGCAAGTTA 623 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029315 1 GGGATCACAGGGAGC 372 CGG GGGATCACAGGGAGCAGGAGGTTTTAGAGCTAGAAATAGCAAGTTA 624 AGGAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029316 1 GGATCACAGGGAGCA 373 GGG GGATCACAGGGAGCAGGAGCGTTTTAGAGCTAGAAATAGCAAGTTA 625 GGAGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029317 1 GATCACAGGGAGCAG 374 GGG GATCACAGGGAGCAGGAGCGGTTTTAGAGCTAGAAATAGCAAGTTA 626 GAGCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029323 1 AGGGAGCAGGAGCGG 375 TGG AGGGAGCAGGAGCGGGGAATGTTTTAGAGCTAGAAATAGCAAGTTA 627 GGAAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029326 1 GAGCAGGAGCGGGGA 376 AGG GAGCAGGAGCGGGGAATTGGGTTTTAGAGCTAGAAATAGCAAGTTA 628 ATTGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029335 1 CGGGGAATTGGAGGT 377 TGG CGGGGAATTGGAGGTGAATCGTTTTAGAGCTAGAAATAGCAAGTTA 629 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GAATC GTGCTTTT 43029347 −1 AATGGACTGGAAGTT 378 GGG AATGGACTGGAAGTTTGGGAGTTTTAGAGCTAGAAATAGCAAGTTA 630 TGGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029348 −1 GAATGGACTGGAAGT 379 AGG GAATGGACTGGAAGTTTGGGGTTTTAGAGCTAGAAATAGCAAGTTA 631 TTGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029351 −1 GCAGAATGGACTGGA 380 GGG GCAGAATGGACTGGAAGTTTGTTTTAGAGCTAGAAATAGCAAGTTA 632 AGTTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029352 −1 AGCAGAATGGACTGGAAGTT 381 TGG AGCAGAATGGACTGGAAGTTGTTTTAGAGCTAGAAATAGCAAGTTA 633 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029360 −1 CCCCTGGGAGCAGAA 382 TGG CCCCTGGGAGCAGAATGGACGTTTTAGAGCTAGAAATAGCAAGTTA 634 TGGAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029365 −1 CGGTTCCCCTGGGAG 383 TGG CGGTTCCCCTGGGAGCAGAAGTTTTAGAGCTAGAAATAGCAAGTTA 635 CAGAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029369 1 TTCCAGTCCATTCTG 384 AGG TTCCAGTCCATTCTGCTCCCGTTTTAGAGCTAGAAATAGCAAGTTA 636 CTCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029370 1 TCCAGTCCATTCTGC 385 GGG TCCAGTCCATTCTGCTCCCAGTTTTAGAGCTAGAAATAGCAAGTTA 637 TCCCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029371 1 CCAGTCCATTCTGCT 386 GGG CCAGTCCATTCTGCTCCCAGGTTTTAGAGCTAGAAATAGCAAGTTA 638 CCCAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029375 −1 CGCAGTTTCCCGGTT 387 GGG CGCAGTTTCCCGGTTCCCCTGTTTTAGAGCTAGAAATAGCAAGTTA 639 CCCCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029376 −1 CCGCAGTTTCCCGGT 388 TGG CCGCAGTTTCCCGGTTCCCCGTTTTAGAGCTAGAAATAGCAAGTTA 640 TCCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029377 1 CATTCTGCTCCCAGG 389 CGG CATTCTGCTCCCAGGGGAACGTTTTAGAGCTAGAAATAGCAAGTTA 641 GGAAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029378 1 ATTCTGCTCCCAGGG 390 GGG ATTCTGCTCCCAGGGGAACCGTTTTAGAGCTAGAAATAGCAAGTTA 642 GAACC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029385 −1 CCAGTTCCCCCGCAG 391 CGG CCAGTTCCCCCGCAGTTTCCGTTTTAGAGCTAGAAATAGCAAGTTA 643 TTTCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029387 1 CCAGGGGAACCGGGA 392 CGG CCAGGGGAACCGGGAAACTGGTTTTAGAGCTAGAAATAGCAAGTTA 644 AACTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029388 1 CAGGGGAACCGGGAA 393 GGG CAGGGGAACCGGGAAACTGCGTTTTAGAGCTAGAAATAGCAAGTTA 645 ACTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029389 1 AGGGGAACCGGGAAA 394 GGG AGGGGAACCGGGAAACTGCGGTTTTAGAGCTAGAAATAGCAAGTTA 646 CTGCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029390 1 GGGGAACCGGGAAAC 395 GGG GGGGAACCGGGAAACTGCGGGTTTTAGAGCTAGAAATAGCAAGTTA 647 TGCGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029396 1 CCGGGAAACTGCGGG 396 TGG CCGGGAAACTGCGGGGGAACGTTTTAGAGCTAGAAATAGCAAGTTA 648 GGAAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029400 1 GAAACTGCGGGGGAA 397 AGG GAAACTGCGGGGGAACTGGAGTTTTAGAGCTAGAAATAGCAAGTTA 649 CTGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029401 1 AAACTGCGGGGGAAC 398 GGG AAACTGCGGGGGAACTGGAAGTTTTAGAGCTAGAAATAGCAAGTTA 650 TGGAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029417 1 GGAAGGGAGCTCCCA 399 AGG GGAAGGGAGCTCCCAGAACAGTTTTAGAGCTAGAAATAGCAAGTTA 651 GAACA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029417 −1 ATCTTCTGGATCCTT 400 GGG ATCTTCTGGATCCTTGTTCTGTTTTAGAGCTAGAAATAGCAAGTTA 652 GTTCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029418 −1 AATCTTCTGGATCCTTGTTC 401 TGG AATCTTCTGGATCCTTGTTCGTTTTAGAGCTAGAAATAGCAAGTTA 653 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029431 1 AGAACAAGGATCCAG 402 TGG AGAACAAGGATCCAGAAGATGTTTTAGAGCTAGAAATAGCAAGTTA 654 AAGAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029431 −1 GGCCCCAGATGCCAA 403 TGG GGCCCCAGATGCCAATCTTCGTTTTAGAGCTAGAAATAGCAAGTTA 655 TCTTC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029438 1 GGATCCAGAAGATTG 404 TGG GGATCCAGAAGATTGGCATCGTTTTAGAGCTAGAAATAGCAAGTTA 656 GCATC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029439 1 GATCCAGAAGATTGG 405 GGG GATCCAGAAGATTGGCATCTGTTTTAGAGCTAGAAATAGCAAGTTA 657 CATCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029440 1 ATCCAGAAGATTGGC 406 GGG ATCCAGAAGATTGGCATCTGGTTTTAGAGCTAGAAATAGCAAGTTA 658 ATCTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029445 1 GAAGATTGGCATCTG 407 TGG GAAGATTGGCATCTGGGGCCGTTTTAGAGCTAGAAATAGCAAGTTA 659 GGGCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029446 1 AAGATTGGCATCTGG 408 GGG AAGATTGGCATCTGGGGCCTGTTTTAGAGCTAGAAATAGCAAGTTA 660 GGCCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029452 −1 GATTTAGAAACCTAA 409 AGG GATTTAGAAACCTAAATCCCGTTTTAGAGCTAGAAATAGCAAGTTA 661 ATCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029453 1 GCATCTGGGGCCTGG 410 AGG GCATCTGGGGCCTGGGATTTGTTTTAGAGCTAGAAATAGCAAGTTA 662 GATTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029467 1 GGATTTAGGTTTCTA 411 TGG GGATTTAGGTTTCTAAATCGGTTTTAGAGCTAGAAATAGCAAGTTA 663 AATCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029468 1 GATTTAGGTTTCTAA 412 GGG GATTTAGGTTTCTAAATCGTGTTTTAGAGCTAGAAATAGCAAGTTA 664 ATCGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029474 1 GGTTTCTAAATCGTG 413 TGG GGTTTCTAAATCGTGGGCCAGTTTTAGAGCTAGAAATAGCAAGTTA 665 GGCCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029475 1 GTTTCTAAATCGTGG 414 GGG GTTTCTAAATCGTGGGCCATGTTTTAGAGCTAGAAATAGCAAGTTA 666 GCCAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029476 1 TTTCTAAATCGTGGG 415 GGG TTTCTAAATCGTGGGCCATGGTTTTAGAGCTAGAAATAGCAAGTTA 667 CCATG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029480 −1 GCAGAGATAAGGCTG 416 TGG GCAGAGATAAGGCTGCCCCAGTTTTAGAGCTAGAAATAGCAAGTTA 668 CCCCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029491 −1 TCAATGCTTTTGCAG 417 AGG TCAATGCTTTTGCAGAGATAGTTTTAGAGCTAGAAATAGCAAGTTA 669 AGATA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029504 1 TTATCTCTGCAAAAG 418 AGG TTATCTCTGCAAAAGCATTGGTTTTAGAGCTAGAAATAGCAAGTTA 670 CATTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029505 1 TATCTCTGCAAAAGC 419 GGG TATCTCTGCAAAAGCATTGAGTTTTAGAGCTAGAAATAGCAAGTTA 671 ATTGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029523 1 GAGGGTAGAAGTCAA 420 TGG GAGGGTAGAAGTCAATGATTGTTTTAGAGCTAGAAATAGCAAGTTA 672 TGATT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029524 1 AGGGTAGAAGTCAATGATTT 421 GGG AGGGTAGAAGTCAATGATTTGTTTTAGAGCTAGAAATAGCAAGTTA 673 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029540 1 ATTTGGGAAGTTATT 422 AGG ATTTGGGAAGTTATTGAATTGTTTTAGAGCTAGAAATAGCAAGTTA 674 GAATT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029541 1 TTTGGGAAGTTATTG 423 GGG TTTGGGAAGTTATTGAATTAGTTTTAGAGCTAGAAATAGCAAGTTA 675 AATTA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029542 1 TTGGGAAGTTATTGA 424 GGG TTGGGAAGTTATTGAATTAGGTTTTAGAGCTAGAAATAGCAAGTTA 676 ATTAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029549 1 GTTATTGAATTAGGG 425 CGG GTTATTGAATTAGGGGATCTGTTTTAGAGCTAGAAATAGCAAGTTA 677 GATCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029552 1 ATTGAATTAGGGGAT 333 AGG ATTGAATTAGGGGATCTCGGGTTTTAGAGCTAGAAATAGCAAGTTA 678 CTCGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029556 1 AATTAGGGGATCTCG 426 AGG AATTAGGGGATCTCGGAGGTGTTTTAGAGCTAGAAATAGCAAGTTA 679 GAGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029577 −1 GCATTCTAACTGATA 427 AGG GCATTCTAACTGATACTATCGTTTTAGAGCTAGAAATAGCAAGTTA 680 CTATC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029597 1 ATCAGTTAGAATGCC 428 TGG ATCAGTTAGAATGCCTGACTGTTTTAGAGCTAGAAATAGCAAGTTA 681 TGACT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029598 1 TCAGTTAGAATGCCT 429 GGG TCAGTTAGAATGCCTGACTTGTTTTAGAGCTAGAAATAGCAAGTTA 682 GACTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029599 1 CAGTTAGAATGCCTG 430 GGG CAGTTAGAATGCCTGACTTGGTTTTAGAGCTAGAAATAGCAAGTTA 683 ACTTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029599 −1 AGCCATTGTCACCCC 340 AGG AGCCATTGTCACCCCAAGTCGTTTTAGAGCTAGAAATAGCAAGTTA 684 AAGTC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029608 1 TGCCTGACTTGGGGT 431 TGG TGCCTGACTTGGGGTGACAAGTTTTAGAGCTAGAAATAGCAAGTTA 685 GACAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029613 1 GACTTGGGGTGACAA 334 TGG GACTTGGGGTGACAATGGCTGTTTTAGAGCTAGAAATAGCAAGTTA 686 TGGCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029616 1 TTGGGGTGACAATGG 432 AGG TTGGGGTGACAATGGCTTGGGTTTTAGAGCTAGAAATAGCAAGTTA 687 CTTGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029617 1 TGGGGTGACAATGGC 433 GGG TGGGGTGACAATGGCTTGGAGTTTTAGAGCTAGAAATAGCAAGTTA 688 TTGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029618 1 GGGGTGACAATGGCT 434 GGG GGGGTGACAATGGCTTGGAGGTTTTAGAGCTAGAAATAGCAAGTTA 689 TGGAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029621 1 GTGACAATGGCTTGG 435 TGG GTGACAATGGCTTGGAGGGGGTTTTAGAGCTAGAAATAGCAAGTTA 690 AGGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029622 1 TGACAATGGCTTGGA 436 GGG TGACAATGGCTTGGAGGGGTGTTTTAGAGCTAGAAATAGCAAGTTA 691 GGGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029632 1 TTGGAGGGGTGGGTG 437 AGG TTGGAGGGGTGGGTGAGTCAGTTTTAGAGCTAGAAATAGCAAGTTA 692 AGTCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029633 1 TGGAGGGGTGGGTGA 438 GGG TGGAGGGGTGGGTGAGTCAAGTTTTAGAGCTAGAAATAGCAAGTTA 693 GTCAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029656 −1 AGGCAGGCATCATGA 439 GGG AGGCAGGCATCATGACTCACGTTTTAGAGCTAGAAATAGCAAGTTA 694 CTCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029657 −1 AAGGCAGGCATCATG 440 CGG AAGGCAGGCATCATGACTCAGTTTTAGAGCTAGAAATAGCAAGTTA 695 ACTCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029672 −1 AGTTATCAATTGTAC 441 AGG AGTTATCAATTGTACAAGGCGTTTTAGAGCTAGAAATAGCAAGTTA 696 AAGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029676 −1 GTTCAGTTATCAATT 442 AGG GTTCAGTTATCAATTGTACAGTTTTAGAGCTAGAAATAGCAAGTTA 697 GTACA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029692 1 TACAATTGATAACTG 443 CGG TACAATTGATAACTGAACATGTTTTAGAGCTAGAAATAGCAAGTTA 698 AACAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029701 1 TAACTGAACATCGGT 444 AGG TAACTGAACATCGGTGAGTTGTTTTAGAGCTAGAAATAGCAAGTTA 699 GAGTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029702 1 AACTGAACATCGGTG 2511 GGG AACTGAACATCGGTGAGTTAGTTTTAGAGCTAGAAATAGCAAGTTA 700 AGTTA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029714 −1 GGTGCTAATTACAAC 445 GGG GGTGCTAATTACAACTGCTGGTTTTAGAGCTAGAAATAGCAAGTTA 701 TGCTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029715 −1 GGGTGCTAATTACAA 446 GGG GGGTGCTAATTACAACTGCTGTTTTAGAGCTAGAAATAGCAAGTTA 702 CTGCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029716 −1 GGGGTGCTAATTACA 447 TGG GGGGTGCTAATTACAACTGCGTTTTAGAGCTAGAAATAGCAAGTTA 703 ACTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029729 1 AGCAGTTGTAATTAG 448 CGG AGCAGTTGTAATTAGCACCCGTTTTAGAGCTAGAAATAGCAAGTTA 704 CACCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029730 1 GCAGTTGTAATTAGC 449 GGG GCAGTTGTAATTAGCACCCCGTTTTAGAGCTAGAAATAGCAAGTTA 705 ACCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029735 −1 TGGTTTCTGGCTGAC 2512 GGG TGGTTTCTGGCTGACACCCGGTTTTAGAGCTAGAAATAGCAAGTTA 706 ACCCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029736 −1 TTGGTTTCTGGCTGA 450 GGG TTGGTTTCTGGCTGACACCCGTTTTAGAGCTAGAAATAGCAAGTTA 707 CACCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029737 −1 GTTGGTTTCTGGCTG 451 CGG GTTGGTTTCTGGCTGACACCGTTTTAGAGCTAGAAATAGCAAGTTA 708 ACACC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029748 −1 TTTGGCTGTTTGTTG 452 TGG TTTGGCTGTTTGTTGGTTTCGTTTTAGAGCTAGAAATAGCAAGTTA 709 GTTTC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029755 −1 GCAGGGATTTGGCTG 453 TGG GCAGGGATTTGGCTGTTTGTGTTTTAGAGCTAGAAATAGCAAGTTA 710 TTTGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029766 -1 TGGGCGGGGCTGCAG 454 TGG TGGGCGGGGCTGCAGGGATTGTTTTAGAGCTAGAAATAGCAAGTTA 711 GGATT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029772 −1 ATAGGCTGGGCGGGG 455 GGG ATAGGCTGGGCGGGGCTGCAGTTTTAGAGCTAGAAATAGCAAGTTA 712 CTGCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029773 −1 GATAGGCTGGGCGGG 456 AGG GATAGGCTGGGCGGGGCTGCGTTTTAGAGCTAGAAATAGCAAGTTA 713 GCTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029780 −1 GCCGGTGGATAGGCT 457 GGG GCCGGTGGATAGGCTGGGCGGTTTTAGAGCTAGAAATAGCAAGTTA 714 GGGCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029781 −1 CGCCGGTGGATAGGC 458 GGG CGCCGGTGGATAGGCTGGGCGTTTTAGAGCTAGAAATAGCAAGTTA 715 TGGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029782 −1 CCGCCGGTGGATAGG 459 CGG CCGCCGGTGGATAGGCTGGGGTTTTAGAGCTAGAAATAGCAAGTTA 716 CTGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029785 −1 CCCCCGCCGGTGGAT 460 GGG CCCCCGCCGGTGGATAGGCTGTTTTAGAGCTAGAAATAGCAAGTTA 717 AGGCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029786 −1 TCCCCCGCCGGTGGA 461 TGG TCCCCCGCCGGTGGATAGGCGTTTTAGAGCTAGAAATAGCAAGTTA 718 TAGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029790 1 GCCCCGCCCAGCCTA 462 CGG GCCCCGCCCAGCCTATCCACGTTTTAGAGCTAGAAATAGCAAGTTA 719 TCCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029790 −1 TCGGTCCCCCGCCGG 463 AGG TCGGTCCCCCGCCGGTGGATGTTTTAGAGCTAGAAATAGCAAGTTA 720 TGGAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029793 1 CCGCCCAGCCTATCC 464 CGG CCGCCCAGCCTATCCACCGGGTTTTAGAGCTAGAAATAGCAAGTTA 721 ACCGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029794 1 CGCCCAGCCTATCCA 465 GGG CGCCCAGCCTATCCACCGGCGTTTTAGAGCTAGAAATAGCAAGTTA 722 CCGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029795 1 GCCCAGCCTATCCAC 466 GGG GCCCAGCCTATCCACCGGCGGTTTTAGAGCTAGAAATAGCAAGTTA 723 CGGCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029795 −1 GTTAATCGGTCCCCC 467 TGG GTTAATCGGTCCCCCGCCGGGTTTTAGAGCTAGAAATAGCAAGTTA 724 GCCGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029796 1 CCCAGCCTATCCACC 468 GGG CCCAGCCTATCCACCGGCGGGTTTTAGAGCTAGAAATAGCAAGTTA 725 GGCGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029798 −1 ATGGTTAATCGGTCC 2513 CGG ATGGTTAATCGGTCCCCCGCGTTTTAGAGCTAGAAATAGCAAGTTA 726 CCCGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029809 −1 GGTGGGGGTTAATGG 469 CGG GGTGGGGGTTAATGGTTAATGTTTTAGAGCTAGAAATAGCAAGTTA 727 TTAAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029817 −1 CGGGGAGGGGTGGGG 470 TGG CGGGGAGGGGTGGGGGTTAAGTTTTAGAGCTAGAAATAGCAAGTTA 728 GTTAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029824 −1 GCTCTGCCGGGGAGG 471 GGG GCTCTGCCGGGGAGGGGTGGGTTTTAGAGCTAGAAATAGCAAGTTA 729 GGTGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029825 −1 GGCTCTGCCGGGGAG 472 GGG GGCTCTGCCGGGGAGGGGTGGTTTTAGAGCTAGAAATAGCAAGTTA 730 GGGTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029826 −1 AGGCTCTGCCGGGGA 473 GGG AGGCTCTGCCGGGGAGGGGTGTTTTAGAGCTAGAAATAGCAAGTTA 731 GGGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029827 −1 GAGGCTCTGCCGGGG 474 TGG GAGGCTCTGCCGGGGAGGGGGTTTTAGAGCTAGAAATAGCAAGTTA 732 AGGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029829 1 CATTAACCCCCACCC 475 CGG CATTAACCCCCACCCCTCCCGTTTTAGAGCTAGAAATAGCAAGTTA 733 CTCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029830 −1 GTGGAGGCTCTGCCG 476 GGG GTGGAGGCTCTGCCGGGGAGGTTTTAGAGCTAGAAATAGCAAGTTA 734 GGGAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029831 −1 GGTGGAGGCTCTGCC 477 GGG GGTGGAGGCTCTGCCGGGGAGTTTTAGAGCTAGAAATAGCAAGTTA 735 GGGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029832 −1 GGGTGGAGGCTCTGC 478 AGG GGGTGGAGGCTCTGCCGGGGGTTTTAGAGCTAGAAATAGCAAGTTA 736 CGGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029835 −1 AAGGGGTGGAGGCTC 479 GGG AAGGGGTGGAGGCTCTGCCGGTTTTAGAGCTAGAAATAGCAAGTTA 737 TGCCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029836 −1 GAAGGGGTGGAGGCT 480 GGG GAAGGGGTGGAGGCTCTGCCGTTTTAGAGCTAGAAATAGCAAGTTA 738 CTGCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029837 −1 TGAAGGGGTGGAGGC 481 CGG TGAAGGGGTGGAGGCTCTGCGTTTTAGAGCTAGAAATAGCAAGTTA 739 TCTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029846 −1 TAGCCTCTGTGAAGG 482 AGG TAGCCTCTGTGAAGGGGTGGGTTTTAGAGCTAGAAATAGCAAGTTA 740 GGTGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029849 −1 GCCTAGCCTCTGTGA 483 TGG GCCTAGCCTCTGTGAAGGGGGTTTTAGAGCTAGAAATAGCAAGTTA 741 AGGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029852 −1 TTGGCCTAGCCTCTG 484 GGG TTGGCCTAGCCTCTGTGAAGGTTTTAGAGCTAGAAATAGCAAGTTA 742 TGAAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029853 −1 CTTGGCCTAGCCTCT 485 GGG CTTGGCCTAGCCTCTGTGAAGTTTTAGAGCTAGAAATAGCAAGTTA 743 GTGAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029854 1 GAGCCTCCACCCCTT 486 AGG GAGCCTCCACCCCTTCACAGGTTTTAGAGCTAGAAATAGCAAGTTA 744 CACAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029854 −1 TCTTGGCCTAGCCTC 487 AGG TCTTGGCCTAGCCTCTGTGAGTTTTAGAGCTAGAAATAGCAAGTTA 745 TGTGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029859 1 TCCACCCCTTCACAG 488 AGG TCCACCCCTTCACAGAGGCTGTTTTAGAGCTAGAAATAGCAAGTTA 746 AGGCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029871 −1 GGAAGATCTGCTGGG 489 TGG GGAAGATCTGCTGGGAGTCTGTTTTAGAGCTAGAAATAGCAAGTTA 747 AGTCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029879 −1 GTCCTCTGGGAAGAT 2514 GGG GTCCTCTGGGAAGATCTGCTGTTTTAGAGCTAGAAATAGCAAGTTA 748 CTGCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029880 −1 CGTCCTCTGGGAAGA 490 TGG CGTCCTCTGGGAAGATCTGCGTTTTAGAGCTAGAAATAGCAAGTTA 749 TCTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029888 1 CTCCCAGCAGATCTT 491 AGG CTCCCAGCAGATCTTCCCAGGTTTTAGAGCTAGAAATAGCAAGTTA 750 CCCAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029892 1 CAGCAGATCTTCCCA 492 CGG CAGCAGATCTTCCCAGAGGAGTTTTAGAGCTAGAAATAGCAAGTTA 751 GAGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029892 −1 TTCCTTTCAAACCGT 493 GGG TTCCTTTCAAACCGTCCTCTGTTTTAGAGCTAGAAATAGCAAGTTA 752 CCTCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029893 −1 CTTCCTTTCAAACCG 494 TGG CTTCCTTTCAAACCGTCCTCGTTTTAGAGCTAGAAATAGCAAGTTA 753 TCCTC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029901 1 TTCCCAGAGGACGGT 495 AGG TTCCCAGAGGACGGTTTGAAGTTTTAGAGCTAGAAATAGCAAGTTA 754 TTGAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029905 1 CAGAGGACGGTTTGA 496 AGG CAGAGGACGGTTTGAAAGGAGTTTTAGAGCTAGAAATAGCAAGTTA 755 AAGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029913 1 GGTTTGAAAGGAAGG 2515 AGG GGTTTGAAAGGAAGGCAGAGGTTTTAGAGCTAGAAATAGCAAGTTA 756 CAGAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029914 1 GTTTGAAAGGAAGGC 497 GGG GTTTGAAAGGAAGGCAGAGAGTTTTAGAGCTAGAAATAGCAAGTTA 757 AGAGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029920 1 AAGGAAGGCAGAGAG 498 TGG AAGGAAGGCAGAGAGGGCACGTTTTAGAGCTAGAAATAGCAAGTTA 758 GGCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029921 1 AGGAAGGCAGAGAGG 499 GGG AGGAAGGCAGAGAGGGCACTGTTTTAGAGCTAGAAATAGCAAGTTA 759 GCACT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029924 1 AAGGCAGAGAGGGCA 500 AGG AAGGCAGAGAGGGCACTGGGGTTTTAGAGCTAGAAATAGCAAGTTA 760 CTGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029927 1 GCAGAGAGGGCACTG 501 AGG GCAGAGAGGGCACTGGGAGGGTTTTAGAGCTAGAAATAGCAAGTTA 761 GGAGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029933 1 AGGGCACTGGGAGGA 502 TGG AGGGCACTGGGAGGAGGCAGGTTTTAGAGCTAGAAATAGCAAGTTA 762 GGCAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029934 1 GGGCACTGGGAGGAGGCAGT 503 GGG GGGCACTGGGAGGAGGCAGTGTTTTAGAGCTAGAAATAGCAAGTTA 763 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029937 1 CACTGGGAGGAGGCA 504 AGG CACTGGGAGGAGGCAGTGGGGTTTTAGAGCTAGAAATAGCAAGTTA 764 GTGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029938 1 ACTGGGAGGAGGCAG 505 GGG ACTGGGAGGAGGCAGTGGGAGTTTTAGAGCTAGAAATAGCAAGTTA 765 TGGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029941 1 GGGAGGAGGCAGTGG 506 CGG GGGAGGAGGCAGTGGGAGGGGTTTTAGAGCTAGAAATAGCAAGTTA 766 GAGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029944 1 AGGAGGCAGTGGGAG 507 AGG AGGAGGCAGTGGGAGGGCGGGTTTTAGAGCTAGAAATAGCAAGTTA 767 GGCGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029945 1 GGAGGCAGTGGGAGG 508 GGG GGAGGCAGTGGGAGGGCGGAGTTTTAGAGCTAGAAATAGCAAGTTA 768 GCGGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029948 1 GGCAGTGGGAGGGCG 509 CGG GGCAGTGGGAGGGCGGAGGGGTTTTAGAGCTAGAAATAGCAAGTTA 769 GAGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029949 1 GCAGTGGGAGGGCGG 510 GGG GCAGTGGGAGGGCGGAGGGCGTTTTAGAGCTAGAAATAGCAAGTTA 770 AGGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029950 1 CAGTGGGAGGGCGGA 511 GGG CAGTGGGAGGGCGGAGGGCGGTTTTAGAGCTAGAAATAGCAAGTTA 771 GGGCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029951 1 AGTGGGAGGGCGGAG 512 GGG AGTGGGAGGGCGGAGGGCGGGTTTTAGAGCTAGAAATAGCAAGTTA 772 GGCGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029958 1 GGGCGGAGGGCGGGG 513 CGG GGGCGGAGGGCGGGGGCCTTGTTTTAGAGCTAGAAATAGCAAGTTA 773 GCCTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029959 1 GGCGGAGGGCGGGGG 514 GGG GGCGGAGGGCGGGGGCCTTCGTTTTAGAGCTAGAAATAGCAAGTTA 774 CCTTC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029960 1 GCGGAGGGCGGGGGC 515 GGG GCGGAGGGCGGGGGCCTTCGGTTTTAGAGCTAGAAATAGCAAGTTA 775 CTTCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029963 1 GAGGGCGGGGGCCTT 516 TGG GAGGGCGGGGGCCTTCGGGGGTTTTAGAGCTAGAAATAGCAAGTTA 776 CGGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029963 −1 ACCCTGGGCGCCCAC 2516 AGG ACCCTGGGCGCCCACCCCGAGTTTTAGAGCTAGAAATAGCAAGTTA 777 CCCGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029964 1 AGGGCGGGGGCCTTC 517 GGG AGGGCGGGGGCCTTCGGGGTGTTTTAGAGCTAGAAATAGCAAGTTA 778 GGGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029972 1 GGCCTTCGGGGTGGG 518 AGG GGCCTTCGGGGTGGGCGCCCGTTTTAGAGCTAGAAATAGCAAGTTA 779 CGCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029973 1 GCCTTCGGGGTGGGC 519 GGG GCCTTCGGGGTGGGCGCCCAGTTTTAGAGCTAGAAATAGCAAGTTA 780 GCCCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029977 1 TCGGGGTGGGCGCCC 2517 AGG TCGGGGTGGGCGCCCAGGGTGTTTTAGAGCTAGAAATAGCAAGTTA 781 AGGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029978 1 CGGGGTGGGCGCCCA 520 GGG CGGGGTGGGCGCCCAGGGTAGTTTTAGAGCTAGAAATAGCAAGTTA 782 GGGTA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029978 −1 GCGGCCACCTGCCCT 521 GGG GCGGCCACCTGCCCTACCCTGTTTTAGAGCTAGAAATAGCAAGTTA 783 ACCCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029979 −1 CGCGGCCACCTGCCC 522 TGG CGCGGCCACCTGCCCTACCCGTTTTAGAGCTAGAAATAGCAAGTTA 784 TACCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029982 1 GTGGGCGCCCAGGGT 523 AGG GTGGGCGCCCAGGGTAGGGCGTTTTAGAGCTAGAAATAGCAAGTTA 785 AGGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029985 1 GGCGCCCAGGGTAGG 524 TGG GGCGCCCAGGGTAGGGCAGGGTTTTAGAGCTAGAAATAGCAAGTTA 786 GCAGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029991 1 CAGGGTAGGGCAGGT 525 CGG CAGGGTAGGGCAGGTGGCCGGTTTTAGAGCTAGAAATAGCAAGTTA 787 GGCCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029996 1 TAGGGCAGGTGGCCG 526 TGG TAGGGCAGGTGGCCGCGGCGGTTTTAGAGCTAGAAATAGCAAGTTA 788 CGGCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029997 −1 TTCTCCCTGCCTCCA 2518 CGG TTCTCCCTGCCTCCACGCCGGTTTTAGAGCTAGAAATAGCAAGTTA 789 CGCCG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43029999 1 GGCAGGTGGCCGCGG 527 AGG GGCAGGTGGCCGCGGCGTGGGTTTTAGAGCTAGAAATAGCAAGTTA 790 CGTGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030003 1 GGTGGCCGCGGCGTG 528 AGG GGTGGCCGCGGCGTGGAGGCGTTTTAGAGCTAGAAATAGCAAGTTA 791 GAGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030004 1 GTGGCCGCGGCGTGG 529 GGG GTGGCCGCGGCGTGGAGGCAGTTTTAGAGCTAGAAATAGCAAGTTA 792 AGGCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030029 −1 GTCCATGTCGACGAG 530 TGG GTCCATGTCGACGAGGGTTTGTTTTAGAGCTAGAAATAGCAAGTTA 793 GGTTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030035 −1 GGCCATGTCCATGTC 531 GGG GGCCATGTCCATGTCGACGAGTTTTAGAGCTAGAAATAGCAAGTTA 794 GACGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030036 −1 CGGCCATGTCCATGT 532 AGG CGGCCATGTCCATGTCGACGGTTTTAGAGCTAGAAATAGCAAGTTA 795 CGACG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030038 1 CTCCAAAACCCTCGT 533 TGG CTCCAAAACCCTCGTCGACAGTTTTAGAGCTAGAAATAGCAAGTTA 796 CGACA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030044 1 AACCCTCGTCGACAT 534 TGG AACCCTCGTCGACATGGACAGTTTTAGAGCTAGAAATAGCAAGTTA 797 GGACA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030056 −1 GTCCAGTGCAGCACT 535 CGG GTCCAGTGCAGCACTGTAGTGTTTTAGAGCTAGAAATAGCAAGTTA 798 GTAGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030065 1 GGCCGACTACAGTGC 536 TGG GGCCGACTACAGTGCTGCACGTTTTAGAGCTAGAAATAGCAAGTTA 799 TGCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030078 −1 ATTCCAGGGTGGTGT 537 GGG ATTCCAGGGTGGTGTAGGCTGTTTTAGAGCTAGAAATAGCAAGTTA 800 AGGCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030079 −1 AATTCCAGGGTGGTG 538 TGG AATTCCAGGGTGGTGTAGGCGTTTTAGAGCTAGAAATAGCAAGTTA 801 TAGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030083 −1 CTCAAATTCCAGGGT 539 AGG CTCAAATTCCAGGGTGGTGTGTTTTAGAGCTAGAAATAGCAAGTTA 802 GGTGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030086 1 GGACCCAGCCTACACCACCC 540 TGG GGACCCAGCCTACACCACCCGTTTTAGAGCTAGAAATAGCAAGTTA 803 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030089 −1 CACATTCTCAAATTC 541 TGG CACATTCTCAAATTCCAGGGGTTTTAGAGCTAGAAATAGCAAGTTA 804 CAGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030092 −1 CTGCACATTCTCAAA 542 GGG CTGCACATTCTCAAATTCCAGTTTTAGAGCTAGAAATAGCAAGTTA 805 TTCCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030093 −1 CCTGCACATTCTCAA 543 AGG CCTGCACATTCTCAAATTCCGTTTTAGAGCTAGAAATAGCAAGTTA 806 ATTCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030104 1 CCTGGAATTTGAGAA 544 AGG CCTGGAATTTGAGAATGTGCGTTTTAGAGCTAGAAATAGCAAGTTA 807 TGTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030116 1 GAATGTGCAGGTGTT 545 TGG GAATGTGCAGGTGTTGACGAGTTTTAGAGCTAGAAATAGCAAGTTA 808 GACGA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030117 1 AATGTGCAGGTGTTG 546 GGG AATGTGCAGGTGTTGACGATGTTTTAGAGCTAGAAATAGCAAGTTA 809 ACGAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030123 1 CAGGTGTTGACGATG 547 TGG CAGGTGTTGACGATGGGCAAGTTTTAGAGCTAGAAATAGCAAGTTA 810 GGCAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030127 1 TGTTGACGATGGGCA 548 AGG TGTTGACGATGGGCAATGGTGTTTTAGAGCTAGAAATAGCAAGTTA 811 ATGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030130 1 TGACGATGGGCAATG 549 TGG TGACGATGGGCAATGGTAGGGTTTTAGAGCTAGAAATAGCAAGTTA 812 GTAGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030131 1 GACGATGGGCAATGGTAGGT 550 GGG GACGATGGGCAATGGTAGGTGTTTTAGAGCTAGAAATAGCAAGTTA 813 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030132 1 ACGATGGGCAATGGT 551 GGG ACGATGGGCAATGGTAGGTGGTTTTAGAGCTAGAAATAGCAAGTTA 814 AGGTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030133 1 CGATGGGCAATGGTA 552 GGG CGATGGGCAATGGTAGGTGGGTTTTAGAGCTAGAAATAGCAAGTTA 815 GGTGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030147 1 AGGTGGGGGCAGATG 553 AGG AGGTGGGGGCAGATGTGCCCGTTTTAGAGCTAGAAATAGCAAGTTA 816 TGCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030153 −1 CTGCCCCCACTGGCA 554 GGG CTGCCCCCACTGGCACACCTGTTTTAGAGCTAGAAATAGCAAGTTA 817 CACCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030154 −1 CCTGCCCCCACTGGC 555 TGG CCTGCCCCCACTGGCACACCGTTTTAGAGCTAGAAATAGCAAGTTA 818 ACACC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030158 1 GATGTGCCCAGGTGT 556 TGG GATGTGCCCAGGTGTGCCAGGTTTTAGAGCTAGAAATAGCAAGTTA 819 GCCAG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030159 1 ATGTGCCCAGGTGTG 557 GGG ATGTGCCCAGGTGTGCCAGTGTTTTAGAGCTAGAAATAGCAAGTTA 820 CCAGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030160 1 TGTGCCCAGGTGTGC 558 GGG TGTGCCCAGGTGTGCCAGTGGTTTTAGAGCTAGAAATAGCAAGTTA 821 CAGTG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030161 1 GTGCCCAGGTGTGCC 559 GGG GTGCCCAGGTGTGCCAGTGGGTTTTAGAGCTAGAAATAGCAAGTTA 822 AGTGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030163 −1 CCAGGCACACCTGCC 560 TGG CCAGGCACACCTGCCCCCACGTTTTAGAGCTAGAAATAGCAAGTTA 823 CCCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030165 1 CCAGGTGTGCCAGTG 561 AGG CCAGGTGTGCCAGTGGGGGCGTTTTAGAGCTAGAAATAGCAAGTTA 824 GGGGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030174 1 CCAGTGGGGGCAGGT 562 TGG CCAGTGGGGGCAGGTGTGCCGTTTTAGAGCTAGAAATAGCAAGTTA 825 GTGCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030175 1 CAGTGGGGGCAGGTG 563 GGG CAGTGGGGGCAGGTGTGCCTGTTTTAGAGCTAGAAATAGCAAGTTA 826 TGCCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030181 1 GGGCAGGTGTGCCTG 564 AGG GGGCAGGTGTGCCTGGGTCCGTTTTAGAGCTAGAAATAGCAAGTTA 827 GGTCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030181 −1 AAAGATCTGCTCCTG 565 AGG AAAGATCTGCTCCTGGACCCGTTTTAGAGCTAGAAATAGCAAGTTA 828 GACCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030188 −1 GAGTGCCAAAGATCT 566 TGG GAGTGCCAAAGATCTGCTCCGTTTTAGAGCTAGAAATAGCAAGTTA 829 GCTCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030194 1 TGGGTCCAGGAGCAG 567 TGG TGGGTCCAGGAGCAGATCTTGTTTTAGAGCTAGAAATAGCAAGTTA 830 ATCTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030207 1 AGATCTTTGGCACTC 568 TGG AGATCTTTGGCACTCAACTTGTTTTAGAGCTAGAAATAGCAAGTTA 831 AACTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030208 1 GATCTTTGGCACTCA 569 GGG GATCTTTGGCACTCAACTTTGTTTTAGAGCTAGAAATAGCAAGTTA 832 ACTTT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030209 1 ATCTTTGGCACTCAACTTTG 570 GGG ATCTTTGGCACTCAACTTTGGTTTTAGAGCTAGAAATAGCAAGTTA 833 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030212 1 TTTGGCACTCAACTT 571 TGG TTTGGCACTCAACTTTGGGGGTTTTAGAGCTAGAAATAGCAAGTTA 834 TGGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030213 1 TTGGCACTCAACTTT 572 GGG TTGGCACTCAACTTTGGGGTGTTTTAGAGCTAGAAATAGCAAGTTA 835 GGGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030216 1 GCACTCAACTTTGGG 573 AGG GCACTCAACTTTGGGGTGGGGTTTTAGAGCTAGAAATAGCAAGTTA 836 GTGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030233 1 GGGAGGAGAATGATA 574 TGG GGGAGGAGAATGATACAAAAGTTTTAGAGCTAGAAATAGCAAGTTA 837 CAAAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030237 1 GGAGAATGATACAAA 575 AGG GGAGAATGATACAAAATGGTGTTTTAGAGCTAGAAATAGCAAGTTA 838 ATGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030241 1 AATGATACAAAATGG 576 TGG AATGATACAAAATGGTAGGTGTTTTAGAGCTAGAAATAGCAAGTTA 839 TAGGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030250 1 AAATGGTAGGTTGGT 577 AGG AAATGGTAGGTTGGTCCTACGTTTTAGAGCTAGAAATAGCAAGTTA 840 CCTAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030254 −1 CAACACCTGTGCTGG 578 AGG CAACACCTGTGCTGGCCTGTGTTTTAGAGCTAGAAATAGCAAGTTA 841 CCTGT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030260 1 TTGGTCCTACAGGCC 579 AGG TTGGTCCTACAGGCCAGCACGTTTTAGAGCTAGAAATAGCAAGTTA 842 AGCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030262 −1 TCACTTGGCAACACC 580 TGG TCACTTGGCAACACCTGTGCGTTTTAGAGCTAGAAATAGCAAGTTA 843 TGTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030277 −1 CTGGGCACATGGGCT 581 TGG CTGGGCACATGGGCTTCACTGTTTTAGAGCTAGAAATAGCAAGTTA 844 TCACT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030287 −1 ATCACTGTGCCTGGG 582 GGG ATCACTGTGCCTGGGCACATGTTTTAGAGCTAGAAATAGCAAGTTA 845 CACAT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030288 −1 GATCACTGTGCCTGG 583 TGG GATCACTGTGCCTGGGCACAGTTTTAGAGCTAGAAATAGCAAGTTA 846 GCACA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030289 1 CAAGTGAAGCCCATG 584 AGG CAAGTGAAGCCCATGTGCCCGTTTTAGAGCTAGAAATAGCAAGTTA 847 TGCCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030295 −1 TGCCTGTGATCACTG 585 GGG TGCCTGTGATCACTGTGCCTGTTTTAGAGCTAGAAATAGCAAGTTA 848 TGCCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030296 −1 ATGCCTGTGATCACT 586 TGG ATGCCTGTGATCACTGTGCCGTTTTAGAGCTAGAAATAGCAAGTTA 849 GTGCC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030304 1 TGCCCAGGCACAGTG 587 AGG TGCCCAGGCACAGTGATCACGTTTTAGAGCTAGAAATAGCAAGTTA 850 ATCAC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030312 1 CACAGTGATCACAGG 588 TGG CACAGTGATCACAGGCATTCGTTTTAGAGCTAGAAATAGCAAGTTA 851 CATTC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030313 1 ACAGTGATCACAGGC 589 GGG ACAGTGATCACAGGCATTCTGTTTTAGAGCTAGAAATAGCAAGTTA 852 ATTCT AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030319 1 ATCACAGGCATTCTGGGTGA 590 AGG ATCACAGGCATTCTGGGTGAGTTTTAGAGCTAGAAATAGCAAGTTA 853 AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030320 1 TCACAGGCATTCTGG 591 GGG TCACAGGCATTCTGGGTGAAGTTTTAGAGCTAGAAATAGCAAGTTA 854 GTGAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030323 1 CAGGCATTCTGGGTG 592 AGG CAGGCATTCTGGGTGAAGGGGTTTTAGAGCTAGAAATAGCAAGTTA 855 AAGGG AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030332 1 TGGGTGAAGGGAGGC 593 AGG TGGGTGAAGGGAGGCCTGCAGTTTTAGAGCTAGAAATAGCAAGTTA 856 CTGCA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030333 1 GGGTGAAGGGAGGCC 594 GGG GGGTGAAGGGAGGCCTGCAAGTTTTAGAGCTAGAAATAGCAAGTTA 857 TGCAA AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT 43030335 −1 TGCTGGAAATTGGCC 595 AGG TGCTGGAAATTGGCCCTTGCGTTTTAGAGCTAGAAATAGCAAGTTA 858 CTTGC AAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCG GTGCTTTT

Table 10 below provides exemplary target nucleotide sequences of an HNF4α expression control genomic region and the corresponding zinc finger DNA binding domain amino acid sequences and amino acid structures of disrupting agent fusion proteins comprising a zing finger polypeptide and an effector suitable for use in the present invention.

The forward strand of the HNF4α expression control region targeted by the exemplary target nucleotide sequence in Table 10 comprises the nucleotide sequence of:

(SEQ ID NO: 859) CTCCGGGAGGGGGTGGGGGTGAGGGAAACAGGAGAATGTGATGGGAAAATC CGAGATGGAGCCAGCCTGGGCCAGAAACACTGGGAGCTGTGGGAGACGGAG AGGGGCAGGGTGGGATCACAGGGAGCAGGAGCGGGGAATTGGAGGTGAATC TGGCCCTCCCAAACTTCCAGTCCATTCTGCTCCCAGGGGAACCGGGAAACT GCGGGGGAACTGGAAGGGAGCTCCCAGAACAAGGATCCAGAAGATTGGCAT CTGGGGCCTGGGATTTAGGTTTCTAAATCGTGGGCCATGGGGCAGCCTTAT CTCTGCAAAAGCATTGAGGGTAGAAGTCAATGATTTGGGAAGTTATTGAAT TAGGGGATCTCGGAGGTAGGCTGTCAGTGCCTGATAGTATCAGTTAGAATG CCTGACTTGGGGTGACAATGGCTTGGAGGGGTGGGTGAGTCAAGGGTCAAA TGAGTGCCCGTGAGTCATGATGCCTGCCTTGTACAATTGATAACTGAACAT CGGTGAGTTAGGGCCCCAGCAGTTGTAATTAGCACCCCGGGTGTCAGCCAG AAACCAACAAACAGCCAAATCCCTGCAGCCCCGCCCAGCCTATCCACCGGC GGGGGACCGATTAACCATTAACCCCCACCCCTCCCCGGCAGAGCCTCCACC CCTTCACAGAGGCTAGGCCAAGACTCCCAGCAGATCTTCCCAGAGGACGGT TTGAAAGGAAGGCAGAGAGGGCACTGGGAGGAGGCAGTGGGAGGGCGGAGG GCGGGGGCCTTCGGGGTGGGCGCCCAGGGTAGGGCAGGTGGCCGCGGCGTG GAGGCAGGGAGAATGCGACTCTCCAAAACCCTCGTCGACATGGACATGGCC GACTACAGTGCTGCACTGGACCCAGCCTACACCACCCTGGAATTTGAGAAT GTGCAGGTGTTGACGATGGGCAATGGTAGGTGGGGGCAGATGTGCCCAGGT GTGCCAGTGGGGGCAGGTGTGCCTGGGTCCAGGAGCAGATCTTTGGCACTC AACTTTGGGGTGGGAGGAGAATGATACAAAATGGTAGGTTGGTCCTACAGG CCAGCACAGGTGTTGCCAAGTGAAGCCCATGTGCCCAGGCACAGTGATCAC AGGCATTCTGGGTGAAGGGAGGCCTGCAAGGGCCAATTTCCAGCAAAAGTT GAT

The reverse strand of the HNF4α expression control region targeted by the exemplary target nucleotide sequence in Table 10 comprises the sequence of:

(SEQ ID NO: 860) ATCGACTTTTGCTGGAAATTGGCCCTTGCAGGCCTCCCTTCACCCAGAATG CCTGTGATCACTGTGCCTGGGCACATGGGCTTCACTTGGCAACACCTGTGC TGGCCTGTAGGACCAACCTACCATTTTGTATCATTCTCCTCCCACCCCAAA GTTGAGTGCCAAAGATCTGCTCCTGGACCCAGGCACACCTGCCCCCACTGG CACACCTGGGCACATCTGCCCCCACCTACCATTGCCCATCGTCAACACCTG CACATTCTCAAATTCCAGGGTGGTGTAGGCTGGGTCCAGTGCAGCACTGTA GTCGGCCATGTCCATGTCGACGAGGGTTTTGGAGAGTCGCATTCTCCCTGC CTCCACGCCGCGGCCACCTGCCCTACCCTGGGCGCCCACCCCGAAGGCCCC CGCCCTCCGCCCTCCCACTGCCTCCTCCCAGTGCCCTCTCTGCCTTCCTTT CAAACCGTCCTCTGGGAAGATCTGCTGGGAGTCTTGGCCTAGCCTCTGTGA AGGGGTGGAGGCTCTGCCGGGGAGGGGTGGGGGTTAATGGTTAATCGGTCC CCCGCCGGTGGATAGGCTGGGCGGGGCTGCAGGGATTTGGCTGTTTGTTGG TTTCTGGCTGACACCCGGGGTGCTAATTACAACTGCTGGGGCCCTAACTCA CCGATGTTCAGTTATCAATTGTACAAGGCAGGCATCATGACTCACGGGCAC TCATTTGACCCTTGACTCACCCACCCCTCCAAGCCATTGTCACCCCAAGTC AGGCATTCTAACTGATACTATCAGGCACTGACAGCCTACCTCCGAGATCCC CTAATTCAATAACTTCCCAAATCATTGACTTCTACCCTCAATGCTTTTGCA GAGATAAGGCTGCCCCATGGCCCACGATTTAGAAACCTAAATCCCAGGCCC CAGATGCCAATCTTCTGGATCCTTGTTCTGGGAGCTCCCTTCCAGTTCCCC CGCAGTTTCCCGGTTCCCCTGGGAGCAGAATGGACTGGAAGTTTGGGAGGG CCAGATTCACCTCCAATTCCCCGCTCCTGCTCCCTGTGATCCCACCCTGCC CCTCTCCGTCTCCCACAGCTCCCAGTGTTTCTGGCCCAGGCTGGCTCCATC TCGGATTTTCCCATCACATTCTCCTGTTTCCCTCACCCCCACCCCCTCCCG GAG

In some embodiments, the linker has the amino acid sequence of THPRAPIPKPFQ (SEQ ID NO: 311). In other embodiments, the linker has the amino acid sequence of TPNPHRRTDPSHKPFQ (SEQ ID NO: 312).

TABLE 10 Column 1 Nucleot1de Sequence of Column 2 Target Site SEQ ID NO. Column 4 in HNF4α Column 3 (corresponds Amino acid Sequence of Zinc Column 6 Expression Target to sequences Finger DNA Binding Domain Column 5 Amino Acid Sequence Structure of Zinc Finger DNA Binding Column 7 Control sequence in Columns 1 Polypeptides Targeting the SEQ ID Domain Polypeptides Targeting the Target Site in Column 1 SEQ ID Region with space and 3) Target Site in Column 1 NO: (see Table 1B above and description thereof) NO: agatggagc AGA TGG 861 LEPGEKPYKCPECGKSFSTSHSL 1410 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 1959 cagcctggg AGC CAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cca CCT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ CCA GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL HLTTHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS cagcctggg CAG CCT 862 LEPGEKPYKCPECGKSFSRNDAL 1411 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 1960 ccagaaaca ggg CCA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ ctg GAA ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ CTG GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA SLTEHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS agccagcct AGC CAG 863 LEPGEKPYKCPECGKSFSSPADL 1412 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 1961 gggccagaa CCT ggg TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ aca CCA GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ ACA GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆ER NLTEHQRTHTGEKPYKCPECGKS SHLREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS tggagccag TGG AGC 864 LEPGEKPYKCPECGKSFSQSSNL 1413 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 1962 cctgggcca CAG CCT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ gaa ggg CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GAA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX10X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLREHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS ccgagatgg CCG AGA 865 LEPGEKPYKCPECGKSFSRSDKL 1414 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 1963 agccagcct TGG AGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ ggg CAG CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ GGG GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREH KCPECGKSFSERSHLREHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLRAHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS aatccgaga AGA TGG 866 LEPGEKPYKCPECGKSFSTKNSL 1415 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 1964 tggagccag AAT CCG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ cct AGC CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇ CCT GKSFSERSHLREHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT TLTEHQRTHTGEKPYKCPECGKS GNLTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGNLTVHQRTHTGEKPTGKK TS aggagaatg AGG AGA 867 LEPGEKPYKCPECGKSFSTTGNL 1416 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 1965 tgatgggaa ATG TGA TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ aat TGG GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ AAT GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CXHX₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELN GEKPYKCPECGKSFSRRDELNVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLRAHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS aacaggaga AAC AGG 868 LEPGEKPYKCPECGKSFSQSSNL 1417 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 1966 atgtgatgg AGA ATG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RDSDHLTTHX₁₇X₁₈ gaa TGA TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄HX₁₅X₁₆QAGHLASHX₁₇ GAA GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVH KCPECGKSFSRRDELNVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DS HLTNHQRTHTGEKPYKCPECGKS GNLRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDSGNLRVHQRTHTGEKPTGKK TS tgatgggaa TGA TGG 869 LEPGEKPYKCPECGKSFSRSDHL 1418 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 1967 aatccgaga GAA AAT TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ tgg CCG AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇ TGG GKSFSRNDTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA HLTTHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS gaaaatccg GAA AAT 870 LEPGEKPYKCPECGKSFSRADNL 1419 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 1968 agatggagc CCG AGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X2022X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ cag TGG AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CAG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLTVHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS tgggaaaat TGG GAA 871 LEPGEKPYKCPECGKSFSERSHL 1420 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 1969 ccgagatgg AAT CCG REHQRTHTGEKPYKCPECGKSFS HX₂₀X2022X₂₃X₂₄X₈X₉C10X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ agc AGA TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ AGC GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS cctgggcca CCT ggg 872 LEPGEKPYKCPECGKSFSQRAHL 1421 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 1970 gaaacactg CCA GAA ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ gga ACA CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ GGA GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK KLVRHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS ccagaaaca CCA GAA 873 LEPGEKPYKCPECGKSFSRSDEL 1422 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₁X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 1971 ctgggagct ACA CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈ gtg GGA GCT TSGELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GTG GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gggccagaa ggg CCA 874 LEPGEKPYKCPECGKSFSTSGEL 1423 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈X₁₉ 1972 acactggga GAA ACA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gct CTG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GCT GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLTEHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gagggaaac GAG GGA 875 LEPGEKPYKCPECGKSFSQAGHL 1424 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈X₁₉ 1973 aggagaatg AAC AGG ASHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ tga AGA ATG RRDELNVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ TGA GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLR GEKPYKCPECGKSFSDSGNLRVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLERHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS ggaaacagg GGA AAC 876 LEPGEKPYKCPECGKSFSRSDHL 1425 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 1974 agaatgtga AGG AGA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈ tgg ATG TGA QAGHLASHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ TGG GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR NLRVHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS atgtgatgg ATG TGA 877 LEPGEKPYKCPECGKSFSQLAHL 1426 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 1975 gaaaatccg TGG GAA RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ aga AAT CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ AGA GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLY GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RR HLASHQRTHTGEKPYKCPECGKS DELNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRRDELNVHQRTHTGEKPTGKK TS agaatgtga AGA ATG 878 LEPGEKPYKCPECGKSFSRNDTL 1427 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 1976 tgggaaaat TGA TGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ ccg GAA AT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ CCG GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDE QRTHTGEKPYKCPECGKSFSRRD LNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL  ELNVHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS gaaacactg GAA ACA 879 LEPGEKPYKCPECGKSFSQRAHL 1428 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 1977 ggagctgtg CTG GGA ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ gga GCT GTG RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇ GGA GKSFSTSGELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS DLTRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS gtgggagac GTG GGA 880 LEPGEKPYKCPECGKSFSRADNL 1429 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 1978 ggagagggg GAC GGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cag GAG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ CAG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLV GEKPYKCPECGKSFSDPGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLERHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS acactggga ACA CTG 881 LEPGEKPYKCPECGKSFSDPGNL 1430 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇X₁₈X₁₉ 1979 gctgtggga GGA GCT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gac GTG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GAC GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP ALTEHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS gctgtggga GCT GTG 882 LEPGEKPYKCPECGKSFSRSDKL 1431 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 1980 gacggagag GGA GAC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ ggg GGA GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GGG GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRH KCPECGKSFSDPGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ELVRHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS ctgggagct CTG GGA 883 LEPGEKPYKCPECGKSFSQRAHL 1432 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 1981 gtgggagac GCT GTG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇X₁₈ gga GGA GAC DPGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GGA GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLERHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS ggagctgtg GGA GCT 884 LEPGEKPYKCPECGKSFSRSDNL 1433 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 1982 ggagacgga GTG GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gag GAC GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇ GAG GKSFSDPGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR ELVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS gggggtgag GGG GGT 885 LEPGEKPYKCPECGKSFSQLAHL 1434 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 1983 ggaaacagg GAG GGA RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ aga AAC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇ AGA GKSFSDSGNLRVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS  HLVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gacggagag GAC GGA 886 LEPGEKPYKCPECGKSFSRSDKL 1435 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 1984 gggcagggt GAG ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ ggg CAG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ GGG GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLERHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGNLVRHQRTHTGEKPTGKK TS ggtgaggga GGT GAG 887 LEPGEKPYKCPECGKSFSRRDEL 1436 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 1985 aacaggaga GGA AAC NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ atg AGG AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ ATG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVH KCPECGKSFSDSGNLRVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS ggagacgga GGA GAC 888 LEPGEKPYKCPECGKSFSTSGHL 1437 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 1986 gaggggcag GGA GAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ ggt ggg CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGN QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR NLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS gggggtggg GGG GGT 889 LEPGEKPYKCPECGKSFSDSGNL 1438 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈X₁₉ 1987 ggtgaggga GGG GGT RVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ aac GAG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ AAC GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS ggtgggggt GGT GGG 890 LEPGEKPYKCPECGKSFSRSDHL 1439 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 1988 gagggaaac GGT GAG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈ agg GGA AAC DSGNLRVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ AGG GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS ggagggggt GGA GGG 891 LEPGEKPYKCPECGKSFSQRAHL 1440 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 1989 gggggtgag GGT GGG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ gga GGT GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GGA GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR KLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS ccgggaggg CCG GGA 892 LEPGEKPYKCPECGKSFSRSDNL 1441 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 1990 ggtgggggt GGG GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ gag GGG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GAG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN  HLERHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS cgggagggg CGG GAG 893 LEPGEKPYKCPECGKSFSRSDHL 1442 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 1991 gtgggggtg GGG GTG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ agg GGG gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ AGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS gagggggtg GAG GGG 894 LEPGEKPYKCPECGKSFSQSSNL 1443 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 1992 ggggtgagg GTG GGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gaa gtg AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GAA GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS ggggtgggg GGG GTG 895 LEPGEKPYKCPECGKSFSSPADL 1444 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 1993 gtgagggaa GGG gtg TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ aca AGG GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ ACA GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gtgggggtg GTG GGG 896 LEPGEKPYKCPECGKSFSQRAHL 1445 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 1994 agggaaaca gtg AGG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ gga GAA ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ GGA GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS ggggtgagg GGG gtg 897 LEPGEKPYKCPECGKSFSQSSNL 1446 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 1995 gaaacagga AGG GAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gaa ACA GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ GAA GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gggtgaggg GGG TGA 898 LEPGEKPYKCPECGKSFSTTGNL 1447 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 1996 aaacaggag ggg AAA TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ aat CAG gag RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ AAT GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAH KCPECGKSFSQRANLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLASHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gggtggggg GGG TGG 899 LEPGEKPYKCPECGKSFSRADNL 1448 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 1997 tgagggaaa GGG TGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈ cag ggg AAA QRANLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CAG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTTHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS tgagggaaa TGA ggg 900 LEPGEKPYKCPECGKSFSRSDEL 1449 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 1998 caggagaat AAA CAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ gtg gag AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GTG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA KLVRHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS tgggggtga TGG GGG 901 LEPGEKPYKCPECGKSFSRSDNL 1450 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 1999 gggaaacag TGA ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ gag AAA CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ GAG GKSFSQRANLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gggaggggg ggg AGG 902 LEPGEKPYKCPECGKSFSRSDKL 1451 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2000 tgggggtga GGG TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈ ggg GGG TGA QAGHLASHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS agggggtgg AGG GGG 903 LEPGEKPYKCPECGKSFSQRANL 1452 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2001 gggtgaggg TGG GGG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ aaa TGA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ AAA GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS gggaaacag ggg AAA 904 LEPGEKPYKCPECGKSFSRRDEL 1453 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 2002 gagaatgtg CAG gag NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ atg AAT gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ ATG GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAN QRTHTGEKPYKCPECGKSFSQRA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLRAHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS aaacaggag AAA CAG 905 LEPGEKPYKCPECGKSFSQRAHL 1454 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2003 aatgtgatg gag AAT ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ gga gtg ATG RRDELNVHQRTHTGEKPYKCPEC X₁₁HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GGA GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR NLTEHQRTHTGEKPYKCPECGKS ANLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRANLRAHQRTHTGEKPTGKK TS caggagaat CAG gag 906 LEPGEKPYKCPECGKSFSQRANL 1455 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2004 gtgatggga AAT gtg RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ aaa ATG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ AAA GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA NLVRHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS ggccagaaa GGC CAG 907 LEPGEKPYKCPECGKSFSRNDAL 1456 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2005 cactgggag AAA CAC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ ctg TGG gag RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CTG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP NLTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ctgggccag CTG GGC 908 LEPGEKPYKCPECGKSFSRSDNL 1457 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2006 aaacactgg CAG AAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gag CAC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GAG GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAH KCPECGKSFSQRANLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS aaacactgg AAA CAC 909 LEPGEKPYKCPECGKSFSRSDNL 1458 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2007 gagctgtgg TGG gag VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gag CTG TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GAG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR ALTEHQRTHTGEKPYKCPECGKS ANLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRANLRAHQRTHTGEKPTGKK TS gccagcctg GCC AGC 910 LEPGEKPYKCPECGKSFSSKKAL 1459 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2008 ggccagaaa CTG GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈ cac CAG AAA QRANLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ CAC GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLREHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS agcctgggc AGC CTG 911 LEPGEKPYKCPECGKSFSRSDHL 1460 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2009 cagaaacac GGC CAG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ tgg AAA CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ TGG GKSFSQRANLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ER ALTEHQRTHTGEKPYKCPECGKS SHLREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS cagaaacac CAG AAA 912 LEPGEKPYKCPECGKSFSRSDHL 1461 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2010 tgggagctg CAC TGG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ tgg gag CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ TGG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAN QRTHTGEKPYKCPECGKSFSQRA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA NLRAHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gatggagcc GAT GGA 913 LEPGEKPYKCPECGKSFSRADNL 1462 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2011 agcctgggc GCC AGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ cag CTG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CAG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREH KCPECGKSFSERSHLREHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLERHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS ggagccagc GGA GCC 914 LEPGEKPYKCPECGKSFSQRANL 1463 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2012 ctgggccag AGC CTG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ aaa GGC CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ AAA GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR DLARHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS tgggagctg TGG gag 915 LEPGEKPYKCPECGKSFSRSDNL 1464 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2013 tgggagacg CTG TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDHX₁₇X₁₈ gag gag ACG RTDTLRDHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GAG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gagctgtgg gag CTG 916 LEPGEKPYKCPECGKSFSRSDHL 1465 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2014 gagacggag TGG gag TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ agg ACG gag RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDHX₁₇ AGG GKSFSRTDTLRDHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS ctgtgggag CTG TGG 917 LEPGEKPYKCPECGKSFSDPGHL 1466 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2015 acggagagg gag ACG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ ggc gag AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GGC GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDH KCPECGKSFSRTDTLRDHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLTTHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS gagacggag gag ACG 918 LEPGEKPYKCPECGKSFSRSDEL 1467 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2016 aggggcagg gag AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gtg GGC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GTG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDT QRTHTGEKPYKCPECGKSFSRTD LRDHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS TLRDHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS tgggagacg TGG gag 919 LEPGEKPYKCPECGKSFSRSDHL 1468 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2017 gagaggggc ACG gag TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ agg AGG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ AGG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLR GEKPYKCPECGKSFSRTDTLRDH DHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS cactgggag CAC TGG 920 LEPGEKPYKCPECGKSFSRTDTL 1469 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDHX₁₇X₁₈X₁₉ 2018 ctgtgggag gag CTG RDHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ acg TGG gag RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ ACG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK  HLTTHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS acggagagg ACG gag 921 LEPGEKPYKCPECGKSFSQRAHL 1470 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2019 ggcagggtg AGG GGC ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ gga AGG GTG RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGA GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RT NLVRHQRTHTGEKPYKCPECGKS DTLRDHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRTDTLRDHQRTHTGEKPTGKK TS cgagatgga CGA GAT 922 LEPGEKPYKCPECGKSFSDPGHL 1471 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2020 gccagcctg GGA GCC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ggc AGC CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇ GGC GKSFSERSHLREHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLVRHQRTHTGEKPYKCPECGKS GHLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGHLTEHQRTHTGEKPTGKK TS gcctgggcc GCC TGG 923 LEPGEKPYKCPECGKSFSRSDKL 1472 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2021 agaaacact GCC AGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ ggg AAC ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇ GGG GKSFSDSGNLRVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLTTHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS cagcctgg CCA GCC 924 LEPGEKPYKCPECGKSFSTHLDL 1473 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2022 gccagaaac TGG GCC IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈ act AGA AAC DSGNLRVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ ACT GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS DLARHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS tgggccaga TGG GCC 925 LEPGEKPYKCPECGKSFSERSHL 1474 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2023 aacactggg AGA AAC REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ agc ACT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ AGC GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVH KCPECGKSFSDSGNLRVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLARHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gagccagcc gag CCA 926 LEPGEKPYKCPECGKSFSDSGNL 1475 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈X₁₉ 2024 tgggccaga GCC TGG RVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ aac GCC AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ AAC GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLTEHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS atggagcca ATG gag 927 LEPGEKPYKCPECGKSFSQLAHL 1476 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2025 gcctgggcc CCA GCC RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ aga TGG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ AGA GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RR  NLVRHQRTHTGEKPYKCPECGKS DELNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRRDELNVHQRTHTGEKPTGKK TS gagatggag gag ATG 928 LEPGEKPYKCPECGKSFSDCRDL 1477 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2026 ccagcctgg gag CCA ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gcc GCC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ GCC GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDE QRTHTGEKPYKCPECGKSFSRRD LNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELNVHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS gggagacgg ggg AGA 929 LEPGEKPYKCPECGKSFSRSDKL 1478 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2027 agaggggca CGG AGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ ggg GGG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLRAHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS agacggaga AGA CGG 930 LEPGEKPYKCPECGKSFSRSDHL 1479 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2028 ggggcaggg AGA GGG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ tgg GCA GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ TGG GKSF SQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL KLTEHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS cggagaggg CGG AGA 931 LEPGEKPYKCPECGKSFSTSGNL 1480 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈X₁₉ 2029 gcagggtgg GGG GCA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gat GGG TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GAT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLRAHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS agaggggca AGA GGG 932 LEPGEKPYKCPECGKSFSSKKAL 1481 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2030 gggtgggat GCA GGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ cac TGG GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CAC GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL KLVRHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS gatcacagg GAT CAC 933 LEPGEKPYKCPECGKSFSRSDKL 1482 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2031 gagcaggag AGG gag TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ cgg CAG gag RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ CGG GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALTEHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS ggggcaggg GGG GCA 934 LEPGEKPYKCPECGKSFSRSDHL 1483 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2032 tgggatcac GGG TGG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ agg GAT CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ AGG GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS  DLRRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gggtgggat GGG TGG 935 LEPGEKPYKCPECGKSFSRADNL 1484 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2033 cacagggag GAT CAC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ cag AGG gag RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CAG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTTHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS tgggatcac TGG GAT 936 LEPGEKPYKCPECGKSFSRSDNL 1485 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2034 agggagcag CAC AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ gag gag CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GAG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gcagggtgg GCA GGG 937 LEPGEKPYKCPECGKSFSRSDNL 1486 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2035 gatcacagg TGG GAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gag CAC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GAG GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS KLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS agggagcag AGG gag 938 LEPGEKPYKCPECGKSFSHKNAL 1487 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2036 gagcgggga CAG gag QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ att CGG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ ATT GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS cacagggag CAC AGG 939 LEPGEKPYKCPECGKSFSQRAHL 1488 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2037 caggagcgg gag CAG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ gga gag CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GGA GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTNHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS gagcaggag gag CAG 940 LEPGEKPYKCPECGKSFSQRAHL 1489 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2038 cggggaatt gag CGG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ gga GGA ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GGA GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTEHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS caggagcgg CAG gag 941 LEPGEKPYKCPECGKSFSTSGHL 1490 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2039 ggaattgga CGG GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ggt ATT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ GGT GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA NLVRHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gagcgggga gag CGG 942 LEPGEKPYKCPECGKSFSQSSNL 1491 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2040 attggaggt GGA ATT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ gaa GGA GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GAA GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNH KCPECGKSFSHKNALQNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLTEHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS acagggagc ACA ggg 943 LEPGEKPYKCPECGKSFSQSSNL 1492 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2041 aggagcggg AGC AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gaa AGC GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇ GAA GKSFSERSHLREHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP KLVRHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS gcaggagcg GCA GGA 944 LEPGEKPYKCPECGKSFSRSDHL 1493 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2042 gggaattgg GCG ggg TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ agg AAT TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ AGG GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLERHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS ggagcgggg GGA GCG 945 LEPGEKPYKCPECGKSFSQAGHL 1494 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈X₁₉ 2043 aattggagg ggg AAT ASHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ tga TGG AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ TGA GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDD QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR DLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS cagggagca CAG GGA 946 LEPGEKPYKCPECGKSFSTTGNL 1495 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2044 ggagcgggg GCA GGA TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ aat GCG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ AAT GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA HLERHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS ggagcagga GGA GCA 947 LEPGEKPYKCPECGKSFSRSDHL 1496 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2045 gcggggaat GGA GCG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ tgg ggg AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ TGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRH KCPECGKSFSRSDDLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR DLRRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS ggccctccc GGC CCT 948 LEPGEKPYKCPECGKSFSDPGAL 1497 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈X₁₉ 2046 aaacttcca CCC AAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ gtc CTT CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ GTC GKSFSTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAH KCPECGKSFSQRANLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP  SLTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS cctcccaaa CCT CCC 949 LEPGEKPYKCPECGKSFSTSGNL 1498 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2047 cttccagtc AAA CTT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈ cat CCA GTC DPGALVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ CAT GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK HLAEHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS gggaaactg ggg AAA 950 LEPGEKPYKCPECGKSFSRSDHL 1499 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2048 cgggggaac CTG CGG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈ tgg ggg AAC DSGNLRVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ TGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAN QRTHTGEKPYKCPECGKSFSQRA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLRAHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS accgggaaa ACC ggg 951 LEPGEKPYKCPECGKSFSDSGNL 1500 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈X₁₉ 2049 ctgcggggg AAA CTG RVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ aac CGG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ AAC GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆DK KLVRHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS aaactgcgg AAA CTG 952 LEPGEKPYKCPECGKSFSRKDNL 1501 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2050 gggaactgg CGG ggg KNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ aag AAC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇ AAG GKSFSDSGNLRVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR ALTEHQRTHTGEKPYKCPECGKS ANLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRANLRAHQRTHTGEKPTGKK TS ggaaccggg GGA ACC 953 LEPGEKPYKCPECGKSFSRSDKL 1502 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2051 aaactgcgg ggg AAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ ggg CTG CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GGG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAH KCPECGKSFSQRANLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR DLTRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS aggggaacc AGG GGA 954 LEPGEKPYKCPECGKSFSRSDKL 1503 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2052 gggaaactg ACC ggg TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ cgg AAA CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ CGG GKSFSQRANLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLERHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS ctgcggggg CTG CGG 955 LEPGEKPYKCPECGKSFSQRAHL 1504 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QPAHLERHX₁₇X₁₈X₁₉ 2053 aactggaag ggg AAC ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈ gga TGG AAG RKDNLKNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGA GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVH KCPECGKSFSDSGNLRVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN KLTEHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS cgggggaac CGG ggg 956 LEPGEKPYKCPECGKSFSTSGEL 1505 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈X₁₉ 2054 tggaaggga AAC TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gct AAG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇ GCT GKSFSRKDNLKNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLR GEKPYKCPECGKSFSDSGNLRVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS cccagggga CCC AGG 957 LEPGEKPYKCPECGKSFSRNDAL 1506 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2055 accgggaaa GGA ACC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈ ctg ggg AAA QRANLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CTG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTNHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS gctcccagg GCT CCC 958 LEPGEKPYKCPECGKSFSQRANL 1507 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2056 ggaaccggg AGG GGA RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ aaa ACC ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇ AAA GKSFSDKKDLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLAEHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS gggaactgg ggg AAC 959 LEPGEKPYKCPECGKSFSSKKHL 1508 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2057 aagggagct TGG AAG AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈ ccc GGA GCT TSGELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ CCC GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNH KCPECGKSFSRKDNLKNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLRVHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS aactggaag AAC TGG 960 LEPGEKPYKCPECGKSFSQLAHL 1509 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2058 ggagctccc AAG GGA RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ aga GCT CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇ AGA GKSFSTSGELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DS HLTTHQRTHTGEKPYKCPECGKS GNLRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDSGNLRVHQRTHTGEKPTGKK TS tggaaggga TGG AAG 961 LEPGEKPYKCPECGKSFSSPADL 1510 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2059 gctcccaga GGA GCT TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ aca CCC AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ ACA GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLKNHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS aagggagct AAG GGA 962 LEPGEKPYKCPECGKSFSRSDHL 1511 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2060 cccagaaca GCT CCC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ agg AGA ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ AGG GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RK  HLERHQRTHTGEKPYKCPECGKS DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRKDNLKNHQRTHTGEKPTGKK TS caggggaac CAG ggg 963 LEPGEKPYKCPECGKSFSRSDDL 1512 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2061 cgggaaact AAC CGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ gcg GAA ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ GCG GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLR GEKPYKCPECGKSFSDSGNLRVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA KLVRHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gggaaccgg ggg AAC 964 LEPGEKPYKCPECGKSFSRSDKL 1513 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2062 gaaactgcg CGG GAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ ggg ACT GCG RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLTRHX₁₇ GGG GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLRVHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS aaccgggaa AAC CGG 965 LEPGEKPYKCPECGKSFSQSSNL 1514 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2063 actgcgggg GAA ACT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gaa GCG GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ GAA GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRH KCPECGKSFSTHLDLIRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DS KLTEHQRTHTGEKPYKCPECGKS GNLRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDSGNLRVHQRTHTGEKPTGKK TS gcgggggaa GCG GGG 966 LEPGEKPYKCPECGKSFSERSHL 1515 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2064 ctggaaggg GAA CTG REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ agc GAA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ AGC GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DDLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDDLVRHQRTHTGEKPTGKK TS actgcgggg ACT GCG 967 LEPGEKPYKCPECGKSFSRSDKL 1516 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2065 gaactggaa GGG GAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ ggg CTG GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GGG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDD QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH DLVRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS cgggaaact CGG GAA 968 LEPGEKPYKCPECGKSFSRNDAL 1517 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2066 gcgggggaa ACT GCG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ ctg GGG GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CTG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRH KCPECGKSFSRSDDLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLI GEKPYKCPECGKSFSTHLDLIRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS gaaactgcg GAA ACT 969 LEPGEKPYKCPECGKSFSQSSNL 1518 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2067 ggggaactg GCG GGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ gaa GAA CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ GAA GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS DLIRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS catctgggg CAT CTG 970 LEPGEKPYKCPECGKSFSREDNL 1519 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2068 cctgggatt ggg CCT HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ tag ggg ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ TAG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALTEHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLTEHQRTHTGEKPTGKK TS gattggcat GAT TGG 971 LEPGEKPYKCPECGKSFSRSDKL 1520 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2069 ctggggcct CAT CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ ggg ggg CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLTTHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS tggcatctg TGG CAT 972 LEPGEKPYKCPECGKSFSHKNAL 1521 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2070 gggcctggg CTG ggg QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ att CCT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ ATT GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTEHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS cagaacaag CAG AAC 973 LEPGEKPYKCPECGKSFSTSGNL 1522 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈X₁₉ 2071 gatccagaa AAG GAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ gat CCA GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ GAT GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA NLRVHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gaagattgg GAA GAT 974 LEPGEKPYKCPECGKSFSTKNSL 1523 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2072 catctgggg TGG CAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cct CTG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CCT GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLVRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS aacaaggat AAC AAG 975 LEPGEKPYKCPECGKSFSRSDHL 1524 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2073 ccagaagat GAT CCA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ tgg GAA GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ TGG GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DS NLKNHQRTHTGEKPYKCPECGKS GNLRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDSGNLRVHQRTHTGEKPTGKK TS ccagaagat CCA GAA 976 LEPGEKPYKCPECGKSFSRSDKL 1525 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2074 tggcatctg GAT TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ggg CAT CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ GGG GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gatccagaa GAT CCA 977 LEPGEKPYKCPECGKSFSRNDAL 1526 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2075 gattggcat GAA GAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ ctg TGG CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CTG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLTEHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS aaggatcca AAG GAT 978 LEPGEKPYKCPECGKSFSTSGNL 1527 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2076 gaagattgg CCA GAA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ cat GAT TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ CAT GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RK NLVRHQRTHTGEKPYKCPECGKS DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRKDNLKNHQRTHTGEKPTGKK TS ctggggcct CTG ggg 979 LEPGEKPYKCPECGKSFSTSGSL 1528 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈X₁₉ 2077 gggatttag CCT ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈ gtt ATT TAG REDNLHTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ GTT GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN KLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS ctaaatcgt CTA AAT 980 LEPGEKPYKCPECGKSFSDPGHL 1529 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2078 gggccatgg CGT ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ ggc CCA TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ GGC GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCR GEKPYKCPECGKSFSSRRTCRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QN NLTVHQRTHTGEKPYKCPECGKS STLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQNSTLTEHQRTHTGEKPTGKK TS aatcgtggg AAT CGT 981 LEPGEKPYKCPECGKSFSERSHL 1530 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2079 ccatggggc ggg CCA REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ agc TGG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ AGC GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRT QRTHTGEKPYKCPECGKSFSSRR CRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT TCRAHQRTHTGEKPYKCPECGKS GNLTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGNLTVHQRTHTGEKPTGKK TS cgtgggcca CGT ggg 982 LEPGEKPYKCPECGKSFSTTGAL 1531 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈X₁₉ 2080 tggggcagc CCA TGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ ctt GGC AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CTT GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆SR KLVRHQRTHTGEKPYKCPECGKS RTCRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSRRTCRAHQRTHTGEKPTGKK TS ctgcaaaag CTG CAA 983 LEPGEKPYKCPECGKSFSREDNL 152 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2081 cattgaggg AAG CAT HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ tag TGA GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ TAG GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGN QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN NLTEHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS caaaagcat CAA AAG 984 LEPGEKPYKCPECGKSFSRKDNL 1533 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2082 tgagggtag CAT TGA KNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈ aag GGG TAG REDNLHTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ APG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLKNHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGNLTEHQRTHTGEKPTGKK TS aaaagcatt AAA AGC 985 LEPGEKPYKCPECGKSFSHRTTL 1534 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2083 gagggtaga ATT GAG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ agt GGT AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ AGT GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQ GEKPYKCPECGKSFSHKNALQNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLREHQRTHTGEKPYKCPECGKS ANLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRANLRAHQRTHTGEKPTGKK TS attgagggt ATT GAG 986 LEPGEKPYKCPECGKSFSQAGHL 1535 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈X₁₉ 2084 agaagtcaa GGT AGA ASHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ tga AGT CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ TGA GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HK NLVRHQRTHTGEKPYKCPECGKS NALQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHKNALQNHQRTHTGEKPTGKK TS agcattgag AGC ATT 987 LEPGEKPYKCPECGKSFSQSGNL 1536 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈X₁₉ 2085 ggtagaagt GAG GGT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ caa AGA AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ CAA GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNA QRTHTGEKPYKCPECGKSFSHKN LQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ER ALQNHQRTHTGEKPYKCPECGKS SHLREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS atgatttgg ATG ATT 988 LEPGEKPYKCPECGKSFSQSSNL 1537 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2086 gaagttatt TGG GAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ gaa GTT ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ GAA GKSFSTSGSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNA QRTHTGEKPYKCPECGKSFSHKN LQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RR ALQNHQRTHTGEKPYKCPECGKS DELNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRRDELNVHQRTHTGEKPTGKK TS taggctgtc TAG GCT 989 LEPGEKPYKCPECGKSFSREDNL 1538 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2087 agtgcctga GTC AGT HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈ tag GCC TGA QAGHLASHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ TAG GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNH KCPECGKSFSHRTTLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALV GEKPYKCPECGKSFSDPGALVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RE ELVRHQRTHTGEKPYKCPECGKS DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSREDNLHTHQRTHTGEKPTGKK TS aggtaggct AGG TAG 990 LEPGEKPYKCPECGKSFSQAGHL 1539 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈X₁₉ 2088 gtcagtgcc GCT GTC ASHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ tga AGT GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ TGA GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRH KCPECGKSFSDPGALVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS  NLHTHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS cggaggtag CGG AGG 991 LEPGEKPYKCPECGKSFSDCRDL 1540 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2089 gctgtcagt TAG GCT ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ gcc GTC AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇ GCC GKSFSDPGALVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS tagaatgcc TAG AAT 992 LEPGEKPYKCPECGKSFSRSDEL 1541 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2090 tgacttggg GCC TGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gtg CTT GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ GTG GKSFSTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RE NLTVHQRTHTGEKPYKCPECGKS DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSREDNLHTHQRTHTGEKPTGKK TS aatgcctga AAT GCC 993 LEPGEKPYKCPECGKSFSSPADL 1542 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2091 cttggggtg TGA CTT TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ aca GGG gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ ACA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆TT DLARHQRTHTGEKPYKCPECGKS GNLTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGNLTVHQRTHTGEKPTGKK TS agttagaat AGT TAG 994 LEPGEKPYKCPECGKSFSRSDKL 1543 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2092 gcctgactt AT GCC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈ ggg TGA CTT TTGALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ GGG GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HR NLHTHQRTHTGEKPYKCPECGKS TTLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHRTTLTNHQRTHTGEKPTGKK TS gcctgactt GCC TGA 995 LEPGEKPYKCPECGKSFSRRDEL 1544 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 2093 ggggtgaca CTT GGG NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ atg gtg ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ ATG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALT GEKPYKCPECGKSFSTTGALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLASHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS ggggtgaca GGG gtg 996 LEPGEKPYKCPECGKSFSRSDHL 1545 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2094 atggcttgg ACA ATG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ agg GCT TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇ AGG GKSFSTSGELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVH KCPECGKSFSRRDELNVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS tgacttggg TGA CTT 997 LEPGEKPYKCPECGKSFSTSGEL 1546 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈X₁₉ 2095 gtgacaatg GGG gtg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ gct ACA ATG RRDELNVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ GCT GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGA QRTHTGEKPYKCPECGKSFSTTG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA  ALTEHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS cttggggtg CTT GGG 130 LEPGEKPYKCPECGKSFSRSDHL 131 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 320 acaatggct gtg ACA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈ tgg ATG GCT TSGELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ TGG GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆TT KLVRHQRTHTGEKPYKCPECGKS GALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGALTEHQRTHTGEKPTGKK TS gcttggagg GCT TGG 998 LEPGEKPYKCPECGKSFSDPGAL 1547 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈X₁₉ 2096 ggtgggtga AGG GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈ gtc GGG TGA QAGHLASHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GTC GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLTTHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS tggaggggt TGG AGG 999 LEPGEKPYKCPECGKSFSRKDNL 1548 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2097 gggtgagtc GGT GGG KNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈ aag TGA GTC DPGALVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ APG GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gtgacaatg gtg ACA 1000 LEPGEKPYKCPECGKSFSTSGHL 1549 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2098 gcttggagg ATG GCT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ ggt TGG AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGT GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₂₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELN GEKPYKCPECGKSFSRRDELNVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLTRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS atggcttgg ATG GCT 1001 LEPGEKPYKCPECGKSFSQAGHL 1550 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈X₁₉ 2099 aggggtggg TGG AGG ASHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ tga GGT GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ TGA GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RR ELVRHQRTHTGEKPYKCPECGKS DELNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRRDELNVHQRTHTGEKPTGKK TS acaatggct ACA ATG 1002 LEPGEKPYKCPECGKSFSRSDKL 1551 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2100 tggaggggt GCT TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ ggg AGG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDE QRTHTGEKPYKCPECGKSFSRRD LNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP ELNVHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS gggtgagtc GGG TGA 1003 LEPGEKPYKCPECGKSFSRRDEL 1552 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 2101 aagggtcaa GTC AAG NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ atg GGT CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ ATG GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNH KCPECGKSFSRKDNLKNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALV GEKPYKCPECGKSFSDPGALVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS  HLASHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS ggtcaaatg GGT CAA 1004 LEPGEKPYKCPECGKSFSRSDNL 1553 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2102 agtgcccgt ATG AGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇X₁₈ gag GCC CGT SRRTCRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ GAG GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNH KCPECGKSFSHRTTLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELN GEKPYKCPECGKSFSRRDELNVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGN QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS tgagtcaag TGA GTC 1005 LEPGEKPYKCPECGKSFSHRTTL 1554 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2103 ggtcaaatg AAG GGT TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ agt CAA ATG RRDELNVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇ AGT GKSFSQSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGA QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA ALVRHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS gtcaagggt GTC AAG 1006 LEPGEKPYKCPECGKSFSDCRDL 1555 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2104 caaatgagt GGT CAA ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ gcc ATG AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ GCC GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP NLKNHQRTHTGEKPYKCPECGKS GALVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGALVRHQRTHTGEKPTGKK TS aagggtcaa AAG GGT 1007 LEPGEKPYKCPECGKSFSSRRTC 1556 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇X₁₈X₁₉ 2105 atgagtgcc CAA ATG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ cgt AGT GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ CGT GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVH KCPECGKSFSRRDELNVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RK HLVRHQRTHTGEKPYKCPECGKS DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRKDNLKNHQRTHTGEKPTGKK TS aggggtggg AGG GGT 1008 LEPGEKPYKCPECGKSFSTSGHL 1557 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2106 tgagtcaag GGG TGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈ ggt GTC AAG RKDNLKNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇ GGT GKSFSDPGALVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS ggtgggtga GGT GGG 1009 LEPGEKPYKCPECGKSFSQSGNL 1558 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈X₁₉ 2107 gtcaagggt TGA GTC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ caa AAG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇ CAA GKSFSRKDNLKNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRH KCPECGKSFSDPGALVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS ctgacttgg CTG ACT 1010 LEPGEKPYKCPECGKSFSDPGHL 1559 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2108 ggtgacaat TGG GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ ggc GAC AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇ GGC GKSFSDPGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN  DLIRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉XHX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS gggtgacaa GGG TGA 1011 LEPGEKPYKCPECGKSFSRSDKL 1560 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX_(l0)X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2109 tggcttgga CAA TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ggg CTT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ GGG GKSFSTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLASHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS tgacaatgg TGA CAA 1012 LEPGEKPYKCPECGKSFSRSDEL 1561 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2110 cttggaggg TGG CTT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gtg GGA GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GTG GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGN QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA NLTEHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS tggcttgga TGG CTT 1013 LEPGEKPYKCPECGKSFSRSDNL 1562 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2111 ggggtgggt GGA GGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄Z15X₁₆TSGHLVRHX₁₇X₁₈ gag GTG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GAG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGA QRTHTGEKPYKCPECGKSFSTTG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS caatggctt CAA TGG 1014 LEPGEKPYKCPECGKSFSTSGHL 1563 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2112 ggaggggtg CTT GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ ggt GGG GTG RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALT GEKPYKCPECGKSFSTTGALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLTTHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGNLTEHQRTHTGEKPTGKK TS gaggggtgg GAG GGG 1015 LEPGEKPYKCPECGKSFSRSDKL 1564 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2113 gtgagtcaa TGG gtg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ ggg AGT CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ GGG GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS agggtcaaa AGG GTC 1016 LEPGEKPYKCPECGKSFSRSDEL 1565 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2114 tgagtgccc AAA TGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ gtg gtg CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GTG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGA QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALVRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS gtcaaatga GTC AAA 1017 LEPGEKPYKCPECGKSFSHRTTL 1566 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2115 gtgcccgtg TGA gtg TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ agt CCC gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ AGT GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAN QRTHTGEKPYKCPECGKSFSQRA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP NLRAHQRTHTGEKPYKCPECGKS GALVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGALVRHQRTHTGEKPTGKK TS aaatgagtg AAA TGA 1018 LEPGEKPYKCPECGKSFSTSGNL 1567 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2116 cccgtgagt gtg CCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ cat gtg AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ CAT GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLASHQRTHTGEKPYKCPECGKS ANLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRANLRAHQRTHTGEKPTGKK TS tgagtgccc TGA gtg 1019 LEPGEKPYKCPECGKSFSTSGNL 1568 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈X₁₉ 2117 gtgagtcat CCC gtg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ gat AGT CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ GAT GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA ELVRHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS gtgcccgtg gtg CCC 1020 LEPGEKPYKCPECGKSFSDCRDL 1569 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2118 agtcatgat gtg AGT ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ gcc CAT GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ GCC GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNH KCPECGKSFSHRTTLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLAEHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS ccgtgagtc CCG TGA 1021 LEPGEKPYKCPECGKSFSDCRDL 1570 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2119 atgatgcct GTC ATG ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ gcc ATG CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ GCC GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVH KCPECGKSFSRRDELNVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALV GEKPYKCPECGKSFSDPGALVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLASHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS gtcagccag GTC AGC 1022 LEPGEKPYKCPECGKSFSDSGNL 1571 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈X₁₉ 2120 aaaccaaca CAG AAA RVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ aac CCA ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ AAC GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAH KCPECGKSFSQRANLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLREHQRTHTGEKPYKCPECGKS GALVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGALVRHQRTHTGEKPTGKK TS agccagaaa AGC CAG 1023 LEPGEKPYKCPECGKSFSERSHL 1572 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2121 ccaacaaac AAA CCA REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈ agc ACA AAC DSGNLRVHQRTHTGEKPYKCPEC X9HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ AGC GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ER NLTEHQRTHTGEKPYKCPECGKS SHLREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS cagaaacca CAG AAA 1024 LEPGEKPYKCPECGKSFSQSGNL 1573 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈X₁₉ 2122 acaaacagc CCA ACA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ caa AAC AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇ CAA GKSFSDSGNLRVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAN QRTHTGEKPYKCPECGKSFSQRA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA NLRAHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gccccagca GCC CCA 1025 LEPGEKPYKCPECGKSFSERSHL 1574 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2123 gttgtaatt GCA GTT REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ agc GTA ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRHX₁₇ AGC GKSFSQSSSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRH KCPECGKSFSTSGSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC SLTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X3 FSDCRDLARHQRTHTGEKPTGKK TS cggtgagtt CGG TGA 1026 LEPGEKPYKCPECGKSFSQSGDL 1575 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2124 agggcccca GTT AGG RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ gca GCC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ GCA GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLV GEKPYKCPECGKSFSTSGSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLASHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS ggtgtcagc GGT GTC 1027 LEPGEKPYKCPECGKSFSSPADL 1576 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2125 cagaaacca AGC CAG TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ aca AAA CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ ACA GKSFSQRANLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGA QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS agggcccca AGG GCC 1028 LEPGEKPYKCPECGKSFSHKNAL 1577 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2126 gcagttgta CCA GCA QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRHX₁₇X₁₈ att GTT GTA QSSSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ ATT GKSFSTSGSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLARHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS ccagcagtt CCA GCA 1029 LEPGEKPYKCPECGKSFSDKKDL 1578 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈X₁₉ 2127 gtaattagc GTT GTA TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ acc ATT AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ ACC GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRH KCPECGKSFSQSSSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLV GEKPYKCPECGKSFSTSGSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS DLRRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS ataactgaa ATA ACT 1030 LEPGEKPYKCPECGKSFSTSGSL 1579 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈X₁₉ 2128 catcggtga GAA CAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈ gtt CGG TGA QAGHLASHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ GTT GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QK DLIRHQRTHTGEKPYKCPECGKS SSLIAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQKSSLIAHQRTHTGEKPTGKK TS catcggtga CAT CGG 1031 LEPGEKPYKCPECGKSFSTSHSL 1580 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2129 gttagggcc TGA GTT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ cca AGG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CCA GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRH KCPECGKSFSTSGSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLTEHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLTEHQRTHTGEKPTGKK TS ccgggtgtc CCG GGT 122 LEPGEKPYKCPECGKSFSTSHSL 123 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 318 agccagaaa GTC AGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈ cca CAG AAA QRANLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ CCA GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREH KCPECGKSFSERSHLREHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALV GEKPYKCPECGKSFSDPGALVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLVRHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS actgaacat ACT GAA 126 LEPGEKPYKCPECGKSFSRSDHL 127 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 319 cggtgagtt CAT CGG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈ agg TGA GTT TSGSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ AGG GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH NLVRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS gaacatcgg GAA CAT 1032 LEPGEKPYKCPECGKSFSDCRDL 1581 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2130 tgagttagg CGG TGA ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gcc GTT AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ GCC GKSFSTSGSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLTEHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS accccgggt ACC CCG 1033 LEPGEKPYKCPECGKSFSQRANL 1582 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2131 gtcagccag GGT GTC RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ aaa AGC CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇ AAA GKSFSERSHLREHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRH KCPECGKSFSDPGALVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁XX9HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK TLTEHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS agcaccccg AGC ACC 1034 LEPGEKPYKCPECGKSFSRADNL 1583 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2132 ggtgtcagc CCG GGT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ cag GTC AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇ CAG GKSFSDPGALVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ER DLTRHQRTHTGEKPYKCPECGKS SHLREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS gcagttgta GCA GTT 1035 LEPGEKPYKCPECGKSFSRNDTL 1584 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 2133 attagcacc GTA ATT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈ ccg AGC ACC DKKDLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇ CCG GKSFSERSHLREHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNH KCPECGKSFSHKNALQNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLV GEKPYKCPECGKSFSQSSSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS SLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS attagcacc ATT AGC 1036 LEPGEKPYKCPECGKSFSERSHL 1585 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2134 ccgggtgtc ACC CCG REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈ agc GGT GTC DPGALVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ AGC GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HK HLREHQRTHTGEKPYKCPECGKS NALQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHKNALQNHQRTHTGEKPTGKK TS gtaattagc GTA ATT 1037 LEPGEKPYKCPECGKSFSDPGAL 1586 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈X₁₉ 2135 accccgggt AGC ACC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ gtc CCG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇ GTC GKSFSRNDTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNA QRTHTGEKPYKCPECGKSFSHKN LQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS ALQNHQRTHTGEKPYKCPECGKS SSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSSLVRHQRTHTGEKPTGKK TS tgagttagg TGA GTT 1038 LEPGEKPYKCPECGKSFSTSGSL 1587 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈X₁₉ 2136 gccccagca AGG GCC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ gtt CCA GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ GTT GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA SLVRHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS gttagggcc GTT AGG 1039 LEPGEKPYKCPECGKSFSQSSSL 1588 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRHX₁₇X₁₈X₁₉ 2137 ccagcagtt GCC CCA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈ gta GCA GTT TSGSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ GTA GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLTNHQRTHTGEKPYKCPECGKS GSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGSLVRHQRTHTGEKPTGKK TS gttgtaatt GTT GTA 1040 LEPGEKPYKCPECGKSFSTSGHL 1589 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2138 agcaccccg ATT AGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ ggt ACC CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇ GGT GKSFSDKKDLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREH KCPECGKSFSERSHLREHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQ GEKPYKCPECGKSFSHKNALQNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSS QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLVRHQRTHTGEKPYKCPECGKS GSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGSLVRHQRTHTGEKPTGKK TS gtgagttag gtg AGT 1041 LEPGEKPYKCPECGKSFSHRTTL 1590 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2139 ggccccagc TAG GGC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ agt CCC AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ AGT GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTT QRTHTGEKPYKCPECGKSFSHRT LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS TLTNHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS cagccagaa CAG CCA 1042 LEPGEKPYKCPECGKSFSRADNL 1591 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2140 accaacaaa GAA ACC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈ cag AAC AAA QRANLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇ CAG GKSFSDSGNLRVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA SLTEHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gaaaccaac GAA ACC 1043 LEPGEKPYKCPECGKSFSTTGNL 1592 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2141 aaacagcca AAC AAA TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ aat CAG CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ AAT GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAH KCPECGKSFSQRANLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLR GEKPYKCPECGKSFSDSGNLRVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS DLTRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS ccagaaacc CCA GAA 1044 LEPGEKPYKCPECGKSFSTSHSL 1593 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2142 aacaaacag ACC AAC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ cca AAA CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ CCA GKSFSQRANLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVH KCPECGKSFSDSGNLRVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS accaacaaa ACC AAC 1045 LEPGEKPYKCPECGKSFSSKKHL 1594 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2143 cagccaaat AAA CAG AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ ccc CCA AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ CCC GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK NLRVHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS gccagaaac GCC AGA 1046 LEPGEKPYKCPECGKSFSDCRDL 1595 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2144 caacaaaca AAC CAA ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ gcc CAA ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇ GCC GKSFSQSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLR GEKPYKCPECGKSFSDSGNLRVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLRAHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS agaaaccaa AGA AAC 1047 LEPGEKPYKCPECGKSFSQRANL 1596 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁X₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2145 caaacagcc CAA CAA RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ aaa ACA GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ AAA GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL NLRVHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS cctgcagcc CCT GCA 138 LEPGEKPYKCPECGKSFSQNSTL 139 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈X₁₉ 322 ccgcccagc GCC CCG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ cta CCC AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CTA GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK DLRRHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS accggcggg ACC GGC 1048 LEPGEKPYKCPECGKSFSDSGNL 1597 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈X₁₉ 2146 ggaccgatt GGG GGA RVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ aac CCG ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇ AAC GKSFSRNDTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆DK HLVRHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS ggcggggga GGC GGG 118 LEPGEKPYKCPECGKSFSTSGNL 119 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 317 ccgattaac GGA CCG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGNLRVHX₁₇X₁₈ cat ATT AAC DSGNLRVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ CAT GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP KLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS cccacccct CCC ACC 142 LEPGEKPYKCPECGKSFSERSHL 143 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 323 ccccggcag CCT CCC REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ agc CGG CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ AGC GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK DLTRHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS acccccacc ACC CCC 1049 LEPGEKPYKCPECGKSFSRADNL 1598 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2147 cctccccgg ACC CCT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ cag CCC CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CAG GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK HLAEHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS cacagaggc CAC AGA 1050 LEPGEKPYKCPECGKSFSTHLDL 1599 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2148 taggccaag GGC TAG IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈ act GCC AAG RKDNLKNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ ACT GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTH KCPECGKSFSREDNLHTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLRAHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS agaggctag AGA GGC 146 LEPGEKPYKCPECGKSFSSKKHL 147 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 324 gccaagact TAG GCC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ ccc AAG ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇ CCC GKSFSRKDNLKNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL HLVRHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS cttcacaga CTT CAC 1051 LEPGEKPYKCPECGKSFSRKDNL 1600 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2149 ggctaggcc AGA GGC KNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ aag TAG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇ APG GKSFSREDNLHTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT ALTEHQRTHTGEKPYKCPECGKS GALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGALTEHQRTHTGEKPTGKK TS taggccaag TAG GCC 1052 LEPGEKPYKCPECGKSFSQLAHL 1601 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2150 actcccagc AAG ACT RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ aga CCC AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ AGA GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRH KCPECGKSFSTHLDLIRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RE DLARHQRTHTGEKPYKCPECGKS DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSREDNLHTHQRTHTGEKPTGKK TS ggctaggcc GGC TAG 1053 LEPGEKPYKCPECGKSFSERSHL 1602 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2151 aagactccc GCC AAG REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ agc ACT CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ AGC GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNH KCPECGKSFSRKDNLKNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP NLHTHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ccccttcac CCC CTT 1054 LEPGEKPYKCPECGKSFSDCRDL 1603 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2152 agaggctag CAC AGA ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈ gcc GGC TAG REDNLHTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GCC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGA QRTHTGEKPYKCPECGKSFSTTG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK ALTEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS ccacccctt CCA CCC 1055 LEPGEKPYKCPECGKSFSREDNL 1604 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2153 cacagaggc CTT CAC HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ tag AGA GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ TAG GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALT GEKPYKCPECGKSFSTTGALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLAEHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS cctccaccc CCT CCA 1056 LEPGEKPYKCPECGKSFSDPGHL 1605 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2154 cttcacaga CCC CTT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ ggc CAC AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GGC GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK SLTEHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS gcagagcct GCA gag 1057 LEPGEKPYKCPECGKSFSSKKAL 1606 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2155 ccacccctt CCT CCA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈ cac CCC CTT TTGALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CAC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS gagcctcca gag CCT 1058 LEPGEKPYKCPECGKSFSQLAHL 1607 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2156 ccccttcac CCA CCC RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ aga CTT CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ AGA GKSFSTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLTEHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS ccggcagag CCG GCA 1059 LEPGEKPYKCPECGKSFSTTGAL 1608 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈X₁₉ 2157 cctccaccc gag CCT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ ctt CCA CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ CTT GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN DLRRHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS gcagatctt GCA GAT 1060 LEPGEKPYKCPECGKSFSRSDKL 1609 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2158 cccagagga CTT CCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ cgg AGA GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ CGG GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALT GEKPYKCPECGKSFSTTGALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS ccagcagat CCA GCA 114 LEPGEKPYKCPECGKSFSQRAHL 115 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 316 cttcccaga GAT CTT ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ gga CCC AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ GGA GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS DLRRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS ggcagagag GGC AGA 1061 LEPGEKPYKCPECGKSFSRSDHL 1610 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2159 ggcactggg GAG GGC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ agg ACT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ AGG GKSFSTHLDIIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLRAHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS gaaggcaga GAA GGC 1062 LEPGEKPYKCPECGKSFSRSDKL 1611 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2160 gagggcact AGA GAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ ggg GGC ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GGG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLVRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS gagggcact GAG GGC 1063 LEPGEKPYKCPECGKSFSRADNL 1612 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2161 gggaggagg ACT ggg TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ cag AGG AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CAG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLI GEKPYKCPECGKSFSTHLDLIRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS agagagggc AGA GAG 1064 LEPGEKPYKCPECGKSFSRSDHL 1613 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2162 actgggagg GGC ACT TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ agg ggg AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ AGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRH KCPECGKSFSTHLDLIRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL NLVRHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS gggaggagg ggg AGG 1065 LEPGEKPYKCPECGKSFSDPGHL 1614 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2163 cagtgggag AGG CAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ ggc TGG GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGC GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈KX₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS ggcactggg GGC ACT 1066 LEPGEKPYKCPECGKSFSRSDHL 1615 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2164 aggaggcag ggg AGG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ tgg AGG CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ TGG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP DLIRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS gagggcgga GAG GGC 1067 LEPGEKPYKCPECGKSFSTKNSL 1616 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2165 gggcggggg GGA ggg TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cct CGG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ CCT GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS actgggagg ACT ggg 1068 LEPGEKPYKCPECGKSFSRSDNL 1617 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2166 aggcagtgg AGG AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gag CAG TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ GAG GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH KLVRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS tgaaaggaa TGA AAG 1069 LEPGEKPYKCPECGKSFSDPGHL 1618 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2167 ggcagagag GAA GGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ ggc AGA GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ GGC GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA NLKNHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS aaggaaggc AAG GAA 1070 LEPGEKPYKCPECGKSFSTHLDL 1619 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2168 agagagggc GGC AGA IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ act GAG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ ACT GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RK NLVRHQRTHTGEKPYKCPECGKS DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRKDNLKNHQRTHTGEKPTGKK TS tgggagggc TGG GAG 1071 LEPGEKPYKCPECGKSFSRSDKL 1620 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2169 ggagggcgg GGC GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ ggg ggg CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD VLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS cagtgggag CAG TGG 1072 LEPGEKPYKCPECGKSFSRSDKL 1621 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2170 ggcggaggg GAG GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cgg GGA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ CGG GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA HLTTHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS aggcagtgg AGG CAG 1073 LEPGEKPYKCPECGKSFSRSDKL 1622 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2171 gagggcgga TGG GAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ggg GGC GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GGG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTEHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS aggaggcag AGG AGG 1074 LEPGEKPYKCPECGKSFSQRAHL 1623 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2172 tgggagggc CAG TGG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ gga GAG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GGA GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS gtttgaaag GTT TGA 110 LEPGEKPYKCPECGKSFSRSDNL 111 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 315 gaaggcaga AAG GAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ gag GGC AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GAG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGH QRTHTGEKPYKCPECGKSFSQAG LASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLASHQRTHTGEKPYKCPECGKS GSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FVSTSGSLVRHQRTHTGEKPTGK TS acggtttga ACG GTT 1075 LEPGEKPYKCPECGKSFSQLAHL 1624 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2173 aaggaaggc TGA AAG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ aga GAA GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ AGA GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNH KCPECGKSFSRKDNLKNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RT SLVRHQRTHTGEKPYKCPECGKS DTLRDHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRTDTLRDHQRTHTGEKPTGKK TS aggacggtt AGG ACG 1076 LEPGEKPYKCPECGKSFSDPGHL 1625 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2174 tgaaaggaa GTT TGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ ggc AAG GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇ GGC GKSFSRKDNLKNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CXHX₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLV GEKPYKCPECGKSFSTSGSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDT QRTHTGEKPYKCPECGKSFSRTD LRDHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS TLRDHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS cagaggacg CAG AGG 1077 LEPGEKPYKCPECGKSFSQSSNL 1626 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2175 gtttgaaag ACG GTT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈ gaa TGA AAG RKDNLKNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ GAA GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRH KCPECGKSFSTSGSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLR GEKPYKCPECGKSFSRTDTLRDH DHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA HLTNHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gggcgccca ggg CGC 1078 LEPGEKPYKCPECGKSFSRSDHL 1627 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2176 gggtagggc CCA GGG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ agg TAG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇ AGG GKSFSREDNLHTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGH QRTHTGEKPYKCPECGKSFSHTG LLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLLEHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS cgcccaggg CGC CCA 1079 LEPGEKPYKCPECGKSFSRSDHL 1628 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2177 tagggcagg GGG TAG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ tgg GGC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ TGG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTH KCPECGKSFSREDNLHTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HT SLTEHQRTHTGEKPYKCPECGKS GHLLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHTGHLLEHQRTHTGEKPTGKK TS gggagggcg ggg AGG 1080 LEPGEKPYKCPECGKSFSDPGHL 1629 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2178 gagggcggg GCG GAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ ggc GGC GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GGC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS cggcgtgga CGG CGT 1081 LEPGEKPYKCPECGKSFSTTGNL 1630 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2179 ggcagggag GGA GGC TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ aat AGG gag RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ AAT GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRT QRTHTGEKPYKCPECGKSFSSRR CRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS TCRAHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS aggaaggca AGG AAG 1082 LEPGEKPYKCPECGKSFSRNDAL 1631 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2180 gagagggca GCA gag TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ ctg AGG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CTG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLKNHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS tagggcagg TAG GGC 1083 LEPGEKPYKCPECGKSFSSRRTC 1632 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇X₁₈X₁₉ 2181 tggccgcgg AGG TGG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ cgt CCG CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇ CGT GKSFSRNDTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RE HLVRHQRTHTGEKPYKCPECGKS DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSREDNLHTHQRTHTGEKPTGKK TS gggtagggc GGG TAG 1084 LEPGEKPYKCPECGKSFSRSDKL 1633 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2182 aggtggccg GGC AGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ cgg TGG CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CGG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLHTHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X9HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS ccagggtag CCA GGG 1085 LEPGEKPYKCPECGKSFSRNDTL 1634 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 2183 ggcaggtgg TAG GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ ccg AGG TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CCG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gcggagggc GCG GAG 1086 LEPGEKPYKCPECGKSFSRSDKL 1635 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2184 gggggcctt GGC GGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈ cgg GGC CTT TTGALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CGG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DDLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDDLVRHQRTHTGEKPTGKK TS gaaaggaag GAA AGG 1087 LEPGEKPYKCPECGKSFSQSGDL 1636 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2185 gcagagagg AAG GCA RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gca gag AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GCA GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLTNHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS ggcagtggg GGC AGT 1088 LEPGEKPYKCPECGKSFSDPGHL 1637 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2186 agggcggag ggg AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ ggc GCG GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ GGC GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSSRSDHLVTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTT QRTHTGEKPYKCPECGKSFSHRT LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP TLTNHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS agtgggagg AGT ggg 1089 LEPGEKPYKCPECGKSFSRSDKL 1638 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2187 gcggagggc AGG GCG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ ggg GAG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GGG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRH KCPECGKSFSRSDDLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HR KLVRHQRTHTGEKPYKCPECGKS TTLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHRTTLTNHQRTHTGEKPTGKK TS agggcggag AGG GCG 1090 LEPGEKPYKCPECGKSFSTTGAL 1639 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈X₁₉ 2188 ggcgggggc GAG GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ ctt GGG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CTT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKYKCPEVCGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDD QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLVRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS aaggcagag AAG GCA 1091 LEPGEKPYKCPECGKSFSQRAHL 1640 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2189 agggcactg gag AGG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ gga GCA CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ GGA GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RK DLRRHQRTHTGEKPYKCPECGKS DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRKDNLKNHQRTHTGEKPTGKK TS ccgcggcgt CCG CGG 102 LEPGEKPYKCPECGKSFSRSDNL 103 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 313 ggaggcagg CGT GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gag GGC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GAG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCR GEKPYKCPECGKSFSSRRTCRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN KLTEHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS cgtggaggc CGT GGA 1092 LEPGEKPYKCPECGKSFSRSDDL 1641 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2190 agggagaat GGC AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ gcg gag AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GCG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SR  HLERHQRTHTGEKPYKCPECGKS RTCRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSRRTCRAHQRTHTGEKPTGKK TS gcagagagg GCA gag 1093 LEPGEKPYKCPECGKSFSQRAHL 1642 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2191 gcactggga AGG GCA ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gga CTG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GGA GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS gagagggca gag AGG 1094 LEPGEKPYKCPECGKSFSDPGHL 1643 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2192 ctgggagga GCA CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ggc GGA GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GGC GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS aggtggccg AGG TGG 1095 LEPGEKPYKCPECGKSFSDPGHL 1644 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2193 cggcgtgga CCG CGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ggc CGT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇ GGC GKSFSSRRTCRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTTHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS tggccgcgg TGG CCG 1096 LEPGEKPYKCPECGKSFSRSDHL 1645 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2194 cgtggaggc CGG CGT TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ agg GGA GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ AGG GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAH KCPECGKSFSSRRTCRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS TLTEHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS ggcaggtgg GGC AGG 1097 LEPGEKPYKCPECGKSFSQRAHL 1646 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2195 ccgcggcgt TGG CCG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇X₁₈ gga CGG CGT SRRTCRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ GGA GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLTNHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ggaggcagg GGA GGC 1098 LEPGEKPYKCPECGKSFSTHLDL 1647 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2196 gagaatgcg AGG gag IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ act AAT gcg RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ ACT GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS gcactggga GCA CTG 1099 LEPGEKPYKCPECGKSFSRSDKL 1648 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2197 ggaggcagt GGA GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ ggg GGC AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GGG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS  ALTEHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS ggaggcagt GGA GGC 1100 LEPGEKPYKCPECGKSFSRSDNL 1649 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2198 gggagggcg AGT ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ gag AGG GCG RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GAG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLT GEKPYKCPECGKSFSHRTTLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS agggcactg AGG GCA 1101 LEPGEKPYKCPECGKSFSHRTTL 1650 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2199 ggaggaggc CTG GGA TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ agt GGA GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ AGT GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLRRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS ctgggagga CTG GGA 1102 LEPGEKPYKCPECGKSFSRSDHL 1651 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2200 ggcagtggg GGA GGC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ agg AGT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ AGG GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLERHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS ggtgggcgc GGT ggg 1103 LEPGEKPYKCPECGKSFSDPGHL 1652 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2201 ccagggtag CGC CCA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈ ggc GGG TAG REDNLHTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGC GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLL GEKPYKCPECGKSFSHTGHLLEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS cggggtggg CGG GGT 1104 LEPGEKPYKCPECGKSFSREDNL 1653 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2202 cgcccaggg ggg CGC HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ tag CCA GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ TAG GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEH KCPECGKSFSHTGHLLEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS ggcgggggc GGC GGG 1105 LEPGEKPYKCPECGKSFSRSDKL 1654 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2203 cttcggggt GGC CTT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ ggg CGG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ GGG GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP KLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS gagggcggg GAG GGC 1106 LEPGEKPYKCPECGKSFSTSGHL 1655 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2204 ggccttcgg GGG GGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ ggt CTT CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ GGT GKSFSTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS gggggcctt GGG GGC 1107 LEPGEKPYKCPECGKSFSHTGHL 1656 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇X₁₈X₁₉ 2205 cggggtggg CTT CGG LEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cgc GGT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ CGC GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALT GEKPYKCPECGKSFSTTGALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS ggaggaggc GGA GGA 1108 LEPGEKPYKCPECGKSFSRSDDL 1657 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2206 agtgggagg GGC AGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gcg ggg AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GCG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNH KCPECGKSFSHRTTLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLERHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS ggccttcgg GGC CTT 1109 LEPGEKPYKCPECGKSFSTSHSL 1658 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2207 ggtgggcgc CGG GGT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇X₁₈ cca ggg CGC HTGHLLEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CCA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGA QRTHTGEKPYKCPECGKSFSTTG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP ALTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS cttcggggt CTT CGG 1110 LEPGEKPYKCPECGKSFSRSDKL 1659 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2208 gggcgccca GGT ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ ggg CGC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇ GGG GKSFSHTGHLLEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT KLTEHQRTHTGEKPYKCPECGKS GALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGALTEHQRTHTGEKPTGKK TS cagagaggg CAG AGA 1111 LEPGEKPYKCPECGKSFSRSDNL 1660 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2209 cactgggag ggg CAC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ gag TGG GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GAG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA HLRAHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS agagggcac AGA ggg 1112 LEPGEKPYKCPECGKSFSQSGDL 1661 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2210 tgggaggag CAC TGG RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ gca GAG GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GCA GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL KLVRHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS gggcactgg ggg CAC 1113 LEPGEKPYKCPECGKSFSRSDEL 1662 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2211 gaggaggca TGG GAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ gtg GAG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GTG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS aggcagaga AGG CAG 1114 LEPGEKPYKCPECGKSFSRSDNL 1663 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2212 gggcactgg AGA ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gag CAC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GAG GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTEHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS gaggaggca GAG GAG 1115 LEPGEKPYKCPECGKSFSRSDKL 1664 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2213 gtgggaggg GCA GTG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cgg GGA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ CGG GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS tgggaggag TGG GAG 1116 LEPGEKPYKCPECGKSFSRSDKL 1665 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2214 gcagtggga GAG GCA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ggg GTG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GGG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gaggcagtg GAG GCA 1117 LEPGEKPYKCPECGKSFSRSDHL 1666 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2215 ggagggcgg GTG GGA TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ agg ggg CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ AGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLRRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS cactgggag CAC TGG 1118 LEPGEKPYKCPECGKSFSQRAHL 1667 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2216 gaggcagtg GAG GAG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ gga GCA GTG RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ GGA GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTTHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS aaaggaagg AAA GGA 1119 LEPGEKPYKCPECGKSFSSKKAL 1668 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2217 cagagaggg AGG CAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cac AGA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ CAC GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLERHQRTHTGEKPYKCPECGKS ANLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRANLRAHQRTHTGEKPTGKK TS ggaaggcag GGA AGG 1120 LEPGEKPYKCPECGKSFSRSDHL 1669 X₁X₂X₃X₄X₅X₆X₇X₈X₉CC10X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2218 agagggcac CAG AGA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ tgg ggg CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ TGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR  HLTNHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS gtgggaggg GTG GGA 1121 LEPGEKPYKCPECGKSFSRSDKL 1670 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2219 cggagggcg ggg CGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ ggg AGG GCG RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLERHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS gcagtggga GCA GTG 1122 LEPGEKPYKCPECGKSFSRSDDL 1671 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2220 gggcggagg GGA ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gcg CGG AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ GCG GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS ELVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS ggagggcgg GGA ggg 1123 LEPGEKPYKCPECGKSFSDCRDL 1672 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2221 agggcgggg CGG AGG ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gcc GCG GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ GCC GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR KLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS cgcggcgtg CGC GGC 1124 LEPGEKPYKCPECGKSFSQLAHL 1673 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2222 gaggcaggg GTG GAG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ aga GCA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ AGA GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HT HLVRHQRTHTGEKPYKCPECGKS GHLLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHTGHLLEHQRTHTGEKPTGKK TS ggccgcggc GGC CGC 1125 LEPGEKPYKCPECGKSFSRSDKL 1674 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2223 gtggaggca GGC GTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ ggg GAG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ GGG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGH QRTHTGEKPYKCPECGKSFSHTG LLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLLEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ggcgtggag GGC GTG 1126 LEPGEKPYKCPECGKSFSRRDEL 1675 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 2224 gcagggaga GAG GCA NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ atg ggg AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ ATG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP ELVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS gtggaggca GTG GAG 1127 LEPGEKPYKCPECGKSFSQSGHL 1676 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇X₁₈X₁₉ 2225 gggagaatg GCA ggg TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ cga AGA ATG RRDELNVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ CGA GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS  NLVRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS ggggtgggc GGG GTG 1128 LEPGEKPYKCPECGKSFSRSDHL 1677 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2226 gcccagggt GGC GCC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ agg CAG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ AGG GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gtgggcgcc GTG GGC 1129 LEPGEKPYKCPECGKSFSQSGDL 1678 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2227 cagggtagg GCC CAG RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gca GGT AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GCA GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS gcaggtggc GCA GGT 1130 LEPGEKPYKCPECGKSFSRSDNL 1679 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2228 cgcggcgtg GGC CGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ gag GGC GTG RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GAG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEH KCPECGKSFSHTGHLLEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS ggtggccgc GGT GGC 1131 LEPGEKPYKCPECGKSFSQSGDL 1680 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ ggcgtggag CGC GGC RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ 2229 gca GTG GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GCA GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLL GEKPYKCPECGKSFSHTGHLLEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS agggcaggt AGG GCA 1132 LEPGEKPYKCPECGKSFSRSDEL 1681 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2230 ggccgcggc GGT GGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ gtg CGC GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇ GTG GKSFSHTGHLLEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLRRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS gcccagggt GCC CAG 1133 LEPGEKPYKCPECGKSFSDPGHL 1682 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2231 agggcaggt GGT AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ ggc GCA GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ GGC GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC NLTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS ggcgcccag GGC GCC 1134 LEPGEKPYKCPECGKSFSTSGHL 1683 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2232 ggtagggca CAG GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ ggt AGG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGT GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP DLARHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS cagggtagg CAG GGT 1135 LEPGEKPYKCPECGKSFSHTGHL 1684 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇X₁₈X₁₉ 2233 gcaggtggc AGG GCA LEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ cgc GGT GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ CGC GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA HLVRHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS ggtagggca GGT AGG 1136 LEPGEKPYKCPECGKSFSDPGHL 1685 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2234 ggtggccgc GCA GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇X₁₈ ggc GGC CGC HTGHLLEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GGC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD VLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLTNHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS agggtaggg AGG GTA 1137 LEPGEKPYKCPECGKSFSRSDDL 1686 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2235 caggtggcc ggg CAG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ gcg GTG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GCG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSS QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLVRHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS cccagggta CCC AGG 1138 LEPGEKPYKCPECGKSFSDCRDL 1687 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2236 gggcaggtg GTA ggg ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ gcc CAG GTG RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ GCC GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLV GEKPYKCPECGKSFSQSSSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTNHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS gtagggcag GTA ggg 1139 LEPGEKPYKCPECGKSFSRSDDL 1688 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2237 gtggccgcg CAG GTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ gcg GCC GCG RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ GCG GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS KLVRHQRTHTGEKPYKCPECGKS SSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSSLVRHQRTHTGEKPTGKK TS gggcaggtg ggg CAG 1140 LEPGEKPYKCPECGKSFSRSDHL 1689 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2238 gccgcggcg GTG GCC TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ tgg GCG GCG RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ TGG GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTEHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gtggccgcg GTG GCC 1141 LEPGEKPYKCPECGKSFSRADNL 1690 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2239 gcgtggagg GCG GCG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ cag TGG AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CAG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRH KCPECGKSFSRSDDLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLARHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS caggtggcc CAG GTG 1142 LEPGEKPYKCPECGKSFSRSDHL 1691 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2240 gcggcgtgg GCC GCG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ agg GCG TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ AGG GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRH KCPECGKSFSRSDDLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA ELVRHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gcgcccagg gcg CCC 1143 LEPGEKPYKCPECGKSFSRSDEL 1692 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2241 gtagggcag AGG GTA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ gtg ggg CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GTG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRH KCPECGKSFSQSSSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLAEHQRTHTGEKPYKCPECGKS DDLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDDLVRHQRTHTGEKPTGKK TS gggtgggcg GGG TGG 1144 LEPGEKPYKCPECGKSFSRSDKL 1693 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2242 cccagggta gcg CCC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRHX₁₇X₁₈ ggg AGG GTA QSSSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTTHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS tgggcgccc TGG gcg 1145 LEPGEKPYKCPECGKSFSRADNL 1694 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2243 agggtaggg CCC AGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cag GTA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRHX₁₇ CAG GKSFSQSSSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDD QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gcggcgtgg GCG GCG 1146 LEPGEKPYKCPECGKSFSQSSNL 1695 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2244 aggcaggga TGG AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gaa CAG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ GAA GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDD QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLVRHQRTHTGEKPYKCPECGKS DDLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDDLVRHQRTHTGEKPTGKK TS gccgcggcg GCC GCG 1147 LEPGEKPYKCPECGKSFSQRAHL 1696 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2245 tggaggcag GCG TGG ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ gga AGG CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGA GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDD QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC DLVRHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS aaccctcgt AAC CCT 1148 LEPGEKPYKCPECGKSFSTSGNL 1697 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2246 cgacatgga CGT CGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ cat CAT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ CAT GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEH KCPECGKSFSQSGHLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCR GEKPYKCPECGKSFSSRRTCRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DS SLTEHQRTHTGEKPYKCPECGKS GNLRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDSGNLRVHQRTHTGEKPTGKK TS cctcgtcga CCT CGT 1149 LEPGEKPYKCPECGKSFSDPGHL 1698 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2247 catggacat CGA CAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ ggc GGA CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GGC GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLT GEKPYKCPECGKSFSQSGHLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRT QRTHTGEKPYKCPECGKSFSSRR CRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK TCRAHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS catggacat CAT GGA 1150 LEPGEKPYKCPECGKSFSRADNL 1699 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2248 ggccgacta CAT GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈ cag CGA CTA QNSTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇ CAG GKSFSQSGHLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLERHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLTEHQRTHTGEKPTGKK TS caaaaccct CAA AAC 1151 LEPGEKPYKCPECGKSFSQRAHL 1700 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2249 cgtcgacat CCT CGT ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ gga CGA CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇ GGA GKSFSQSGHLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAH KCPECGKSFSSRRTCRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLRVHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGNLTEHQRTHTGEKPTGKK TS cgtcgacat CGT CGA 1152 LEPGEKPYKCPECGKSFSQSGHL 1701 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇X₁₈X₁₉ 2250 ggacatggc CAT GGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ cga CAT GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ CGA GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGH QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SR HLTEHQRTHTGEKPYKCPECGKS RTCRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSRRTCRAHQRTHTGEKPTGKK TS cgacatgga CGA CAT 1153 LEPGEKPYKCPECGKSFSQNSTL 1702 XX₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈X₁₉ 2251 catggccga GGA CAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇X₁₈ cta GGC CGA QSGHLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CTA GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLTEHQRTHTGEKPYKCPECGKS GHLTEHX₁₇X₁₈KX₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGHLTEHQRTHTGEKPTGKK TS gtcgacatg GTC GAC 1154 LEPGEKPYKCPECGKSFSDPGNL 1703 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇X₁₈X₁₉ 2252 gacatggcc ATG GAC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ gac ATG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ GAC GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRH KCPECGKSFSDPGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELN GEKPYKCPECGKSFSRRDELNVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGN QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP NLVRHQRTHTGEKPYKCPECGKS GALVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGALVRHQRTHTGEKPTGKK TS gtgctgcac gtg CTG 1155 LEPGEKPYKCPECGKSFSTKNSL 1704 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2253 tggacccag CAC TGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ cct ACC CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇ CCT GKSFSDKKDLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS acagtgctg ACA gtg 1156 LEPGEKPYKCPECGKSFSRADNL 1705 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2254 cactggacc CTG CAC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈ cag TGG ACC DKKDLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CAG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP ELVRHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS ctgcactgg CTG CAC 1157 LEPGEKPYKCPECGKSFSSPADL 1706 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2255 acccagcct TGG ACC TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ aca CAG CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ ACA GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN ALTEHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS cactggacc CAC TGG 1158 LEPGEKPYKCPECGKSFSTSHSL 1707 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2256 cagcctaca ACC CAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ cca CCT ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ CCA GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTTHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS actacagtg ACT ACA 1159 LEPGEKPYKCPECGKSFSDKKDL 1708 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈X₁₉ 2257 ctgcactgg gtg CTG TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ acc CAC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ ACC GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH DLTRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS acatggccg ACA TGG 1160 LEPGEKPYKCPECGKSFSRNDAL 1709 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2258 actacagtg CCG ACT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ ctg ACA gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ CTG GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRH KCPECGKSFSTHLDLIRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP HLTTHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS tggacatgg TGG ACA 1161 LEPGEKPYKCPECGKSFSRSDEL 1710 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2259 ccgactaca TGG CCG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ gtg ACT ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ GTG GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLTRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS cagcctaca CAG CCT 1162 LEPGEKPYKCPECGKSFSTTGNL 1711 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2260 ccaccctgg ACA CCA TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ aat CCC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ AAT GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA SLTEHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS acatggaca ACA TGG 1163 LEPGEKPYKCPECGKSFSSPADL 1712 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2261 tggccgact ACA TGG TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ aca CCG ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇ ACA GKSFSRNDTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP HLTTHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS tggacccag TGG ACC 1164 LEPGEKPYKCPECGKSFSSKKHL 1713 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2262 cctacacca CAG CCT AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ ccc ACA CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ CCC GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLTRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS acccagcct ACC CAG 1165 LEPGEKPYKCPECGKSFSRSDHL 1714 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2263 acaccaccc CCT ACA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ tgg CCA CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ TGG GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK NLTEHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS ccgactaca CCG ACT 1166 LEPGEKPYKCPECGKSFSRSDHL 1715 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2264 gtgctgcac ACA gtg TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ tgg CTG CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ TGG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN DLIRHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS tggccgact TGG CCG 1167 LEPGEKPYKCPECGKSFSSKKAL 1716 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2265 acagtgctg ACT ACA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ cac gtg CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ CAC GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLI GEKPYKCPECGKSFSTHLDLIRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS TLTEHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS agtgctgca AGT GCT 1168 LEPGEKPYKCPECGKSFSDCRDL 1717 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2266 ctggaccca GCA CTG ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ gcc GAC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇ GCC GKSFSDPGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HR ELVRHQRTHTGEKPYKCPECGKS TTLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHRTTLTNHQRTHTGEKPTGKK TS ctacaccac CTA CAC 1169 LEPGEKPYKCPECGKSFSQAGHL 1718 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈X₁₉ 2267 cctggaatt CAC CCT ASHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ tga GGA ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ TGA GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QN ALTEHQRTHTGEKPYKCPECGKS STLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQNSTLTEHQRTHTGEKPTGKK TS agcctacac AGC CTA 1170 LEPGEKPYKCPECGKSFSHKNAL 1719 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2268 caccctgga CAC CAC QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ att CCT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ ATT GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNST QRTHTGEKPYKCPECGKSFSQNS LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ER TLTEHQRTHTGEKPYKCPECGKS SHLREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS caccaccct CAC CAC 1171 LEPGEKPYKCPECGKSFSQSSNL 1720 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2269 ggaatttga CCT GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈ gaa ATT TGA QAGHLASHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ GAA GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK ALTEHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS ggacccagc GGA CCC 1172 LEPGEKPYKCPECGKSFSTKNSL 1721 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2270 ctacaccac AGC CTA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ cct CAC CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ CCT GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEH KCPECGKSFSQNSTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLAEHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS cccagccta CCC AGC 1173 LEPGEKPYKCPECGKSFSQRAHL 1722 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2271 caccaccct CTA CAC ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ gga CAC CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GGA GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLT GEKPYKCPECGKSFSQNSTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLREHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS actggaccc ACT GGA 1174 LEPGEKPYKCPECGKSFSSKKAL 1723 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2272 agcctacac CCC AGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ cac CTA CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇ CAC GKSFSQNSTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREH KCPECGKSFSERSHLREHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH HLERHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS tggtaggtg TGG TAG 1175 LEPGEKPYKCPECGKSFSRSDEL 1724 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2273 ggggcagat GTG GGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ gtg GCA GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ GTG GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLHTHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS taggtgggg TAG GTG 1176 LEPGEKPYKCPECGKSFSSKKHL 1725 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2274 gcagatgtg GGG GCA AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ ccc GAT gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ CCC GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RE ELVRHQRTHTGEKPYKCPECGKS DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSREDNLHTHQRTHTGEKPTGKK TS gatgggcaa GAT ggg 1177 LEPGEKPYKCPECGKSFSRSDKL 1726 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2275 tggtaggtg CAA TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ ggg TAG GTG RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇ GGG GKSFSREDNLHTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS gggcaatgg ggg CAA 1178 LEPGEKPYKCPECGKSFSQSGDL 1727 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2276 taggtgggg TGG TAG RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gca GTG GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GCA GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTH KCPECGKSFSREDNLHTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGN QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTEHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS caatggtag CAA TGG 1179 LEPGEKPYKCPECGKSFSTSGNL 1728 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈X₁₉ 2277 gtgggggca TAG GTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ gat GGG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GAT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLTTHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGNLTEHQRTHTGEKPTGKK TS gtgggggca GTG GGG 1180 LEPGEKPYKCPECGKSFSRSDHL 1729 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2278 gatgtgccc GCA GAT TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ agg gtg CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ AGG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS gacgatggg GAC GAT 1181 LEPGEKPYKCPECGKSFSRSDEL 1730 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2279 caatggtag ggg CAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈ gtg TGG TAG REDNLHTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GTG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP NLVRHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGNLVRHQRTHTGEKPTGKK TS gttgacgat GTT GAC 1182 LEPGEKPYKCPECGKSFSREDNL 1731 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2280 gggcaatgg GAT ggg HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ tag CAA TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇ TAG GKSFSQSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGN QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS GSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGSLVRHQRTHTGEKPTGKK TS gcaggtgtt GCA GGT 1183 LEPGEKPYKCPECGKSFSQSGNL 1732 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈X₁₉ 2281 gacgatggg GTT GAC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ caa GAT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ CAA GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRH KCPECGKSFSDPGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLV GEKPYKCPECGKSFSTSGSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS ggtgttgac GGT GTT 1184 LEPGEKPYKCPECGKSFSRSDHL 1733 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2282 gatgggcaa GAC GAT TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ tgg ggg CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ TGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLV GEKPYKCPECGKSFSDPGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS gcaatggta GCA ATG 1185 LEPGEKPYKCPECGKSFSQLAHL 1734 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2283 ggtgggggc GTA GGT RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ aga GGG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ AGA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLV GEKPYKCPECGKSFSQSSSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDE QRTHTGEKPYKCPECGKSFSRRD LNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS ELNVHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS tgggcaatg TGG GCA 1186 LEPGEKPYKCPECGKSFSDPGHL 1735 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2284 gtaggtggg ATG GTA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ ggc GGT GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GGC GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRH KCPECGKSFSQSSSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELN GEKPYKCPECGKSFSRRDELNVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆4SGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLRRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS tgacgatgg TGA CGA 1187 LEPGEKPYKCPECGKSFSTSGHL 1736 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ gcaatggta TGG GCA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRHX₁₇X₁₈ 2285 ggt ATG GTA QSSSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ GGT GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGH QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QA HLTEHQRTHTGEKPYKCPECGKS GHLASHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQAGHLASHQRTHTGEKPTGKK TS cgatgggca CGA TGG 1188 LEPGEKPYKCPECGKSFSRSDKL 1737 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2286 atggtaggt GCA ATG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ ggg GTA GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRHX₁₇ GGG GKSFSQSSSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVH KCPECGKSFSRRDELNVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLTTHQRTHTGEKPYKCPECGKS GHLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGHLTEHQRTHTGEKPTGKK TS ggcaatggt GGC AAT 1189 LEPGEKPYKCPECGKSFSRADNL 1738 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2287 aggtggggg GGT AGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cag TGG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CAG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP NLTVHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS atgggcaat ATG GGC 1190 LEPGEKPYKCPECGKSFSRSDKL 1739 XX₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2288 ggtaggtgg AAT GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ ggg AGG TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RR HLVRHQRTHTGEKPYKCPECGKS DELNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRRDELNVHQRTHTGEKPTGKK TS aatggtagg AAT GGT 1191 LEPGEKPYKCPECGKSFSRRDEL 1740 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 2289 tgggggcag AGG TGG NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ atg ggg CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ ATG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT HLVRHQRTHTGEKPYKCPECGKS GNLTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGNLTVHQRTHTGEKPTGKK TS acgatgggc ACG ATG 1192 LEPGEKPYKCPECGKSFSRSDHL 1741 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2290 aatggtagg GGC AAT TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ tgg GGT AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CKX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ TGG GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDE QRTHTGEKPYKCPECGKSFSRRD LNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RT ELNVHQRTHTGEKPYKCPECGKS DTLRDHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRTDTLRDHQRTHTGEKPTGKK TS gtgggggca GTG GGG 1193 LEPGEKPYKCPECGKSFSRSDKL 1742 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2291 ggtgtgcct GCA GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ ggg gtg CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GGG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X15KX₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS KLVRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS ccagtgggg CCA GTG 1194 LEPGEKPYKCPECGKSFSTKNSL 1743 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2292 gcaggtgtg GGG GCA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ cct GGT gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ CCT GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ELVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gtgccagtg gtg CCA 1195 LEPGEKPYKCPECGKSFSRSDEL 1744 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈X₁₉ 2293 ggggcaggt GTG GGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ gtg GCA GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ GTG GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLTEHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS ccaggtgtg CCA GGT 1196 LEPGEKPYKCPECGKSFSQSGDL 1745 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2294 ccagtgggg gtg CCA RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gca GTG GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ GCA GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS ggtgtgcca GGT gtg 1197 LEPGEKPYKCPECGKSFSTSGHL 1746 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2295 gtgggggca CCA GTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ ggt GGG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ELVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS ccaggagca CCA GGA 1198 LEPGEKPYKCPECGKSFSSKKAL 1747 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2296 gatctttgg GCA GAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ cac CTT TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ CAC GKSFSTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLERHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS ctgggtcca CTG GGT 1199 LEPGEKPYKCPECGKSFSTTGAL 1748 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈X₁₉ 2297 ggagcagat CCA GGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ ctt GCA GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ CTT GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS ggtccagga GGT CCA 1200 LEPGEKPYKCPECGKSFSRSDHL 1749 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2298 gcagatctt GGA GCA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈ tgg GAT CTT TTGALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ TGG GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS gggaggaga ggg AGG 1201 LEPGEKPYKCPECGKSFSTTGNL 1750 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2299 atgatacaa AGA ATG TVHQRTHTGEKPYKCPECGKSFS 9HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ aat ATA CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLIAHX₁₇ AAT GKSFSQKSSLIAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVH KCPECGKSFSRRDELNVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS tggggtggg TGG GGT 1202 LEPGEKPYKCPECGKSFSQKSSL 1751 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLIAHX₁₇X₁₈X₁₉ 2300 aggagaatg ggg AGG IAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ ata AGA ATG RRDELNVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇ ATA GKSFSQLAHLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS ctttggggt CTT TGG 1203 LEPGEKPYKCPECGKSFSRRDEL 1752 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 2301 gggaggaga GGT ggg NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₁X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈ atg AGG AGA QLAHLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ ATG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT HLTTHQRTHTGEKPYKCPECGKS GALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGALTEHQRTHTGEKPTGKK TS ggcactcaa GGC ACT 1204 LEPGEKPYKCPECGKSFSRSDKL 1753 X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2302 ctttggggt CAA CTT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ ggg TGG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP DLIRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS aggagaatg AGG AGA 1205 LEPGEKPYKCPECGKSFSTSGHL 1754 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2303 atacaaaat ATG ATA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ ggt CAA AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇ GGT GKSFSQSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLIAH KCPECGKSFSQKSSLIAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELN GEKPYKCPECGKSFSRRDELNVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X1CX₁₂X₁₃X₁₄X₁₅X₁₆QLAH QRTHTGEKPYKCPECGKSFSQLA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLRAHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS agaatgata AGA ATG 1206 LEPGEKPYKCPECGKSFSRSDHL 1755 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2304 caaaatggt ATA CAA TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ agg AAT GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ AGG GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLI GEKPYKCPECGKSFSQKSSLIAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDE QRTHTGEKPYKCPECGKSFSRRD LNVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL ELNVHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS ggtgggagg GGT ggg 1207 LEPGEKPYKCPECGKSFSQSGNL 1756 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈X₁₉ 2305 agaatgata AGG AGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLIAHX₁₇X₁₈ caa ATG ATA QKSSLIAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ CAA GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS caactttgg CAA CTT 1208 LEPGEKPYKCPECGKSFSQLAHL 1757 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2306 ggtgggagg TGG GGT RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ aga ggg AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ AGA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGA QRTHTGEKPYKCPECGKSFSTTG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS ALTEHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGNLTEHQRTHTGEKPTGKK TS actcaactt ACT CAA 1209 LEPGEKPYKCPECGKSFSRSDHL 1758 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2307 tggggtggg CTT TGG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ agg GGT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ AGG GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALT GEKPYKCPECGKSFSTTGALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGN QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH NLTEHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS gggtgggag GGG TGG 1210 LEPGEKPYKCPECGKSFSSPADL 1759 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2308 gagaatgat GAG gag TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ aca AAT GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ ACA GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTTHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gagaatgat gag AAT 1211 LEPGEKPYKCPECGKSFSREDNL 1760 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2309 acaaaatgg GAT ACA HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ tag AAA TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ TAG GKSFSQRANLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTVHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS tgggaggag TGG GAG 1212 LEPGEKPYKCPECGKSFSQRANL 1761 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2310 aatgataca gag AAT RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ aaa GAT ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ AAA GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gaggagaat GAG gag 1213 LEPGEKPYKCPECGKSFSRSDHL 1762 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2311 gatacaaaa AAT GAT TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈ tgg ACA AAA QRANLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ TGG GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS aatgataca AAT GAT 1214 LEPGEKPYKCPECGKSFSTSGSL 1763 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈X₁₉ 2312 aaatggtag ACA AAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈ gtt TGG TAG REDNLHTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GTT GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAH KCPECGKSFSQRANLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT NLVRHQRTHTGEKPYKCPECGKS GNLTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGNLTVHQRTHTGEKPTGKK TS ggtcctaca GGT CCT 1215 LEPGEKPYKCPECGKSFSRSDHL 1764 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2313 ggccagcac ACA GGC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ agg CAG CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ AGG GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS taggttggt TAG GTT 1216 LEPGEKPYKCPECGKSFSRADNL 1765 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2314 cctacaggc GGT CCT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ cag ACA GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ CAG GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RE SLVRHQRTHTGEKPYKCPECGKS DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSREDNLHTHQRTHTGEKPTGKK TS tggtaggtt TGG TAG 1217 LEPGEKPYKCPECGKSFSDPGHL 1766 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2315 ggtcctaca GTT GGT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ ggc CCT ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ GGC GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLV GEKPYKCPECGKSFSTSGSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLHTHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS aaatggtag AAA TGG 1218 LEPGEKPYKCPECGKSFSSPADL 1767 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2316 gttggtcct TAG GTT TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ aca GGT CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GAC GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRH KCPECGKSFSTSGSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH ARTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLTTHQRTHTGEKPYKCPECGKS ANLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRANLRAHQRTHTGEKPTGKK TS acaaaatgg ACA AAA 1219 LEPGEKPYKCPECGKSFSTKNSL 1768 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2317 taggttggt TGG TAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ cct GTT GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ CCT GKSFSTSGSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTH KCPECGKSFSREDNLHTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAN QRTHTGEKPYKCPECGKSFSQRA LRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP NLRAHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS gatacaaaa GAT ACA 1220 LEPGEKPYKCPECGKSFSTSGHL 1769 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2318 tggtaggtt AAA TGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈ ggt TAG GTT TSGSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇ GGT GKSFSREDNLHTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLR GEKPYKCPECGKSFSQRANLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS DLTRHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS gttggtcct GTT GGT 1221 LEPGEKPYKCPECGKSFSSKKAL 1770 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2319 acaggccag CCT ACA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ cac GGC CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CAC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLVRHQRTHTGEKPYKCPECGKS GSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGSLVRHQRTHTGEKPTGKK TS gtcctacag GTC CTA 1222 LEPGEKPYKCPECGKSFSTSGHL 1771 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2320 gccagcaca CAG GCC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ ggt AGC ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇ GGT GKSFSERSHLREHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNST QRTHTGEKPYKCPECGKSFSQNS LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP TLTEHQRTHTGEKPYKCPECGKS GALVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGALVRHQRTHTGEKPTGKK TS caggccagc CAG GCC 1223 LEPGEKPYKCPECGKSFSDCRDL 1772 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2321 acaggtgtt AGC ACA ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈ gcc GGT GTT TSGSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GCC GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA DLARHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS ctacaggcc CTA CAG 1224 LEPGEKPYKCPECGKSFSTSGSL 1773 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈X₁₉ 2322 agcacaggt GCC AGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ gtt ACA GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ GTT GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREH KCPECGKSFSERSHLREHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QN NLTEHQRTHTGEKPYKCPECGKS STLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQNSTLTEHQRTHTGEKPTGKK TS ggtgttgcc GGT GTT 1225 LEPGEKPYKCPECGKSFSTSHSL 1774 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2323 aagtgaagc GCC AAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈ cca TGA AGC ERSHLREHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ CCA GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNH KCPECGKSFSRKDNLKNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS agcacaggt AGC ACA 1226 LEPGEKPYKCPECGKSFSQAGHL 1775 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈X₁₉ 2324 gttgccaag GGT GTT ASHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀XCX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈ tga GCC AAG RKDNLKNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ TGA GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRH KCPECGKSFSTSGSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ER DLTRHQRTHTGEKPYKCPECGKS SSHLREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS acaggtgtt ACA GGT 1227 LEPGEKPYKCPECGKSFSERSHL 1776 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREHX₁₇X₁₈X₁₉ 2325 gccaagtga GTT GCC REHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇X₁₈ agc AAG TGA QAGHLASHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇ AGC GKSFSRKDNLKNHQRTHTGEKPY X₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLV GEKPYKCPECGKSFSTSGSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP HLVRHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS gccagcaca GCC AGC 1228 LEPGEKPYKCPECGKSFSRKDNL 1777 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2326 ggtgttgcc ACA GGT KNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ aag GTT GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ APG GKSFSTSGSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLREHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS aggcacagt AGG CAC 1229 LEPGEKPYKCPECGKSFSTSGNL 1778 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2327 gatcacagg AGT GAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ cat CAC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ CAT GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLT GEKPYKCPECGKSFSHRTTLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS ccaagtgaa CCA AGT 1230 LEPGEKPYKCPECGKSFSSKKHL 1779 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2328 gcccatgtg GAA GCC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ ccc CAT gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ CCC GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTT QRTHTGEKPYKCPECGKSFSHRT LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS TLTNHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gaagcccat GAA GCC 1231 LEPGEKPYKCPECGKSFSSKKAL 1780 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2329 gtgcccagg CAT gtg TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ cac CCC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CAC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS DLARHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS agtgaagcc AGT GAA 1232 LEPGEKPYKCPECGKSFSRSDHL 1781 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2330 catgtgccc GCC CAT TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ agg gtg CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ AGG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HR  NLVRHQRTHTGEKPYKCPECGKS TTLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHRTTLTNHQRTHTGEKPTGKK TS gtgcccagg gtg CCC 1233 LEPGEKPYKCPECGKSFSSKKAL 1782 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2331 cacagtgat AGG CAC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ cac AGT GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ CAC GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLAEHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS gcccatgtg GCC CAT 1234 LEPGEKPYKCPECGKSFSHRTTL 1783 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2332 cccaggcac gtg CCC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ agt AGG CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ AGT GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC NLTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS catgtgccc CAT gtg 1235 LEPGEKPYKCPECGKSFSTSGNL 1784 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈X₁₉ 2333 aggcacagt CCC AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ gat CAC AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GAT GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ELVRHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLTEHQRTHTGEKPTGKK TS cccaggcac CCC AGG 1236 LEPGEKPYKCPECGKSFSRSDHL 1785 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2334 agtgatcac CAC AGT TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ agg GAT CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ AGG GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNH KCPECGKSFSHRTTLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X1CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTNHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ ESSKKHLAEHQRTHTGEKPTGKK TS gggaggcct ggg AGG 1237 LEPGEKPYKCPECGKSFSTTGNL 1786 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2335 gcaagggcc CCT GCA TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ aat AGG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ AAT GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTNHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gaagggagg GAA ggg 1238 LEPGEKPYKCPECGKSFSDCRDL 1787 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2336 cctgcaagg AGG CCT ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ gcc GCA AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ GCC GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS KLVRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS acaggcatt ACA GGC 1239 LEPGEKPYKCPECGKSFSRSDKL 1788 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2337 ctgggtgaa ATT CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ ggg GGT GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GGG GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQ GEKPYKCPECGKSFSHKNALQNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP HLVRHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS ctgggtgaa CTG GGT 1240 LEPGEKPYKCPECGKSFSQSGDL 1789 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2338 gggaggcct GAA ggg RRHQRTHTGEKPYKCPECGKSIS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ gca AGG CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GCA GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS attctgggt ATT CTG 1241 LEPGEKPYKCPECGKSFSTKNSL 1790 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2339 gaagggagg GGT GAA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ cct ggg AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CCT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HK ALTEHQRTHTGEKPYKCPECGKS NALQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHKNALQNHQRTHTGEKPTGKK TS ggcattctg GGC ATT 1242 LEPGEKPYKCPECGKSFSRSDHL 1791 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2340 ggtgaaggg CTG GGT TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ agg GAA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ AGG GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRH KCPECGKSFSTSGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNA QRTHTGEKPYKCPECGKSFSHKN LQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆DP ALQNHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ggtgaaggg GGT GAA 1243 LEPGEKPYKCPECGKSFSRSDHL 1792 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2341 aggcctgca ggg AGG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ agg CCT GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ AGG GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS ggaggcctg GGA GGC 1244 LEPGEKPYKCPECGKSFSHKNAL 1793 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2342 caagggcca CTG CAA QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ att ggg CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ ATT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR HLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS gtgaaggga gtg AAG 1245 LEPGEKPYKCPECGKSFSRSDKL 1794 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2343 ggcctgcaa GGA GGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ ggg CTG CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GGG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLKNHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS tgggtgaag TGG gtg 1246 LEPGEKPYKCPECGKSFSQSGNL 1795 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈X₁₉ 2344 ggaggcctg AAG GGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ caa GGC CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CAA GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS aagggaggc AAG GGA 1247 LEPGEKPYKCPECGKSFSTSHSL 1796 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2345 ctgcaaggg GGC CTG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cca CAA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇ CCA GKSFSQSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RK HLERHQRTHTGEKPYKCPECGKS DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRKDNLKNHQRTHTGEKPTGKK TS actgtgcct ACT gtg 1248 LEPGEKPYKCPECGKSFSDPGHL 1797 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2346 gggcacatg CCT ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ ggc CAC ATG RRDELNVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GGC GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH ELVRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS gcctgggca GCC TGG 1249 LEPGEKPYKCPECGKSFSSKKAL 1798 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2347 catgggctt GCA CAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈ cac ggg CTT TTGALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CAC GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLTTHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS gctggcctg GCT GGC 1250 LEPGEKPYKCPECGKSFSTKNSL 1799 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2348 taggaccaa CTG TAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ cct GAC CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇ CCT GKSFSDPGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTH KCPECGKSFSREDNLHTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLVRHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS ggcctgtag GGC CTG 1251 LEPGEKPYKCPECGKSFSDKKDL 1800 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈X₁₉ 2349 gaccaacct TAG GAC TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ acc CAA CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇ ACC GKSFSQSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRH KCPECGKSFSDPGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP ALTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ctgtaggac CTG TAG 1252 LEPGEKPYKCPECGKSFSHKNAL 1801 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2350 caacctacc GAC CAA QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈ att CCT ACC DKKDLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ ATT GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLV GEKPYKCPECGKSFSDPGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN NLHTHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS ccaccccaa CCA CCC 1253 LEPGEKPYKCPECGKSFSTSHSL 1802 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2351 agttgagtg CAA AGT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ cca TGA gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ CCA GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNH KCPECGKSFSHRTTLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLAEHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS ccccaaagt CCC CAA 1254 LEPGEKPYKCPECGKSFSRKDNL 1803 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2352 tgagtgcca AGT TGA KNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ aag gtg CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ AAG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLT GEKPYKCPECGKSFSHRTTLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGN QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK NLTEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS gctcctgga GCT CCT 1255 LEPGEKPYKCPECGKSFSDKKDL 1804 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈X₁₉ 2353 cccaggcac GGA CCC TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ acc AGG CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ ACC GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLTEHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS ctggaccca CTG GAC 1256 LEPGEKPYKCPECGKSFSDCRDL 1805 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2354 ggcacacct CCA GGC ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ gcc ACA CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ GCC GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGN QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN NLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS gcccccact GCC CCC 1257 LEPGEKPYKCPECGKSFSRSDKL 1806 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2355 ggcacacct ACT GGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X20X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ ggg ACA CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ GGG GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDL GEKPYKCPECGKSFSTHLDLIRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLAEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS cctgccccc CCT GCC 1258 LEPGEKPYKCPECGKSFSTKNSL 1807 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2356 actggcaca CCC ACT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ cct GGC ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CCT GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRH KCPECGKSFSTHLDLIRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK DLARHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS ggcacacct GGC ACA 1259 LEPGEKPYKCPECGKSFSDPGHL 1808 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2357 gcccccact CCT GCC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ ggc CCC ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ GGC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP DLTRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS acacctgcc ACA CCT 1260 LEPGEKPYKCPECGKSFSSPADL 1809 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2358 cccactggc GCC CCC TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ aca ACT GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ ACA GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP  SLTEHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS ccaggcaca CCA GGC 1261 LEPGEKPYKCPECGKSFSTHLDL 1810 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2359 cctgccccc ACA CCT IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ act GCC CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ ACT GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS cccactggc CCC ACT 1262 LEPGEKPYKCPECGKSFSSKKAL 1811 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2360 acacctggg GGC ACA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cac CCT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ CAC GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK DLIRHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS gacccaggc GAC CCA 1263 LEPGEKPYKCPECGKSFSSKKHL 1812 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2361 acacctgcc GGC ACA AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ ccc CCT GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ CCC GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP SLTEHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGNLVRHQRTHTGEKPTGKK TS ccactggca CCA CTG 1264 LEPGEKPYKCPECGKSFSSPADL 1813 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2362 cacctgggc GCA CAC TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ aca CTG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ ACA GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALTEHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gcacacctg GCA CAC 1265 LEPGEKPYKCPECGKSFSQSGDL 1814 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2363 cccccactg CTG CCC RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ gca CCA CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ GCA GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS ALTEHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS ctgccccca CTG CCC 1266 LEPGEKPYKCPECGKSFSRNDAL 1815 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2364 ctggcacac CCA CTG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ ctg GCA CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ CTG GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLAEHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS cccccactg CCC CCA 1267 LEPGEKPYKCPECGKSFSDPGHL 1816 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2365 gcacacctg CTG GCA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ggc CAC CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GGC GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK  SLTEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS caggcacac CAG GCA 1268 LEPGEKPYKCPECGKSFSRNDAL 1817 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2366 ctgccccca CAC CTG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ ctg CCC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CTG GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA DLRRHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS tggacccag TGG ACC 1269 LEPGEKPYKCPECGKSFSSKKHL 1818 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2367 gcacacctg CAG GCA AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ccc CAC CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ CCC GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLTRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS acccaggca ACC CAG 1270 LEPGEKPYKCPECGKSFSTSHSL 1819 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2368 cacctgccc GCA CAC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ cca CTG CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CCA GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK NLTEHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS cacctgccc CAC CTG 1271 LEPGEKPYKCPECGKSFSSKKAL 1820 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2369 ccactggca CCC CCA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ cac CTG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CAC GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK ALTEHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS ccacctacc CCA CCT 1272 LEPGEKPYKCPECGKSFSSRRTC 1821 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇X₁₈X₁₉ 2370 attgcccat ACC ATT RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ cgt GCC CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ CGT GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNH KCPECGKSFSHKNALQNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLTEHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS tggcacacc TGG CAC 1273 LEPGEKPYKCPECGKSFSRNDAL 1822 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2371 tgggcacat ACC TGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ ctg GCA CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ CTG GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS cactggcac CAC TGG 1274 LEPGEKPYKCPECGKSFSTSGNL 1823 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2372 acctgggca CAC ACC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ cat TGG GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CAT GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTTHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS ctgccccca CTG CCC 1275 LEPGEKPYKCPECGKSFSDCRDL 1824 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2373 cctaccatt CCA CCT ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ gcc ACC ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇ GCC GKSFSDKKDLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLAEHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS tgggcacat TGG GCA 1276 LEPGEKPYKCPECGKSFSTKNSL 1825 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2374 ctgccccca CAT CTG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ cct CCC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CCT GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLRRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS acctgggca ACC TGG 1277 LEPGEKPYKCPECGKSFSTSHSL 1826 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2375 catctgccc GCA CAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ cca CTG CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CCA GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK HLTTHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS gcacatctg GCA CAT 1278 LEPGEKPYKCPECGKSFSDKKDL 1827 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈X₁₉ 2376 cccccacct CTG CCC TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ acc CCA CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ ACC GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLTEHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS cctaccatt CCT ACC 1279 LEPGEKPYKCPECGKSFSQSGNL 1828 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈X₁₉ 2377 gcccatcgt ATT GCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇X₁₈ caa CAT CGT SRRTCRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ CAA GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQ GEKPYKCPECGKSFSHKNALQNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK DLTRHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS catctgccc CAT CTG 1280 LEPGEKPYKCPECGKSFSHKNAL 1829 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2378 ccacctacc CCC CCA QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈ att CCT ACC DKKDLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ ATT GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALTEHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLTEHQRTHTGEKPTGKK TS ccccactgg CCC CAC 1281 LEPGEKPYKCPECGKSFSQSGDL 1830 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2379 cacacctgg TGG CAC RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gca ACC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇ GCA GKSFSDKKDLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK ALTEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS cccccacct CCC CCA 1282 LEPGEKPYKCPECGKSFSTSGNL 1831 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2380 accattgcc CCT ACC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ cat ATT GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ CAT GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK SLTEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS cacacctgg CAC ACC 1283 LEPGEKPYKCPECGKSFSSKKHL 1832 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2381 gcacatctg TGG GCA AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ccc CAT CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ CCC GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK DLTRHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS attgcccat ATT GCC 1284 LEPGEKPYKCPECGKSFSRNDAL 1833 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2382 cgtcaacac CAT CGT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ ctg CAA CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇ CTG GKSFSQSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAH KCPECGKSFSSRRTCRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HK DLARHQRTHTGEKPYKCPECGKS NALQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHKNALQNHQRTHTGEKPTGKK TS catcgtcaa CAT CGT 1285 LEPGEKPYKCPECGKSFSHKNAL 1834 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2383 cacctgcac CAA CAC QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ att CTG CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ ATT GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRT QRTHTGEKPYKCPECGKSFSSRR CRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS TCRAHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLTEHQRTHTGEKPTGKK TS accattgcc ACC ATT 1286 LEPGEKPYKCPECGKSFSSKKAL 1835 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2384 catcgtcaa GCC CAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEHX₁₇X₁₈ cac CGT CAA QSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCRAHX₁₇ CAC GKSFSSRRTCRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNA QRTHTGEKPYKCPECGKSFSHKN LQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK ALQNHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS gcccatcgt GCC CAT 1287 LEPGEKPYKCPECGKSFSSKKAL 1836 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2385 caacacctg CGT CAA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ cac CAC CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ CAC GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLTEH KCPECGKSFSQSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SRRTCR GEKPYKCPECGKSFSSRRTCRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC NLTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS cagggtggt CAG GGT 1288 LEPGEKPYKCPECGKSFSDPGAL 1837 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈X₁₉ 2386 gtaggctgg GGT GTA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gtc GGC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GTC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLVRH KCPECGKSFSQSSSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA HLVRHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS ggtggtgta GGT GGT 1289 LEPGEKPYKCPECGKSFSRADNL 1838 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2387 ggctgggtc GTA GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈ cag TGG GTC DPGALVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CAG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSSLV GEKPYKCPECGKSFSQSSSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS aggctgggt AGG CTG 1290 LEPGEKPYKCPECGKSFSSKKAL 1839 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2388 ccagtgcag GGT CCA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ cac gtg CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ CAC GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS agcactgta AGC ACT 1291 LEPGEKPYKCPECGKSFSDPGAL 1840 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈X₁₉ 2389 gtcggccat GTA GTC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ gtc GGC CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GTC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRH KCPECGKSFSDPGALVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSS SLV GEKPYKCPECGKSFSQSSSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X20X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ER DLIRHQRTHTGEKPYKCPECGKS SHLREHX₁₇X₁₈X₁₉HX₂₀X20X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSERSHLREHQRTHTGEKPTGKK TS actgtagtc ACT GTA 1292 LEPGEKPYKCPECGKSFSTSGNL 1841 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2390 ggccatgtc GTC GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈ cat CAT GTC DPGALVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ CAT GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALV GEKPYKCPECGKSFSDPGALVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSS QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH SLVRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS gtagtcggc GTA GTC 1293 LEPGEKPYKCPECGKSFSDPGAL 1842 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈X₁₉ 2391 catgtccat GGC CAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ gtc GTC CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇ GTC GKSFSDPGALVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGA QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS ALVRHQRTHTGEKPYKCPECGKS SSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSSLVRHQRTHTGEKPTGKK TS gtcggccat GTC GGC 1294 LEPGEKPYKCPECGKSFSDPGNL 1843 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇X₁₈X₁₉ 2392 gtccatgtc CAT GTC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈ gac CAT GTC DPGALVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ GAC GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRH KCPECGKSFSDPGALVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLVRHQRTHTGEKPYKCPECGKS GALVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGALVRHQRTHTGEKPTGKK TS ggccatgtc GGC CAT 1295 LEPGEKPYKCPECGKSFSRSDNL 1844 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2393 catgtcgac GTC CAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇X₁₈ gag GTC GAC DPGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇ GAG GKSFSDPGALVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALV GEKPYKCPECGKSFSDPGALVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP  NLTEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS catgtccat CAT GTC 1296 LEPGEKPYKCPECGKSFSTSGHL 1845 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2394 gtcgacgag CAT GTC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ ggt GAC GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇ GGT GKSFSDPGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRH KCPECGKSFSDPGALVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGA QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALVRHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLTEHQRTHTGEKPTGKK TS ctgcctcca CTG CCT 1297 LEPGEKPYKCPECGKSFSSKKAL 1846 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2395 cgccgcggc CCA CGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ cac CGC GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇ CAC GKSFSHTGHLLEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEH KCPECGKSFSHTGHLLEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN SLTEHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS cctccacgc CCT CCA 1298 LEPGEKPYKCPECGKSFSRNDAL 1847 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2396 cgcggccac CGC CGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ ctg GGC CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CTG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEH KCPECGKSFSHTGHLLEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLL GEKPYKCPECGKSFSHTGHLLEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆TK SLTEHQRTHTGEKPYKCPECGKS N5LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS ccacgccgc CCA CGC 1299 LEPGEKPYKCPECGKSFSSKKHL 1848 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2397 ggccacctg CGC GGC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ccc CAC CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ CCC GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLL GEKPYKCPECGKSFSHTGHLLEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGH QRTHTGEKPYKCPECGKSFSHTG LLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLLEHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS cggccacct CGG CCA 1300 LEPGEKPYKCPECGKSFSRSDHL 1849 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2398 gccctaccc CCT GCC TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ tgg CTA CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇ TGG GKSFSQNSTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLTEHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS acgccgcgg ACG CCG 1301 LEPGEKPYKCPECGKSFSQNSTL 1850 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈X₁₉ 2399 ccacctgcc CGG CCA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ cta CCT GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ CTA GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RT TLTEHQRTHTGEKPYKCPECGKS DTLRDHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRTDTLRDHQRTHTGEKPTGKK TS ccgcggcca CCG CGG 1302 LEPGEKPYKCPECGKSFSSKKHL 1851 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2400 cctgcccta CCA CCT AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈ ccc GCC CTA QNSTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ CCC GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN KLTEHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS ccacctgcc CCA CCT 1303 LEPGEKPYKCPECGKSFSRSDDL 1852 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2401 ctaccctgg GCC CTA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gcg CCC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ GCG GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEH KCPECGKSFSQNSTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS SLTEHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS cctgcccta CCT GCC 1304 LEPGEKPYKCPECGKSFSSKKHL 1853 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2402 ccctgggcg CTA CCC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ ccc TGG gcg RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ CCC GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLT GEKPYKCPECGKSFSQNSTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK DLARHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS gccctaccc GCC CTA 1305 LEPGEKPYKCPECGKSFSDKKDL 1854 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈X₁₉ 2403 tgggcgccc CCC TGG TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ acc gcg CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ ACC GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNST QRTHTGEKPYKCPECGKSFSQNS LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC TLTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS ccctgggcg CCC TGG 1306 LEPGEKPYKCPECGKSFSRKDNL 1855 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2404 cccaccccg gcg CCC KNHQRTHTGEKPYKCPECGKSFS HX₂₀X20X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ aag ACC CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇ AAG  GKSFSDKKDLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆SK HLTTHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS tgggcgccc TGG gcg 1307 LEPGEKPYKCPECGKSFSDCRDL 1856 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2405 accccgaag CCC ACC ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈ gcc CCG AAG RKDNLKNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇ GCC GKSFSRNDTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDD QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS DLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS ctaccctgg CTA CCC 1308 LEPGEKPYKCPECGKSFSRNDTL 1857 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 2406 gcgcccacc TGG gcg TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇X₁₈ ccg CCC ACC DKKDLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CCG GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRH KCPECGKSFSRSDDLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QN HLAEHQRTHTGEKPYKCPECGKS STLTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQNSTLTEHQRTHTGEKPTGKK TS cccaccccg CCC ACC 1309 LEPGEKPYKCPECGKSFSDCRDL 1858 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2407 aaggccccc CCG AAG ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ gcc GCC CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ GCC GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNH KCPECGKSFSRKDNLKNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK DLTRHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS gcgcccacc gcg CCC 1310 LEPGEKPYKCPECGKSFSSKKHL 1859 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2408 ccgaaggcc ACC CCG AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ ccc AAG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇ CCC GKSFSRKDNLKNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLAEHQRTHTGEKPYKCPECGKS DDLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDDLVRHQRTHTGEKPTGKK TS cctaccctg CCT ACC 1311 LEPGEKPYKCPECGKSFSSKKHL 1860 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2409 ggcgcccac CTG GGC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ ccc GCC CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ CCC GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKD QRTHTGEKPYKCPECGKSFSDKK LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK DLTRHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS ctgggcgcc CTG GGC 1312 LEPGEKPYKCPECGKSFSDPGHL 1861 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2410 caccccgaa GCC CAC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ ggc CCC GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ GGC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEH KCPECGKSFSSKKALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RN HLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS accctgggc ACC CTG 106 LEPGEKPYKCPECGKSFSQSSNL 107 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 314 gcccacccc GGC GCC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ gaa CAC CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇ GAA GKSFSSKKALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DK ALTEHQRTHTGEKPYKCPECGKS KDLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDKKDLTRHQRTHTGEKPTGKK TS ggcgcccac GGC GCC 1313 LEPGEKPYKCPECGKSFSSKKHL 1862 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2411 cccgaaggc CAC CCC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ ccc GAA GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ CCC GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALT GEKPYKCPECGKSFSSKKALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP DLARHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS caccccgaa CAC CCC 1314 LEPGEKPYKCPECGKSFSTKNSL 1863 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2412 ggcccccgc GAA GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇X₁₈ cct CCC CGC HTGHLLEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CCT GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLAEHQRTHTGEKPYKCPECGKS KALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKALTEHQRTHTGEKPTGKK TS gcccacccc GCC CAC 1315 LEPGEKPYKCPECGKSFSHTGHL 1864 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇X₁₈X₁₉ 2413 gaaggcccc CCC GAA LEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ cgc GGC CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CGC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKA QRTHTGEKPYKCPECGKSFSSKK LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC ALTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS cccgaaggc CCC GAA 1316 LEPGEKPYKCPECGKSFSRNDTL 1865 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 2414 ccccgccct GGC CCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ ccg CGC CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEHX₁₇ CCG GKSFSHTGHLLEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK NLVRHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS gaaggcccc GAA GGC 1317 LEPGEKPYKCPECGKSFSSKKHL 1866 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2415 cgccctccg CCC CGC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ ccc CCT CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ CCC GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLLEH KCPECGKSFSHTGHLLEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS HLVRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS cctgggcgc CCT ggg 1318 LEPGEKPYKCPECGKSFSRSDHL 1867 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₁X1BX₁₉ 2416 ccaccccga CGC CCA TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇X₁₈ agg CCC CGA QSGHLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ AGG GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLL GEKPYKCPECGKSFSHTGHLLEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK KLVRHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS gggcgccca ggg CGC 1319 LEPGEKPYKCPECGKSFSSKKHL 1868 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2417 ccccgaagg CCA CCC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ ccc CGA AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇ CCC GKSFSQSGHLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGH QRTHTGEKPYKCPECGKSFSHTG LLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLLEHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS cgcccaccc CGC CCA 1320 LEPGEKPYKCPECGKSFSRNDTL 1869 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 2418 cgaaggccc CCC CGA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ ccg AGG CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CCG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEH KCPECGKSFSQSGHLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HT SLTEHQRTHTGEKPYKCPECGKS GHLLEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHTGHLLEHQRTHTGEKPTGKK TS ccaccccga CCA CCC 1321 LEPGEKPYKCPECGKSFSSKKHL 1870 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2419 aggcccccg CGA AGG AEHQRTHTGEKPYKCPECGKSFS HX₂₀XX₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ ccc CCC CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CCC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLT GEKPYKCPECGKSFSQSGHLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLAEHQRTHTGEKPYKCPECGKS H5LTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS ccactgcct CCA CTG 1322 LEPGEKPYKCPECGKSFSDCRDL 1871 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2420 cctcccagt CCT CCT ARHQRTHTGEKPYKCPECGKSFS HX₂₀XX₂₀X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ gcc CCC AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ GCC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEH KCPECGKSFSTKNSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALTEHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS tgggaagat TGG GAA 1323 LEPGEKPYKCPECGKSFSDPGAL 1872 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRHX₁₇X₁₈X₁₉ 2421 ctgctggga GAT CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ gtc CTG GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GTC GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS gctgggagt GCT ggg 1324 LEPGEKPYKCPECGKSFSDCRDL 1873 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2422 cttggccta AGT CTT ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈ gcc GGC CTA QNSTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GCC GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CXHX₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLT GEKPYKCPECGKSFSHRTTLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS gcctagcct GCC TAG 1325 LEPGEKPYKCPECGKSFSTSGHL 1874 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2423 ctgtgaagg CCT CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ ggt TGA AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASHX₁₇ GGT GKSFSQAGHLASHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLT GEKPYKCPECGKSFSTKNSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDN QRTHTGEKPYKCPECGKSFSRED LHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC NLHTHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS tagcctctg TAG CCT 1326 LEPGEKPYKCPECGKSFSQRAHL 1875 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2424 tgaaggggt CTG TGA ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ gga AGG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGA GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNS QRTHTGEKPYKCPECGKSFSTKN LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RE SLTEHQRTHTGEKPYKCPECGKS DNLHTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSREDNLHTHQRTHTGEKPTGKK TS cctctgtga CCT CTG 1327 LEPGEKPYKCPECGKSFSDPGHL 1876 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2425 aggggtgga TGA AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ggc GGT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GGC GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLA GEKPYKCPECGKSFSQAGHLASH SHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CXHX₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK ALTEHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS ggggtggag GGG GTG 1328 LEPGEKPYKCPECGKSFSRSDKL 1877 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2426 gctctgccg GAG GCT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ ggg CTG CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GGG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS gaaggggtg GAA GGG 158 LEPGEKPYKCPECGKSFSRNDTL 159 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 327 gaggctctg GTG GAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ccg GCT CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇ CCG GKSFSTSGELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS KLVRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS gtggaggct GTG GAG 1329 LEPGEKPYKCPECGKSFSRSDHL 1878 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2427 ctgccgggg GCT CTG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ agg CCG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇ AGG GKSFSRNDTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS gaggctctg GAG GCT 1330 LEPGEKPYKCPECGKSFSTSGHL 1879 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2428 ccggggagg CTG CCG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ ggt ggg AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS gctctgccg GCT CTG 1331 LEPGEKPYKCPECGKSFSRSDKL 1880 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2429 gggaggggt CCG ggg VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ ggg AGG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS ALTEHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS ctgccgggg CTG CCG 1332 LEPGEKPYKCPECGKSFSTSGHL 1881 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 2430 aggggtggg ggg AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLvRHX₁₇X₁₈ ggt GGT GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ GGT  GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RN TLTEHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS cggggaggg CGG GGA 1333 LEPGEKPYKCPECGKSFSTTGNL 1882 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2431 gtgggggtt GGG GTG TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈ aat GGG GTT TSGSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ AAT GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLERHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS ggaggggtg GGA GGG 154 LEPGEKPYKCPECGKSFSTSGHL 155 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈X₁₉ 326 ggggttaat GTG GGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ ggt GTT AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ GGT GKSFSTSGSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR KLVRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS ggcggggct GGC GGG 1334 LEPGEKPYKCPECGKSFSRSDHL 1883 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2432 gcagggatt GCT GCA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ tgg ggg ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ TGG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CXHX₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP  KLVRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ctgggcggg CTG GGC 1335 LEPGEKPYKCPECGKSFSHKNAL 1884 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2433 gctgcaggg GGG GCT QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ att GCA ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ ATT GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS ggggctgca GGG GCT 1336 LEPGEKPYKCPECGKSFSRNDAL 1885 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2434 gggatttgg GCA ggg TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ ctg ATT TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ CTG GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDDR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS aggctgggc AGG CTG 150 LEPGEKPYKCPECGKSFSRSDKL 151 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 325 ggggctgca GGC GGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ ggg GCT GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃XHX₁₅X₁₆TSGELVRHX₁₇ GGG GKSFSTSGELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS gtggatagg GTG GAT 1337 LEPGEKPYKCPECGKSFSTSGEL 1886 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈X₁₉ 2435 ctgggcggg AGG CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gct GGC GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GCT GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS gataggctg GAT AGG 1338 LEPGEKPYKCPECGKSFSQSGDL 1887 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2436 ggcggggct CTG GGC RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈ gca GGG GCT TSGELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GCA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLTNHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS ccggtggat CCG GTG 1339 LEPGEKPYKCPECGKSFSRSDKL 1888 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2437 aggctgggc GAT AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ ggg CTG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GGG GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN ELVRHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS ccgccggtg CCG CCG 1340 LEPGEKPYKCPECGKSFSDPGHL 1889 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2438 gataggctg GTG GAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ ggc AGG CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ GGC GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN TLTEHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS cccccgccg CCC CCG 1341 LEPGEKPYKCPECGKSFSRNDAL 1890 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2439 gtggatagg CCG GTG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ ctg GAT AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇ CTG GKSFSTSGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDT QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK TLTEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS ggtcccccg GGT CCC 1342 LEPGEKPYKCPECGKSFSRSDHL 1891 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈X₁₉ 2440 ccggtggat CCG CCG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ agg GTG GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ AGG GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEH KCPECGKSFSRNDTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLT GEKPYKCPECGKSFSRNDTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLAEHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS ataggctgg ATA GGC 1343 LEPGEKPYKCPECGKSFSRADNL 1892 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2441 gcggggctg TGG GCG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ cag ggg CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CAG GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRH KCPECGKSFSRSDDLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGH QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆QK HLVRHQRTHTGEKPYKCPECGKS SSLIAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQKSSLIAHQRTHTGEKPTGKK TS cggtggata CGG TGG 1344 LEPGEKPYKCPECGKSFSRSDKL 1893 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2442 ggctgggcg ATA GGC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈ ggg TGG GCG RSDDLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGG  GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLI GEKPYKCPECGKSFSQKSSLIAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLTTHQRTHTGEKPYKCPECGKS DKLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLTEHQRTHTGEKPTGKK TS tggataggc TGG ATA 1345 LEPGEKPYKCPECGKSFSRNDAL 1894 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2443 tgggcgggg GGC TGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ ctg GCG ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇ CTG GKSFSRSDDLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSS QRTHTGEKPYKCPECGKSFSQKS LIAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLIAHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS cgccggtgg CGC CGG 1346 LEPGEKPYKCPECGKSFSRSDDL 1895 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLVRHX₁₇X₁₈X₁₉ 2444 ataggctgg TGG ATA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gcg GGC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ GCG GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLIAH KCPECGKSFSQKSSLIAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HT KLTEHQRTHTGEKPYKCPECGKS GHLLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHTGHLLEHQRTHTGEKPTGKK TS gtcccccgc GTC CCC 1347 LEPGEKPYKCPECGKSFSDPGHL 1896 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2445 cggtggata CGC CGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLIAHX₁₇X₁₈ ggc TGG ATA QKSSLIAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGC GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGHLL GEKPYKCPECGKSFSHTGHLLEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLAEHQRTHTGEKPYKCPECGKS GALVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGALVRHQRTHTGEKPTGKK TS ccccgccgg CCC CGC 1348 LEPGEKPYKCPECGKSFSRSDHL 1897 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX_(l0)X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇XHX₁₉ 2446 tggataggc CGG TGG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ tgg ATA GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLIAHX₁₇ TGG GKSFSQKSSLIAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLT GEKPYKCPECGKSFSRSDKLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HTGH QRTHTGEKPYKCPECGKSFSHTG LLEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLLEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS ggctgggcg GGC TGG 1349 LEPGEKPYKCPECGKSFSQRAHL 1898 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2447 gggctgcag GCG ggg ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ gga CTG CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GGA GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDDLV GEKPYKCPECGKSFSRSDDLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP HLTTHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS ggtggatag GGT GGA 1350 LEPGEKPYKCPECGKSFSDPGHL 1899 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2448 gctgggcgg TAG GCT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈ ggc ggg CGG RSDKLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ GGC GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLH GEKPYKCPECGKSFSREDNLHTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLERHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGHLVRHQRTHTGEKPTGKK TS gccggtgga GCC GGT 1351 LEPGEKPYKCPECGKSFSRSDKL 1900 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇X₁₈X₁₉ 2449 taggctggg GGA TAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ cgg GCT ggg RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇ CGG GKSFSTSGELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTH KCPECGKSFSREDNLHTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGH QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC HLVRHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS cccgccggt CCC GCC 1352 LEPGEKPYKCPECGKSFSRSDKL 1901 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2450 ggataggct GGT GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈ ggg TAG GCT TSGELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇ GGG GKSFSREDNLHTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLV GEKPYKCPECGKSFSTSGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK DLARHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS gctgacacc GCT GAC 1353 LEPGEKPYKCPECGKSFSTTGNL 1902 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈X₁₉ 2451 cggggtgct ACC CGG TVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈ aat GGT GCT TSGELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇ AAT GKSFSTSGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEH KCPECGKSFSRSDKLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGN QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS ctggctgac CTG GCT 1354 LEPGEKPYKCPECGKSFSTSGEL 1903 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈X₁₉ 2452 acccggggt GAC ACC VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGHLVRHX₁₇X₁₈ gct CGG GGT TSGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLTEHX₁₇ GCT GKSFSRSDKLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLV GEKPYKCPECGKSFSDPGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN ELVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS acaactgct ACA ACT 1355 LEPGEKPYKCPECGKSFSTHLDL 1904 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2453 ggggcccta GCT GGG IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈ act GCC CTA QNSTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ ACT GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP DLIRHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS ctaattaca CTA ATT 1356 LEPGEKPYKCPECGKSFSDCRDL 1905 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈X₁₉ 2454 actgctggg ACA ACT ARHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈ gcc GCT GGG RSDKLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇ GCC GKSFSTSGELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRH KCPECGKSFSTHLDLIRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNA QRTHTGEKPYKCPECGKSFSHKN LQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QN ALQNHQRTHTGEKPYKCPECGKS STLTEHX₁₇EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQNSTLTEHQRTHTGEKPTGKK TS attacaact ATT ACA 1357 LEPGEKPYKCPECGKSFSQNSTL 1906 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈X₁₉ 2455 gctggggcc ACT GCT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇X₁₈ cta GGG GCC DCRDLARHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CTA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLI GEKPYKCPECGKSFSTHLDLIRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HK DLTRHQRTHTGEKPYKCPECGKS NALQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHKNALQNHQRTHTGEKPTGKK TS gtgctaatt gtg CTA 1358 LEPGEKPYKCPECGKSFSRSDKL 1907 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇X₁₈X₁₉ 2456 acaactgct ATT ACA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈ ggg ACT GCT TSGELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ GGG GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRH KCPECGKSFSSPADLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQ GEKPYKCPECGKSFSHKNALQNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNST QRTHTGEKPYKCPECGKSFSQNS LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS TLTEHQRTHTGEKPYKCPECGKS DELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDELVRHQRTHTGEKPTGKK TS ggggtgcta GGG gtg 1359 LEPGEKPYKCPECGKSFSTSGEL 1908 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRHX₁₇X₁₈X₁₉ 2457 attacaact CTA ATT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ gct ACA ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇ GCT GKSFSSPADLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNH KCPECGKSFSHKNALQNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNS+32 GEKPYKCPECGKSFSQNSTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDE QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ELVRHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS actgctggg ACT GCT 1360 LEPGEKPYKCPECGKSFSSKKAL 1909 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈X₁₉ 2458 gccctaact GGG GCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ cac CTA ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇ CAC GKSFSQNSTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆TH ELVRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS cccggggtg CCC GGG 1361 LEPGEKPYKCPECGKSFSTHLDL 1910 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2459 ctaattaca gtg CTA IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈ act ATT ACA SPADLTRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ ACT GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEH KCPECGKSFSQNSTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELV GEKPYKCPECGKSFSRSDELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK KLVRHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS tggctgaca TGG CTG 1362 LEPGEKPYKCPECGKSFSQNSTL 1911 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈X₁₉ 2460 cccggggtg ACA CCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇X₁₈ cta GGG gtg RSDELVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRHX₁₇ CTA GKSFSRSDKLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLT GEKPYKCPECGKSFSSPADLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS acacccggg ACA CCC 1363 LEPGEKPYKCPECGKSFSSPADL 1912 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPADLTRHX₁₇X₁₈X₁₉ 2461 gtgctaatt GGG gtg TRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ aca CTA ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇ ACA GKSFSQNSTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRH KCPECGKSFSRSDELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLV GEKPYKCPECGKSFSRSDKLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SP HLAEHQRTHTGEKPYKCPECGKS ADLTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSPADLTRHQRTHTGEKPTGKK TS ctgacaccc CTG ACA 1364 LEPGEKPYKCPECGKSFSHKNAL 1913 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2462 ggggtgcta CCC GGG QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈ att gtg CTA QNSTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDELVRHX₁₇ ATT GKSFSRSDELVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDKLVRH KCPECGKSFSRSDKLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SPAD QRTHTGEKPYKCPECGKSFSSPA LTRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RN DLTRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS gctggggcc GCT GGG 1365 LEPGEKPYKCPECGKSFSQSGHL 1914 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇X₁₈X₁₉ 2463 ctaactcac GCC CTA TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKALTEHX₁₇X₁₈ cga ACT CAC SKKALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ CGA GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEH KCPECGKSFSQNSTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS KLVRHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS attgtacaa ATT GTA 1366 LEPGEKPYKCPECGKSFSTSGNL 1915 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2464 ggcaggcat CAA GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ cat AGG CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CAT GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGNLT GEKPYKCPECGKSFSQSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSS QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HK SLVRHQRTHTGEKPYKCPECGKS NALQNHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHKNALQNHQRTHTGEKPTGKK TS gtacaaggc GTA CAA 1367 LEPGEKPYKCPECGKSFSDPGNL 1916 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇X₁₈X₁₉ 2465 aggcatcat GGC AGG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ gac CAT CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ GAC GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLV GEKPYKCPECGKSFSDPGHLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGN QRTHTGEKPYKCPECGKSFSQSG LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLTEHQRTHTGEKPYKCPECGKS SSLVRHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSSLVRHQRTHTGEKPTGKK TS atgtcaccc ATT GTC 1368 LEPGEKPYKCPECGKSFSQSGDL 1917 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈X₁₉ 2466 ccaagtcag ACC CCA RRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ gca AGT CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇ GCA GKSFSHRTTLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLT GEKPYKCPECGKSFSDKKDLTRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGA QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HK  ALVRHQRTHTGEKPYKCPECGKS NALQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSHKNALQNHQRTHTGEKPTGKK TS gccattgtc GCC ATT 1369 LEPGEKPYKCPECGKSFSRADNL 1918 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2467 accccaagt GTC ACC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈ cag CCA AGT HRTTLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ CAG GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRH KCPECGKSFSDKKDLTRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALV GEKPYKCPECGKSFSDPGALVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNA QRTHTGEKPYKCPECGKSFSHKN LQNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC ALQNHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS caagccatt CAA GCC 1370 LEPGEKPYKCPECGKSFSHRTTL 1919 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2468 gtcacccca ATT GTC TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ agt ACC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DKKDLTRHX₁₇ AGT GKSFSDKKDLTRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGALVRH KCPECGKSFSDPGALVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQ GEKPYKCPECGKSFSHKNALQNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS DLARHQRTHTGEKPYKCPECGKS GNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGNLTEHQRTHTGEKPTGKK TS ggcactgac GGC ACT 1371 LEPGEKPYKCPECGKSFSRNDTL 1920 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈X₁₉ 2469 agcctacct GAC AGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ ccg CTA CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇ CCG GKSFSQNSTLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLREH KCPECGKSFSERSHLREHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLV GEKPYKCPECGKSFSDPGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLD QRTHTGEKPYKCPECGKSFSTHL LIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CK₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DP DLIRHQRTHTGEKPYKCPECGKS GHLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDPGHLVRHQRTHTGEKPTGKK TS actgacagc ACT GAC 1372 LEPGEKPYKCPECGKSFSQLAHL 1921 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAHX₁₇X₁₈X₁₉ 2470 ctacctccg AGC CTA RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDTLTEHX₁₇X₁₈ aga CCT CCG RNDTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇ AGA GKSFSTKNSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEH KCPECGKSFSQNSTLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGN QRTHTGEKPYKCPECGKSFSDPG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TH NLVRHQRTHTGEKPYKCPECGKS LDLIRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTHLDLIRHQRTHTGEKPTGKK TS ccaaatcat CCA AAT 1373 LEPGEKPYKCPECGKSFSSKKHL 1922 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2471 tgacttcta CAT TGA AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLTEHX₁₇X₁₈ ccc CTT CTA QNSTLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ CCC GKSFSTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QAGHLASH KCPECGKSFSQAGHLASHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLT GEKPYKCPECGKSFSTSGNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLTVHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gcagagata GCA gag 1374 LEPGEKPYKCPECGKSFSTSGNL 1923 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈X₁₉ 2472 aggctgccc ATA AGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ cat CTG CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CAT GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CXHX₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSSLI GEKPYKCPECGKSFSQKSSLIAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS NLVRHQRTHTGEKPYKCPECGKS GDLRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSGDLRRHQRTHTGEKPTGKK TS gagataagg gag ATA 1375 LEPGEKPYKCPECGKSFSDPGHL 1924 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2473 ctgccccat AGG CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇X₁₈ ggc CCC CAT TSGNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ GGC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QKSS QRTHTGEKPYKCPECGKSFSQKS LIAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS SLIAHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS ataaggctg ATA AGG 1376 LEPGEKPYKCPECGKSFSTSHSL 1925 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2474 ccccatggc CTG CCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ cca CAT GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEHX₁₇ CCA GKSFSTSGNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QK HLTNHQRTHTGEKPYKCPECGKS SSLIAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQKSSLIAHQRTHTGEKPTGKK TS aggctgccc AGG CTG 1377 LEPGEKPYKCPECGKSFSQSGHL 1926 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGHLTEHX₁₇X₁₈X₁₉ 2475 catggccca CCC CAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ cga GGC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ CGA GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLTEH KCPECGKSFSTSGNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS ALTEHQRTHTGEKPYKCPECGKS DHLTNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTNHQRTHTGEKPTGKK TS agagataag AGA GAT 1378 LEPGEKPYKCPECGKSFSRSDHL 1927 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2476 gctgcccca AAG GCT TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈ tgg GCC CCA TSHSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ TGG GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELVRH KCPECGKSFSTSGELVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLK GEKPYKCPECGKSFSRKDNLKNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL NLVRHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS cccacgatt CCC ACG 1379 LEPGEKPYKCPECGKSFSQRANL 1928 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2477 tagaaacct ATT TAG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈ aaa AAA CCT TKNSLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇ AAA GKSFSQRANLRAHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTH KCPECGKSFSREDNLHTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQ GEKPYKCPECGKSFSHKNALQNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDT QRTHTGEKPYKCPECGKSFSRTD LRDHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK TLRDHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS tggcccacg TGG CCC 1380 LEPGEKPYKCPECGKSFSTKNSL 1929 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2478 atttagaaa ACG ATT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈ cct TAG AAA QRANLRAHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇ CCT GKSFSREDNLHTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNH KCPECGKSFSHKNALQNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CXHX₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLR GEKPYKCPECGKSFSRTDTLRDH DHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLAEHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK TS ccatggccc CCA TGG 1381 LEPGEKPYKCPECGKSFSQRANL 1930 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRANLRAHX₁₇X₁₈X₁₉ 2479 acgatttag CCC ACG RAHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈ aaa ATT TAG REDNLHTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇ AAA GKSFSHKNALQNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDH KCPECGKSFSRTDTLRDHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLTTHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS gccccatgg GCC CCA 1382 LEPGEKPYKCPECGKSFSREDNL 1931 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆REDNLHTHX₁₇X₁₈X₁₉ 2480 cccacgatt TGG CCC HTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈ tag ACG ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDHX₁₇ TAG GKSFSRTDTLRDHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC  SLTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS gataaggct GAT AAG 1383 LEPGEKPYKCPECGKSFSSKKHL 1932 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2481 gccccatgg GCT GCC AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ ccc CCA TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇ CCC GKSFSTSHSLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGELV GEKPYKCPECGKSFSTSGELVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDN QRTHTGEKPYKCPECGKSFSRKD LKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLKNHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS gctgcccca GCT GCC 1384 LEPGEKPYKCPECGKSFSHKNAL 1933 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2482 tggcccacg CCA TGG QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDHX₁₇X₁₈ att CCC ACG RTDTLRDHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ ATT GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS DLARHQRTHTGEKPYKCPECGKS GELVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGELVRHQRTHTGEKPTGKK TS aaggctgcc AAG GCT 1385 LEPGEKPYKCPECGKSFSRTDTL 1934 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RTDTLRDHX₁₇X₁₈X₁₉ 2483 ccatggccc GCC CCA RDHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ acg TGG CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ ACG GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEH KCPECGKSFSTSHSLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGE QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RK ELVRHQRTHTGEKPYKCPECGKS DNLKNHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRKDNLKNHQRTHTGEKPTGKK TS agaaaccta AGA AAC 1386 LEPGEKPYKCPECGKSFSSKKHL 1935 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈X₁₉ 2484 aatcccagg CTA AAT AEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇X₁₈ ccc CCC AGG RSDHLTNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ CCC GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNSTLT GEKPYKCPECGKSFSQNSTLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DSGN QRTHTGEKPYKCPECGKSFSDSG LRVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QL NLRVHQRTHTGEKPYKCPECGKS AHLRAHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQLAHLRAHQRTHTGEKPTGKK TS aacctaaat AAC CTA 1387 LEPGEKPYKCPECGKSFSRADNL 1936 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2485 cccaggccc AAT CCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇X₁₈ cag AGG CCC SKKHLAEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNHX₁₇ CAG GKSFSRSDHLTNHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QNST QRTHTGEKPYKCPECGKSFSQNS LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DS TLTEHQRTHTGEKPYKCPECGKS GNLRVHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDSGNLRVHQRTHTGEKPTGKK TS ctaaatccc CTA AAT 1388 LEPGEKPYKCPECGKSFSRRDEL 1937 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈X₁₉ 2486 aggccccag CCC AGG NVHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ atg CCC CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEHX₁₇ ATG GKSFSSKKHLAEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTNH KCPECGKSFSRSDHLTNHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆QN NLTVHQRTHTGEKPYKCPECGKS STLTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQNSTLTEHQRTHTGEKPTGKK TS aatcccagg AAT CCC 1389 LEPGEKPYKCPECGKSFSTSHSL 1938 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLTEHX₁₇X₁₈X₁₉ 2487 ccccagatg AGG CCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇X₁₈ cca CAG ATG RRDELNVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇ CCA GKSFSRADNLTEHQRTHTGEKPY X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLAEH KCPECGKSFSSKKHLAEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGKSFSRSDHLTNH NHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT  HLAEHQRTHTGEKPYKCPECGKS GNLTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGNLTVHQRTHTGEKPTGKK TS caggcccca CAG GCC 1390 LEPGEKPYKCPECGKSFSTTGAL 1939 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈X₁₉ 2488 gatgccaat CCA GAT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇X₁₈ ctt GCC AAT TTGNLTVHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARHX₁₇ CTT GKSFSDCRDLARHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRH KCPECGKSFSTSGNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHSLT GEKPYKCPECGKSFSTSHSLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA DLARHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS gatgccaat GAT GCC 1391 LEPGEKPYKCPECGKSFSTKNSL 1940 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TKNSLTEHX₁₇X₁₈X₁₉ 2489 cttctggat AAT CTT TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈ cct CTG GAT TSGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CCT GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEH KCPECGKSFSTTGALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRD QRTHTGEKPYKCPECGKSFSDCR LARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS DLARHQRTHTGEKPYKCPECGKS GNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGNLVRHQRTHTGEKPTGKK TS gccccagat GCC CCA 1392 LEPGEKPYKCPECGKSFSRNDAL 1941 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2490 gccaatctt GAT GCC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇X₁₈ ctg AAT CTT TTGALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ CTG GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLARH KCPECGKSFSDCRDLARHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLV GEKPYKCPECGKSFSTSGNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSHS QRTHTGEKPYKCPECGKSFSTSH LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DC SLTEHQRTHTGEKPYKCPECGKS RDLARHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSDCRDLARHQRTHTGEKPTGKK TS ccagatgcc CCA GAT 1393 LEPGEKPYKCPECGKSFSTSGNL 1942 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGNLVRHX₁₇X₁₈X₁₉ 2491 aatcttctg GCC AAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ gat CTT CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGALTEHX₁₇ GAT GKSFTTGALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DCRDLA GEKPYKCPECGKSFSDCRDLARH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGN QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS NLVRHQRTHTGEKPYKCPECGKS HSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSHSLTEHQRTHTGEKPTGKK TS ctgggagca CTG GGA 1394 LEPGEKPYKCPECGKSFSQRAHL 1943 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈X₁₉ 2492 gaatggact GCA GAA ERHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈ gga TGG ACT THLDLIRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGA GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLR GEKPYKCPECGKSFSQSGDLRRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN HLERHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS cccctggga CCC CTG 1395 LEPGEKPYKCPECGKSFSTHLDL 1944 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇X₁₈X₁₉ 2493 gcagaatgg GGA GCA IRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ act GAA TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₁ ACT GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRH KCPECGKSFSQSGDLRRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK ALTEHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS ggagcagaa GGA GCA 1396 LEPGEKPYKCPECGKSFSHRTTL 1945 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HRTTLTNHX₁₇X₁₈X₁₉ 2494 tggactgga GAA TGG TNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ agt ACT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆THLDLIRHX₁₇ AGT GKSFSTHLDLIRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGD QRTHTGEKPYKCPECGKSFSQSG LRRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QR  DLRRHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS gttcccctg GTT CCC 1397 LEPGEKPYKCPECGKSFSRSDHL 1946 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2495 ggagcagaa CTG GGA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ tgg GCA GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇ TGG GKSFSQSGDLRRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKH QRTHTGEKPYKCPECGKSFSSKK LAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLAEHQRTHTGEKPYKCPECGKS GSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGSLVRHQRTHTGEKPTGKK TS ccggttccc CCG GTT 1398 LEPGEKPYKCPECGKSFSQSSNL 1947 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2496 ctgggagca CCC CTG VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSGDLRRHX₁₇X₁₈ gaa GGA GCA QSGDLRRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GAA GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SKKHLA GEKPYKCPECGKSFSSKKHLAEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN SLVRHQRTHTGEKPYKCPECGKS DTLTEHX₁₇X₁₃X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDTLTEHQRTHTGEKPTGKK TS tgggagcag TGG gag 1399 LEPGEKPYKCPECGKSFSQSSNL 1948 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈X₁₉ 2497 aatggactg CAG AAT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈ gaa GGA CTG RNDALTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇ GAA GKSFSQRAHLERHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVH KCPECGKSFSTTGNLTVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLT GEKPYKCPECGKSFSRADNLTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDN QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLVRHQRTHTGEKPYKCPECGKS DHLTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDHLTTHQRTHTGEKPTGKK ccctgggag CCC TGG 1400 LEPGEKPYKCPECGKSFSRNDAL 1949 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇X₁₈X₁₉ 2498 cagaatgga gag CAG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERHX₁₇X₁₈ ctg AAT GGA QRAHLERHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLTVHX₁₇ CTG GKSFSTTGNLTVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEH KCPECGKSFSRADNLTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆SK HLTTHQRTHTGEKPYKCPECGKS KHLAEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSSKKHLAEHQRTHTGEKPTGKK TS ctggaagtt CTG GAA 1401 LEPGEKPYKCPECGKSFSRADNL 1950 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈X₁₉ 2499 tgggagggc GTT TGG TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈ cag GAG GGC DPGHLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇ CAG GKSFSRSDNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTH KCPECGKSFSRSDHLTTHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLV GEKPYKCPECGKSFSTSGSLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSN QRTHTGEKPYKCPECGKSFSQSS LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RN NLVRHQRTHTGEKPYKCPECGKS DALTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRNDALTEHQRTHTGEKPTGKK TS gaagtttgg GAA GTT 1402 LEPGEKPYKCPECGKSFSHKNAL 1951 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆HKNALQNHX₁₇X₁₈X₁₉ 2500 gagggccag TGG GAG QNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆RADNLTEHX₁₇X₁₈ att GGC CAG RADNLTEHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇ ATT GKSFSDPGHLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRH KCPECGKSFSRSDNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLT GEKPYKCPECGXSFSRSDHLTTH THX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGS QRTHTGEKPYKCPECGKSFSTSG LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QS SLVRHQRTHTGEKPYKCPECGKS SNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQSSNLVRHQRTHTGEKPTGKK TS gtttgggag GTT TGG 1403 LEPGEKPYKCPECGKSFSSKKAL 1952 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈X₁₉ 2501 ggccagatt GAG GGC TEHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ cac CAG ATT HKNALQNHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ CAC GKSFSRADNLTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSDPGHLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLV GEKPYKCPECGKSFSRSDNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDH QRTHTGEKPYKCPECGKSFSRSD LTTHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TS HLTTHQRTHTGEKPYKCPECGKS GSLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTSGSLVRHQRTHTGEKPTGKK TS gagcagaat gag CAG 1404 LEPGEKPYKCPECGKSFSTSGSL 1953 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈X₁₉ 2502 ggactggaa AAT GGA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇X₁₈ gtt CTG GAA QSSNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEHX₁₇ GTT GKSFSRNDALTEHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLERH KCPECGKSFSQRAHLERHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGNLT GEKPYKCPECGKSFSTTGNLTVH VHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RADN QRTHTGEKPYKCPECGKSFSRAD LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS NLTEHQRTHTGEKPYKCPECGKS DNLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDNLVRHQRTHTGEKPTGKK TS aatggactg AAT GGA 1405 LEPGEKPYKCPECGKSFSRSDNL 1954 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈X₁₉ 2503 gaagtttgg CTG GAA VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ gag GTT TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇ GAG GKSFSTSGSLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRH KCPECGKSFSQSSNLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALT GEKPYKCPECGKSFSRNDALTEH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAH QRTHTGEKPYKCPECGKSFSQRA LERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TT HLERHQRTHTGEKPYKCPECGKS GNLTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTTGNLTVHQRTHTGEKPTGKK TS ggactggaa GGA CTG 1406 LEPGEKPYKCPECGKSFSDPGHL 1955 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGHLVRHX₁₇X₁₈X₁₉ 2504 gtttgggag GAA GTT VRHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDNLVRHX₁₇X₁₈ ggc TGG GAG RSDNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇ GGC GKSFSRSDHLTTHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRH KCPECGKSFSTSGSLVRHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLV GEKPYKCPECGKSFSQSSNLVRH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDA QRTHTGEKPYKCPECGKSFSRND LTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂XEX₁₄X₁₅X₁₆QR ALTEHQRTHTGEKPYKCPECGKS AHLERHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSQRAHLERHQRTHTGEKPTGKK TS cagaatgga CAG AAT 1407 LEPGEKPYKCPECGKSFSRSDHL 1956 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2505 ctggaagtt GGA CTG TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TSGSLVRHX₁₇X₁₈ tgg GAA GTT TSGSLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QSSNLVRHX₁₇ TGG GKSFSQSSNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RNDALTEH KCPECGKSFSRNDALTEHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QRAHLE GEKPYKCPECGKSFSQRAHLERH RHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TTGN QRTHTGEKPYKCPECGKSFSTTG LTVHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RA NLTVHQRTHTGEKPYKCPECGKS DNLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRADNLTEHQRTHTGEKPTGKK TS cctgggagc CCT ggg 1408 LEPGEKPYKCPECGKSFSRSDHL 1957 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈X₁₉ 2506 agaatggac AGC AGA TTHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇X₁₈ tgg ATG GAC DPGNLVRHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVHX₁₇ TGG GKSFSRRDELNVHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLRAH KCPECGKSFSQLAHLRAHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSHLR GEKPYKCPECGKSFSERSHLREH EHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDK QRTHTGEKPYKCPECGKSFSRSD LVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄K₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆TK KLVRHQRTHTGEKPYKCPECGKS NSLTEHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSTKNSLTEHQRTHTGEKPTGKK TS gggagcaga ggg AGC 1409 LEPGEKPYKCPECGKSFSRKDNL 1958 X₁X₂X₃X₄X₅X₆X₇X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RKDNLKNHX₁₇X₁₈X₁₉ 2507 atggactgg AGA ATG KNHQRTHTGEKPYKCPECGKSFS HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RSDHLTTHX₁₇X₁₈ aag GAC TGG RSDHLTTHQRTHTGEKPYKCPEC X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆DPGNLVRHX₁₇ AAG GKSFSDPGNLVRHQRTHTGEKPY X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RRDELNVH KCPECGKSFSRRDELNVHQRTHT X₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆QLAHLR GEKPYKCPECGKSFSQLAHLRAH AHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀X₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆ERSH QRTHTGEKPYKCPECGKSFSERS LREHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₈X₉CX₁₀K₁₁CX₁₂X₁₃X₁₄X₁₅X₁₆RS HLREHQRTHTGEKPYKCPECGKS DKLVRHX₁₇X₁₈X₁₉HX₂₀X₂₁X₂₂X₂₃X₂₄X₂₅X₂₆X₂₇X₂₈X₂₉X₃₀ FSRSDKLVRHQRTHTGEKPTGKK TS

Informal Sequence Listing >dCas9-VPR Protein SEQ ID NO.: 95 MAPKKKRKVGIHGVPAADKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRT ARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKAD LRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEK KNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAP LSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLL RKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVV DKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLK EDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVM KQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSP AIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY YLQNGRDMYVDQELDINRLSDYDVAAIVPQSFLKDDSIDNKVLTRSDKARGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKF DNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINN YHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLI ETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVV AKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALP SKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHL FTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDKRPAATKKAGQAKKKKGRADALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRIRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA >dCas9-VPR mRNA SEQ ID NO.: 96 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGACAAGAAGUACAGCAUCGGCCUGGCCAUCGGCACCAACAGCGUGGGCUGGGCCGUGAUCACCGACGA GUACAAGGUGCCCAGCAAGAAGUUCAAGGUGCUGGGCAACACCGACCGGCACAGCAUCAAGAAGAACCUGAUCGGCGCCCUGC UGUUCGACAGCGGCGAGACCGCCGAGGCCACCCGGCUGAAGCGGACCGCCCGGCGGCGGUACACCCGGCGGAAGAACCGGAUC UGCUACCUGCAGGAGAUCUUCAGCAACGAGAUGGCCAAGGUGGACGACAGCUUCUUCCACCGGCUGGAGGAGAGCUUCCUGGU GGAGGAGGACAAGAAGCACGAGCGGCACCCCAUCUUCGGCAACAUCGUGGACGAGGUGGCCUACCACGAGAAGUACCCCACCA UCUACCACCUGCGGAAGAAGCUGGUGGACAGCACCGACAAGGCCGACCUGCGGCUGAUCUACCUGGCCCUGGCCCACAUGAUC AAGUUCCGGGGCCACUUCCUGAUCGAGGGCGACCUGAACCCCGACAACAGCGACGUGGACAAGCUGUUCAUCCAGCUGGUGCA GACCUACAACCAGCUGUUCGAGGAGAACCCCAUCAACGCCAGCGGCGUGGACGCCAAGGCCAUCCUGAGCGCCCGGCUGAGCA AGAGCCGGCGGCUGGAGAACCUGAUCGCCCAGCUGCCCGGCGAGAAGAAGAACGGCCUGUUCGGCAACCUGAUCGCCCUGAGC CUGGGCCUGACCCCCAACUUCAAGAGCAACUUCGACCUGGCCGAGGACGCCAAGCUGCAGCUGAGCAAGGACACCUACGACGA CGACCUGGACAACCUGCUGGCCCAGAUCGGCGACCAGUACGCCGACCUGUUCCUGGCCGCCAAGAACCUGAGCGACGCCAUCC UGCUGAGCGACAUCCUGCGGGUGAACACCGAGAUCACCAAGGCCCCCCUGAGCGCCAGCAUGAUCAAGCGGUACGACGAGCAC CACCAGGACCUGACCCUGCUGAAGGCCCUGGUGCGGCAGCAGCUGCCCGAGAAGUACAAGGAGAUCUUCUUCGACCAGAGCAA GAACGGCUACGCCGGCUACAUCGACGGCGGCGCCAGCCAGGAGGAGUUCUACAAGUUCAUCAAGCCCAUCCUGGAGAAGAUGG ACGGCACCGAGGAGCUGCUGGUGAAGCUGAACCGGGAGGACCUGCUGCGGAAGCAGCGGACCUUCGACAACGGCAGCAUCCCC CACCAGAUCCACCUGGGCGAGCUGCACGCCAUCCUGCGGCGGCAGGAGGACUUCUACCCCUUCCUGAAGGACAACCGGGAGAA GAUCGAGAAGAUCCUGACCUUCCGGAUCCCCUACUACGUGGGCCCCCUGGCCCGGGGCAACAGCCGGUUCGCCUGGAUGACCC GGAAAUCCGAGGAGACCAUCACCCCCUGGAACUUCGAGGAGGUGGUGGACAAGGGCGCCAGCGCCCAGAGCUUCAUCGAGCGG AUGACCAACUUCGACAAGAACCUGCCCAACGAGAAGGUGCUGCCCAAGCACAGCCUGCUGUACGAGUACUUCACCGUGUACAA CGAGCUGACCAAGGUGAAGUACGUGACCGAGGGCAUGCGGAAGCCCGCCUUCCUGAGCGGCGAGCAGAAGAAGGCCAUCGUGG ACCUGCUGUUCAAGACCAACCGGAAGGUGACCGUGAAGCAGCUGAAGGAGGACUACUUCAAGAAGAUCGAGUGCUUCGACAGC GUGGAGAUCAGCGGCGUGGAGGACCGGUUCAACGCCAGCCUGGGCACCUACCACGACCUGCUGAAGAUCAUCAAGGACAAGGA CUUCCUGGACAACGAGGAGAACGAGGACAUCCUGGAGGACAUCGUGCUGACCCUGACCCUGUUCGAGGACCGGGAGAUGAUCG AGGAGCGGCUGAAAACCUACGCCCACCUGUUCGACGACAAGGUGAUGAAGCAGCUGAAGCGGCGGCGGUACACCGGCUGGGGC CGGCUGAGCCGGAAGCUGAUCAACGGCAUCCGGGACAAGCAGAGCGGCAAGACCAUCCUGGACUUCCUGAAAUCCGACGGCUU CGCCAACCGGAACUUCAUGCAGCUGAUCCACGACGACAGCCUGACCUUCAAGGAGGACAUCCAGAAGGCCCAGGUGAGCGGCC AGGGCGACAGCCUGCACGAGCACAUCGCCAACCUGGCCGGCAGCCCCGCCAUCAAGAAGGGCAUCCUGCAGACCGUGAAGGUG GUGGACGAGCUGGUGAAGGUGAUGGGCCGGCACAAGCCCGAGAACAUCGUGAUCGAGAUGGCCCGGGAGAACCAGACCACCCA GAAGGGCCAGAAGAACAGCCGGGAGCGGAUGAAGCGGAUCGAGGAGGGCAUCAAGGAGCUGGGCAGCCAGAUCCUGAAGGAGC ACCCCGUGGAGAACACCCAGCUGCAGAACGAGAAGCUGUACCUGUACUACCUGCAGAACGGCCGGGACAUGUACGUGGACCAG GAGCUGGACAUCAACCGGCUGAGCGACUACGACGUGGCCGCCAUCGUGCCCCAGAGCUUCCUGAAGGACGACAGCAUCGACAA CAAGGUGCUGACCCGGAGCGACAAGGCCCGGGGCAAGAGCGACAACGUGCCCAGCGAGGAGGUGGUGAAGAAGAUGAAGAACU ACUGGCGGCAGCUGCUGAACGCCAAGCUGAUCACCCAGCGGAAGUUCGACAACCUGACCAAGGCCGAGCGGGGCGGCCUGAGC GAGCUGGACAAGGCCGGCUUCAUCAAGCGGCAGCUGGUGGAGACCCGGCAGAUCACCAAGCACGUGGCCCAGAUCCUGGACAG CCGGAUGAACACCAAGUACGACGAGAACGACAAGCUGAUCCGGGAGGUGAAGGUGAUCACCCUGAAAUCCAAGCUGGUGAGCG ACUUCCGGAAGGACUUCCAGUUCUACAAGGUGCGGGAGAUCAACAACUACCACCACGCCCACGACGCCUACCUGAACGCCGUG GUGGGCACCGCCCUGAUCAAGAAGUACCCCAAGCUGGAGAGCGAGUUCGUGUACGGCGACUACAAGGUGUACGACGUGCGGAA GAUGAUCGCCAAGAGCGAGCAGGAGAUCGGCAAGGCCACCGCCAAGUACUUCUUCUACAGCAACAUCAUGAACUUCUUCAAGA CCGAGAUCACCCUGGCCAACGGCGAGAUCCGGAAGCGGCCCCUGAUCGAGACCAACGGCGAGACCGGCGAGAUCGUGUGGGAC AAGGGCCGGGACUUCGCCACCGUGCGGAAGGUGCUGAGCAUGCCCCAGGUGAACAUCGUGAAGAAAACCGAGGUGCAGACCGG CGGCUUCAGCAAGGAGAGCAUCCUGCCCAAGCGGAACAGCGACAAGCUGAUCGCCCGGAAGAAGGACUGGGACCCCAAGAAGU ACGGCGGCUUCGACAGCCCCACCGUGGCCUACAGCGUGCUGGUGGUGGCCAAGGUGGAGAAGGGCAAGAGCAAGAAGCUGAAA UCCGUGAAGGAGCUGCUGGGCAUCACCAUCAUGGAGCGGAGCAGCUUCGAGAAGAACCCCAUCGACUUCCUGGAGGCCAAGGG CUACAAGGAGGUGAAGAAGGACCUGAUCAUCAAGCUGCCCAAGUACAGCCUGUUCGAGCUGGAGAACGGCCGGAAGCGGAUGC UGGCCAGCGCCGGCGAGCUGCAGAAGGGCAACGAGCUGGCCCUGCCCAGCAAGUACGUGAACUUCCUGUACCUGGCCAGCCAC UACGAGAAGCUGAAGGGCAGCCCCGAGGACAACGAGCAGAAGCAGCUGUUCGUGGAGCAGCACAAGCACUACCUGGACGAGAU CAUCGAGCAGAUCAGCGAGUUCAGCAAGCGGGUGAUCCUGGCCGACGCCAACCUGGACAAGGUGCUGAGCGCCUACAACAAGC ACCGGGACAAGCCCAUCCGGGAGCAGGCCGAGAACAUCAUCCACCUGUUCACCCUGACCAACCUGGGCGCCCCCGCCGCCUUC AAGUACUUCGACACCACCAUCGACCGGAAGCGGUACACCAGCACCAAGGAGGUGCUGGACGCCACCCUGAUCCACCAGAGCAU CACCGGCCUGUACGAGACCCGGAUCGACCUGAGCCAGCUGGGCGGCGACAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGG CCAAGAAGAAGAAGGGCCGGGCCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGAUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >dCas9 amino acid sequence SEQ ID NO.: 97 DKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRTARRRYTRRKNRICYLQE IFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKADLRLIYLALAHMIKFRGH FLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEKKNGLFGNLIALSLGLTP NFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAPLSASMIKRYDEHHQDLT LLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLLRKQRTFDNGSIPHQIHL GELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVVDKGASAQSFIERMTNFD KNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLKEDYFKKIECFDSVEISG VEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVMKQLKRRRYTGWGRLSRK LINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSPAIKKGILQTVKVVDELV KVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLYYLQNGRDMYVDQELDIN RLSDYDVAAIVPQSFLKDDSIDNKVLTRSDKARGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKFDNLTKAERGGLSELDKA GFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINNYHHAHDAYLNAVVGTAL IKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLIETNGETGEIVWDKGRDF ATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVVAKVEKGKSKKLKSVKEL LGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALPSKYVNFLYLASHYEKLK GSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHLFTLTNLGAPAAFKYFDT TIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGD >dCas9 mRNA sequence SEQ ID NO.: 300 GACAAGAAGUACAGCAUCGGCCUGGCCAUCGGCACCAACAGCGUGGGCUGGGCCGUGAUCACCGACGAGUACAAGGUGCCCAG CAAGAAGUUCAAGGUGCUGGGCAACACCGACCGGCACAGCAUCAAGAAGAACCUGAUCGGCGCCCUGCUGUUCGACAGCGGCG AGACCGCCGAGGCCACCCGGCUGAAGCGGACCGCCCGGCGGCGGUACACCCGGCGGAAGAACCGGAUCUGCUACCUGCAGGAG AUCUUCAGCAACGAGAUGGCCAAGGUGGACGACAGCUUCUUCCACCGGCUGGAGGAGAGCUUCCUGGUGGAGGAGGACAAGAA GCACGAGCGGCACCCCAUCUUCGGCAACAUCGUGGACGAGGUGGCCUACCACGAGAAGUACCCCACCAUCUACCACCUGCGGA AGAAGCUGGUGGACAGCACCGACAAGGCCGACCUGCGGCUGAUCUACCUGGCCCUGGCCCACAUGAUCAAGUUCCGGGGCCAC UUCCUGAUCGAGGGCGACCUGAACCCCGACAACAGCGACGUGGACAAGCUGUUCAUCCAGCUGGUGCAGACCUACAACCAGCU GUUCGAGGAGAACCCCAUCAACGCCAGCGGCGUGGACGCCAAGGCCAUCCUGAGCGCCCGGCUGAGCAAGAGCCGGCGGCUGG AGAACCUGAUCGCCCAGCUGCCCGGCGAGAAGAAGAACGGCCUGUUCGGCAACCUGAUCGCCCUGAGCCUGGGCCUGACCCCC AACUUCAAGAGCAACUUCGACCUGGCCGAGGACGCCAAGCUGCAGCUGAGCAAGGACACCUACGACGACGACCUGGACAACCU GCUGGCCCAGAUCGGCGACCAGUACGCCGACCUGUUCCUGGCCGCCAAGAACCUGAGCGACGCCAUCCUGCUGAGCGACAUCC UGCGGGUGAACACCGAGAUCACCAAGGCCCCCCUGAGCGCCAGCAUGAUCAAGCGGUACGACGAGCACCACCAGGACCUGACC CUGCUGAAGGCCCUGGUGCGGCAGCAGCUGCCCGAGAAGUACAAGGAGAUCUUCUUCGACCAGAGCAAGAACGGCUACGCCGG CUACAUCGACGGCGGCGCCAGCCAGGAGGAGUUCUACAAGUUCAUCAAGCCCAUCCUGGAGAAGAUGGACGGCACCGAGGAGC UGCUGGUGAAGCUGAACCGGGAGGACCUGCUGCGGAAGCAGCGGACCUUCGACAACGGCAGCAUCCCCCACCAGAUCCACCUG GGCGAGCUGCACGCCAUCCUGCGGCGGCAGGAGGACUUCUACCCCUUCCUGAAGGACAACCGGGAGAAGAUCGAGAAGAUCCU GACCUUCCGGAUCCCCUACUACGUGGGCCCCCUGGCCCGGGGCAACAGCCGGUUCGCCUGGAUGACCCGGAAAUCCGAGGAGA CCAUCACCCCCUGGAACUUCGAGGAGGUGGUGGACAAGGGCGCCAGCGCCCAGAGCUUCAUCGAGCGGAUGACCAACUUCGAC AAGAACCUGCCCAACGAGAAGGUGCUGCCCAAGCACAGCCUGCUGUACGAGUACUUCACCGUGUACAACGAGCUGACCAAGGU GAAGUACGUGACCGAGGGCAUGCGGAAGCCCGCCUUCCUGAGCGGCGAGCAGAAGAAGGCCAUCGUGGACCUGCUGUUCAAGA CCAACCGGAAGGUGACCGUGAAGCAGCUGAAGGAGGACUACUUCAAGAAGAUCGAGUGCUUCGACAGCGUGGAGAUCAGCGGC GUGGAGGACCGGUUCAACGCCAGCCUGGGCACCUACCACGACCUGCUGAAGAUCAUCAAGGACAAGGACUUCCUGGACAACGA GGAGAACGAGGACAUCCUGGAGGACAUCGUGCUGACCCUGACCCUGUUCGAGGACCGGGAGAUGAUCGAGGAGCGGCUGAAAA CCUACGCCCACCUGUUCGACGACAAGGUGAUGAAGCAGCUGAAGCGGCGGCGGUACACCGGCUGGGGCCGGCUGAGCCGGAAG CUGAUCAACGGCAUCCGGGACAAGCAGAGCGGCAAGACCAUCCUGGACUUCCUGAAAUCCGACGGCUUCGCCAACCGGAACUU CAUGCAGCUGAUCCACGACGACAGCCUGACCUUCAAGGAGGACAUCCAGAAGGCCCAGGUGAGCGGCCAGGGCGACAGCCUGC ACGAGCACAUCGCCAACCUGGCCGGCAGCCCCGCCAUCAAGAAGGGCAUCCUGCAGACCGUGAAGGUGGUGGACGAGCUGGUG AAGGUGAUGGGCCGGCACAAGCCCGAGAACAUCGUGAUCGAGAUGGCCCGGGAGAACCAGACCACCCAGAAGGGCCAGAAGAA CAGCCGGGAGCGGAUGAAGCGGAUCGAGGAGGGCAUCAAGGAGCUGGGCAGCCAGAUCCUGAAGGAGCACCCCGUGGAGAACA CCCAGCUGCAGAACGAGAAGCUGUACCUGUACUACCUGCAGAACGGCCGGGACAUGUACGUGGACCAGGAGCUGGACAUCAAC CGGCUGAGCGACUACGACGUGGCCGCCAUCGUGCCCCAGAGCUUCCUGAAGGACGACAGCAUCGACAACAAGGUGCUGACCCG GAGCGACAAGGCCCGGGGCAAGAGCGACAACGUGCCCAGCGAGGAGGUGGUGAAGAAGAUGAAGAACUACUGGCGGCAGCUGC UGAACGCCAAGCUGAUCACCCAGCGGAAGUUCGACAACCUGACCAAGGCCGAGCGGGGCGGCCUGAGCGAGCUGGACAAGGCC GGCUUCAUCAAGCGGCAGCUGGUGGAGACCCGGCAGAUCACCAAGCACGUGGCCCAGAUCCUGGACAGCCGGAUGAACACCAA GUACGACGAGAACGACAAGCUGAUCCGGGAGGUGAAGGUGAUCACCCUGAAAUCCAAGCUGGUGAGCGACUUCCGGAAGGACU UCCAGUUCUACAAGGUGCGGGAGAUCAACAACUACCACCACGCCCACGACGCCUACCUGAACGCCGUGGUGGGCACCGCCCUG AUCAAGAAGUACCCCAAGCUGGAGAGCGAGUUCGUGUACGGCGACUACAAGGUGUACGACGUGCGGAAGAUGAUCGCCAAGAG CGAGCAGGAGAUCGGCAAGGCCACCGCCAAGUACUUCUUCUACAGCAACAUCAUGAACUUCUUCAAGACCGAGAUCACCCUGG CCAACGGCGAGAUCCGGAAGCGGCCCCUGAUCGAGACCAACGGCGAGACCGGCGAGAUCGUGUGGGACAAGGGCCGGGACUUC GCCACCGUGCGGAAGGUGCUGAGCAUGCCCCAGGUGAACAUCGUGAAGAAAACCGAGGUGCAGACCGGCGGCUUCAGCAAGGA GAGCAUCCUGCCCAAGCGGAACAGCGACAAGCUGAUCGCCCGGAAGAAGGACUGGGACCCCAAGAAGUACGGCGGCUUCGACA GCCCCACCGUGGCCUACAGCGUGCUGGUGGUGGCCAAGGUGGAGAAGGGCAAGAGCAAGAAGCUGAAAUCCGUGAAGGAGCUG CUGGGCAUCACCAUCAUGGAGCGGAGCAGCUUCGAGAAGAACCCCAUCGACUUCCUGGAGGCCAAGGGCUACAAGGAGGUGAA GAAGGACCUGAUCAUCAAGCUGCCCAAGUACAGCCUGUUCGAGCUGGAGAACGGCCGGAAGCGGAUGCUGGCCAGCGCCGGCG AGCUGCAGAAGGGCAACGAGCUGGCCCUGCCCAGCAAGUACGUGAACUUCCUGUACCUGGCCAGCCACUACGAGAAGCUGAAG GGCAGCCCCGAGGACAACGAGCAGAAGCAGCUGUUCGUGGAGCAGCACAAGCACUACCUGGACGAGAUCAUCGAGCAGAUCAG CGAGUUCAGCAAGCGGGUGAUCCUGGCCGACGCCAACCUGGACAAGGUGCUGAGCGCCUACAACAAGCACCGGGACAAGCCCA UCCGGGAGCAGGCCGAGAACAUCAUCCACCUGUUCACCCUGACCAACCUGGGCGCCCCCGCCGCCUUCAAGUACUUCGACACC ACCAUCGACCGGAAGCGGUACACCAGCACCAAGGAGGUGCUGGACGCCACCCUGAUCCACCAGAGCAUCACCGGCCUGUACGA GACCCGGAUCGACCUGAGCCAGCUGGGCGGCGAC >dCas9-P300 protein SEQ ID NO.: 98 MAPKKKRKVGIHGVPAADKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRT ARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKAD LRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEK KNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAP LSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLL RKQRTEDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVV DKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLK EDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVM KQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSP AIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY YLQNGRDMYVDQELDINRLSDYDVAAIVPQSFLKDDSIDNKVLTRSDKARGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKF DNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINN YHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLI ETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDEKKYGGFDSPTVAYSVLVV AKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALP SKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHL FTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDKRPAATKKAGQAKKKKGRAIFKPEELR QALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRV YKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQ PQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLEN RVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPP PNQRRVYISYLDSVHFFREKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKM LDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNN KKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARD KHLEFSSLRRAQWSTMCMLVELHTQSQDSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >dCas9-p300 mRNA SEQ ID NO.: 99 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGACAAGAAGUACAGCAUCGGCCUGGCCAUCGGCACCAACAGCGUGGGCUGGGCCGUGAUCACCGACGA GUACAAGGUGCCCAGCAAGAAGUUCAAGGUGCUGGGCAACACCGACCGGCACAGCAUCAAGAAGAACCUGAUCGGCGCCCUGC UGUUCGACAGCGGCGAGACCGCCGAGGCCACCCGGCUGAAGCGGACCGCCCGGCGGCGGUACACCCGGCGGAAGAACCGGAUC UGCUACCUGCAGGAGAUCUUCAGCAACGAGAUGGCCAAGGUGGACGACAGCUUCUUCCACCGGCUGGAGGAGAGCUUCCUGGU GGAGGAGGACAAGAAGCACGAGCGGCACCCCAUCUUCGGCAACAUCGUGGACGAGGUGGCCUACCACGAGAAGUACCCCACCA UCUACCACCUGCGGAAGAAGCUGGUGGACAGCACCGACAAGGCCGACCUGCGGCUGAUCUACCUGGCCCUGGCCCACAUGAUC AAGUUCCGGGGCCACUUCCUGAUCGAGGGCGACCUGAACCCCGACAACAGCGACGUGGACAAGCUGUUCAUCCAGCUGGUGCA GACCUACAACCAGCUGUUCGAGGAGAACCCCAUCAACGCCAGCGGCGUGGACGCCAAGGCCAUCCUGAGCGCCCGGCUGAGCA AGAGCCGGCGGCUGGAGAACCUGAUCGCCCAGCUGCCCGGCGAGAAGAAGAACGGCCUGUUCGGCAACCUGAUCGCCCUGAGC CUGGGCCUGACCCCCAACUUCAAGAGCAACUUCGACCUGGCCGAGGACGCCAAGCUGCAGCUGAGCAAGGACACCUACGACGA CGACCUGGACAACCUGCUGGCCCAGAUCGGCGACCAGUACGCCGACCUGUUCCUGGCCGCCAAGAACCUGAGCGACGCCAUCC UGCUGAGCGACAUCCUGCGGGUGAACACCGAGAUCACCAAGGCCCCCCUGAGCGCCAGCAUGAUCAAGCGGUACGACGAGCAC CACCAGGACCUGACCCUGCUGAAGGCCCUGGUGCGGCAGCAGCUGCCCGAGAAGUACAAGGAGAUCUUCUUCGACCAGAGCAA GAACGGCUACGCCGGCUACAUCGACGGCGGCGCCAGCCAGGAGGAGUUCUACAAGUUCAUCAAGCCCAUCCUGGAGAAGAUGG ACGGCACCGAGGAGCUGCUGGUGAAGCUGAACCGGGAGGACCUGCUGCGGAAGCAGCGGACCUUCGACAACGGCAGCAUCCCC CACCAGAUCCACCUGGGCGAGCUGCACGCCAUCCUGCGGCGGCAGGAGGACUUCUACCCCUUCCUGAAGGACAACCGGGAGAA GAUCGAGAAGAUCCUGACCUUCCGGAUCCCCUACUACGUGGGCCCCCUGGCCCGGGGCAACAGCCGGUUCGCCUGGAUGACCC GGAAAUCCGAGGAGACCAUCACCCCCUGGAACUUCGAGGAGGUGGUGGACAAGGGCGCCAGCGCCCAGAGCUUCAUCGAGCGG AUGACCAACUUCGACAAGAACCUGCCCAACGAGAAGGUGCUGCCCAAGCACAGCCUGCUGUACGAGUACUUCACCGUGUACAA CGAGCUGACCAAGGUGAAGUACGUGACCGAGGGCAUGCGGAAGCCCGCCUUCCUGAGCGGCGAGCAGAAGAAGGCCAUCGUGG ACCUGCUGUUCAAGACCAACCGGAAGGUGACCGUGAAGCAGCUGAAGGAGGACUACUUCAAGAAGAUCGAGUGCUUCGACAGC GUGGAGAUCAGCGGCGUGGAGGACCGGUUCAACGCCAGCCUGGGCACCUACCACGACCUGCUGAAGAUCAUCAAGGACAAGGA CUUCCUGGACAACGAGGAGAACGAGGACAUCCUGGAGGACAUCGUGCUGACCCUGACCCUGUUCGAGGACCGGGAGAUGAUCG AGGAGCGGCUGAAAACCUACGCCCACCUGUUCGACGACAAGGUGAUGAAGCAGCUGAAGCGGCGGCGGUACACCGGCUGGGGC CGGCUGAGCCGGAAGCUGAUCAACGGCAUCCGGGACAAGCAGAGCGGCAAGACCAUCCUGGACUUCCUGAAAUCCGACGGCUU CGCCAACCGGAACUUCAUGCAGCUGAUCCACGACGACAGCCUGACCUUCAAGGAGGACAUCCAGAAGGCCCAGGUGAGCGGCC AGGGCGACAGCCUGCACGAGCACAUCGCCAACCUGGCCGGCAGCCCCGCCAUCAAGAAGGGCAUCCUGCAGACCGUGAAGGUG GUGGACGAGCUGGUGAAGGUGAUGGGCCGGCACAAGCCCGAGAACAUCGUGAUCGAGAUGGCCCGGGAGAACCAGACCACCCA GAAGGGCCAGAAGAACAGCCGGGAGCGGAUGAAGCGGAUCGAGGAGGGCAUCAAGGAGCUGGGCAGCCAGAUCCUGAAGGAGC ACCCCGUGGAGAACACCCAGCUGCAGAACGAGAAGCUGUACCUGUACUACCUGCAGAACGGCCGGGACAUGUACGUGGACCAG GAGCUGGACAUCAACCGGCUGAGCGACUACGACGUGGCCGCCAUCGUGCCCCAGAGCUUCCUGAAGGACGACAGCAUCGACAA CAAGGUGCUGACCCGGAGCGACAAGGCCCGGGGCAAGAGCGACAACGUGCCCAGCGAGGAGGUGGUGAAGAAGAUGAAGAACU ACUGGCGGCAGCUGCUGAACGCCAAGCUGAUCACCCAGCGGAAGUUCGACAACCUGACCAAGGCCGAGCGGGGCGGCCUGAGC GAGCUGGACAAGGCCGGCUUCAUCAAGCGGCAGCUGGUGGAGACCCGGCAGAUCACCAAGCACGUGGCCCAGAUCCUGGACAG CCGGAUGAACACCAAGUACGACGAGAACGACAAGCUGAUCCGGGAGGUGAAGGUGAUCACCCUGAAAUCCAAGCUGGUGAGCG ACUUCCGGAAGGACUUCCAGUUCUACAAGGUGCGGGAGAUCAACAACUACCACCACGCCCACGACGCCUACCUGAACGCCGUG GUGGGCACCGCCCUGAUCAAGAAGUACCCCAAGCUGGAGAGCGAGUUCGUGUACGGCGACUACAAGGUGUACGACGUGCGGAA GAUGAUCGCCAAGAGCGAGCAGGAGAUCGGCAAGGCCACCGCCAAGUACUUCUUCUACAGCAACAUCAUGAACUUCUUCAAGA CCGAGAUCACCCUGGCCAACGGCGAGAUCCGGAAGCGGCCCCUGAUCGAGACCAACGGCGAGACCGGCGAGAUCGUGUGGGAC AAGGGCCGGGACUUCGCCACCGUGCGGAAGGUGCUGAGCAUGCCCCAGGUGAACAUCGUGAAGAAAACCGAGGUGCAGACCGG CGGCUUCAGCAAGGAGAGCAUCCUGCCCAAGCGGAACAGCGACAAGCUGAUCGCCCGGAAGAAGGACUGGGACCCCAAGAAGU ACGGCGGCUUCGACAGCCCCACCGUGGCCUACAGCGUGCUGGUGGUGGCCAAGGUGGAGAAGGGCAAGAGCAAGAAGCUGAAA UCCGUGAAGGAGCUGCUGGGCAUCACCAUCAUGGAGCGGAGCAGCUUCGAGAAGAACCCCAUCGACUUCCUGGAGGCCAAGGG CUACAAGGAGGUGAAGAAGGACCUGAUCAUCAAGCUGCCCAAGUACAGCCUGUUCGAGCUGGAGAACGGCCGGAAGCGGAUGC UGGCCAGCGCCGGCGAGCUGCAGAAGGGCAACGAGCUGGCCCUGCCCAGCAAGUACGUGAACUUCCUGUACCUGGCCAGCCAC UACGAGAAGCUGAAGGGCAGCCCCGAGGACAACGAGCAGAAGCAGCUGUUCGUGGAGCAGCACAAGCACUACCUGGACGAGAU CAUCGAGCAGAUCAGCGAGUUCAGCAAGCGGGUGAUCCUGGCCGACGCCAACCUGGACAAGGUGCUGAGCGCCUACAACAAGC ACCGGGACAAGCCCAUCCGGGAGCAGGCCGAGAACAUCAUCCACCUGUUCACCCUGACCAACCUGGGCGCCCCCGCCGCCUUC AAGUACUUCGACACCACCAUCGACCGGAAGCGGUACACCAGCACCAAGGAGGUGCUGGACGCCACCCUGAUCCACCAGAGCAU CACCGGCCUGUACGAGACCCGGAUCGACCUGAGCCAGCUGGGCGGCGACAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGG CCAAGAAGAAGAAGGGCCGGGCCAUCUUCAAGCCCGAGGAGCUGCGGCAGGCCCUGAUGCCCACCCUGGAGGCCCUGUACCGG CAGGACCCCGAGAGCCUGCCCUUCCGGCAGCCCGUGGACCCCCAGCUGCUGGGCAUCCCCGACUACUUCGACAUCGUGAAAUC CCCCAUGGACCUGAGCACCAUCAAGCGGAAGCUGGACACCGGCCAGUACCAGGAGCCCUGGCAGUACGUGGACGACAUCUGGC UGAUGUUCAACAACGCCUGGCUGUACAACCGGAAAACCAGCCGGGUGUACAAGUACUGCAGCAAGCUGAGCGAGGUGUUCGAG CAGGAGAUCGACCCCGUGAUGCAGAGCCUGGGCUACUGCUGCGGCCGGAAGCUGGAGUUCAGCCCCCAGACCCUGUGCUGCUA CGGCAAGCAGCUGUGCACCAUCCCCCGGGACGCCACCUACUACAGCUACCAGAACCGGUACCACUUCUGCGAGAAGUGCUUCA ACGAGAUCCAGGGCGAGAGCGUGAGCCUGGGCGACGACCCCAGCCAGCCCCAGACCACCAUCAACAAGGAGCAGUUCAGCAAG CGGAAGAACGACACCCUGGACCCCGAGCUGUUCGUGGAGUGCACCGAGUGCGGCCGGAAGAUGCACCAGAUCUGCGUGCUGCA CCACGAGAUCAUCUGGCCCGCCGGCUUCGUGUGCGACGGCUGCCUGAAGAAAUCCGCCCGGACCCGGAAGGAGAACAAGUUCA GCGCCAAGCGGCUGCCCAGCACCCGGCUGGGCACCUUCCUGGAGAACCGGGUGAACGACUUCCUGCGGCGGCAGAACCACCCC GAGAGCGGCGAGGUGACCGUGCGGGUGGUGCACGCCAGCGACAAGACCGUGGAGGUGAAGCCCGGCAUGAAGGCCCGGUUCGU GGACAGCGGCGAGAUGGCCGAGAGCUUCCCCUACCGGACCAAGGCCCUGUUCGCCUUCGAGGAGAUCGACGGCGUGGACCUGU GCUUCUUCGGCAUGCACGUGCAGGAGUACGGCAGCGACUGCCCCCCCCCCAACCAGCGGCGGGUGUACAUCAGCUACCUGGAC AGCGUGCACUUCUUCCGGCCCAAGUGCCUGCGGACCGCCGUGUACCACGAGAUCCUGAUCGGCUACCUGGAGUACGUGAAGAA GCUGGGCUACACCACCGGCCACAUCUGGGCCUGCCCCCCCAGCGAGGGCGACGACUACAUCUUCCACUGCCACCCCCCCGACC AGAAGAUCCCCAAGCCCAAGCGGCUGCAGGAGUGGUACAAGAAGAUGCUGGACAAGGCCGUGAGCGAGCGGAUCGUGCACGAC UACAAGGACAUCUUCAAGCAGGCCACCGAGGACCGGCUGACCAGCGCCAAGGAGCUGCCCUACUUCGAGGGCGACUUCUGGCC CAACGUGCUGGAGGAGAGCAUCAAGGAGCUGGAGCAGGAGGAGGAGGAGCGGAAGCGGGAGGAGAACACCAGCAACGAGAGCA CCGACGUGACCAAGGGCGACAGCAAGAACGCCAAGAAGAAGAACAACAAGAAAACCAGCAAGAACAAGAGCAGCCUGAGCCGG GGCAACAAGAAGAAGCCCGGCAUGCCCAACGUGAGCAACGACCUGAGCCAGAAGCUGUACGCCACCAUGGAGAAGCACAAGGA GGUGUUCUUCGUGAUCCGGCUGAUCGCCGGCCCCGCCGCCAACAGCCUGCCCCCCAUCGUGGACCCCGACCCCCUGAUCCCCU GCGACCUGAUGGACGGCCGGGACGCCUUCCUGACCCUGGCCCGGGACAAGCACCUGGAGUUCAGCAGCCUGCGGCGGGCCCAG UGGAGCACCAUGUGCAUGCUGGUGGAGCUGCACACCCAGAGCCAGGACAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGC CGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGACUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUC UGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAA GUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAA >ZF1-VPR protein SEQ ID NO.: 100 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDNLVRHQRTHTGEKPYKCPECGKSFSRSDHLTNHQRTHTGE KPYKCPECGKSFSDPGHLVRHQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSSRRTCRAHQRTHTG EKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* ZF1-VPR mRNA SEQ ID No.: 101 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAGCCGGGUGAGAAGCCAUACAAGUGCCCAGAAUGCGGCAAGAGCUUUAG CCGCAGCGAUAAUCUGGUUCGUCAUCAGCGCACGCAUACGGGUGAGAAACCGUACAAAUGUCCAGAAUGCGGCAAAAGCUUUA GUCGCAGCGAUCAUCUGACGAAUCACCAGCGCACCCAUACCGGCGAAAAACCGUACAAGUGCCCGGAGUGCGGUAAAAGCUUC AGCGACCCGGGUCAUCUGGUGCGCCACCAACGCACGCACACCGGUGAGAAACCAUAUAAAUGUCCAGAGUGCGGCAAGAGUUU UAGCCAGCGUGCCCAUCUGGAACGUCAUCAGCGUACCCACACGGGUGAAAAACCAUAUAAGUGCCCGGAGUGCGGUAAGAGUU UUAGUAGCCGCCGUACGUGCCGUGCGCACCAACGCACCCACACCGGUGAAAAGCCAUACAAGUGUCCGGAAUGCGGCAAGAGC UUCAGCCGCAGCGACAAACUCACCGAACAUCAACGUACCCAUACGGGCGAGAAGCCGUACAAAUGCCCAGAAUGUGGCAAAAG CUUCAGUCGCAACGAUACGCUGACCGAGCAUCAGCGUACGCACACCGGCGAAAAGCCAACCGGCAAGAAAACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF1 target sequence SEQ ID NO.: 102 CCGCGGCGTGGAGGCAGGGAG >ZF1 amino acid sequence SEQ ID NO.: 103 LEPGEKPYKCPECGKSFSRSDNLVRHQRTHTGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSDPGHLVRHQ RTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSSRRTCRAHQRTHTGEKPYKCPECGKSFSRSDKLTEH QRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPTGKKTS >ZF1 mRNA sequence SEQ ID NO.: 211 CUGGAGCCGGGUGAGAAGCCAUACAAGUGCCCAGAAUGCGGCAAGAGCUUUAGCCGCAGCGAUAAUCUGGUUCGUCAUCAGCG CACGCAUACGGGUGAGAAACCGUACAAAUGUCCAGAAUGCGGCAAAAGCUUUAGUCGCAGCGAUCAUCUGACGAAUCACCAGC GCACCCAUACCGGCGAAAAACCGUACAAGUGCCCGGAGUGCGGUAAAAGCUUCAGCGACCCGGGUCAUCUGGUGCGCCACCAA CGCACGCACACCGGUGAGAAACCAUAUAAAUGUCCAGAGUGCGGCAAGAGUUUUAGCCAGCGUGCCCAUCUGGAACGUCAUCA GCGUACCCACACGGGUGAAAAACCAUAUAAGUGCCCGGAGUGCGGUAAGAGUUUUAGUAGCCGCCGUACGUGCCGUGCGCACC AACGCACCCACACCGGUGAAAAGCCAUACAAGUGUCCGGAAUGCGGCAAGAGCUUCAGCCGCAGCGACAAACUCACCGAACAU CAACGUACCCAUACGGGCGAGAAGCCGUACAAAUGCCCAGAAUGUGGCAAAAGCUUCAGUCGCAACGAUACGCUGACCGAGCA UCAGCGUACGCACACCGGCGAAAAGCCAACCGGCAAGAAAACCAGC >ZF2-VPR protein SEQ ID NO.: 104 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGE KPYKCPECGKSFSSKKALTEHQRTHTGEKPYKCPECGKSFSDCRDLARHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTG EKPYKCPECGKSFSRNDALTEHQRTHTGEKPYKCPECGKSFSDKKDLTRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF2-VPR mRNA SEQ ID NO.: 105 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAACCGGGCGAGAAACCGUACAAGUGCCCAGAAUGCGGUAAAAGCUUCAG CCAGAGCAGUAAUCUGGUUCGUCACCAGCGCACCCACACGGGUGAAAAGCCAUACAAAUGUCCAGAGUGUGGUAAGAGUUUCA GUAGCAAAAAGCAUCUGGCGGAACACCAACGUACGCAUACGGGUGAAAAGCCGUACAAGUGUCCGGAAUGUGGCAAGAGCUUU AGCAGCAAGAAGGCGCUGACCGAACAUCAGCGUACCCAUACCGGUGAAAAACCAUACAAGUGCCCGGAGUGCGGCAAAAGUUU CAGCGAUUGUCGCGAUCUGGCCCGUCAUCAACGCACCCACACCGGCGAGAAACCAUAUAAGUGUCCGGAGUGCGGUAAAAGCU UUAGCGAUCCGGGCCAUCUGGUUCGCCACCAACGCACGCACACCGGCGAGAAACCGUAUAAGUGCCCAGAGUGCGGUAAGAGU UUUAGCCGUAACGAUGCGCUGACGGAGCAUCAGCGCACGCACACGGGCGAGAAACCAUAUAAAUGCCCGGAAUGUGGUAAGAG CUUCAGUGACAAAAAGGAUCUGACCCGCCAUCAACGUACGCAUACGGGCGAGAAGCCAACCGGCAAGAAAACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAA >ZF2 target sequence SEQ ID NO.: 106 ACCCTGGGCGCCCACCCCGAA >ZF2 amino acid sequence SEQ ID NO.: 107 LEPGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSSKKALTEHQ RTHTGEKPYKCPECGKSFSDCRDLARHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPYKCPECGKSFSRNDALTEH QRTHTGEKPYKCPECGKSFSDKKDLTRHQRTHTGEKPTGKKTS >ZF2 mRNA sequence SEQ ID NO.: 212 CUGGAACCGGGCGAGAAACCGUACAAGUGCCCAGAAUGCGGUAAAAGCUUCAGCCAGAGCAGUAAUCUGGUUCGUCACCAGCG CACCCACACGGGUGAAAAGCCAUACAAAUGUCCAGAGUGUGGUAAGAGUUUCAGUAGCAAAAAGCAUCUGGCGGAACACCAAC GUACGCAUACGGGUGAAAAGCCGUACAAGUGUCCGGAAUGUGGCAAGAGCUUUAGCAGCAAGAAGGCGCUGACCGAACAUCAG CGUACCCAUACCGGUGAAAAACCAUACAAGUGCCCGGAGUGCGGCAAAAGUUUCAGCGAUUGUCGCGAUCUGGCCCGUCAUCA ACGCACCCACACCGGCGAGAAACCAUAUAAGUGUCCGGAGUGCGGUAAAAGCUUUAGCGAUCCGGGCCAUCUGGUUCGCCACC AACGCACGCACACCGGCGAGAAACCGUAUAAGUGCCCAGAGUGCGGUAAGAGUUUUAGCCGUAACGAUGCGCUGACGGAGCAU CAGCGCACGCACACGGGCGAGAAACCAUAUAAAUGCCCGGAAUGUGGUAAGAGCUUCAGUGACAAAAAGGAUCUGACCCGCCA UCAACGUACGCAUACGGGCGAGAAGCCAACCGGCAAGAAAACCAGC >ZF3-VPR protein SEQ ID No.: 108 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDNLVRHQRTHTGEKPYKCPECGKSFSQLAHLRAHQRTHTGE KPYKCPECGKSFSDPGHLVRHQRTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSRKDNLKNHQRTHTG EKPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF3-VPR mRNA SEQ ID NO.: 109 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUCGAACCGGGCGAGAAACCAUAUAAGUGUCCGGAAUGUGGUAAAAGUUUUAG CCGCAGCGAUAAUCUCGUGCGUCACCAGCGUACGCAUACCGGUGAGAAGCCAUACAAGUGUCCGGAGUGUGGCAAAAGCUUCA GUCAGCUGGCGCAUCUGCGCGCGCAUCAGCGCACCCACACCGGUGAGAAACCGUACAAGUGUCCAGAAUGCGGCAAAAGCUUU AGCGAUCCGGGUCAUCUGGUGCGUCAUCAACGUACGCACACGGGCGAAAAACCGUACAAAUGUCCGGAGUGCGGCAAGAGCUU CAGCCAGAGCAGCAAUCUGGUUCGCCACCAGCGUACGCACACCGGUGAAAAGCCAUACAAGUGCCCGGAGUGCGGCAAGAGUU UCAGUCGCAAGGACAAUCUGAAGAACCAUCAACGCACCCAUACGGGCGAGAAGCCGUACAAAUGUCCGGAAUGCGGUAAAAGU UUUAGCCAAGCCGGUCAUCUGGCCAGCCAUCAGCGUACCCAUACGGGUGAGAAACCGUAUAAAUGUCCAGAAUGUGGUAAGAG UUUCAGCACCAGCGGUAGUCUGGUUCGUCAUCAACGCACGCAUACGGGUGAAAAACCAACCGGCAAGAAAACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF3 target sequence SEQ ID No.: 110 GTTTGAAAGGAAGGCAGAGAG >ZF3 amino acid sequence SEQ ID NO.: 111 LEPGEKPYKCPECGKSFSRSDNLVRHQRTHTGEKPYKCPECGKSFSQLAHLRAHQRTHTGEKPYKCPECGKSFSDPGHLVRHQ RTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSRKDNLKNHQRTHTGEKPYKCPECGKSFSQAGHLASH QRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPTGKKTS >ZF3 mRNA SEQ ID NO.: 213 CUCGAACCGGGCGAGAAACCAUAUAAGUGUCCGGAAUGUGGUAAAAGUUUUAGCCGCAGCGAUAAUCUCGUGCGUCACCAGCG UACGCAUACCGGUGAGAAGCCAUACAAGUGUCCGGAGUGUGGCAAAAGCUUCAGUCAGCUGGCGCAUCUGCGCGCGCAUCAGC GCACCCACACCGGUGAGAAACCGUACAAGUGUCCAGAAUGCGGCAAAAGCUUUAGCGAUCCGGGUCAUCUGGUGCGUCAUCAA CGUACGCACACGGGCGAAAAACCGUACAAAUGUCCGGAGUGCGGCAAGAGCUUCAGCCAGAGCAGCAAUCUGGUUCGCCACCA GCGUACGCACACCGGUGAAAAGCCAUACAAGUGCCCGGAGUGCGGCAAGAGUUUCAGUCGCAAGGACAAUCUGAAGAACCAUC AACGCACCCAUACGGGCGAGAAGCCGUACAAAUGUCCGGAAUGCGGUAAAAGUUUUAGCCAAGCCGGUCAUCUGGCCAGCCAU CAGCGUACCCAUACGGGUGAGAAACCGUAUAAAUGUCCAGAAUGUGGUAAGAGUUUCAGCACCAGCGGUAGUCUGGUUCGUCA UCAACGCACGCAUACGGGUGAAAAACCAACCGGCAAGAAAACCAGC >ZF4-VPR protein SEQ ID NO.: 112 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSQLAHLRAHQRTHTGE KPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTTGALTEHQRTHTGEKPYKCPECGKSFSTSGNLVRHQRTHTG EKPYKCPECGKSFSQSGDLRRHQRTHTGEKPYKCPECGKSFSTSHSLTEHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF4-mRNA SEQ ID NO.: 113 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUCGAACCGGGCGAAAAGCCGUAUAAGUGCCCGGAAUGCGGCAAGAGUUUUAG CCAGCGCGCCCAUCUGGAACGUCACCAGCGUACCCAUACCGGUGAAAAGCCAUAUAAAUGCCCAGAAUGUGGUAAAAGCUUUA GUCAGCUGGCCCAUCUGCGCGCCCACCAACGUACGCACACGGGCGAGAAGCCGUACAAAUGCCCAGAAUGCGGUAAAAGCUUC AGCAGCAAAAAGCAUCUGGCGGAACAUCAACGUACCCACACCGGCGAGAAACCAUACAAGUGCCCGGAAUGCGGUAAAAGCUU CAGCACCACCGGUGCGCUGACGGAGCAUCAGCGCACCCACACGGGCGAAAAACCGUAUAAGUGUCCGGAGUGUGGCAAAAGUU UUAGUACCAGCGGCAAUCUGGUGCGCCAUCAACGUACGCAUACCGGCGAGAAGCCAUAUAAAUGUCCAGAGUGUGGCAAGAGC UUUAGCCAAAGCGGUGAUCUGCGUCGCCACCAACGCACGCACACCGGCGAAAAACCAUACAAAUGUCCGGAAUGCGGUAAGAG UUUCAGCACGAGCCAUAGUCUGACCGAACAUCAACGUACCCAUACGGGUGAGAAACCAACCGGCAAGAAAACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF4 target sequence SEQ ID NO.: 114 CCAGCAGATCTTCCCAGAGGA >ZF4 amino acid sequence SEQ ID NO.: 115 LEPGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSQLAHLRAHQRTHTGEKPYKCPECGKSFSSKKHLAEHQ RTHTGEKPYKCPECGKSFSTTGALTEHQRTHTGEKPYKCPECGKSFSTSGNLVRHQRTHTGEKPYKCPECGKSFSQSGDLRRH QRTHTGEKPYKCPECGKSFSTSHSLTEHQRTHTGEKPTGKKTS >ZF4 mRNA sequence SEQ ID NO.: 214 CUCGAACCGGGCGAAAAGCCGUAUAAGUGCCCGGAAUGCGGCAAGAGUUUUAGCCAGCGCGCCCAUCUGGAACGUCACCAGCG UACCCAUACCGGUGAAAAGCCAUAUAAAUGCCCAGAAUGUGGUAAAAGCUUUAGUCAGCUGGCCCAUCUGCGCGCCCACCAAC GUACGCACACGGGCGAGAAGCCGUACAAAUGCCCAGAAUGCGGUAAAAGCUUCAGCAGCAAAAAGCAUCUGGCGGAACAUCAA CGUACCCACACCGGCGAGAAACCAUACAAGUGCCCGGAAUGCGGUAAAAGCUUCAGCACCACCGGUGCGCUGACGGAGCAUCA GCGCACCCACACGGGCGAAAAACCGUAUAAGUGUCCGGAGUGUGGCAAAAGUUUUAGUACCAGCGGCAAUCUGGUGCGCCAUC AACGUACGCAUACCGGCGAGAAGCCAUAUAAAUGUCCAGAGUGUGGCAAGAGCUUUAGCCAAAGCGGUGAUCUGCGUCGCCAC CAACGCACGCACACCGGCGAAAAACCAUACAAAUGUCCGGAAUGCGGUAAGAGUUUCAGCACGAGCCAUAGUCUGACCGAACA UCAACGUACCCAUACGGGUGAGAAACCAACCGGCAAGAAAACCAGC >ZF5-VPR protein SEQ ID NO.: 116 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHTGE KPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTG EKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF5-VPR mRNA SEQ ID NO.: 117 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUCGAACCGGGCGAGAAACCAUAUAAGUGUCCAGAGUGUGGUAAGAGCUUUAG CACCAGUGGCAAUCUGACCGAGCAUCAACGCACGCAUACGGGUGAGAAACCGUACAAGUGCCCGGAAUGCGGCAAAAGUUUCA GCGAUAGCGGCAAUCUGCGUGUGCACCAGCGUACGCAUACGGGCGAAAAGCCGUAUAAGUGCCCAGAAUGCGGUAAGAGUUUU AGCCACAAAAACGCGCUGCAGAACCACCAGCGCACCCACACGGGUGAGAAGCCAUACAAAUGUCCGGAAUGCGGCAAAAGCUU CAGCCGCAACGAUACGCUGACGGAACACCAACGUACGCAUACCGGCGAAAAGCCAUACAAGUGCCCGGAGUGCGGUAAAAGCU UUAGCCAGCGCGCGCAUCUCGAACGUCAUCAACGUACCCAUACCGGUGAAAAACCAUAUAAAUGCCCGGAAUGUGGUAAAAGU UUUAGCCGCAGCGACAAACUGGUGCGUCAUCAACGCACCCAUACCGGUGAAAAGCCAUAUAAGUGCCCGGAGUGUGGUAAAAG CUUCAGCGAUCCGGGUCAUCUGGUUCGCCAUCAACGUACGCACACCGGCGAGAAGCCAACCGGCAAGAAAACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5 target sequence SEQ ID NO.: 118 GGCGGGGGACCGATTAACCAT >ZF5 amino acid sequence SEQ ID NO.: 119 LEPGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGKSFSHKNALQNHQ RTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSRSDKLVRH QRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTS >ZF5 mRNA sequence SEQ ID NO.: 215 CUCGAACCGGGCGAGAAACCAUAUAAGUGUCCAGAGUGUGGUAAGAGCUUUAGCACCAGUGGCAAUCUGACCGAGCAUCAACG CACGCAUACGGGUGAGAAACCGUACAAGUGCCCGGAAUGCGGCAAAAGUUUCAGCGAUAGCGGCAAUCUGCGUGUGCACCAGC GUACGCAUACGGGCGAAAAGCCGUAUAAGUGCCCAGAAUGCGGUAAGAGUUUUAGCCACAAAAACGCGCUGCAGAACCACCAG CGCACCCACACGGGUGAGAAGCCAUACAAAUGUCCGGAAUGCGGCAAAAGCUUCAGCCGCAACGAUACGCUGACGGAACACCA ACGUACGCAUACCGGCGAAAAGCCAUACAAGUGCCCGGAGUGCGGUAAAAGCUUUAGCCAGCGCGCGCAUCUCGAACGUCAUC AACGUACCCAUACCGGUGAAAAACCAUAUAAAUGCCCGGAAUGUGGUAAAAGUUUUAGCCGCAGCGACAAACUGGUGCGUCAU CAACGCACCCAUACCGGUGAAAAGCCAUAUAAGUGCCCGGAGUGUGGUAAAAGCUUCAGCGAUCCGGGUCAUCUGGUUCGCCA UCAACGUACGCACACCGGCGAGAAGCCAACCGGCAAGAAAACCAGC >ZF6-VPR protein SEQ ID NO.: 120 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSHSLTEHQRTHTGEKPYKCPECGKSFSQRANLRAHQRTHTGE KPYKCPECGKSFSRADNLTEHQRTHTGEKPYKCPECGKSFSERSHLREHQRTHTGEKPYKCPECGKSFSDPGALVRHQRTHTG EKPYKCPECGKSFSTSGHLVRHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF6-VPR  mRNA SEQ ID NO.: 121 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUCGAACCGGGCGAAAAACCGUAUAAGUGUCCGGAGUGCGGCAAGAGCUUCAG CACGAGCCAUAGUCUGACCGAACACCAGCGCACCCACACGGGCGAAAAGCCGUACAAAUGUCCAGAGUGUGGUAAGAGUUUCA GCCAGCGUGCCAAUCUGCGCGCCCACCAACGUACCCACACCGGUGAGAAGCCGUAUAAGUGCCCAGAGUGUGGUAAAAGCUUC AGCCGCGCCGAUAAUCUGACGGAGCACCAACGCACCCACACCGGCGAAAAGCCAUACAAGUGCCCGGAGUGUGGCAAGAGCUU UAGCGAACGCAGCCAUCUGCGCGAACACCAACGUACGCACACGGGUGAGAAACCAUACAAAUGUCCAGAAUGUGGUAAAAGUU UUAGCGAUCCGGGCGCGCUGGUUCGCCACCAGCGCACGCACACCGGUGAAAAGCCGUAUAAAUGUCCAGAAUGCGGCAAAAGC UUCAGUACCAGCGGUCAUCUGGUUCGUCAUCAGCGUACCCAUACCGGCGAGAAGCCAUAUAAGUGCCCGGAGUGUGGCAAAAG UUUCAGCCGCAAUGAUACGCUGACCGAGCAUCAGCGUACGCAUACCGGUGAAAAACCAACCGGCAAGAAAACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF6 target sequence SEQ ID NO.: 122 CCGGGTGTCAGCCAGAAACCA >ZF6 amino acid sequence SEQ ID No.: 123 LEPGEKPYKCPECGKSFSTSHSLTEHQRTHTGEKPYKCPECGKSFSQRANLRAHQRTHTGEKPYKCPECGKSFSRADNLTEHQ RTHTGEKPYKCPECGKSFSERSHLREHQRTHTGEKPYKCPECGKSFSDPGALVRHQRTHTGEKPYKCPECGKSFSTSGHLVRH QRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPTGKKTS >ZF6 mRNA sequence SEQ ID NO.: 216 CUCGAACCGGGCGAAAAACCGUAUAAGUGUCCGGAGUGCGGCAAGAGCUUCAGCACGAGCCAUAGUCUGACCGAACACCAGCG CACCCACACGGGCGAAAAGCCGUACAAAUGUCCAGAGUGUGGUAAGAGUUUCAGCCAGCGUGCCAAUCUGCGCGCCCACCAAC GUACCCACACCGGUGAGAAGCCGUAUAAGUGCCCAGAGUGUGGUAAAAGCUUCAGCCGCGCCGAUAAUCUGACGGAGCACCAA CGCACCCACACCGGCGAAAAGCCAUACAAGUGCCCGGAGUGUGGCAAGAGCUUUAGCGAACGCAGCCAUCUGCGCGAACACCA ACGUACGCACACGGGUGAGAAACCAUACAAAUGUCCAGAAUGUGGUAAAAGUUUUAGCGAUCCGGGCGCGCUGGUUCGCCACC AGCGCACGCACACCGGUGAAAAGCCGUAUAAAUGUCCAGAAUGCGGCAAAAGCUUCAGUACCAGCGGUCAUCUGGUUCGUCAU CAGCGUACCCAUACCGGCGAGAAGCCAUAUAAGUGCCCGGAGUGUGGCAAAAGUUUCAGCCGCAAUGAUACGCUGACCGAGCA UCAGCGUACGCAUACCGGUGAAAAACCAACCGGCAAGAAAACCAGC >ZF7-VPR protein SEQ ID NO.: 124 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGE KPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTG EKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF7-VPR mRNA SEQ ID No.: 125 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAG CCGCAGCGACCAUCUGACCAAUCACCAACGCACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUA GUACCAGUGGCAGUCUGGUUCGUCAUCAGCGCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUU AGCCAAGCCGGUCAUCUGGCGAGCCAUCAACGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUU UAGCCGUAGCGAUAAACUGACCGAACACCAACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUU UCAGCACCAGCGGCAAUCUGACCGAGCAUCAACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGU UUUAGUCAGAGCAGUAAUCUGGUGCGCCAUCAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAG UUUUAGCACCCAUCUGGAUCUGAUCCGUCAUCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGUGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF7.4-VPR mRNA sequence SEQ ID NO.: 2508 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCGAAGAAAAAGAGGAAGGUCGGGAUCCAC GGAGUCCCAGCCGCAGGAAGCAGCGGAAGCCUGGAACCCGGAGAAAAACCCUACAAGUGCCCAGAAUGCGGCAAGAGCUUCAG CCGCAGCGACCACCUGACCAACCACCAGAGAACCCACACCGGAGAAAAGCCAUACAAAUGCCCAGAGUGCGGGAAAAGCUUCA GCACAAGCGGCAGCCUCGUCAGGCACCAGCGGACACACACCGGCGAGAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUC AGCCAAGCCGGACACCUCGCCAGCCACCAGAGGACCCACACAGGAGAGAAACCGUACAAAUGCCCGGAGUGCGGCAAGAGCUU CAGCCGGAGCGACAAGCUGACCGAACACCAGCGAACCCACACGGGCGAAAAGCCGUACAAGUGCCCCGAGUGCGGAAAAAGCU UCAGCACGAGCGGAAACCUCACCGAGCACCAGCGCACCCACACGGGAGAGAAGCCGUACAAGUGCCCCGAAUGCGGAAAGAGC UUCAGCCAGAGCAGCAACCUCGUGCGCCACCAACGGACGCACACAGGGGAAAAGCCCUACAAGUGCCCGGAAUGCGGCAAAAG CUUCAGCACCCACCUGGACCUGAUCCGGCACCAACGCACGCACACCGGGGAAAAACCGACCGGAAAAAAGACCAGCGCGAGCG GAAGCGGAGGAGGAAGCGGAGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGGAGCGACGCACUGGACGACUUCGAC CUGGACAUGCUGGGAAGCGACGCGCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUCGACGACUUCGACCUCGA CAUGCUGAGCGGCGGACCCAAGAAGAAGAGAAAGGUCGGAAGCCAGUACCUCCCGGACACCGACGACAGGCACCGCAUCGAAG AGAAGCGGAAAAGAACCUACGAAACCUUCAAGAGCAUCAUGAAAAAGAGCCCGUUCAGCGGACCAACCGACCCCAGACCACCA CCGAGAAGAAUCGCGGUCCCAAGCAGGAGCAGCGCCAGCGUCCCGAAGCCAGCCCCACAGCCGUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCGAGCGGCCAGAUAAGCCAGGCCAGCGCACUGGCACCAGCCC CACCGCAAGUGCUGCCCCAAGCACCCGCACCAGCACCCGCCCCCGCGAUGGUCAGCGCCCUGGCACAAGCCCCAGCCCCAGUC CCGGUGCUCGCACCAGGACCACCCCAAGCAGUCGCACCGCCAGCCCCAAAGCCGACCCAAGCCGGAGAAGGCACCCUCAGCGA GGCGCUCCUGCAACUCCAAUUCGACGACGAGGACCUGGGAGCCCUGCUGGGCAACAGCACCGACCCGGCAGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAAUUCCAGCAGCUCCUGAACCAAGGAAUCCCAGUCGCGCCACACACCACCGAGCCGAUGCUG AUGGAAUACCCAGAAGCGAUCACGAGACUGGUCACCGGGGCCCAAAGACCGCCGGACCCAGCGCCAGCACCACUGGGAGCCCC AGGACUGCCCAACGGACUGCUCAGCGGCGACGAGGACUUCAGCAGCAUCGCGGACAUGGACUUCAGCGCACUCCUCGGAAGCG GAAGCGGCAGCAGAGACAGCCGGGAAGGAAUGUUCCUCCCCAAGCCAGAAGCCGGAAGCGCAAUCAGCGACGUGUUCGAAGGA CGGGAAGUCUGCCAGCCGAAGCGCCUCAGACCGUUCCACCCACCGGGAAGCCCAUGGGCCAACAGACCGCUGCCAGCCAGCCU GGCACCGACCCCAACCGGACCAGUCCACGAACCAGUCGGCAGCCUGACACCAGCACCAGUGCCCCAGCCACUGGACCCAGCAC CGGCAGUGACCCCAGAAGCCAGCCACCUCCUGGAGGACCCCGACGAAGAAACCAGCCAGGCCGUGAAGGCCCUGAGGGAGAUG GCCGACACGGUGAUCCCACAGAAGGAAGAAGCAGCGAUCUGCGGCCAAAUGGACCUCAGCCACCCACCGCCAAGAGGCCACCU GGACGAGCUCACCACCACCCUGGAAAGCAUGACCGAGGACCUCAACCUCGACAGCCCCCUGACACCGGAGCUCAACGAGAUCC UGGACACCUUCCUCAACGACGAAUGCCUGCUCCACGCCAUGCACAUCAGCACCGGACUGAGCAUCUUCGACACCAGCCUGUUC AGCGGGGGAAAACGACCGGCAGCCACCAAAAAGGCCGGACAGGCGAAGAAGAAGAAGGGGAGCUACCCGUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF7 target sequence SEQ ID NO.: 126 ACTGAACATCGGTGAGTTAGG >ZF7 amino acid sequence SEQ ID NO.: 127 LEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKCPECGKSFSQAGHLASHQ RTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSQSSNLVRH QRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTS >ZF7 mRNA SEQ ID NO.: 217 CUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAGCCGCAGCGACCAUCUGACCAAUCACCAACG CACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUAGUACCAGUGGCAGUCUGGUUCGUCAUCAGC GCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUUAGCCAAGCCGGUCAUCUGGCGAGCCAUCAA CGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUUUAGCCGUAGCGAUAAACUGACCGAACACCA ACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUUUCAGCACCAGCGGCAAUCUGACCGAGCAUC AACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGUUUUAGUCAGAGCAGUAAUCUGGUGCGCCAU CAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAGUUUUAGCACCCAUCUGGAUCUGAUCCGUCA UCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGU >ZF7.4 mRNA sequence SEQ ID NO.: 2509 CUGGAACCCGGAGAAAAACCCUACAAGUGCCCAGAAUGCGGCAAGAGCUUCAGCCGCAGCGACCACCUGACCAACCACCAGAG AACCCACACCGGAGAAAAGCCAUACAAAUGCCCAGAGUGCGGGAAAAGCUUCAGCACAAGCGGCAGCCUCGUCAGGCACCAGC GGACACACACCGGCGAGAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUCAGCCAAGCCGGACACCUCGCCAGCCACCAG AGGACCCACACAGGAGAGAAACCGUACAAAUGCCCGGAGUGCGGCAAGAGCUUCAGCCGGAGCGACAAGCUGACCGAACACCA GCGAACCCACACGGGCGAAAAGCCGUACAAGUGCCCCGAGUGCGGAAAAAGCUUCAGCACGAGCGGAAACCUCACCGAGCACC AGCGCACCCACACGGGAGAGAAGCCGUACAAGUGCCCCGAAUGCGGAAAGAGCUUCAGCCAGAGCAGCAACCUCGUGCGCCAC CAACGGACGCACACAGGGGAAAAGCCCUACAAGUGCCCGGAAUGCGGCAAAAGCUUCAGCACCCACCUGGACCUGAUCCGGCA CCAACGCACGCACACCGGGGAAAAACCGACCGGAAAAAAGACCAGC >ZF8-VPR protein SEQ ID NO.: 128 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTTHQRTHTGEKPYKCPECGKSFSTSGELVRHQRTHTGE KPYKCPECGKSFSRRDELNVHQRTHTGEKPYKCPECGKSFSSPADLTRHQRTHTGEKPYKCPECGKSFSRSDELVRHQRTHTG EKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSTTGALTEHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF8-VPR mRNA SEQ ID No.: 129 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAACCGGGCGAAAAGCCGUACAAGUGCCCGGAAUGUGGCAAAAGUUUUAG UCGCAGCGAUCAUCUGACCACCCAUCAGCGUACCCAUACCGGUGAGAAGCCAUACAAAUGCCCAGAAUGUGGUAAGAGCUUUA GCACCAGCGGCGAGCUGGUUCGUCACCAGCGUACCCACACCGGCGAGAAGCCGUAUAAGUGUCCAGAAUGCGGUAAAAGCUUU AGCCGCCGCGACGAGCUGAAUGUGCAUCAACGCACCCACACGGGCGAGAAGCCAUAUAAGUGCCCGGAGUGUGGUAAGAGUUU CAGUAGCCCAGCGGAUCUGACCCGUCAUCAACGUACGCACACGGGCGAGAAACCAUACAAGUGUCCGGAGUGCGGCAAAAGUU UUAGCCGCAGUGAUGAACUGGUGCGCCACCAGCGCACCCAUACCGGCGAAAAACCGUAUAAGUGCCCAGAGUGCGGUAAGAGC UUCAGCCGCAGCGACAAACUGGUGCGUCACCAGCGCACGCAUACGGGUGAGAAACCGUACAAGUGCCCGGAGUGCGGCAAAAG CUUCAGCACCACCGGCGCGCUGACCGAACAUCAACGUACCCAUACGGGUGAGAAACCAACGGGCAAAAAGACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF8 target sequence SEQ ID NO.: 130 CTTGGGGTGACAATGGCTTGG >ZF8  amino acid sequence SEQ ID NO.: 131 LEPGEKPYKCPECGKSFSRSDHLTTHQRTHTGEKPYKCPECGKSFSTSGELVRHQRTHTGEKPYKCPECGKSFSRRDELNVHQ RTHTGEKPYKCPECGKSFSSPADLTRHQRTHTGEKPYKCPECGKSFSRSDELVRHQRTHTGEKPYKCPECGKSFSRSDKLVRH QRTHTGEKPYKCPECGKSFSTTGALTEHQRTHTGEKPTGKKTS >ZF8 mRNA sequence SEQ ID NO.: 218 CUGGAACCGGGCGAAAAGCCGUACAAGUGCCCGGAAUGUGGCAAAAGUUUUAGUCGCAGCGAUCAUCUGACCACCCAUCAGCG UACCCAUACCGGUGAGAAGCCAUACAAAUGCCCAGAAUGUGGUAAGAGCUUUAGCACCAGCGGCGAGCUGGUUCGUCACCAGC GUACCCACACCGGCGAGAAGCCGUAUAAGUGUCCAGAAUGCGGUAAAAGCUUUAGCCGCCGCGACGAGCUGAAUGUGCAUCAA CGCACCCACACGGGCGAGAAGCCAUAUAAGUGCCCGGAGUGUGGUAAGAGUUUCAGUAGCCCAGCGGAUCUGACCCGUCAUCA ACGUACGCACACGGGCGAGAAACCAUACAAGUGUCCGGAGUGCGGCAAAAGUUUUAGCCGCAGUGAUGAACUGGUGCGCCACC AGCGCACCCAUACCGGCGAAAAACCGUAUAAGUGCCCAGAGUGCGGUAAGAGCUUCAGCCGCAGCGACAAACUGGUGCGUCAC CAGCGCACGCAUACGGGUGAGAAACCGUACAAGUGCCCGGAGUGCGGCAAAAGCUUCAGCACCACCGGCGCGCUGACCGAACA UCAACGUACCCAUACGGGUGAGAAACCAACGGGCAAAAAGACCAGC >ZF9-VPR protein SEQ ID NO.: 132 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSQSGNLTEHQRTHTGEKPYKCPECGKSFSHKNALQNHQRTHTGE KPYKCPECGKSFSQNSTLTEHQRTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTSGNLVRHQRTHTG EKPYKCPECGKSFSQSGHLTEHQRTHTPNPHRRTDPSHKPFQYKCPECGKSFSDKKDLTRHQRTHTGEKPTGKKTSASGSGGG SGGDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKR TYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVL PQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVD NSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSR DSREGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTP EASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFL NDECLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF9-VPR mRNA SEQ ID NO.: 133 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUCGAACCGGGCGAAAAGCCAUACAAAUGUCCGGAGUGUGGCAAGAGUUUCAG CCAAAGCGGCAACCUCACCGAGCACCAGCGCACGCACACCGGCGAGAAGCCAUAUAAAUGUCCAGAAUGCGGCAAGAGCUUCA GCCAUAAGAAUGCGCUGCAGAACCAUCAGCGCACCCACACCGGUGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGUUUC AGCCAGAAUAGCACCCUCACGGAGCAUCAACGCACGCAUACGGGUGAAAAGCCGUACAAAUGCCCAGAAUGUGGCAAGAGCUU UAGCAGCAAGAAACAUCUGGCGGAGCAUCAGCGUACCCACACGGGCGAAAAGCCAUACAAAUGUCCGGAAUGCGGCAAAAGCU UCAGCACGAGUGGCAAUCUGGUGCGCCAUCAACGUACGCACACGGGUGAGAAACCGUAUAAAUGCCCAGAGUGUGGUAAAAGC UUCAGUCAGAGCGGCCAUCUGACCGAACACCAGCGCACCCAUACGCCAAACCCGCAUCGCCGCACCGAUCCGAGCCACAAGCC GUUCCAGUACAAGUGUCCAGAGUGCGGUAAAAGUUUUAGCGACAAGAAGGAUCUGACCCGUCACCAACGUACCCAUACCGGUG AAAAACCAACGGGCAAGAAAACCAGCGCUAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGAC AUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCU GGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACC UGCCCGACACCGACGACCGGCACCGGAUCGAGGAGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCC CCCUUCAGCGGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCC CGCCCCCCAGCCCUACCCCUUCACCAGCAGCCUGAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCC AGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCCCCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUG GUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUGCCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAA GCCCACCCAGGCCGGCGAGGGCACCCUGAGCGAGGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGG GCAACAGCACCGACCCCGCCGUGUUCACCGACCUGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUC CCCGUGGCCCCCCACACCACCGAGCCCAUGCUGAUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCC CCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCCCGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCG CCGACAUGGACUUCAGCGCCCUGCUGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAG GCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGCCGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAG CCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCUGGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCC CCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCCCCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAG ACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUGGCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAU GGACCUGAGCCACCCCCCCCCCCGGGGCCACCUGGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGG ACAGCCCCCUGACCCCCGAGCUGAACGAGAUCCUGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGC ACCGGCCUGAGCAUCUUCGACACCAGCCUGUUCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAA GAAGAAGGGCAGCUACCCCUACGACGUGCCCGACUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUU CUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF9 target SEQ ID NO.: 134 ACCTCCGAGATCCCCTAATTCAA >ZF9 amino acid sequence SEQ ID NO.: 135 LEPGEKPYKCPECGKSFSQSGNLTEHQRTHTGEKPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSQNSTLTEHQ RTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTSGNLVRHQRTHTGEKPYKCPECGKSFSQSGHLTEH QRTHTPNPHRRTDPSHKPFQYKCPECGKSFSDKKDLTRHQRTHTGEKPTGKKTS >ZF9 mRNA sequnce SEQ ID NO.: 219 CUCGAACCGGGCGAAAAGCCAUACAAAUGUCCGGAGUGUGGCAAGAGUUUCAGCCAAAGCGGCAACCUCACCGAGCACCAGCG CACGCACACCGGCGAGAAGCCAUAUAAAUGUCCAGAAUGCGGCAAGAGCUUCAGCCAUAAGAAUGCGCUGCAGAACCAUCAGC GCACCCACACCGGUGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGUUUCAGCCAGAAUAGCACCCUCACGGAGCAUCAA CGCACGCAUACGGGUGAAAAGCCGUACAAAUGCCCAGAAUGUGGCAAGAGCUUUAGCAGCAAGAAACAUCUGGCGGAGCAUCA GCGUACCCACACGGGCGAAAAGCCAUACAAAUGUCCGGAAUGCGGCAAAAGCUUCAGCACGAGUGGCAAUCUGGUGCGCCAUC AACGUACGCACACGGGUGAGAAACCGUAUAAAUGCCCAGAGUGUGGUAAAAGCUUCAGUCAGAGCGGCCAUCUGACCGAACAC CAGCGCACCCAUACGCCAAACCCGCAUCGCCGCACCGAUCCGAGCCACAAGCCGUUCCAGUACAAGUGUCCAGAGUGCGGUAA AAGUUUUAGCGACAAGAAGGAUCUGACCCGUCACCAACGUACCCAUACCGGUGAAAAACCAACGGGCAAGAAAACCAGC >ZF10-VPR protein SEQ ID NO.: 136 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSQNSTLTEHQRTHTGEKPYKCPECGKSFSERSHLREHQRTHTGE KPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSDCRDLARHQRTHTG EKPYKCPECGKSFSQSGDLRRHQRTHTGEKPYKCPECGKSFSTKNSLTEHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF10-VPR mRNA SEQ ID NO.: 137 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAGCCCGGCGAGAAGCCCUACAAAUGUCCCGAGUGUGGCAAGUCCUUCUC CCAGAAUAGCACACUGACAGAACACCAGAGGACACACACCGGCGAGAAACCUUAUAAGUGCCCCGAAUGCGGCAAAAGCUUUU CCGAGAGGAGCCACCUGAGGGAACACCAGAGAACACACACCGGAGAAAAACCUUACAAAUGCCCCGAGUGCGGAAAGUCCUUC AGCAGCAAGAAGCACCUGGCUGAACACCAGAGAACCCACACCGGCGAGAAGCCUUACAAGUGCCCCGAAUGUGGCAAAAGCUU CUCUAGAAACGACACACUCACCGAGCACCAGAGAACCCACACCGGCGAAAAGCCUUAUAAGUGUCCCGAGUGUGGCAAGAGCU UCAGCGAUUGUAGAGAUCUGGCCAGACACCAAAGGACCCACACCGGAGAAAAACCUUACAAGUGCCCCGAGUGUGGAAAGAGC UUUAGCCAAAGCGGCGAUCUGAGGAGACACCAGAGAACACACACCGGCGAAAAACCCUAUAAGUGUCCCGAAUGCGGAAAAUC CUUCAGCACCAAAAACUCUCUGACCGAGCACCAAAGAACCCACACCGGCGAAAAGCCUACCGGCAAAAAGACAAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF10 target sequence SEQ ID NO.: 138 CCTGCAGCCCCGCCCAGCCTA >ZF10 amino acid sequence SEQ ID NO.: 139 LEPGEKPYKCPECGKSFSQNSTLTEHQRTHTGEKPYKCPECGKSFSERSHLREHQRTHTGEKPYKCPECGKSFSSKKHLAEHQ RTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSDCRDLARHQRTHTGEKPYKCPECGKSFSQSGDLRRH QRTHTGEKPYKCPECGKSFSTKNSLTEHQRTHTGEKPTGKKTS >ZF10 mRNA sequence SEQ ID NO.: 220 CUGGAGCCCGGCGAGAAGCCCUACAAAUGUCCCGAGUGUGGCAAGUCCUUCUCCCAGAAUAGCACACUGACAGAACACCAGAG GACACACACCGGCGAGAAACCUUAUAAGUGCCCCGAAUGCGGCAAAAGCUUUUCCGAGAGGAGCCACCUGAGGGAACACCAGA GAACACACACCGGAGAAAAACCUUACAAAUGCCCCGAGUGCGGAAAGUCCUUCAGCAGCAAGAAGCACCUGGCUGAACACCAG AGAACCCACACCGGCGAGAAGCCUUACAAGUGCCCCGAAUGUGGCAAAAGCUUCUCUAGAAACGACACACUCACCGAGCACCA GAGAACCCACACCGGCGAAAAGCCUUAUAAGUGUCCCGAGUGUGGCAAGAGCUUCAGCGAUUGUAGAGAUCUGGCCAGACACC AAAGGACCCACACCGGAGAAAAACCUUACAAGUGCCCCGAGUGUGGAAAGAGCUUUAGCCAAAGCGGCGAUCUGAGGAGACAC CAGAGAACACACACCGGCGAAAAACCCUAUAAGUGUCCCGAAUGCGGAAAAUCCUUCAGCACCAAAAACUCUCUGACCGAGCA CCAAAGAACCCACACCGGCGAAAAGCCUACCGGCAAAAAGACAAGC >ZF11-VPR protein SEQ ID NO.: 140 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSERSHLREHQRTHTGEKPYKCPECGKSFSRADNLTEHQRTHTGE KPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTKNSLTEHQRTHTG EKPYKCPECGKSFSDKKDLTRHQRTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF11-VPR mRNA SEQ ID NO.: 141 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAGCCCGGCGAGAAACCCUACAAGUGUCCCGAGUGUGGCAAGAGCUUUUC CGAGAGAAGCCACCUGAGGGAACACCAGAGAACCCACACCGGCGAGAAGCCUUACAAAUGCCCCGAAUGUGGAAAGAGCUUUU CUAGAGCCGACAAUCUGACCGAACACCAAAGAACCCACACCGGCGAAAAACCCUAUAAGUGUCCCGAGUGUGGAAAAAGCUUC UCUAGAAGCGACAAACUCACAGAGCACCAGAGGACACACACCGGCGAGAAGCCCUACAAAUGUCCCGAGUGCGGCAAAAGCUU CAGCAGCAAGAAGCACCUGGCCGAGCACCAAAGAACACACACCGGCGAAAAACCUUAUAAAUGCCCCGAGUGCGGCAAGUCCU UUUCCACCAAGAACUCUCUGACAGAACACCAAAGGACACACACCGGAGAAAAACCCUACAAAUGUCCCGAAUGUGGCAAAUCC UUCAGCGAUAAGAAGGACCUCACCAGACACCAGAGGACACACACCGGCGAAAAACCUUAUAAAUGUCCCGAGUGCGGAAAGUC CUUCUCCAGCAAAAAGCACCUCGCUGAGCACCAAAGGACCCACACCGGCGAGAAGCCCACCGGAAAAAAGACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF11 target sequence SEQ ID NO.: 142 CCCACCCCTCCCCGGCAGAGC >ZF11 amino acid sequence SEQ ID NO.: 143 LEPGEKPYKCPECGKSFSERSHLREHQRTHTGEKPYKCPECGKSFSRADNLTEHQRTHTGEKPYKCPECGKSFSRSDKLTEHQ RTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTKNSLTEHQRTHTGEKPYKCPECGKSFSDKKDLTRH QRTHTGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPTGKKTS >ZF11 mRNA sequence SEQ ID NO.: 221 CUGGAGCCCGGCGAGAAACCCUACAAGUGUCCCGAGUGUGGCAAGAGCUUUUCCGAGAGAAGCCACCUGAGGGAACACCAGAG AACCCACACCGGCGAGAAGCCUUACAAAUGCCCCGAAUGUGGAAAGAGCUUUUCUAGAGCCGACAAUCUGACCGAACACCAAA GAACCCACACCGGCGAAAAACCCUAUAAGUGUCCCGAGUGUGGAAAAAGCUUCUCUAGAAGCGACAAACUCACAGAGCACCAG AGGACACACACCGGCGAGAAGCCCUACAAAUGUCCCGAGUGCGGCAAAAGCUUCAGCAGCAAGAAGCACCUGGCCGAGCACCA AAGAACACACACCGGCGAAAAACCUUAUAAAUGCCCCGAGUGCGGCAAGUCCUUUUCCACCAAGAACUCUCUGACAGAACACC AAAGGACACACACCGGAGAAAAACCCUACAAAUGUCCCGAAUGUGGCAAAUCCUUCAGCGAUAAGAAGGACCUCACCAGACAC CAGAGGACACACACCGGCGAAAAACCUUAUAAAUGUCCCGAGUGCGGAAAGUCCUUCUCCAGCAAAAAGCACCUCGCUGAGCA CCAAAGGACCCACACCGGCGAGAAGCCCACCGGAAAAAAGACCAGC >ZF12-VPR protein SEQ ID NO.: 144 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGE KPYKCPECGKSFSRKDNLKNHQRTHTGEKPYKCPECGKSFSDCRDLARHQRTHTGEKPYKCPECGKSFSREDNLHTHQRTHTG EKPYKCPECGKSFSDPGHLVRHQRTHTGEKPYKCPECGKSFSQLAHLRAHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF12-VPR mRNA SEQ ID NO.: 145 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAGCCCGGCGAAAAGCCCUACAAAUGUCCCGAAUGUGGCAAGAGCUUCAG CAGCAAAAAGCACCUGGCUGAACACCAGAGGACCCACACCGGAGAGAAACCCUAUAAAUGUCCCGAGUGUGGAAAAAGCUUCA GCACCCACCUCGACCUCAUUAGGCACCAAAGAACCCACACCGGCGAAAAACCCUAUAAGUGUCCCGAGUGUGGAAAAUCCUUU UCUAGAAAGGACAAUCUCAAGAAUCACCAAAGAACACACACCGGCGAGAAACCUUACAAGUGUCCCGAGUGCGGAAAGUCCUU CUCCGACUGUAGAGAUCUGGCUAGACACCAGAGAACCCACACCGGCGAGAAGCCCUAUAAGUGCCCCGAGUGCGGCAAGUCCU UCUCUAGAGAGGACAAUCUGCACACACACCAGAGGACCCACACCGGCGAAAAACCUUACAAAUGCCCCGAGUGUGGCAAGAGC UUUAGCGAUCCCGGACACCUGGUGAGACACCAAAGAACCCACACCGGCGAGAAGCCUUACAAGUGUCCCGAAUGUGGAAAAUC CUUUAGCCAGCUGGCCCACCUGAGGGCCCACCAAAGGACACACACCGGCGAAAAACCCACCGGCAAAAAGACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF12 target sequence SEQ ID NO.: 146 AGAGGCTAGGCCAAGACTCCC >ZF12 amino acid sequence SEQ ID NO.: 147 LEPGEKPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPYKCPECGKSFSRKDNLKNHQ RTHTGEKPYKCPECGKSFSDCRDLARHQRTHTGEKPYKCPECGKSFSREDNLHTHQRTHTGEKPYKCPECGKSFSDPGHLVRH QRTHTGEKPYKCPECGKSFSQLAHLRAHQRTHTGEKPTGKKTS >ZF12 mRNA sequence SEQ ID NO.: 222 CUGGAGCCCGGCGAAAAGCCCUACAAAUGUCCCGAAUGUGGCAAGAGCUUCAGCAGCAAAAAGCACCUGGCUGAACACCAGAG GACCCACACCGGAGAGAAACCCUAUAAAUGUCCCGAGUGUGGAAAAAGCUUCAGCACCCACCUCGACCUCAUUAGGCACCAAA GAACCCACACCGGCGAAAAACCCUAUAAGUGUCCCGAGUGUGGAAAAUCCUUUUCUAGAAAGGACAAUCUCAAGAAUCACCAA AGAACACACACCGGCGAGAAACCUUACAAGUGUCCCGAGUGCGGAAAGUCCUUCUCCGACUGUAGAGAUCUGGCUAGACACCA GAGAACCCACACCGGCGAGAAGCCCUAUAAGUGCCCCGAGUGCGGCAAGUCCUUCUCUAGAGAGGACAAUCUGCACACACACC AGAGGACCCACACCGGCGAAAAACCUUACAAAUGCCCCGAGUGUGGCAAGAGCUUUAGCGAUCCCGGACACCUGGUGAGACAC CAAAGAACCCACACCGGCGAGAAGCCUUACAAGUGUCCCGAAUGUGGAAAAUCCUUUAGCCAGCUGGCCCACCUGAGGGCCCA CCAAAGGACACACACCGGCGAAAAACCCACCGGCAAAAAGACCAGC >ZF13-VPR protein SEQ ID NO.: 148 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSQSGDLRRHQRTHTGE KPYKCPECGKSFSTSGELVRHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTG EKPYKCPECGKSFSRNDALTEHQRTHTGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF13-VPR mRNA SEQ ID NO.: 149 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAGCCCGGCGAAAAGCCCUAUAAGUGCCCCGAGUGCGGCAAGAGCUUCUC UAGAAGCGACAAACUCGUGAGACACCAGAGAACACACACCGGAGAGAAACCUUACAAGUGCCCCGAGUGUGGCAAGUCCUUCU CCCAAUCCGGCGAUCUGAGGAGACACCAGAGAACCCACACCGGCGAAAAACCCUACAAAUGCCCCGAGUGCGGAAAGUCCUUU UCCACCUCCGGCGAGCUCGUGAGACACCAAAGGACCCACACCGGCGAGAAGCCUUACAAGUGCCCCGAGUGCGGCAAAUCCUU CUCCAGAUCCGACAAGCUCGUGAGGCACCAGAGGACACACACCGGAGAGAAACCUUAUAAGUGUCCCGAAUGUGGAAAGUCCU UCAGCGACCCCGGACACCUGGUGAGACACCAGAGGACCCACACCGGCGAAAAGCCUUAUAAAUGUCCCGAGUGCGGAAAAAGC UUUUCUAGAAACGAUGCUCUGACAGAGCACCAAAGAACCCACACCGGCGAAAAACCCUACAAGUGUCCCGAGUGCGGAAAGAG CUUCAGCAGAAGCGACCACCUGACCAACCACCAGAGAACACACACCGGAGAAAAACCCACCGGCAAAAAGACCUCCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF13 target sequence SEQ ID NO.: 150 AGGCTGGGCGGGGCTGCAGGG >ZF13 amino acid sequence SEQ ID NO.: 151 LEPGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSQSGDLRRHQRTHTGEKPYKCPECGKSFSTSGELVRHQ RTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPYKCPECGKSFSRNDALTEH QRTHTGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPTGKKTS >ZF13 mRNA sequence SEQ ID NO.: 223 CUGGAGCCCGGCGAAAAGCCCUAUAAGUGCCCCGAGUGCGGCAAGAGCUUCUCUAGAAGCGACAAACUCGUGAGACACCAGAG AACACACACCGGAGAGAAACCUUACAAGUGCCCCGAGUGUGGCAAGUCCUUCUCCCAAUCCGGCGAUCUGAGGAGACACCAGA GAACCCACACCGGCGAAAAACCCUACAAAUGCCCCGAGUGCGGAAAGUCCUUUUCCACCUCCGGCGAGCUCGUGAGACACCAA AGGACCCACACCGGCGAGAAGCCUUACAAGUGCCCCGAGUGCGGCAAAUCCUUCUCCAGAUCCGACAAGCUCGUGAGGCACCA GAGGACACACACCGGAGAGAAACCUUAUAAGUGUCCCGAAUGUGGAAAGUCCUUCAGCGACCCCGGACACCUGGUGAGACACC AGAGGACCCACACCGGCGAAAAGCCUUAUAAAUGUCCCGAGUGCGGAAAAAGCUUUUCUAGAAACGAUGCUCUGACAGAGCAC CAAAGAACCCACACCGGCGAAAAACCCUACAAGUGUCCCGAGUGCGGAAAGAGCUUCAGCAGAAGCGACCACCUGACCAACCA CCAGAGAACACACACCGGAGAAAAACCCACCGGCAAAAAGACCUCC >ZF14-VPR protein SEQ ID NO.: 152 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGHLVRHQRTHTGEKPYKCPECGKSFSTTGNLTVHQRTHTGE KPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSRSDELVRHQRTHTG EKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF14-VPR mRNA SEQ ID NO.: 153 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAGCCCGGCGAAAAGCCCUACAAAUGUCCCGAAUGCGGCAAAUCCUUCUC CACCUCCGGCCACCUCGUGAGACACCAGAGGACACACACCGGCGAGAAGCCUUAUAAGUGCCCCGAAUGCGGCAAAAGCUUCU CCACCACCGGCAAUCUGACCGUCCACCAGAGAACACACACCGGCGAAAAACCUUAUAAGUGUCCCGAGUGUGGCAAAUCCUUU UCCACCAGCGGAUCUCUGGUGAGACACCAAAGGACACACACCGGCGAAAAACCCUACAAAUGCCCCGAGUGUGGAAAAUCCUU CUCUAGAAGCGACAAGCUGGUGAGACACCAGAGGACCCACACCGGCGAGAAACCCUACAAGUGCCCCGAAUGUGGCAAGAGCU UCUCUAGAUCCGACGAGCUCGUGAGACACCAAAGAACCCACACCGGCGAAAAGCCUUACAAAUGUCCCGAGUGCGGAAAGAGC UUUAGCAGAAGCGAUAAGCUGGUCAGACACCAAAGAACACACACCGGAGAAAAACCCUAUAAGUGCCCCGAGUGUGGCAAGUC CUUUAGCCAGAGAGCCCACCUGGAGAGACACCAAAGAACCCACACCGGCGAAAAACCCACCGGAAAAAAGACAAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF14 target sequence SEQ ID NO.: 154 GGAGGGGTGGGGGTTAATGGT >ZF14 amino acid sequence SEQ ID NO.: 155 LEPGEKPYKCPECGKSFSTSGHLVRHQRTHTGEKPYKCPECGKSFSTTGNLTVHQRTHTGEKPYKCPECGKSFSTSGSLVRHQ RTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSRSDELVRHQRTHTGEKPYKCPECGKSFSRSDKLVRH QRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPTGKKTS >ZF14 mRNA sequence SEQ ID NO.: 224 CUGGAGCCCGGCGAAAAGCCCUACAAAUGUCCCGAAUGCGGCAAAUCCUUCUCCACCUCCGGCCACCUCGUGAGACACCAGAG GACACACACCGGCGAGAAGCCUUAUAAGUGCCCCGAAUGCGGCAAAAGCUUCUCCACCACCGGCAAUCUGACCGUCCACCAGA GAACACACACCGGCGAAAAACCUUAUAAGUGUCCCGAGUGUGGCAAAUCCUUUUCCACCAGCGGAUCUCUGGUGAGACACCAA AGGACACACACCGGCGAAAAACCCUACAAAUGCCCCGAGUGUGGAAAAUCCUUCUCUAGAAGCGACAAGCUGGUGAGACACCA GAGGACCCACACCGGCGAGAAACCCUACAAGUGCCCCGAAUGUGGCAAGAGCUUCUCUAGAUCCGACGAGCUCGUGAGACACC AAAGAACCCACACCGGCGAAAAGCCUUACAAAUGUCCCGAGUGCGGAAAGAGCUUUAGCAGAAGCGAUAAGCUGGUCAGACAC CAAAGAACACACACCGGAGAAAAACCCUAUAAGUGCCCCGAGUGUGGCAAGUCCUUUAGCCAGAGAGCCCACCUGGAGAGACA CCAAAGAACCCACACCGGCGAAAAACCCACCGGAAAAAAGACAAGC >ZF15-VPR protein SEQ ID NO.: 156 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSRNDALTEHQRTHTGE KPYKCPECGKSFSTSGELVRHQRTHTGEKPYKCPECGKSFSRSDNLVRHQRTHTGEKPYKCPECGKSFSRSDELVRHQRTHTG EKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF15-VPR mRNA SEQ ID NO.: 157 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAGCCCGGCGAGAAGCCCUACAAAUGUCCCGAAUGUGGCAAGAGCUUCUC UAGAAACGACACACUGACCGAACACCAGAGAACACACACCGGCGAAAAACCUUAUAAAUGUCCCGAGUGUGGAAAAUCCUUCU CUAGAAAUGACGCUCUCACCGAGCACCAAAGAACACACACCGGCGAAAAGCCUUACAAAUGCCCCGAAUGUGGAAAGUCCUUC UCCACCUCCGGAGAGCUGGUGAGACACCAGAGAACCCACACCGGCGAAAAACCCUACAAGUGCCCCGAGUGCGGAAAAAGCUU CUCUAGAAGCGAUAAUCUGGUGAGACACCAAAGGACACACACCGGCGAGAAGCCCUAUAAGUGUCCCGAAUGCGGCAAGUCCU UUUCCAGAAGCGACGAACUGGUGAGACACCAGAGAACCCACACCGGAGAGAAGCCUUAUAAGUGUCCCGAGUGCGGAAAGAGC UUUUCUAGAUCCGACAAGCUCGUGAGACACCAAAGGACCCACACCGGCGAGAAACCCUAUAAAUGUCCCGAGUGUGGCAAAUC CUUUUCCCAGAGCAGCAACCUCGUGAGGCACCAGAGGACCCACACCGGCGAGAAACCCACCGGCAAAAAGACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF15 target sequence SEQ ID NO.: 158 GAAGGGGTGGAGGCTCTGCCG >ZF15 amino acid sequence SEQ ID NO.: 159 LEPGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSRNDALTEHQRTHTGEKPYKCPECGKSFSTSGELVRHQ RTHTGEKPYKCPECGKSFSRSDNLVRHQRTHTGEKPYKCPECGKSFSRSDELVRHQRTHTGEKPYKCPECGKSFSRSDKLVRH QRTHTGEKPYKCPECGKSFSQSSNLVRHQRTHTGEKPTGKKTS >ZF15  mRNA sequence SEQ ID NO.: 225 CUGGAGCCCGGCGAGAAGCCCUACAAAUGUCCCGAAUGUGGCAAGAGCUUCUCUAGAAACGACACACUGACCGAACACCAGAG AACACACACCGGCGAAAAACCUUAUAAAUGUCCCGAGUGUGGAAAAUCCUUCUCUAGAAAUGACGCUCUCACCGAGCACCAAA GAACACACACCGGCGAAAAGCCUUACAAAUGCCCCGAAUGUGGAAAGUCCUUCUCCACCUCCGGAGAGCUGGUGAGACACCAG AGAACCCACACCGGCGAAAAACCCUACAAGUGCCCCGAGUGCGGAAAAAGCUUCUCUAGAAGCGAUAAUCUGGUGAGACACCA AAGGACACACACCGGCGAGAAGCCCUAUAAGUGUCCCGAAUGCGGCAAGUCCUUUUCCAGAAGCGACGAACUGGUGAGACACC AGAGAACCCACACCGGAGAGAAGCCUUAUAAGUGUCCCGAGUGCGGAAAGAGCUUUUCUAGAUCCGACAAGCUCGUGAGACAC CAAAGGACCCACACCGGCGAGAAACCCUAUAAAUGUCCCGAGUGUGGCAAAUCCUUUUCCCAGAGCAGCAACCUCGUGAGGCA CCAGAGGACCCACACCGGCGAGAAACCCACCGGCAAAAAGACCAGC >ZF5.1-VPR mRNA (ZF5-VPR ATUM Opt_1) SEQ ID NO.: 160 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCGAAGAAAAAGCGCAAAGUCGGAAUCCAU GGUGUCCCUGCGGCUGGAAGUUCCGGCUCCUUGGAACCGGGAGAGAAGCCUUAUAAGUGUCCGGAGUGUGGGAAGUCGUUCUC CACCUCGGGCAACCUCACCGAACAUCAGCGCACACAUACGGGGGAGAAACCUUACAAAUGCCCGGAAUGUGGAAAGAGCUUCU CCGAUUCGGGAAAUCUCAGAGUGCACCAACGCACCCACACAGGAGAAAAACCGUAUAAGUGCCCCGAAUGCGGGAAAUCGUUC UCCCACAAGAAUGCGCUGCAGAACCACCAGAGGACACAUACUGGGGAGAAGCCCUACAAGUGUCCUGAAUGCGGAAAGUCCUU CUCGCGCAACGAUACUUUGACCGAGCACCAGCGCACUCACACCGGCGAAAAGCCGUACAAGUGCCCAGAGUGCGGUAAAAGCU UCUCGCAACGGGCCCAUCUGGAACGGCACCAGCGGACUCACACUGGAGAAAAGCCCUACAAGUGUCCCGAGUGCGGGAAGUCC UUUUCCCGGUCCGAUAAGCUCGUGCGCCACCAGAGAACCCAUACUGGAGAGAAACCGUACAAAUGUCCAGAAUGCGGCAAAUC CUUCUCGGACCCGGGACACCUCGUGCGGCAUCAACGGACCCAUACCGGGGAAAAGCCCACCGGAAAGAAAACUAGCGCGUCAG GCUCUGGUGGAGGAUCGGGGGGAGAUGCUCUGGACGACUUUGACCUUGACAUGCUUGGCUCCGACGCCCUUGACGACUUCGAC CUCGAUAUGCUGGGAUCGGACGCCCUGGAUGACUUCGAUCUGGACAUGUUGGGCUCGGACGCGCUAGACGAUUUUGACCUGGA UAUGCUGUCCGGAGGUCCCAAGAAGAAGCGGAAGGUCGGCAGCCAGUAUCUGCCGGAUACUGAUGACCGGCACAGAAUCGAGG AGAAGCGAAAGCGGACCUACGAAACUUUCAAGAGCAUUAUGAAGAAGUCCCCGUUCUCGGGUCCAACCGACCCCAGACCUCCU CCGCGGAGAAUUGCCGUGCCAAGCCGCUCAAGCGCCAGCGUGCCCAAGCCAGCACCACAGCCCUACCCGUUCACCUCCUCCCU UUCGACCAUCAACUACGACGAAUUCCCAACCAUGGUGUUCCCUAGCGGACAAAUCAGCCAGGCUUCCGCUCUGGCACCAGCCC CACCUCAAGUGCUCCCGCAAGCGCCUGCUCCAGCACCGGCUCCUGCCAUGGUUUCAGCGCUGGCCCAAGCACCCGCUCCUGUG CCUGUGCUGGCCCCUGGACCACCACAAGCAGUAGCCCCGCCUGCACCUAAGCCAACUCAGGCCGGCGAAGGAACCCUGAGCGA AGCGUUGCUGCAGCUUCAGUUCGACGACGAGGACCUGGGUGCCCUGUUGGGCAACUCAACUGACCCUGCCGUGUUCACCGACC UGGCAUCCGUCGAUAACUCCGAGUUCCAGCAGUUGCUGAACCAGGGAAUCCCAGUCGCCCCCCAUACCACCGAACCGAUGCUC AUGGAGUACCCCGAAGCCAUCACCAGACUGGUCACCGGCGCACAAAGGCCCCCUGAUCCUGCUCCCGCACCUCUCGGUGCCCC UGGACUGCCAAACGGCCUUCUGUCCGGCGACGAGGACUUCUCGUCCAUCGCCGAUAUGGAUUUCUCCGCCCUGCUCGGAUCCG GCAGCGGAUCACGCGACUCGCGCGAAGGGAUGUUCCUGCCGAAGCCUGAGGCUGGUUCCGCCAUUAGCGACGUGUUCGAGGGG CGCGAAGUCUGCCAACCCAAGAGACUGCGCCCGUUUCAUCCCCCGGGAAGCCCUUGGGCCAACAGACCUCUGCCAGCCUCCCU GGCACCCACUCCGACUGGGCCUGUGCACGAACCCGUGGGCUCCCUGACUCCGGCACCAGUGCCACAGCCCCUGGAUCCAGCCC CUGCUGUGACCCCGGAGGCCUCACACCUUCUGGAAGAUCCGGACGAGGAAACGUCCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCGGACACUGUGAUCCCUCAGAAAGAAGAGGCGGCCAUUUGCGGCCAGAUGGACCUCUCCCAUCCGCCUCCGAGAGGACACCU GGAUGAACUCACGACCACCCUCGAGUCCAUGACCGAGGACCUGAACCUGGACUCCCCCCUGACACCCGAACUCAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUCCACGCCAUGCACAUCUCAACCGGGCUGUCGAUCUUCGACACUAGCUUGUUC UCUGGAGGAAAGAGGCCGGCCGCUACUAAGAAGGCCGGACAAGCGAAGAAGAAGAAGGGAUCGUACCCUUACGACGUGCCCGA CUACGCAUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5.1 mRNA sequence SEQ ID NO.: 226 UUGGAACCGGGAGAGAAGCCUUAUAAGUGUCCGGAGUGUGGGAAGUCGUUCUCCACCUCGGGCAACCUCACCGAACAUCAGCG CACACAUACGGGGGAGAAACCUUACAAAUGCCCGGAAUGUGGAAAGAGCUUCUCCGAUUCGGGAAAUCUCAGAGUGCACCAAC GCACCCACACAGGAGAAAAACCGUAUAAGUGCCCCGAAUGCGGGAAAUCGUUCUCCCACAAGAAUGCGCUGCAGAACCACCAG AGGACACAUACUGGGGAGAAGCCCUACAAGUGUCCUGAAUGCGGAAAGUCCUUCUCGCGCAACGAUACUUUGACCGAGCACCA GCGCACUCACACCGGCGAAAAGCCGUACAAGUGCCCAGAGUGCGGUAAAAGCUUCUCGCAACGGGCCCAUCUGGAACGGCACC AGCGGACUCACACUGGAGAAAAGCCCUACAAGUGUCCCGAGUGCGGGAAGUCCUUUUCCCGGUCCGAUAAGCUCGUGCGCCAC CAGAGAACCCAUACUGGAGAGAAACCGUACAAAUGUCCAGAAUGCGGCAAAUCCUUCUCGGACCCGGGACACCUCGUGCGGCA UCAACGGACCCAUACCGGGGAAAAGCCCACCGGAAAGAAAACUAGC >ZF5.2-VPR mRNA (ZF5-VPR ATUM Opt_2) SEQ ID NO. 161 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCGAAGAAGAAGCGGAAGGUCGGCAUCCAC GGAGUGCCGGCAGCAGGGUCAUCAGGCUCCCUCGAACCCGGGGAAAAGCCGUACAAGUGUCCGGAGUGUGGGAAGUCAUUCUC CACUUCCGGGAAUCUGACCGAGCAUCAACGCACCCACACUGGCGAGAAGCCCUACAAAUGCCCGGAGUGCGGAAAAUCGUUCU CGGACUCCGGGAACCUUCGGGUCCACCAAAGGACUCAUACCGGGGAGAAACCGUACAAAUGUCCCGAAUGCGGGAAGUCGUUC AGCCAUAAGAACGCGCUGCAGAACCAUCAGAGGACCCAUACUGGAGAAAAGCCCUAUAAGUGUCCGGAAUGCGGAAAGUCGUU CUCACGCAACGACACCCUCACCGAACACCAGCGCACUCACACCGGAGAGAAGCCUUACAAGUGCCCGGAAUGUGGAAAGAGCU UCAGCCAGCGGGCACAUCUGGAAAGACACCAGCGAACCCACACCGGGGAAAAACCGUAUAAGUGCCCCGAGUGUGGAAAGUCC UUUUCACGGUCCGAUAAGCUCGUGCGCCACCAGAGAACUCACACUGGGGAGAAGCCGUACAAGUGUCCCGAGUGCGGCAAGAG CUUCUCAGAUCCGGGACACCUUGUGCGACAUCAACGGACCCAUACCGGAGAAAAACCGACCGGGAAAAAGACCUCAGCAUCAG GCUCAGGAGGCGGAUCAGGAGGCGACGCGCUCGAUGACUUCGAUCUGGACAUGUUGGGGUCCGACGCGCUUGACGACUUCGAC CUUGAUAUGCUCGGAUCCGACGCCCUCGACGAUUUUGAUCUCGACAUGCUUGGGUCAGACGCCCUGGACGAUUUCGACCUGGA CAUGCUGUCCGGUGGACCGAAAAAGAAGAGGAAGGUCGGGUCCCAGUACCUCCCGGACACCGAUGACCGACACCGGAUUGAAG AGAAGCGCAAGAGAACCUACGAAACCUUCAAGUCGAUUAUGAAGAAGUCGCCGUUCUCGGGACCGACUGAUCCCAGACCGCCG CCCAGAAGGAUUGCCGUGCCGUCGAGGUCAAGCGCCUCAGUGCCGAAACCCGCUCCGCAACCGUACCCCUUCACCUCAUCACU UUCCACCAUCAACUACGAUGAGUUCCCCACCAUGGUGUUCCCGUCCGGCCAGAUCUCACAGGCCUCAGCCCUUGCACCGGCAC CGCCCCAAGUCCUUCCGCAAGCACCCGCACCCGCUCCCGCUCCGGCAAUGGUGUCCGCGCUCGCACAAGCACCGGCUCCGGUG CCGGUCUUGGCUCCGGGACCGCCGCAAGCAGUGGCACCACCCGCUCCGAAACCGACUCAGGCUGGGGAGGGAACCCUGUCCGA AGCCCUGCUGCAACUUCAAUUCGACGAUGAAGAUCUGGGCGCACUGUUGGGAAACUCCACUGAUCCGGCAGUGUUCACCGAUC UGGCCUCGGUGGACAACUCCGAGUUCCAGCAGCUGCUCAACCAAGGGAUUCCGGUCGCCCCGCAUACUACCGAGCCCAUGCUG AUGGAAUACCCGGAAGCAAUCACCCGGCUGGUCACUGGUGCACAAAGACCCCCCGAUCCUGCUCCGGCACCGUUGGGAGCACC GGGGUUGCCCAAUGGGCUGCUUUCGGGGGACGAGGAUUUCUCGUCAAUUGCCGACAUGGACUUCUCGGCCCUGUUGGGAUCCG GAAGCGGAAGCAGGGACUCACGAGAGGGAAUGUUCCUACCGAAGCCCGAAGCGGGAUCAGCAAUCUCAGACGUGUUUGAAGGC CGCGAAGUCUGCCAGCCGAAGCGCCUUCGCCCGUUCCAUCCGCCGGGAUCACCCUGGGCCAACAGACCCCUGCCGGCAUCACU GGCCCCGACUCCGACUGGUCCGGUGCACGAACCGGUCGGGAGCCUGACUCCGGCACCCGUGCCCCAACCGUUGGAUCCGGCAC CGGCAGUGACUCCGGAAGCUUCCCACCUCCUGGAGGAUCCGGACGAAGAGACUUCGCAGGCAGUGAAGGCCCUGCGCGAAAUG GCGGACACCGUGAUUCCCCAGAAGGAAGAGGCAGCGAUCUGCGGGCAGAUGGACCUGUCACAUCCGCCCCCGAGAGGACACCU GGACGAGCUGACCACUACCCUGGAAUCGAUGACUGAAGAUCUGAACCUGGACUCACCGCUGACUCCCGAGCUGAACGAAAUCC UGGACACCUUCCUGAACGACGAGUGCCUUCUCCACGCCAUGCAUAUCUCCACCGGGCUGAGCAUCUUCGACACCUCGCUGUUC UCGGGAGGAAAACGCCCGGCCGCAACUAAGAAGGCCGGACAGGCCAAGAAGAAGAAGGGGUCAUACCCGUACGACGUGCCCGA CUAUGCGUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5.2 mRNA sequence SEQ ID NO.: 227 CUCGAACCCGGGGAAAAGCCGUACAAGUGUCCGGAGUGUGGGAAGUCAUUCUCCACUUCCGGGAAUCUGACCGAGCAUCAACG CACCCACACUGGCGAGAAGCCCUACAAAUGCCCGGAGUGCGGAAAAUCGUUCUCGGACUCCGGGAACCUUCGGGUCCACCAAA GGACUCAUACCGGGGAGAAACCGUACAAAUGUCCCGAAUGCGGGAAGUCGUUCAGCCAUAAGAACGCGCUGCAGAACCAUCAG AGGACCCAUACUGGAGAAAAGCCCUAUAAGUGUCCGGAAUGCGGAAAGUCGUUCUCACGCAACGACACCCUCACCGAACACCA GCGCACUCACACCGGAGAGAAGCCUUACAAGUGCCCGGAAUGUGGAAAGAGCUUCAGCCAGCGGGCACAUCUGGAAAGACACC AGCGAACCCACACCGGGGAAAAACCGUAUAAGUGCCCCGAGUGUGGAAAGUCCUUUUCACGGUCCGAUAAGCUCGUGCGCCAC CAGAGAACUCACACUGGGGAGAAGCCGUACAAGUGUCCCGAGUGCGGCAAGAGCUUCUCAGAUCCGGGACACCUUGUGCGACA UCAACGGACCCAUACCGGAGAAAAACCGACCGGGAAAAAGACCUCA >ZF5.3-VPR mRNA (ZF5-VPR ATUM Opt_3) SEQ ID NO.: 162 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGCAAGGUCGGGAUCCAC GGAGUCCCGGCAGCAGGAUCCUCAGGCUCACUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAAGAGCUUCUC GACCUCCGGGAACCUGACCGAGCACCAGCGCACCCACACCGGAGAGAAACCGUACAAGUGCCCCGAAUGCGGGAAAUCGUUCU CAGACUCGGGAAACCUCAGGGUGCACCAGCGGACCCACACGGGGGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCAUUC UCCCACAAGAACGCGCUGCAGAACCACCAAAGAACCCACACCGGCGAAAAACCGUACAAGUGCCCCGAGUGCGGAAAGUCCUU CUCCCGCAACGACACCCUCACCGAACACCAACGCACCCACACCGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCU UCAGCCAGAGGGCCCACCUGGAAAGACACCAGAGAACCCACACCGGCGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCC UUCAGCCGGUCAGACAAGCUGGUCCGCCACCAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAAUC GUUCAGCGACCCCGGACACCUGGUCCGGCACCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCUCAGCGAGCG GAUCCGGAGGAGGAUCAGGGGGGGACGCACUGGACGACUUCGACCUGGACAUGCUGGGAUCCGACGCACUGGACGACUUCGAC CUAGACAUGCUCGGAUCGGACGCACUCGACGACUUCGACCUCGACAUGCUAGGAUCAGACGCACUAGACGACUUCGACCUCGA CAUGCUGUCGGGAGGACCGAAGAAAAAGCGGAAGGUCGGAUCACAGUACCUCCCGGACACCGACGACAGGCACAGAAUCGAAG AAAAACGCAAGCGCACCUACGAAACCUUCAAGAGCAUCAUGAAAAAGUCGCCGUUCUCAGGACCGACCGACCCCAGACCGCCA CCGAGGAGAAUAGCCGUCCCGAGCCGAUCCUCCGCAUCCGUGCCGAAACCGGCACCGCAACCCUACCCGUUCACCUCGUCCCU GUCGACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCUCCGGGCAGAUCUCACAGGCCUCGGCACUGGCACCCGCAC CACCGCAAGUGCUGCCCCAAGCACCGGCACCCGCACCGGCGCCCGCAAUGGUGUCAGCGCUGGCACAGGCACCAGCACCGGUG CCAGUCCUCGCACCGGGACCGCCGCAAGCAGUGGCACCGCCGGCACCGAAACCGACCCAGGCCGGAGAAGGGACCCUGUCCGA GGCGCUGCUGCAACUCCAGUUCGACGACGAGGACCUGGGAGCACUCCUGGGAAACUCCACCGACCCGGCAGUGUUCACCGACC UCGCAUCGGUGGACAACUCCGAGUUCCAACAGCUCCUGAACCAGGGGAUACCGGUGGCACCGCACACCACCGAACCGAUGCUG AUGGAAUACCCGGAAGCCAUCACCCGGCUCGUGACCGGAGCGCAAAGACCGCCCGACCCCGCGCCCGCACCGCUGGGAGCACC GGGACUACCGAACGGGCUGCUCUCAGGGGACGAGGACUUCUCCAGCAUCGCAGACAUGGACUUCUCCGCCCUGCUGGGAUCAG GAUCCGGAUCACGCGACUCCCGGGAAGGAAUGUUCCUGCCGAAGCCGGAAGCAGGCAGCGCAAUCUCCGACGUGUUCGAAGGC CGCGAGGUCUGCCAGCCCAAGCGCCUGCGACCGUUCCACCCGCCGGGAUCACCGUGGGCAAACCGCCCGCUACCGGCAUCACU GGCACCGACACCCACCGGACCGGUGCACGAACCGGUCGGGUCACUGACCCCCGCACCGGUCCCGCAACCGCUAGACCCGGCAC CGGCAGUGACCCCGGAAGCAUCGCACCUCCUGGAGGACCCGGACGAGGAAACCUCACAGGCAGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUACCGCAGAAGGAGGAGGCCGCCAUCUGCGGACAAAUGGACCUGUCACACCCGCCCCCGAGAGGACACCU GGACGAACUCACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACUCACCGCUGACCCCGGAGCUGAACGAAAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCAAUGCACAUCAGCACCGGGCUGUCGAUCUUCGACACCAGCCUGUUC UCCGGAGGGAAAAGACCCGCCGCCACCAAGAAAGCGGGCCAAGCAAAGAAAAAGAAGGGAUCGUACCCCUACGACGUGCCGGA CUACGCAUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5.3 mRNA SEQ ID NO.: 228 CUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAAGAGCUUCUCGACCUCCGGGAACCUGACCGAGCACCAGCG CACCCACACCGGAGAGAAACCGUACAAGUGCCCCGAAUGCGGGAAAUCGUUCUCAGACUCGGGAAACCUCAGGGUGCACCAGC GGACCCACACGGGGGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCAUUCUCCCACAAGAACGCGCUGCAGAACCACCAA AGAACCCACACCGGCGAAAAACCGUACAAGUGCCCCGAGUGCGGAAAGUCCUUCUCCCGCAACGACACCCUCACCGAACACCA ACGCACCCACACCGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUCAGCCAGAGGGCCCACCUGGAAAGACACC AGAGAACCCACACCGGCGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCCUUCAGCCGGUCAGACAAGCUGGUCCGCCAC CAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAAUCGUUCAGCGACCCCGGACACCUGGUCCGGCA CCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCUCA >ZF5.4-VPR mRNA (ZF5-VPR ATUM Opt_4) SEQ ID NO.: 163 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCGAAGAAAAAGAGGAAGGUCGGGAUCCAC GGAGUCCCAGCCGCAGGAAGCAGCGGAAGCCUGGAACCCGGAGAAAAACCCUACAAGUGCCCAGAAUGCGGCAAGAGCUUCAG CACCAGCGGAAACCUGACCGAACACCAGCGGACGCACACAGGGGAGAAACCGUACAAAUGCCCGGAGUGCGGAAAGAGCUUCA GCGACAGCGGCAACCUCCGCGUGCACCAGAGAACCCACACGGGAGAGAAGCCGUACAAGUGCCCGGAAUGCGGAAAAAGCUUC AGCCACAAGAACGCGCUGCAGAACCACCAGAGGACACACACGGGCGAGAAGCCCUACAAAUGCCCCGAAUGCGGGAAAAGCUU CAGCCGGAACGACACCCUCACCGAGCACCAGCGAACCCACACCGGAGAAAAGCCGUACAAGUGCCCGGAAUGCGGAAAAAGCU UCAGCCAACGGGCCCACCUGGAACGCCACCAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCAGAGUGCGGCAAAAGC UUCAGCCGGAGCGACAAGCUGGUCCGGCACCAGCGCACACACACCGGCGAAAAGCCAUACAAGUGCCCCGAGUGCGGAAAGAG CUUCAGCGACCCAGGACACCUCGUGCGGCACCAACGCACGCACACCGGGGAAAAACCGACCGGAAAAAAGACCAGCGCGAGCG GAAGCGGAGGAGGAAGCGGAGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGGAGCGACGCACUGGACGACUUCGAC CUGGACAUGCUGGGAAGCGACGCGCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUCGACGACUUCGACCUCGA CAUGCUGAGCGGCGGACCCAAGAAGAAGAGAAAGGUCGGAAGCCAGUACCUCCCGGACACCGACGACAGGCACCGCAUCGAAG AGAAGCGGAAAAGAACCUACGAAACCUUCAAGAGCAUCAUGAAAAAGAGCCCGUUCAGCGGACCAACCGACCCCAGACCACCA CCGAGAAGAAUCGCGGUCCCAAGCAGGAGCAGCGCCAGCGUCCCGAAGCCAGCCCCACAGCCGUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCGAGCGGCCAGAUAAGCCAGGCCAGCGCACUGGCACCAGCCC CACCGCAAGUGCUGCCCCAAGCACCCGCACCAGCACCCGCCCCCGCGAUGGUCAGCGCCCUGGCACAAGCCCCAGCCCCAGUC CCGGUGCUCGCACCAGGACCACCCCAAGCAGUCGCACCGCCAGCCCCAAAGCCGACCCAAGCCGGAGAAGGCACCCUCAGCGA GGCGCUCCUGCAACUCCAAUUCGACGACGAGGACCUGGGAGCCCUGCUGGGCAACAGCACCGACCCGGCAGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAAUUCCAGCAGCUCCUGAACCAAGGAAUCCCAGUCGCGCCACACACCACCGAGCCGAUGCUG AUGGAAUACCCAGAAGCGAUCACGAGACUGGUCACCGGGGCCCAAAGACCGCCGGACCCAGCGCCAGCACCACUGGGAGCCCC AGGACUGCCCAACGGACUGCUCAGCGGCGACGAGGACUUCAGCAGCAUCGCGGACAUGGACUUCAGCGCACUCCUCGGAAGCG GAAGCGGCAGCAGAGACAGCCGGGAAGGAAUGUUCCUCCCCAAGCCAGAAGCCGGAAGCGCAAUCAGCGACGUGUUCGAAGGA CGGGAAGUCUGCCAGCCGAAGCGCCUCAGACCGUUCCACCCACCGGGAAGCCCAUGGGCCAACAGACCGCUGCCAGCCAGCCU GGCACCGACCCCAACCGGACCAGUCCACGAACCAGUCGGCAGCCUGACACCAGCACCAGUGCCCCAGCCACUGGACCCAGCAC CGGCAGUGACCCCAGAAGCCAGCCACCUCCUGGAGGACCCCGACGAAGAAACCAGCCAGGCCGUGAAGGCCCUGAGGGAGAUG GCCGACACGGUGAUCCCACAGAAGGAAGAAGCAGCGAUCUGCGGCCAAAUGGACCUCAGCCACCCACCGCCAAGAGGCCACCU GGACGAGCUCACCACCACCCUGGAAAGCAUGACCGAGGACCUCAACCUCGACAGCCCCCUGACACCGGAGCUCAACGAGAUCC UGGACACCUUCCUCAACGACGAAUGCCUGCUCCACGCCAUGCACAUCAGCACCGGACUGAGCAUCUUCGACACCAGCCUGUUC AGCGGGGGAAAACGACCGGCAGCCACCAAAAAGGCCGGACAGGCGAAGAAGAAGAAGGGGAGCUACCCGUACGACGUGCCCGA CUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5.4 mRNA sequence SEQ ID NO.: 229 CUGGAACCCGGAGAAAAACCCUACAAGUGCCCAGAAUGCGGCAAGAGCUUCAGCACCAGCGGAAACCUGACCGAACACCAGCG GACGCACACAGGGGAGAAACCGUACAAAUGCCCGGAGUGCGGAAAGAGCUUCAGCGACAGCGGCAACCUCCGCGUGCACCAGA GAACCCACACGGGAGAGAAGCCGUACAAGUGCCCGGAAUGCGGAAAAAGCUUCAGCCACAAGAACGCGCUGCAGAACCACCAG AGGACACACACGGGCGAGAAGCCCUACAAAUGCCCCGAAUGCGGGAAAAGCUUCAGCCGGAACGACACCCUCACCGAGCACCA GCGAACCCACACCGGAGAAAAGCCGUACAAGUGCCCGGAAUGCGGAAAAAGCUUCAGCCAACGGGCCCACCUGGAACGCCACC AAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAGCCGGAGCGACAAGCUGGUCCGGCAC CAGCGCACACACACCGGCGAAAAGCCAUACAAGUGCCCCGAGUGCGGAAAGAGCUUCAGCGACCCAGGACACCUCGUGCGGCA CCAACGCACGCACACCGGGGAAAAACCGACCGGAAAAAAGACCAGC >ZF5.5-VPR  (ZF5-VPR ATUM Opt_5) SEQ ID NO.: 164 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCGAAGAAGAAGCGCAAGGUCGGCAUACAC GGAGUCCCAGCCGCUGGAUCCUCCGGAUCCCUGGAACCUGGGGAGAAACCCUAUAAGUGCCCGGAGUGCGGAAAGUCAUUCUC AACUAGCGGAAACCUGACAGAGCACCAGAGGACCCAUACUGGCGAAAAGCCAUACAAAUGCCCCGAAUGCGGGAAAAGCUUCA GCGACAGCGGGAACCUGAGAGUGCACCAGCGGACUCAUACCGGGGAGAAGCCUUACAAGUGCCCCGAGUGUGGAAAGUCCUUC UCCCAUAAGAACGCGCUCCAGAACCACCAGAGAACCCACACCGGAGAAAAGCCGUACAAGUGCCCGGAAUGCGGCAAAUCCUU UUCACGGAACGACACUCUCACCGAGCACCAACGGACGCACACCGGAGAGAAGCCGUACAAGUGCCCUGAAUGCGGAAAGAGCU UUAGCCAGAGGGCCCACCUGGAACGGCAUCAGCGCACUCACACCGGGGAAAAGCCCUACAAGUGCCCAGAGUGCGGCAAGAGC UUCUCCCGGUCUGACAAGCUUGUGCGCCAUCAGCGGACCCACACUGGAGAAAAACCGUACAAGUGUCCGGAGUGUGGCAAAUC GUUCUCAGACCCGGGACACCUGGUCCGACACCAACGCACACACACCGGCGAAAAGCCGACCGGCAAAAAGACCUCGGCCUCGG GAUCUGGAGGAGGAAGCGGCGGAGAUGCCCUGGACGACUUCGACCUGGACAUGUUGGGCAGCGACGCACUGGAUGACUUCGAC CUGGAUAUGCUGGGAUCCGACGCCCUCGACGAUUUCGACCUCGAUAUGCUUGGCUCCGAUGCGCUCGAUGAUUUCGAUUUGGA CAUGCUGUCCGGCGGACCUAAGAAGAAGAGAAAGGUCGGCAGCCAAUACCUCCCGGACACUGAUGACCGGCACCGGAUCGAAG AGAAGCGGAAGCGCACUUACGAGACUUUCAAGUCGAUCAUGAAGAAGUCACCCUUCUCGGGACCUACUGAUCCUCGGCCGCCA CCUAGACGGAUCGCGGUGCCAUCCAGGUCAUCCGCUUCCGUCCCCAAGCCUGCGCCUCAACCGUACCCUUUCACUUCCUCCCU GUCGACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCUCCGGACAGAUUUCCCAAGCCUCGGCGCUAGCACCAGCCC CUCCACAAGUGCUUCCGCAAGCUCCAGCUCCGGCACCAGCACCAGCCAUGGUGUCCGCUCUGGCCCAAGCUCCUGCUCCGGUG CCUGUGCUGGCUCCUGGACCGCCUCAGGCAGUGGCACCACCCGCACCAAAGCCGACCCAAGCGGGAGAGGGAACUCUGUCCGA AGCGCUGCUGCAGCUCCAGUUCGACGACGAGGACCUGGGUGCCCUGCUCGGAAAUUCGACCGAUCCGGCCGUGUUUACCGACU UGGCCAGUGUGGACAACUCCGAGUUCCAACAGCUGCUGAACCAGGGGAUUCCAGUGGCCCCCCACACUACUGAACCGAUGCUG AUGGAAUACCCCGAGGCCAUUACCAGACUGGUCACUGGAGCCCAGAGGCCUCCAGACCCUGCCCCUGCUCCACUGGGUGCCCC AGGACUGCCCAAUGGGCUUCUGUCGGGCGAUGAGGAUUUCAGCUCAAUCGCGGAUAUGGACUUCUCCGCCCUUCUGGGUUCCG GAUCCGGUUCACGGGAUUCCAGAGAGGGCAUGUUCCUACCCAAGCCCGAAGCCGGAAGCGCGAUCAGCGACGUGUUCGAGGGU CGCGAAGUCUGUCAGCCAAAGAGACUCCGGCCGUUUCAUCCACCCGGAUCACCCUGGGCCAAUCGCCCACUCCCUGCCUCAUU GGCCCCGACCCCUACUGGUCCGGUGCACGAGCCUGUCGGGUCGCUCACUCCGGCACCUGUGCCACAACCGCUGGACCCUGCAC CAGCCGUGACCCCAGAGGCGUCCCACCUCCUCGAAGAUCCCGAUGAAGAAACAAGCCAGGCCGUGAAGGCCCUGCGCGAAAUG GCCGACACCGUGAUCCCGCAGAAAGAGGAAGCCGCCAUCUGCGGUCAGAUGGACCUGAGCCAUCCCCCUCCGAGAGGACACCU GGACGAACUGACCACUACACUGGAGAGCAUGACCGAGGACCUGAACCUGGACUCCCCCCUUACCCCGGAACUGAACGAGAUUC UCGACACUUUCCUGAACGACGAGUGUCUGCUCCACGCGAUGCACAUCUCGACCGGACUGUCGAUCUUUGACACCUCGCUGUUC UCCGGUGGCAAAAGGCCUGCCGCCACCAAGAAGGCCGGACAGGCCAAGAAAAAGAAGGGCUCCUACCCGUACGAUGUGCCCGA CUACGCUUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5.5 mRNA SEQ ID NO.: 230 CUGGAACCUGGGGAGAAACCCUAUAAGUGCCCGGAGUGCGGAAAGUCAUUCUCAACUAGCGGAAACCUGACAGAGCACCAGAG GACCCAUACUGGCGAAAAGCCAUACAAAUGCCCCGAAUGCGGGAAAAGCUUCAGCGACAGCGGGAACCUGAGAGUGCACCAGC GGACUCAUACCGGGGAGAAGCCUUACAAGUGCCCCGAGUGUGGAAAGUCCUUCUCCCAUAAGAACGCGCUCCAGAACCACCAG AGAACCCACACCGGAGAAAAGCCGUACAAGUGCCCGGAAUGCGGCAAAUCCUUUUCACGGAACGACACUCUCACCGAGCACCA ACGGACGCACACCGGAGAGAAGCCGUACAAGUGCCCUGAAUGCGGAAAGAGCUUUAGCCAGAGGGCCCACCUGGAACGGCAUC AGCGCACUCACACCGGGGAAAAGCCCUACAAGUGCCCAGAGUGCGGCAAGAGCUUCUCCCGGUCUGACAAGCUUGUGCGCCAU CAGCGGACCCACACUGGAGAAAAACCGUACAAGUGUCCGGAGUGUGGCAAAUCGUUCUCAGACCCGGGACACCUGGUCCGACA CCAACGCACACACACCGGCGAAAAGCCGACCGGCAAAAAGACCUCG >ZF5.6-VPR mRNA (ZF5-VPR ATUM Opt_6) SEQ ID NO.: 165 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAAAAGCGCAAAGUGGGCAUCCAC GGCGUGCCAGCAGCAGGAAGCAGCGGAAGCCUGGAACCCGGGGAGAAGCCGUACAAGUGCCCAGAAUGCGGAAAGAGCUUCAG CACCAGCGGCAACCUCACCGAGCACCAGAGAACCCACACCGGGGAGAAACCGUACAAAUGCCCGGAAUGCGGCAAGAGCUUCA GCGACAGCGGAAACCUGAGAGUGCACCAACGCACCCACACGGGAGAAAAACCCUACAAAUGCCCCGAGUGCGGGAAAAGCUUC AGCCACAAGAACGCGCUGCAGAACCACCAAAGAACGCACACCGGAGAAAAGCCGUACAAGUGCCCAGAAUGCGGAAAGAGCUU CAGCAGAAACGACACCCUGACCGAACACCAGCGGACGCACACAGGCGAAAAACCAUACAAGUGCCCGGAGUGCGGCAAAAGCU UCAGCCAGAGAGCGCACCUGGAAAGGCACCAGCGCACACACACCGGCGAAAAGCCAUACAAAUGCCCAGAGUGCGGAAAAAGC UUCAGCCGGAGCGACAAGCUGGUCCGCCACCAACGGACCCACACAGGGGAAAAGCCCUACAAGUGCCCCGAAUGCGGCAAGAG CUUCAGCGACCCGGGACACCUCGUGCGGCACCAGAGGACCCACACCGGAGAAAAGCCGACCGGGAAAAAGACCAGCGCAAGCG GGAGCGGAGGAGGAAGCGGAGGCGACGCACUCGACGACUUCGACCUGGACAUGCUGGGGAGCGACGCACUGGACGACUUCGAC CUCGACAUGCUCGGAAGCGACGCCCUCGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCGCUGGACGACUUCGACCUCGA CAUGCUCAGCGGGGGACCAAAAAAGAAAAGGAAGGUCGGAAGCCAGUACCUCCCGGACACCGACGACAGGCACCGGAUCGAGG AAAAGCGGAAGCGCACCUACGAAACCUUCAAGAGCAUCAUGAAAAAGAGCCCCUUCAGCGGACCGACAGACCCGAGGCCACCA CCACGGAGAAUCGCCGUGCCAAGCAGGAGCAGCGCCAGCGUGCCCAAACCGGCCCCACAACCCUACCCGUUCACCAGCAGCCU CAGCACCAUCAACUACGACGAGUUCCCAACCAUGGUGUUCCCCAGCGGACAGAUCAGCCAAGCCAGCGCACUGGCACCAGCCC CCCCGCAAGUGCUGCCACAAGCGCCGGCACCAGCGCCAGCACCAGCCAUGGUCAGCGCGCUGGCACAAGCCCCCGCACCAGUG CCAGUGCUCGCACCAGGACCACCCCAGGCAGUAGCACCGCCAGCCCCGAAGCCAACCCAGGCAGGAGAAGGCACCCUCAGCGA GGCGCUGCUGCAGCUCCAGUUCGACGACGAGGACCUCGGAGCCCUGCUGGGAAACAGCACCGACCCAGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAAUUCCAGCAGCUGCUCAACCAAGGAAUCCCGGUGGCCCCACACACCACCGAACCCAUGCUG AUGGAGUACCCGGAGGCCAUCACCAGACUCGUGACAGGAGCCCAGAGGCCACCAGACCCAGCCCCAGCACCACUGGGAGCCCC AGGACUCCCCAACGGACUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCACUCCUCGGGAGCG GAAGCGGAAGCAGAGACAGCAGGGAAGGAAUGUUCCUGCCCAAGCCGGAAGCGGGAAGCGCAAUCAGCGACGUGUUCGAAGGA AGAGAAGUCUGCCAGCCCAAGAGGCUGCGCCCGUUCCACCCACCAGGAAGCCCGUGGGCCAACAGACCACUGCCAGCAAGCCU CGCCCCGACACCAACCGGACCGGUGCACGAACCCGUGGGCAGCCUGACCCCAGCACCGGUCCCACAGCCACUGGACCCAGCAC CCGCAGUGACCCCAGAAGCCAGCCACCUCCUGGAGGACCCGGACGAAGAAACCAGCCAGGCCGUCAAGGCCCUGCGCGAGAUG GCCGACACCGUCAUCCCCCAAAAGGAAGAGGCGGCCAUCUGCGGACAGAUGGACCUGAGCCACCCACCGCCAAGAGGCCACCU CGACGAGCUGACCACCACCCUGGAAAGCAUGACGGAGGACCUGAACCUCGACAGCCCGCUAACGCCCGAGCUGAACGAAAUCC UGGACACCUUCCUCAACGACGAAUGCCUGCUGCACGCCAUGCACAUCAGCACCGGACUGAGCAUCUUCGACACGAGCCUGUUC AGCGGAGGAAAACGGCCAGCCGCAACCAAGAAGGCCGGACAAGCCAAGAAGAAGAAGGGGAGCUACCCGUACGACGUGCCAGA CUACGCAUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUG UACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5.6 mRNA SEQ ID NO.: 231 CUGGAACCCGGGGAGAAGCCGUACAAGUGCCCAGAAUGCGGAAAGAGCUUCAGCACCAGCGGCAACCUCACCGAGCACCAGAG AACCCACACCGGGGAGAAACCGUACAAAUGCCCGGAAUGCGGCAAGAGCUUCAGCGACAGCGGAAACCUGAGAGUGCACCAAC GCACCCACACGGGAGAAAAACCCUACAAAUGCCCCGAGUGCGGGAAAAGCUUCAGCCACAAGAACGCGCUGCAGAACCACCAA AGAACGCACACCGGAGAAAAGCCGUACAAGUGCCCAGAAUGCGGAAAGAGCUUCAGCAGAAACGACACCCUGACCGAACACCA GCGGACGCACACAGGCGAAAAACCAUACAAGUGCCCGGAGUGCGGCAAAAGCUUCAGCCAGAGAGCGCACCUGGAAAGGCACC AGCGCACACACACCGGCGAAAAGCCAUACAAAUGCCCAGAGUGCGGAAAAAGCUUCAGCCGGAGCGACAAGCUGGUCCGCCAC CAACGGACCCACACAGGGGAAAAGCCCUACAAGUGCCCCGAAUGCGGCAAGAGCUUCAGCGACCCGGGACACCUCGUGCGGCA CCAGAGGACCCACACCGGAGAAAAGCCGACCGGGAAAAAGACCAGC >ZF5-P300 protein SEQ ID NO.: 166 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECGKSFSQLAHLRAHQRTHTGE KPYKCPECGKSFSSKKHLAEHQRTHTGEKPYKCPECGKSFSTTGALTEHQRTHTGEKPYKCPECGKSFSTSGNLVRHQRTHTG EKPYKCPECGKSFSQSGDLRRHQRTHTGEKPYKCPECGKSFSTSHSLTEHQRTHTGEKPTGKKTSASGSGGGSGGIFKPEELR QALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRV YKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQ PQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLEN RVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPP PNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKM LDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNN KKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARD KHLEFSSLRRAQWSTMCMLVELHTQSQDSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF5-P300  mRNA SEQ ID NO.: 167 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUCGAACCGGGCGAAAAGCCGUAUAAGUGCCCGGAAUGCGGCAAGAGUUUUAG CCAGCGCGCCCAUCUGGAACGUCACCAGCGUACCCAUACCGGUGAAAAGCCAUAUAAAUGCCCAGAAUGUGGUAAAAGCUUUA GUCAGCUGGCCCAUCUGCGCGCCCACCAACGUACGCACACGGGCGAGAAGCCGUACAAAUGCCCAGAAUGCGGUAAAAGCUUC AGCAGCAAAAAGCAUCUGGCGGAACAUCAACGUACCCACACCGGCGAGAAACCAUACAAGUGCCCGGAAUGCGGUAAAAGCUU CAGCACCACCGGUGCGCUGACGGAGCAUCAGCGCACCCACACGGGCGAAAAACCGUAUAAGUGUCCGGAGUGUGGCAAAAGUU UUAGUACCAGCGGCAAUCUGGUGCGCCAUCAACGUACGCAUACCGGCGAGAAGCCAUAUAAAUGUCCAGAGUGUGGCAAGAGC UUUAGCCAAAGCGGUGAUCUGCGUCGCCACCAACGCACGCACACCGGCGAAAAACCAUACAAAUGUCCGGAAUGCGGUAAGAG UUUCAGCACGAGCCAUAGUCUGACCGAACAUCAACGUACCCAUACGGGUGAGAAACCAACCGGCAAGAAAACCAGCGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCAUCUUCAAGCCCGAGGAGCUGCGGCAGGCCCUGAUGCCCACCCUGGAGGCCCUGUACCGG CAGGACCCCGAGAGCCUGCCCUUCCGGCAGCCCGUGGACCCCCAGCUGCUGGGCAUCCCCGACUACUUCGACAUCGUGAAAUC CCCCAUGGACCUGAGCACCAUCAAGCGGAAGCUGGACACCGGCCAGUACCAGGAGCCCUGGCAGUACGUGGACGACAUCUGGC UGAUGUUCAACAACGCCUGGCUGUACAACCGGAAAACCAGCCGGGUGUACAAGUACUGCAGCAAGCUGAGCGAGGUGUUCGAG CAGGAGAUCGACCCCGUGAUGCAGAGCCUGGGCUACUGCUGCGGCCGGAAGCUGGAGUUCAGCCCCCAGACCCUGUGCUGCUA CGGCAAGCAGCUGUGCACCAUCCCCCGGGACGCCACCUACUACAGCUACCAGAACCGGUACCACUUCUGCGAGAAGUGCUUCA ACGAGAUCCAGGGCGAGAGCGUGAGCCUGGGCGACGACCCCAGCCAGCCCCAGACCACCAUCAACAAGGAGCAGUUCAGCAAG CGGAAGAACGACACCCUGGACCCCGAGCUGUUCGUGGAGUGCACCGAGUGCGGCCGGAAGAUGCACCAGAUCUGCGUGCUGCA CCACGAGAUCAUCUGGCCCGCCGGCUUCGUGUGCGACGGCUGCCUGAAGAAAUCCGCCCGGACCCGGAAGGAGAACAAGUUCA GCGCCAAGCGGCUGCCCAGCACCCGGCUGGGCACCUUCCUGGAGAACCGGGUGAACGACUUCCUGCGGCGGCAGAACCACCCC GAGAGCGGCGAGGUGACCGUGCGGGUGGUGCACGCCAGCGACAAGACCGUGGAGGUGAAGCCCGGCAUGAAGGCCCGGUUCGU GGACAGCGGCGAGAUGGCCGAGAGCUUCCCCUACCGGACCAAGGCCCUGUUCGCCUUCGAGGAGAUCGACGGCGUGGACCUGU GCUUCUUCGGCAUGCACGUGCAGGAGUACGGCAGCGACUGCCCCCCCCCCAACCAGCGGCGGGUGUACAUCAGCUACCUGGAC AGCGUGCACUUCUUCCGGCCCAAGUGCCUGCGGACCGCCGUGUACCACGAGAUCCUGAUCGGCUACCUGGAGUACGUGAAGAA GCUGGGCUACACCACCGGCCACAUCUGGGCCUGCCCCCCCAGCGAGGGCGACGACUACAUCUUCCACUGCCACCCCCCCGACC AGAAGAUCCCCAAGCCCAAGCGGCUGCAGGAGUGGUACAAGAAGAUGCUGGACAAGGCCGUGAGCGAGCGGAUCGUGCACGAC UACAAGGACAUCUUCAAGCAGGCCACCGAGGACCGGCUGACCAGCGCCAAGGAGCUGCCCUACUUCGAGGGCGACUUCUGGCC CAACGUGCUGGAGGAGAGCAUCAAGGAGCUGGAGCAGGAGGAGGAGGAGCGGAAGCGGGAGGAGAACACCAGCAACGAGAGCA CCGACGUGACCAAGGGCGACAGCAAGAACGCCAAGAAGAAGAACAACAAGAAAACCAGCAAGAACAAGAGCAGCCUGAGCCGG GGCAACAAGAAGAAGCCCGGCAUGCCCAACGUGAGCAACGACCUGAGCCAGAAGCUGUACGCCACCAUGGAGAAGCACAAGGA GGUGUUCUUCGUGAUCCGGCUGAUCGCCGGCCCCGCCGCCAACAGCCUGCCCCCCAUCGUGGACCCCGACCCCCUGAUCCCCU GCGACCUGAUGGACGGCCGGGACGCCUUCCUGACCCUGGCCCGGGACAAGCACCUGGAGUUCAGCAGCCUGCGGCGGGCCCAG UGGAGCACCAUGUGCAUGCUGGUGGAGCUGCACACCCAGAGCCAGGACAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGC CGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGACUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUC UGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAA GUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAA >Nucleotide Seqeunce of DNA binding domain of ZF5-P300 SEQ ID NO.: 232 CUCGAACCGGGCGAAAAGCCGUAUAAGUGCCCGGAAUGCGGCAAGAGUUUUAGCCAGCGCGCCCAUCUGGAACGUCACCAGCG UACCCAUACCGGUGAAAAGCCAUAUAAAUGCCCAGAAUGUGGUAAAAGCUUUAGUCAGCUGGCCCAUCUGCGCGCCCACCAAC GUACGCACACGGGCGAGAAGCCGUACAAAUGCCCAGAAUGCGGUAAAAGCUUCAGCAGCAAAAAGCAUCUGGCGGAACAUCAA CGUACCCACACCGGCGAGAAACCAUACAAGUGCCCGGAAUGCGGUAAAAGCUUCAGCACCACCGGUGCGCUGACGGAGCAUCA GCGCACCCACACGGGCGAAAAACCGUAUAAGUGUCCGGAGUGUGGCAAAAGUUUUAGUACCAGCGGCAAUCUGGUGCGCCAUC AACGUACGCAUACCGGCGAGAAGCCAUAUAAAUGUCCAGAGUGUGGCAAGAGCUUUAGCCAAAGCGGUGAUCUGCGUCGCCAC CAACGCACGCACACCGGCGAAAAACCAUACAAAUGUCCGGAAUGCGGUAAGAGUUUCAGCACGAGCCAUAGUCUGACCGAACA UCAACGUACCCAUACGGGUGAGAAACCAACCGGCAAGAAAACCAGC >ZF7-p300 protein SEQ ID NO.: 168 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGE KPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTG EKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGIFKPEELR QALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRV YKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQ PQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLEN RVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPP PNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKM LDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNN KKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARD KHLEFSSLRRAQWSTMCMLVELHTQSQDSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF7-p300 mRNA SEQ ID NO.: 169 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAG CCGCAGCGACCAUCUGACCAAUCACCAACGCACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUA GUACCAGUGGCAGUCUGGUUCGUCAUCAGCGCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUU AGCCAAGCCGGUCAUCUGGCGAGCCAUCAACGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUU UAGCCGUAGCGAUAAACUGACCGAACACCAACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUU UCAGCACCAGCGGCAAUCUGACCGAGCAUCAACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGU UUUAGUCAGAGCAGUAAUCUGGUGCGCCAUCAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAG UUUUAGCACCCAUCUGGAUCUGAUCCGUCAUCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGUGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCAUCUUCAAGCCCGAGGAGCUGCGGCAGGCCCUGAUGCCCACCCUGGAGGCCCUGUACCGG CAGGACCCCGAGAGCCUGCCCUUCCGGCAGCCCGUGGACCCCCAGCUGCUGGGCAUCCCCGACUACUUCGACAUCGUGAAAUC CCCCAUGGACCUGAGCACCAUCAAGCGGAAGCUGGACACCGGCCAGUACCAGGAGCCCUGGCAGUACGUGGACGACAUCUGGC UGAUGUUCAACAACGCCUGGCUGUACAACCGGAAAACCAGCCGGGUGUACAAGUACUGCAGCAAGCUGAGCGAGGUGUUCGAG CAGGAGAUCGACCCCGUGAUGCAGAGCCUGGGCUACUGCUGCGGCCGGAAGCUGGAGUUCAGCCCCCAGACCCUGUGCUGCUA CGGCAAGCAGCUGUGCACCAUCCCCCGGGACGCCACCUACUACAGCUACCAGAACCGGUACCACUUCUGCGAGAAGUGCUUCA ACGAGAUCCAGGGCGAGAGCGUGAGCCUGGGCGACGACCCCAGCCAGCCCCAGACCACCAUCAACAAGGAGCAGUUCAGCAAG CGGAAGAACGACACCCUGGACCCCGAGCUGUUCGUGGAGUGCACCGAGUGCGGCCGGAAGAUGCACCAGAUCUGCGUGCUGCA CCACGAGAUCAUCUGGCCCGCCGGCUUCGUGUGCGACGGCUGCCUGAAGAAAUCCGCCCGGACCCGGAAGGAGAACAAGUUCA GCGCCAAGCGGCUGCCCAGCACCCGGCUGGGCACCUUCCUGGAGAACCGGGUGAACGACUUCCUGCGGCGGCAGAACCACCCC GAGAGCGGCGAGGUGACCGUGCGGGUGGUGCACGCCAGCGACAAGACCGUGGAGGUGAAGCCCGGCAUGAAGGCCCGGUUCGU GGACAGCGGCGAGAUGGCCGAGAGCUUCCCCUACCGGACCAAGGCCCUGUUCGCCUUCGAGGAGAUCGACGGCGUGGACCUGU GCUUCUUCGGCAUGCACGUGCAGGAGUACGGCAGCGACUGCCCCCCCCCCAACCAGCGGCGGGUGUACAUCAGCUACCUGGAC AGCGUGCACUUCUUCCGGCCCAAGUGCCUGCGGACCGCCGUGUACCACGAGAUCCUGAUCGGCUACCUGGAGUACGUGAAGAA GCUGGGCUACACCACCGGCCACAUCUGGGCCUGCCCCCCCAGCGAGGGCGACGACUACAUCUUCCACUGCCACCCCCCCGACC AGAAGAUCCCCAAGCCCAAGCGGCUGCAGGAGUGGUACAAGAAGAUGCUGGACAAGGCCGUGAGCGAGCGGAUCGUGCACGAC UACAAGGACAUCUUCAAGCAGGCCACCGAGGACCGGCUGACCAGCGCCAAGGAGCUGCCCUACUUCGAGGGCGACUUCUGGCC CAACGUGCUGGAGGAGAGCAUCAAGGAGCUGGAGCAGGAGGAGGAGGAGCGGAAGCGGGAGGAGAACACCAGCAACGAGAGCA CCGACGUGACCAAGGGCGACAGCAAGAACGCCAAGAAGAAGAACAACAAGAAAACCAGCAAGAACAAGAGCAGCCUGAGCCGG GGCAACAAGAAGAAGCCCGGCAUGCCCAACGUGAGCAACGACCUGAGCCAGAAGCUGUACGCCACCAUGGAGAAGCACAAGGA GGUGUUCUUCGUGAUCCGGCUGAUCGCCGGCCCCGCCGCCAACAGCCUGCCCCCCAUCGUGGACCCCGACCCCCUGAUCCCCU GCGACCUGAUGGACGGCCGGGACGCCUUCCUGACCCUGGCCCGGGACAAGCACCUGGAGUUCAGCAGCCUGCGGCGGGCCCAG UGGAGCACCAUGUGCAUGCUGGUGGAGCUGCACACCCAGAGCCAGGACAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGC CGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGACUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUC UGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAA GUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAA >Nucleotide Seqeunce of DNA binding domain of ZF7-P300 SEQ ID NO.: 233 CUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAGCCGCAGCGACCAUCUGACCAAUCACCAACG CACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUAGUACCAGUGGCAGUCUGGUUCGUCAUCAGC GCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUUAGCCAAGCCGGUCAUCUGGCGAGCCAUCAA CGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUUUAGCCGUAGCGAUAAACUGACCGAACACCA ACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUUUCAGCACCAGCGGCAAUCUGACCGAGCAUC AACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGUUUUAGUCAGAGCAGUAAUCUGGUGCGCCAU CAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAGUUUUAGCACCCAUCUGGAUCUGAUCCGUCA UCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGU >ZF5.3-VPR3 protein SEQ ID NO.: 170 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGE KPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTG EKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSGSGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGP TDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALA QAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIPVAPH TTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAI SDVFEGREVCQPKRIRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAV KALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTGLSI FDTSLFGSGSGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSGSGSQYLPDTDDRHRIEEK RKRTYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPP QVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLA SVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGS GSRDSREGMFLPKPEAGSAISDVFEGREVCQPKRIRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPA VTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILD TFLNDECLLHAMHISTGLSIFDTSLFGSGSGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLG SGSGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFP TMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDD EDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSG DEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPKRIRPFHPPGSPWANRPLPASLAPTPTGPVH EPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLES MTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTGLSIFDTSLFGSGSGSGGGGSGKRPAATKKAGQAKKKKGSYPYDVPD YA* >ZF5.3-VPR3 mRNA SEQ ID NO.: 171 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGCAAGGUCGGGAUCCAC GGAGUCCCGGCAGCAGGAUCCUCAGGCUCACUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAAGAGCUUCUC GCGGUCCGACCACCUGACCAACCACCAGAGAACACACACCGGCGAGAAGCCGUACAAGUGCCCCGAGUGCGGGAAGUCGUUCA GCACCUCAGGAUCGCUGGUCCGCCACCAACGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUC AGCCAAGCCGGGCACCUGGCAUCACACCAGCGAACCCACACCGGAGAAAAACCGUACAAAUGCCCGGAGUGCGGCAAAUCCUU CUCGCGCUCCGACAAGCUGACCGAACACCAAAGGACACACACCGGAGAGAAGCCCUACAAGUGCCCGGAAUGCGGAAAAUCGU UCUCGACCUCGGGGAACCUGACCGAGCACCAACGCACCCACACCGGCGAAAAACCGUACAAAUGCCCGGAGUGCGGAAAGUCG UUCUCACAAUCCUCCAACCUGGUCCGGCACCAAAGAACGCACACAGGGGAAAAGCCGUACAAGUGCCCCGAAUGCGGGAAAUC CUUCAGCACCCACCUGGACCUCAUCCGGCACCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCUCAGCGAGCG GAUCCGGAGGAGGAUCAGGGGGGGACGCCCUCGACGACUUCGAUCUGGACAUGCUGGGUAGCGACGCCCUGGAUGACUUCGAC CUCGAUAUGCUGGGAUCCGACGCACUUGACGAUUUUGACUUGGACAUGCUCGGCUCCGACGCUCUGGACGAUUUCGACCUUGA CAUGCUUGGCUCCGGCUCAGGAUCCCAGUACCUCCCCGAUACCGACGACAGACACCGGAUCGAAGAAAAGCGCAAGCGCACCU ACGAAACCUUCAAGUCGAUUAUGAAGAAGUCGCCUUUCUCCGGGCCGACUGAUCCUAGACCUCCACCAAGAAGAAUCGCGGUG CCGUCCAGAUCGUCCGCGUCAGUGCCGAAACCAGCACCGCAGCCGUAUCCGUUCACUUCCUCCCUUUCCACCAUUAACUACGA CGAAUUCCCCACGAUGGUGUUCCCUAGCGGACAGAUUUCGCAAGCCAGCGCUCUUGCUCCUGCGCCUCCUCAAGUGCUGCCUC AGGCCCCUGCUCCUGCUCCUGCACCCGCCAUGGUGUCCGCCCUGGCUCAAGCUCCAGCCCCUGUGCCUGUCCUGGCCCCUGGA CCACCUCAGGCAGUAGCACCUCCCGCUCCCAAGCCCACCCAAGCGGGAGAGGGCACUCUUUCCGAGGCCCUGCUGCAACUGCA GUUCGACGACGAGGACCUGGGGGCACUUCUGGGAAAUAGCACCGAUCCGGCCGUGUUCACCGACCUGGCCAGCGUCGACAACU CAGAGUUCCAGCAGCUCCUCAACCAAGGGAUUCCGGUGGCCCCUCACACGACCGAGCCGAUGUUGAUGGAAUACCCGGAAGCC AUCACCCGCCUAGUGACCGGAGCGCAAAGACCGCCUGACCCAGCUCCUGCCCCUUUGGGAGCCCCUGGAUUGCCCAACGGACU CCUGUCCGGCGACGAGGAUUUCUCGUCCAUCGCCGAUAUGGACUUCUCGGCCCUGUUGGGUAGCGGUUCGGGUAGUCGCGAUA GCCGGGAAGGAAUGUUCCUGCCGAAGCCUGAGGCCGGGUCUGCCAUUAGCGAUGUGUUUGAAGGACGGGAAGUCUGUCAGCCC AAGCGGAUUCGCCCAUUCCACCCCCCUGGAUCGCCUUGGGCCAACAGGCCACUCCCCGCUUCGCUUGCGCCGACUCCUACCGG GCCAGUGCACGAACCUGUGGGAUCCCUGACUCCGGCUCCUGUGCCACAGCCUCUGGAUCCGGCUCCCGCUGUCACCCCUGAGG CCUCACACCUUCUCGAGGACCCCGACGAAGAGACUUCCCAGGCCGUGAAAGCGCUCCGGGAGAUGGCGGACACUGUGAUCCCG CAAAAGGAAGAAGCCGCGAUUUGCGGCCAGAUGGACCUGUCGCAUCCUCCACCACGCGGUCACCUCGAUGAACUGACAACUAC CCUGGAGUCGAUGACCGAGGACCUGAACCUGGACUCCCCGCUGACUCCUGAGCUCAACGAAAUCCUGGACACUUUCCUGAACG AUGAGUGCCUGCUGCACGCCAUGCACAUCUCCACUGGGCUGUCAAUCUUCGACACCAGCCUGUUCGGCUCCGGAUCCGGUUCC GACGCACUGGACGAUUUUGACCUGGAUAUGUUGGGGAGCGACGCACUGGACGAUUUUGAUCUGGAUAUGCUGGGAUCCGACGC GCUCGACGAUUUCGACCUGGACAUGCUCGGAUCGGACGCCCUGGACGACUUCGACCUCGAUAUGCUUGGAUCAGGGUCCGGCU CACAAUAUCUGCCGGACACUGAUGACCGGCAUAGAAUCGAAGAAAAGCGCAAGCGGACCUACGAAACUUUCAAGAGCAUCAUG AAGAAAUCGCCGUUCUCUGGGCCGACUGAUCCUAGGCCGCCUCCGAGAAGGAUCGCCGUGCCCUCAAGAUCCUCCGCCUCUGU GCCCAAGCCGGCUCCACAGCCUUACCCCUUCACUUCGUCGCUGAGCACCAUCAACUACGACGAAUUCCCGACCAUGGUCUUUC CGAGCGGCCAGAUUUCCCAGGCGUCCGCCUUGGCUCCUGCACCACCCCAAGUGCUGCCUCAGGCGCCUGCACCAGCUCCAGCC CCUGCCAUGGUGUCCGCGCUGGCACAAGCCCCUGCACCUGUGCCAGUGCUCGCACCUGGUCCUCCGCAAGCUGUGGCACCUCC UGCGCCUAAGCCGACUCAGGCCGGAGAAGGGACCCUGUCAGAGGCCCUGCUGCAACUGCAGUUUGACGAUGAGGAUCUGGGAG CCCUUCUGGGCAACUCGACUGACCCCGCCGUGUUCACCGACCUGGCGUCCGUGGAUAACUCCGAGUUCCAGCAGCUCCUCAAC CAAGGGAUUCCUGUCGCCCCGCACACUACCGAGCCGAUGCUGAUGGAGUACCCGGAGGCCAUCACCCGGCUUGUGACGGGUGC UCAGAGGCCUCCAGAUCCGGCUCCAGCACCGUUAGGAGCCCCCGGACUUCCUAACGGACUGCUGUCCGGCGACGAGGACUUCU CCAGCAUCGCCGACAUGGAUUUUUCCGCGCUGUUGGGAUCGGGUUCCGGCUCAAGAGACAGCCGCGAGGGAAUGUUCCUCCCG AAACCAGAGGCCGGCUCAGCCAUCAGCGACGUGUUCGAAGGGCGCGAAGUCUGCCAGCCCAAGCGGAUCCGCCCGUUUCAUCC GCCUGGAUCACCGUGGGCCAACAGACCCCUACCCGCAAGCUUAGCCCCUACCCCCACUGGCCCUGUCCACGAACCUGUGGGCU CCCUGACACCCGCUCCUGUGCCACAACCUCUGGACCCCGCACCAGCAGUCACACCCGAAGCCAGCCACCUCCUUGAGGAUCCG GACGAGGAGACUAGCCAGGCCGUGAAGGCGCUCCGCGAAAUGGCCGACACUGUGAUCCCUCAAAAGGAAGAGGCGGCCAUUUG UGGACAGAUGGACUUGUCCCACCCGCCUCCAAGAGGUCACCUGGACGAACUUACCACCACGCUCGAAUCCAUGACUGAGGAUC UGAACCUGGAUUCCCCGCUCACUCCCGAGCUCAACGAAAUCCUUGAUACCUUCCUUAACGACGAGUGUCUCCUGCAUGCCAUG CACAUCUCCACCGGACUGAGCAUUUUCGACACCUCGCUGUUCGGUUCCGGAAGCGGCUCAGACGCGCUGGAUGACUUCGAUUU GGACAUGCUUGGCAGCGAUGCCCUGGAUGAUUUCGACCUGGACAUGCUCGGGUCGGAUGCGCUGGACGACUUCGAUCUCGAUA UGUUGGGCUCCGAUGCCCUCGACGACUUUGACCUCGACAUGCUGGGCUCGGGCUCAGGAUCCCAAUACCUCCCGGAUACCGAC GACAGGCAUCGCAUUGAGGAAAAGCGGAAGCGCACCUAUGAAACCUUCAAGUCCAUUAUGAAGAAGUCGCCCUUUUCCGGACC GACUGACCCUCGGCCUCCUCCUCGACGAAUUGCCGUCCCAUCUCGGUCAUCCGCCUCGGUCCCCAAGCCAGCACCGCAGCCUU AUCCGUUCACCUCCUCUCUGUCCACCAUUAACUACGAUGAAUUCCCCACCAUGGUGUUCCCGUCGGGACAGAUCUCCCAAGCC UCAGCCCUUGCUCCUGCCCCUCCACAAGUCCUGCCCCAAGCACCAGCGCCUGCUCCUGCACCCGCGAUGGUGUCCGCACUGGC GCAAGCUCCUGCCCCUGUGCCUGUGCUGGCUCCUGGACCACCCCAGGCAGUAGCACCUCCAGCCCCGAAGCCCACUCAGGCUG GAGAGGGAACCCUGAGCGAAGCGCUGCUGCAGCUCCAGUUCGACGACGAAGAUCUGGGUGCCCUGCUGGGAAAUUCCACCGAU CCGGCGGUGUUCACAGACCUGGCCUCCGUGGACAACUCCGAAUUCCAGCAGUUGUUGAACCAGGGCAUUCCUGUGGCCCCCCA CACCACUGAGCCAAUGCUCAUGGAAUACCCCGAGGCCAUUACCAGACUCGUGACCGGAGCCCAAAGGCCUCCGGAUCCAGCGC CAGCUCCGUUGGGAGCUCCGGGAUUGCCGAACGGGCUGCUGUCGGGAGAUGAAGAUUUCUCCUCAAUCGCCGAUAUGGACUUC UCCGCGCUGCUGGGUUCGGGUUCGGGAUCGCGCGAUAGCCGGGAGGGCAUGUUCCUACCGAAGCCUGAGGCCGGAAGCGCCAU CUCCGAUGUGUUCGAGGGCAGAGAAGUCUGUCAGCCUAAGCGCAUUCGCCCGUUCCACCCUCCUGGAUCGCCCUGGGCCAAUC GGCCACUGCCUGCGUCCCUCGCUCCAACGCCGACCGGACCUGUGCACGAACCGGUCGGCUCACUGACUCCAGCUCCCGUCCCA CAACCGCUCGACCCUGCUCCCGCUGUUACCCCCGAAGCCUCCCAUUUGCUGGAAGAUCCCGAUGAGGAAACUUCCCAGGCCGU CAAGGCCCUGCGGGAGAUGGCAGACACCGUGAUACCCCAGAAGGAAGAAGCUGCCAUCUGCGGGCAGAUGGACCUGUCCCAUC CUCCUCCACGCGGACACUUGGACGAGCUGACCACUACUCUGGAGUCCAUGACCGAGGACCUGAACCUUGACUCGCCUUUGACC CCUGAACUGAACGAAAUUCUGGACACCUUCCUGAAUGACGAGUGCCUCCUGCACGCGAUGCACAUCAGCACCGGACUGUCCAU CUUCGACACUUCCCUCUUUGGGAGCGGGUCCGGAUCAGGCGGUGGUGGUAGCGGGAAACGGCCAGCAGCGACCAAGAAGGCCG GACAGGCCAAGAAGAAGAAAGGCUCAUACCCCUACGACGUGCCGGACUACGCAUGAGCGGCCGCUUAAUUAAGCUGCCUUCUG CGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGU CUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >Nucleotide Seqeunce of DNA binding domain of ZF5.3-VPR3 SEQ ID NO.: 234 CUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAAGAGCUUCUCGCGGUCCGACCACCUGACCAACCACCAGAG AACACACACCGGCGAGAAGCCGUACAAGUGCCCCGAGUGCGGGAAGUCGUUCAGCACCUCAGGAUCGCUGGUCCGCCACCAAC GGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUCAGCCAAGCCGGGCACCUGGCAUCACACCAG CGAACCCACACCGGAGAAAAACCGUACAAAUGCCCGGAGUGCGGCAAAUCCUUCUCGCGCUCCGACAAGCUGACCGAACACCA AAGGACACACACCGGAGAGAAGCCCUACAAGUGCCCGGAAUGCGGAAAAUCGUUCUCGACCUCGGGGAACCUGACCGAGCACC AACGCACCCACACCGGCGAAAAACCGUACAAAUGCCCGGAGUGCGGAAAGUCGUUCUCACAAUCCUCCAACCUGGUCCGGCAC CAAAGAACGCACACAGGGGAAAAGCCGUACAAGUGCCCCGAAUGCGGGAAAUCCUUCAGCACCCACCUGGACCUCAUCCGGCA CCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCUCA >dCas9-VPR3 protein SEQ ID NO.: 172 MAPKKKRKVGIHGVPAADKKYSIGLAIGTNSVGWAVITDEYKVPSKKFKVLGNTDRHSIKKNLIGALLFDSGETAEATRLKRT ARRRYTRRKNRICYLQEIFSNEMAKVDDSFFHRLEESFLVEEDKKHERHPIFGNIVDEVAYHEKYPTIYHLRKKLVDSTDKAD LRLIYLALAHMIKFRGHFLIEGDLNPDNSDVDKLFIQLVQTYNQLFEENPINASGVDAKAILSARLSKSRRLENLIAQLPGEK KNGLFGNLIALSLGLTPNFKSNFDLAEDAKLQLSKDTYDDDLDNLLAQIGDQYADLFLAAKNLSDAILLSDILRVNTEITKAP LSASMIKRYDEHHQDLTLLKALVRQQLPEKYKEIFFDQSKNGYAGYIDGGASQEEFYKFIKPILEKMDGTEELLVKLNREDLL RKQRTFDNGSIPHQIHLGELHAILRRQEDFYPFLKDNREKIEKILTFRIPYYVGPLARGNSRFAWMTRKSEETITPWNFEEVV DKGASAQSFIERMTNFDKNLPNEKVLPKHSLLYEYFTVYNELTKVKYVTEGMRKPAFLSGEQKKAIVDLLFKTNRKVTVKQLK EDYFKKIECFDSVEISGVEDRFNASLGTYHDLLKIIKDKDFLDNEENEDILEDIVLTLTLFEDREMIEERLKTYAHLFDDKVM KQLKRRRYTGWGRLSRKLINGIRDKQSGKTILDFLKSDGFANRNFMQLIHDDSLTFKEDIQKAQVSGQGDSLHEHIANLAGSP AIKKGILQTVKVVDELVKVMGRHKPENIVIEMARENQTTQKGQKNSRERMKRIEEGIKELGSQILKEHPVENTQLQNEKLYLY YLQNGRDMYVDQELDINRLSDYDVAAIVPQSFLKDDSIDNKVLTRSDKARGKSDNVPSEEVVKKMKNYWRQLLNAKLITQRKF DNLTKAERGGLSELDKAGFIKRQLVETRQITKHVAQILDSRMNTKYDENDKLIREVKVITLKSKLVSDFRKDFQFYKVREINN YHHAHDAYLNAVVGTALIKKYPKLESEFVYGDYKVYDVRKMIAKSEQEIGKATAKYFFYSNIMNFFKTEITLANGEIRKRPLI ETNGETGEIVWDKGRDFATVRKVLSMPQVNIVKKTEVQTGGFSKESILPKRNSDKLIARKKDWDPKKYGGFDSPTVAYSVLVV AKVEKGKSKKLKSVKELLGITIMERSSFEKNPIDFLEAKGYKEVKKDLIIKLPKYSLFELENGRKRMLASAGELQKGNELALP SKYVNFLYLASHYEKLKGSPEDNEQKQLFVEQHKHYLDEIIEQISEFSKRVILADANLDKVLSAYNKHRDKPIREQAENIIHL FTLTNLGAPAAFKYFDTTIDRKRYTSTKEVLDATLIHQSITGLYETRIDLSQLGGDSGGKRPAATKKAGQAKKKKSGGGGSDA LDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSGSGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRIRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFGSGSGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSGSGSQYLPDTDDR HRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASA LAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPA VFTDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSA LLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPKRIRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQP LDPAPAVTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPE LNEILDTFLNDECLLHAMHISTGLSIFDTSLFGSGSGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDF DLDMLGSGSGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTI NYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALL QLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLP NGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPKRIRPFHPPGSPWANRPLPASLAPT PTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDEL TTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTGLSIFDTSLFGSGSGSGGGGSGKRPAATKKAGQAKKKKGSY PYDVPDYA* >dCas9-VPR3 mRNA SEQ ID NO. 173 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGAGGAAAGUCGGAAUUCAC GGAGUGCCUGCAGCGGAUAAGAAGUACUCCAUCGGACUCGCAAUCGGCACCAACUCCGUGGGAUGGGCCGUGAUCACCGACGA GUACAAAGUGCCGUCUAAAAAGUUCAAGGUGCUCGGAAACACCGAUAGGCACUCCAUCAAGAAGAACCUGAUUGGGGCCCUGC UGUUUGAUUCCGGGGAAACGGCAGAGGCCACUCGCCUCAAGAGAACUGCACGCCGGCGGUACACUCGUCGGAAGAACCGCAUC UGCUAUCUGCAAGAGAUUUUCUCCAACGAGAUGGCCAAAGUGGACGACUCAUUCUUCCACCGCCUCGAAGAAUCUUUCCUGGU CGAAGAGGACAAGAAGCACGAACGCCACCCCAUUUUCGGGAACAUUGUCGACGAAGUGGCGUACCACGAGAAGUACCCCACCA UCUACCAUCUCCGCAAGAAGCUCGUGGAUUCCACUGACAAGGCCGAUCUCAGACUGAUCUACCUGGCGCUUGCUCACAUGAUU AAGUUCAGGGGUCACUUCCUGAUUGAGGGAGAUCUGAACCCCGACAACAGCGAUGUCGAUAAGCUGUUCAUUCAGCUGGUGCA GACCUACAAUCAGCUGUUCGAAGAGAACCCCAUUAAUGCCUCCGGUGUCGAUGCCAAGGCCAUCCUGUCCGCACGGCUGAGCA AAUCGCGCAGGCUGGAAAACCUGAUCGCCCAGCUGCCUGGAGAGAAAAAGAACGGACUGUUCGGCAACCUUAUCGCGCUGUCC UUGGGACUGACCCCGAACUUCAAGAGCAACUUCGACUUGGCCGAGGAUGCCAAGCUGCAACUGUCGAAGGACACCUACGACGA UGACCUCGAUAAUCUGCUGGCCCAAAUUGGCGAUCAAUAUGCAGACCUGUUCCUUGCCGCAAAGAACCUGAGCGACGCGAUUC UCCUGUCGGACAUCCUGCGGGUCAACACCGAGAUCACCAAGGCACCGUUGUCCGCCUCCAUGAUUAAGCGAUACGACGAACAC CAUCAGGACCUGACUCUGCUGAAGGCCCUGGUCCGCCAACAGCUGCCCGAGAAGUACAAGGAGAUCUUCUUCGACCAAUCCAA GAAUGGAUACGCUGGAUACAUCGAUGGCGGUGCCAGCCAAGAGGAAUUCUACAAGUUCAUCAAACCGAUACUGGAGAAGAUGG ACGGCACAGAGGAACUCCUGGUCAAGCUGAACCGGGAGGAUCUGCUGCGGAAGCAGAGGACCUUCGACAACGGGUCCAUCCCG CACCAGAUUCACCUGGGCGAACUGCAUGCGAUCCUGCGACGGCAGGAGGACUUCUACCCAUUCCUGAAGGAUAACAGAGAGAA AAUCGAGAAGAUCCUCACCUUCCGGAUCCCGUAUUACGUGGGACCCCUGGCUAGGGGCAACAGCCGCUUCGCCUGGAUGACCC GCAAGUCCGAGGAAACUAUUACUCCCUGGAACUUCGAGGAAGUAGUGGACAAAGGCGCCAGCGCGCAAUCCUUCAUCGAACGG AUGACCAACUUCGACAAGAACUUGCCGAACGAAAAGGUGUUGCCGAAGCAUUCUCUGCUGUAUGAGUACUUCACUGUGUACAA CGAACUGACCAAAGUGAAAUACGUCACAGAAGGAAUGAGAAAGCCAGCCUUCCUUAGCGGGGAGCAGAAGAAGGCCAUUGUGG ACCUCCUGUUCAAAACCAACCGAAAGGUCACCGUGAAGCAACUGAAGGAGGAUUACUUCAAGAAGAUCGAAUGUUUCGACUCG GUGGAGAUCUCCGGGGUGGAGGAUCGCUUCAAUGCCUCCCUGGGCACCUACCAUGAUCUGCUCAAGAUCAUCAAGGAUAAGGA CUUCCUCGACAACGAAGAGAACGAAGAUAUCCUGGAGGAUAUCGUGCUCACCCUCACCCUGUUCGAGGAUAGAGAGAUGAUCG AAGAGAGACUUAAGACCUACGCCCACCUGUUCGACGACAAAGUCAUGAAGCAGCUGAAGCGGAGGAGGUACACUGGAUGGGGC AGACUGUCCCGCAAGCUCAUCAACGGGAUUCGAGAUAAGCAGUCCGGAAAGACAAUCCUCGACUUCCUGAAAUCCGACGGAUU UGCCAACAGAAACUUCAUGCAGCUGAUCCAUGAUGACUCGCUGACCUUCAAGGAGGAUAUUCAGAAGGCUCAAGUGUCGGGAC AGGGCGAUUCCCUCCACGAGCACAUCGCCAACCUCGCGGGAUCCCCUGCAAUCAAGAAGGGUAUCCUGCAGACCGUGAAGGUC GUGGACGAAUUAGUGAAAGUCAUGGGCCGGCAUAAGCCUGAAAACAUCGUGAUCGAGAUGGCCCGGGAAAACCAGACCACCCA AAAGGGACAGAAGAACUCCCGCGAGCGCAUGAAGCGGAUCGAGGAAGGGAUCAAGGAGCUGGGGUCGCAGAUCUUAAAGGAGC ACCCCGUGGAAAAUACUCAGCUGCAAAACGAAAAGCUGUACCUGUAUUACUUGCAAAACGGAAGAGAUAUGUACGUGGAUCAA GAAUUGGACAUCAACAGACUCUCCGACUACGACGUCGCUGCGAUUGUGCCACAAAGCUUUCUUAAGGACGACUCCAUCGACAA CAAGGUCCUCACCCGGUCCGAUAAGGCCCGCGGAAAGUCCGACAACGUGCCAAGCGAAGAGGUGGUCAAGAAGAUGAAGAAUU ACUGGCGGCAGCUGCUGAACGCCAAGCUGAUAACUCAGCGGAAGUUCGACAACCUGACUAAGGCUGAGCGGGGAGGACUCUCG GAACUGGACAAGGCUGGGUUCAUCAAGAGACAGUUGGUGGAAACCCGCCAAAUUACCAAACACGUGGCGCAGAUCCUGGACUC ACGCAUGAACACUAAGUACGACGAGAACGAUAAGCUGAUUCGGGAAGUCAAAGUGAUCACCCUGAAGUCCAAGCUCGUCAGCG ACUUCCGGAAGGAUUUCCAGUUUUACAAGGUCCGCGAAAUUAACAACUACCAUCAUGCUCACGACGCCUACUUGAACGCCGUG GUCGGUACCGCCCUGAUCAAGAAGUAUCCAAAGCUCGAGUCCGAGUUUGUGUACGGCGACUACAAGGUCUACGACGUGCGCAA GAUGAUCGCGAAAUCCGAGCAGGAAAUCGGAAAGGCCACCGCCAAGUACUUCUUCUACUCAAACAUUAUGAACUUCUUCAAGA CCGAAAUCACUCUGGCGAACGGCGAAAUCCGGAAAAGACCGCUGAUCGAGACUAACGGCGAAACCGGCGAAAUCGUGUGGGAC AAGGGACGGGACUUCGCCACCGUGCGCAAGGUGCUGUCGAUGCCCCAAGUGAACAUUGUGAAGAAAACCGAAGUCCAGACUGG CGGCUUCAGCAAAGAAUCGAUCCUGCCCAAGAGAAACAGCGACAAGCUGAUCGCCCGCAAGAAGGACUGGGACCCCAAGAAAU ACGGCGGUUUCGACUCACCCACUGUGGCCUACUCGGUCCUCGUGGUCGCCAAGGUCGAGAAGGGCAAAAGCAAAAAGCUUAAA UCGGUGAAGGAACUUCUGGGUAUCACGAUCAUGGAACGCUCCUCCUUCGAAAAGAACCCCAUCGACUUUUUGGAAGCAAAGGG AUACAAGGAAGUCAAGAAGGACCUCAUCAUCAAGCUGCCGAAGUAUAGCCUCUUCGAACUGGAGAACGGUCGGAAGAGAAUGC UGGCUUCAGCGGGAGAGCUGCAAAAGGGAAACGAGCUGGCCCUUCCGAGCAAAUACGUCAACUUUCUGUACCUGGCCUCGCAC UACGAAAAGCUCAAGGGAUCACCCGAGGACAACGAACAGAAGCAACUGUUCGUGGAACAGCAUAAGCAUUACCUGGAUGAGAU UAUCGAACAGAUUUCCGAAUUCUCCAAGCGCGUGAUUCUGGCCGACGCCAACCUGGACAAGGUCCUUUCAGCCUACAACAAGC ACCGGGAUAAGCCGAUCCGGGAACAGGCGGAAAACAUCAUCCAUCUGUUCACGUUGACUAAUCUUGGAGCACCAGCCGCGUUU AAGUACUUUGACACCACCAUUGACAGGAAACGGUACACAUCCACGAAGGAAGUGUUGGAUGCGACGCUGAUUCAUCAGAGUAU CACCGGACUCUACGAAACGCGGAUUGACCUCAGCCAGUUGGGAGGGGACUCCGGAGGAAAGAGGCCAGCCGCCACUAAGAAGG CUGGGCAGGCCAAGAAGAAAAAGUCCGGUGGAGGAGGCUCAGACGCCCUCGACGACUUCGAUCUGGACAUGCUGGGUAGCGAC GCCCUGGAUGACUUCGACCUCGAUAUGCUGGGAUCCGACGCACUUGACGAUUUUGACUUGGACAUGCUCGGCUCCGACGCUCU GGACGAUUUCGACCUUGACAUGCUUGGCUCCGGCUCAGGAUCCCAGUACCUCCCCGAUACCGACGACAGACACCGGAUCGAAG AAAAGCGCAAGCGCACCUACGAAACCUUCAAGUCGAUUAUGAAGAAGUCGCCUUUCUCCGGGCCGACUGAUCCUAGACCUCCA CCAAGAAGAAUCGCGGUGCCGUCCAGAUCGUCCGCGUCAGUGCCGAAACCAGCACCGCAGCCGUAUCCGUUCACUUCCUCCCU UUCCACCAUUAACUACGACGAAUUCCCCACGAUGGUGUUCCCUAGCGGACAGAUUUCGCAAGCCAGCGCUCUUGCUCCUGCGC CUCCUCAAGUGCUGCCUCAGGCCCCUGCUCCUGCUCCUGCACCCGCCAUGGUGUCCGCCCUGGCUCAAGCUCCAGCCCCUGUG CCUGUCCUGGCCCCUGGACCACCUCAGGCAGUAGCACCUCCCGCUCCCAAGCCCACCCAAGCGGGAGAGGGCACUCUUUCCGA GGCCCUGCUGCAACUGCAGUUCGACGACGAGGACCUGGGGGCACUUCUGGGAAAUAGCACCGAUCCGGCCGUGUUCACCGACC UGGCCAGCGUCGACAACUCAGAGUUCCAGCAGCUCCUCAACCAAGGGAUUCCGGUGGCCCCUCACACGACCGAGCCGAUGUUG AUGGAAUACCCGGAAGCCAUCACCCGCCUAGUGACCGGAGCGCAAAGACCGCCUGACCCAGCUCCUGCCCCUUUGGGAGCCCC UGGAUUGCCCAACGGACUCCUGUCCGGCGACGAGGAUUUCUCGUCCAUCGCCGAUAUGGACUUCUCGGCCCUGUUGGGUAGCG GUUCGGGUAGUCGCGAUAGCCGGGAAGGAAUGUUCCUGCCGAAGCCUGAGGCCGGGUCUGCCAUUAGCGAUGUGUUUGAAGGA CGGGAAGUCUGUCAGCCCAAGCGGAUUCGCCCAUUCCACCCCCCUGGAUCGCCUUGGGCCAACAGGCCACUCCCCGCUUCGCU UGCGCCGACUCCUACCGGGCCAGUGCACGAACCUGUGGGAUCCCUGACUCCGGCUCCUGUGCCACAGCCUCUGGAUCCGGCUC CCGCUGUCACCCCUGAGGCCUCACACCUUCUCGAGGACCCCGACGAAGAGACUUCCCAGGCCGUGAAAGCGCUCCGGGAGAUG GCGGACACUGUGAUCCCGCAAAAGGAAGAAGCCGCGAUUUGCGGCCAGAUGGACCUGUCGCAUCCUCCACCACGCGGUCACCU CGAUGAACUGACAACUACCCUGGAGUCGAUGACCGAGGACCUGAACCUGGACUCCCCGCUGACUCCUGAGCUCAACGAAAUCC UGGACACUUUCCUGAACGAUGAGUGCCUGCUGCACGCCAUGCACAUCUCCACUGGGCUGUCAAUCUUCGACACCAGCCUGUUC GGCUCCGGAUCCGGUUCCGACGCACUGGACGAUUUUGACCUGGAUAUGUUGGGGAGCGACGCACUGGACGAUUUUGAUCUGGA UAUGCUGGGAUCCGACGCGCUCGACGAUUUCGACCUGGACAUGCUCGGAUCGGACGCCCUGGACGACUUCGACCUCGAUAUGC UUGGAUCAGGGUCCGGCUCACAAUAUCUGCCGGACACUGAUGACCGGCAUAGAAUCGAAGAAAAGCGCAAGCGGACCUACGAA ACUUUCAAGAGCAUCAUGAAGAAAUCGCCGUUCUCUGGGCCGACUGAUCCUAGGCCGCCUCCGAGAAGGAUCGCCGUGCCCUC AAGAUCCUCCGCCUCUGUGCCCAAGCCGGCUCCACAGCCUUACCCCUUCACUUCGUCGCUGAGCACCAUCAACUACGACGAAU UCCCGACCAUGGUCUUUCCGAGCGGCCAGAUUUCCCAGGCGUCCGCCUUGGCUCCUGCACCACCCCAAGUGCUGCCUCAGGCG CCUGCACCAGCUCCAGCCCCUGCCAUGGUGUCCGCGCUGGCACAAGCCCCUGCACCUGUGCCAGUGCUCGCACCUGGUCCUCC GCAAGCUGUGGCACCUCCUGCGCCUAAGCCGACUCAGGCCGGAGAAGGGACCCUGUCAGAGGCCCUGCUGCAACUGCAGUUUG ACGAUGAGGAUCUGGGAGCCCUUCUGGGCAACUCGACUGACCCCGCCGUGUUCACCGACCUGGCGUCCGUGGAUAACUCCGAG UUCCAGCAGCUCCUCAACCAAGGGAUUCCUGUCGCCCCGCACACUACCGAGCCGAUGCUGAUGGAGUACCCGGAGGCCAUCAC CCGGCUUGUGACGGGUGCUCAGAGGCCUCCAGAUCCGGCUCCAGCACCGUUAGGAGCCCCCGGACUUCCUAACGGACUGCUGU CCGGCGACGAGGACUUCUCCAGCAUCGCCGACAUGGAUUUUUCCGCGCUGUUGGGAUCGGGUUCCGGCUCAAGAGACAGCCGC GAGGGAAUGUUCCUCCCGAAACCAGAGGCCGGCUCAGCCAUCAGCGACGUGUUCGAAGGGCGCGAAGUCUGCCAGCCCAAGCG GAUCCGCCCGUUUCAUCCGCCUGGAUCACCGUGGGCCAACAGACCCCUACCCGCAAGCUUAGCCCCUACCCCCACUGGCCCUG UCCACGAACCUGUGGGCUCCCUGACACCCGCUCCUGUGCCACAACCUCUGGACCCCGCACCAGCAGUCACACCCGAAGCCAGC CACCUCCUUGAGGAUCCGGACGAGGAGACUAGCCAGGCCGUGAAGGCGCUCCGCGAAAUGGCCGACACUGUGAUCCCUCAAAA GGAAGAGGCGGCCAUUUGUGGACAGAUGGACUUGUCCCACCCGCCUCCAAGAGGUCACCUGGACGAACUUACCACCACGCUCG AAUCCAUGACUGAGGAUCUGAACCUGGAUUCCCCGCUCACUCCCGAGCUCAACGAAAUCCUUGAUACCUUCCUUAACGACGAG UGUCUCCUGCAUGCCAUGCACAUCUCCACCGGACUGAGCAUUUUCGACACCUCGCUGUUCGGUUCCGGAAGCGGCUCAGACGC GCUGGAUGACUUCGAUUUGGACAUGCUUGGCAGCGAUGCCCUGGAUGAUUUCGACCUGGACAUGCUCGGGUCGGAUGCGCUGG ACGACUUCGAUCUCGAUAUGUUGGGCUCCGAUGCCCUCGACGACUUUGACCUCGACAUGCUGGGCUCGGGCUCAGGAUCCCAA UACCUCCCGGAUACCGACGACAGGCAUCGCAUUGAGGAAAAGCGGAAGCGCACCUAUGAAACCUUCAAGUCCAUUAUGAAGAA GUCGCCCUUUUCCGGACCGACUGACCCUCGGCCUCCUCCUCGACGAAUUGCCGUCCCAUCUCGGUCAUCCGCCUCGGUCCCCA AGCCAGCACCGCAGCCUUAUCCGUUCACCUCCUCUCUGUCCACCAUUAACUACGAUGAAUUCCCCACCAUGGUGUUCCCGUCG GGACAGAUCUCCCAAGCCUCAGCCCUUGCUCCUGCCCCUCCACAAGUCCUGCCCCAAGCACCAGCGCCUGCUCCUGCACCCGC GAUGGUGUCCGCACUGGCGCAAGCUCCUGCCCCUGUGCCUGUGCUGGCUCCUGGACCACCCCAGGCAGUAGCACCUCCAGCCC CGAAGCCCACUCAGGCUGGAGAGGGAACCCUGAGCGAAGCGCUGCUGCAGCUCCAGUUCGACGACGAAGAUCUGGGUGCCCUG CUGGGAAAUUCCACCGAUCCGGCGGUGUUCACAGACCUGGCCUCCGUGGACAACUCCGAAUUCCAGCAGUUGUUGAACCAGGG CAUUCCUGUGGCCCCCCACACCACUGAGCCAAUGCUCAUGGAAUACCCCGAGGCCAUUACCAGACUCGUGACCGGAGCCCAAA GGCCUCCGGAUCCAGCGCCAGCUCCGUUGGGAGCUCCGGGAUUGCCGAACGGGCUGCUGUCGGGAGAUGAAGAUUUCUCCUCA AUCGCCGAUAUGGACUUCUCCGCGCUGCUGGGUUCGGGUUCGGGAUCGCGCGAUAGCCGGGAGGGCAUGUUCCUACCGAAGCC UGAGGCCGGAAGCGCCAUCUCCGAUGUGUUCGAGGGCAGAGAAGUCUGUCAGCCUAAGCGCAUUCGCCCGUUCCACCCUCCUG GAUCGCCCUGGGCCAAUCGGCCACUGCCUGCGUCCCUCGCUCCAACGCCGACCGGACCUGUGCACGAACCGGUCGGCUCACUG ACUCCAGCUCCCGUCCCACAACCGCUCGACCCUGCUCCCGCUGUUACCCCCGAAGCCUCCCAUUUGCUGGAAGAUCCCGAUGA GGAAACUUCCCAGGCCGUCAAGGCCCUGCGGGAGAUGGCAGACACCGUGAUACCCCAGAAGGAAGAAGCUGCCAUCUGCGGGC AGAUGGACCUGUCCCAUCCUCCUCCACGCGGACACUUGGACGAGCUGACCACUACUCUGGAGUCCAUGACCGAGGACCUGAAC CUUGACUCGCCUUUGACCCCUGAACUGAACGAAAUUCUGGACACCUUCCUGAAUGACGAGUGCCUCCUGCACGCGAUGCACAU CAGCACCGGACUGUCCAUCUUCGACACUUCCCUCUUUGGGAGCGGGUCCGGAUCAGGCGGUGGUGGUAGCGGGAAACGGCCAG CAGCGACCAAGAAGGCCGGACAGGCCAAGAAGAAGAAAGGCUCAUACCCCUACGACGUGCCGGACUACGCAUGAGCGGCCGCU UAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAU AAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5 protein-no effector SEQ ID NO.: 174 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHTGE KPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTG EKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASSGGKRPAATKKAGQAK KKKGSYPYDVPDYA >Nucleotide Seqeunce of DNA binding domain of ZF5 protein-no effector SEQ ID NO.: 235 CUCGAACCGGGCGAGAAACCAUAUAAGUGUCCAGAGUGUGGUAAGAGCUUUAGCACCAGUGGCAAUCUGACCGAGCAUCAACG CACGCAUACGGGUGAGAAACCGUACAAGUGCCCGGAAUGCGGCAAAAGUUUCAGCGAUAGCGGCAAUCUGCGUGUGCACCAGC GUACGCAUACGGGCGAAAAGCCGUAUAAGUGCCCAGAAUGCGGUAAGAGUUUUAGCCACAAAAACGCGCUGCAGAACCACCAG CGCACCCACACGGGUGAGAAGCCAUACAAAUGUCCGGAAUGCGGCAAAAGCUUCAGCCGCAACGAUACGCUGACGGAACACCA ACGUACGCAUACCGGCGAAAAGCCAUACAAGUGCCCGGAGUGCGGUAAAAGCUUUAGCCAGCGCGCGCAUCUCGAACGUCAUC AACGUACCCAUACCGGUGAAAAACCAUAUAAAUGCCCGGAAUGUGGUAAAAGUUUUAGCCGCAGCGACAAACUGGUGCGUCAU CAACGCACCCAUACCGGUGAAAAGCCAUAUAAGUGCCCGGAGUGUGGUAAAAGCUUCAGCGAUCCGGGUCAUCUGGUUCGCCA UCAACGUACGCACACCGGCGAGAAGCCAACCGGCAAGAAAACCAGC >ZF5 mRNA-no effector SEQ ID NO.: 175 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUCGAACCGGGCGAGAAACCAUAUAAGUGUCCAGAGUGUGGUAAGAGCUUUAG CACCAGUGGCAAUCUGACCGAGCAUCAACGCACGCAUACGGGUGAGAAACCGUACAAGUGCCCGGAAUGCGGCAAAAGUUUCA GCGAUAGCGGCAAUCUGCGUGUGCACCAGCGUACGCAUACGGGCGAAAAGCCGUAUAAGUGCCCAGAAUGCGGUAAGAGUUUU AGCCACAAAAACGCGCUGCAGAACCACCAGCGCACCCACACGGGUGAGAAGCCAUACAAAUGUCCGGAAUGCGGCAAAAGCUU CAGCCGCAACGAUACGCUGACGGAACACCAACGUACGCAUACCGGCGAAAAGCCAUACAAGUGCCCGGAGUGCGGUAAAAGCU UUAGCCAGCGCGCGCAUCUCGAACGUCAUCAACGUACCCAUACCGGUGAAAAACCAUAUAAAUGCCCGGAAUGUGGUAAAAGU UUUAGCCGCAGCGACAAACUGGUGCGUCAUCAACGCACCCAUACCGGUGAAAAGCCAUAUAAGUGCCCGGAGUGUGGUAAAAG CUUCAGCGAUCCGGGUCAUCUGGUUCGCCAUCAACGUACGCACACCGGCGAGAAGCCAACCGGCAAGAAAACCAGCGCUAGCA GCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGAC UACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGU ACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >ZF5.3-VPR-tPT2a-ZF7-VPR protein SEQ ID NO.: 176 MAPKKKRKVGIHGVPAAGSSGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTH TGEKPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSQRAHLERHQRT HTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDD FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSI MKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAP APAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLL NQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFL PKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLED PDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHA MHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLKQAGDVEENPGPTSAGKLGSGEGRGSLLTCG DVEENPGPLEGSSGSGSLEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKC PECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYK CPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLDMLGS DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSG PTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSAL AQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIPVAP HTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSA ISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQA VKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTGLS IFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZF5.3-VPR-tPT2a-ZF7-VPR mRNA SEQ ID NO.: 177 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCAUCAGGCUCACUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAA GAGCUUCUCGACCUCCGGGAACCUGACCGAGCACCAGCGCACCCACACCGGAGAGAAACCGUACAAGUGCCCCGAAUGCGGGA AAUCGUUCUCAGACUCGGGAAACCUCAGGGUGCACCAGCGGACCCACACGGGGGAAAAGCCGUACAAAUGCCCGGAGUGCGGG AAGUCAUUCUCCCACAAGAACGCGCUGCAGAACCACCAAAGAACCCACACCGGCGAAAAACCGUACAAGUGCCCCGAGUGCGG AAAGUCCUUCUCCCGCAACGACACCCUCACCGAACACCAACGCACCCACACCGGAGAAAAGCCCUACAAGUGCCCGGAAUGCG GAAAGAGCUUCAGCCAGAGGGCCCACCUGGAAAGACACCAGAGAACCCACACCGGCGAAAAGCCGUACAAAUGCCCGGAGUGC GGGAAGUCCUUCAGCCGGUCAGACAAGCUGGUCCGCCACCAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUG CGGAAAAUCGUUCAGCGACCCCGGACACCUGGUCCGGCACCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCU CAGCGAGCGGAUCAGGAGGAGGAUCAGGGGGGGACGCACUGGACGACUUCGACCUGGACAUGCUGGGAUCAGACGCACUGGAC GACUUCGACCUAGACAUGCUCGGAUCGGACGCACUCGACGACUUCGACCUCGACAUGCUAGGAUCAGACGCACUAGACGACUU CGACCUCGACAUGCUGUCGGGAGGACCGAAGAAAAAGCGGAAGGUCGGAUCACAGUACCUCCCGGACACCGACGACAGGCACA GAAUCGAAGAAAAACGCAAGCGCACCUACGAAACCUUCAAGAGCAUCAUGAAAAAGUCGCCGUUCUCAGGACCGACCGACCCC AGACCGCCACCGAGGAGAAUAGCCGUCCCGAGCCGAUCCUCCGCAUCCGUGCCGAAACCGGCACCGCAACCCUACCCGUUCAC CUCGUCCCUGUCGACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCUCCGGGCAGAUCUCACAGGCCUCGGCACUGG CACCCGCACCACCGCAAGUGCUGCCCCAAGCACCGGCACCCGCACCGGCGCCCGCAAUGGUGUCAGCGCUGGCACAGGCACCA GCACCGGUGCCAGUCCUCGCACCGGGACCGCCGCAAGCAGUGGCACCGCCGGCACCGAAACCGACCCAGGCCGGAGAAGGGAC CCUGUCCGAGGCGCUGCUGCAACUCCAGUUCGACGACGAGGACCUGGGAGCACUCCUGGGAAACUCCACCGACCCGGCAGUGU UCACCGACCUCGCAUCGGUGGACAACUCCGAGUUCCAACAGCUCCUGAACCAGGGGAUACCGGUGGCACCGCACACCACCGAA CCGAUGCUGAUGGAAUACCCGGAAGCCAUCACCCGGCUCGUGACCGGAGCGCAAAGACCGCCCGACCCCGCGCCCGCACCGCU GGGAGCACCGGGACUACCGAACGGGCUGCUCUCAGGGGACGAGGACUUCUCCAGCAUCGCAGACAUGGACUUCUCCGCCCUGC UGGGAUCAGGAUCAGGAUCACGCGACUCCCGGGAAGGAAUGUUCCUGCCGAAGCCGGAAGCAGGCAGCGCAAUCUCCGACGUG UUCGAAGGCCGCGAGGUCUGCCAGCCCAAGCGCCUGCGACCGUUCCACCCGCCGGGAUCACCGUGGGCAAACCGCCCGCUACC GGCAUCACUGGCACCGACACCCACCGGACCGGUGCACGAACCGGUCGGGUCACUGACCCCCGCACCGGUCCCGCAACCGCUAG ACCCGGCACCGGCAGUGACCCCGGAAGCAUCGCACCUCCUGGAGGACCCGGACGAGGAAACCUCACAGGCAGUGAAGGCCCUG CGGGAGAUGGCCGACACCGUGAUACCGCAGAAGGAGGAGGCCGCCAUCUGCGGACAAAUGGACCUGUCACACCCGCCCCCGAG AGGACACCUGGACGAACUCACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACUCACCGCUGACCCCGGAGCUGA ACGAAAUCCUGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCAAUGCACAUCAGCACCGGGCUGUCGAUCUUCGACACC AGCCUGUUCUCCGGAGGGAAAAGACCCGCCGCCACCAAGAAAGCGGGCCAAGCAAAGAAAAAGAAGGGAUCGUACCCCUACGA CGUGCCGGACUACGCAGCCACCAACUUUUCUCUGCUGAAGCAAGCCGGAGAUGUGGAGGAGAAUCCCGGCCCUACCUCCGCCG GAAAACUGGGCUCCGGCGAAGGCAGAGGAAGCCUCCUCACAUGCGGCGACGUGGAGGAGAACCCCGGCCCUCUGGAGGGAUCC UCAGGCUCAGGAUCCCUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAGCCGCAGCGACCAUCU GACCAAUCACCAACGCACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUAGUACCAGUGGCAGUC UGGUUCGUCAUCAGCGCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUUAGCCAAGCCGGUCAU CUGGCGAGCCAUCAACGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUUUAGCCGUAGCGAUAA ACUGACCGAACACCAACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUUUCAGCACCAGCGGCA AUCUGACCGAGCAUCAACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGUUUUAGUCAGAGCAGU AAUCUGGUGCGCCAUCAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAGUUUUAGCACCCAUCU GGAUCUGAUCCGUCAUCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGUGCUAGCGGCAGCGGCGGCGGCA GCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGC AGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGAGCGGCGG CCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGGAGAAGCGGAAGCGGA CCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGAUCGCC GUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCUGAGCACCAUCAACUA CGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCCCCCCCCAGGUGCUGC CCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUGCCCGUGCUGGCCCCC GGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGAGGCCCUGCUGCAGCU GCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACCUGGCCAGCGUGGACA ACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUGAUGGAGUACCCCGAG GCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCCCGGCCUGCCCAACGG CCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCGGCAGCGGCAGCCGGG ACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGCCGGGAGGUGUGCCAG CCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCUGGCCCCCACCCCCAC CGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCCCCGCCGUGACCCCCG AGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUGGCCGACACCGUGAUC CCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCUGGACGAGCUGACCAC CACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCCUGGACACCUUCCUGA ACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUCAGCGGCGGCAAGCGG CCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGACUACGCCUGAGCGGC CGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUU GAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAA >Nucleotide Seqeunce of DNA binding domain of ZF5.3-VPR-tPT2a-ZF7-VPR; 1 SEQ ID NO.: 236 CUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAAGAGCUUCUCGACCUCCGGGAACCUGACCGAGCACCAGCG CACCCACACCGGAGAGAAACCGUACAAGUGCCCCGAAUGCGGGAAAUCGUUCUCAGACUCGGGAAACCUCAGGGUGCACCAGC GGACCCACACGGGGGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCAUUCUCCCACAAGAACGCGCUGCAGAACCACCAA AGAACCCACACCGGCGAAAAACCGUACAAGUGCCCCGAGUGCGGAAAGUCCUUCUCCCGCAACGACACCCUCACCGAACACCA ACGCACCCACACCGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUCAGCCAGAGGGCCCACCUGGAAAGACACC AGAGAACCCACACCGGCGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCCUUCAGCCGGUCAGACAAGCUGGUCCGCCAC CAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAAUCGUUCAGCGACCCCGGACACCUGGUCCGGCA CCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCUCA >Nucleotide Seqeunce of DNA binding domain of ZF5.3-VPR-tPT2a-ZF7-VPR; 2 SEQ ID NO.: 237 CTGGAACCGGGCGAGAAGCCATACAAGTGCCCAGAGTGCGGCAAAAGCTTCAGCCGCAGCGACCATCTGACCAATCACCAACG CACCCATACCGGTGAGAAGCCGTACAAATGCCCAGAGTGCGGTAAGAGCTTTAGTACCAGTGGCAGTCTGGTTCGTCATCAGC GCACGCACACGGGCGAAAAACCATACAAATGCCCGGAGTGCGGCAAAAGCTTTAGCCAAGCCGGTCATCTGGCGAGCCATCAA CGTACGCACACCGGCGAGAAGCCGTATAAATGTCCGGAGTGCGGTAAGAGCTTTAGCCGTAGCGATAAACTGACCGAACACCA ACGTACGCATACGGGCGAGAAACCATATAAATGTCCAGAGTGTGGCAAGAGTTTCAGCACCAGCGGCAATCTGACCGAGCATC AACGTACCCATACCGGTGAAAAGCCATATAAATGTCCAGAATGCGGTAAGAGTTTTAGTCAGAGCAGTAATCTGGTGCGCCAT CAGCGTACCCACACGGGTGAGAAACCATATAAGTGTCCGGAATGCGGCAAGAGTTTTAGCACCCATCTGGATCTGATCCGTCA TCAGCGCACCCACACCGGTGAAAAACCAACCGGCAAGAAAACCAGT >ZF7-VPR-tPT2a-ZF5.3-VPR protein SEQ ID NO.: 178 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGE KPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTG EKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDL DMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKK SPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPA MVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQG IPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKP EAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDE ETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLKQAGDVEENPGPTSAGKLGSGEGRGSLLTCGDVE ENPGPLEGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTHTGEKPYKCPECGK SFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSQRAHLERHQRTHTGEKPYKCPECG KSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDDFDLDMLGSDALDD FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKSPFSGPTDPR PPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPA PVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLLNQGIPVAPHTTEP MLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFLPKPEAGSAISDVF EGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLEDPDEETSQAVKALR EMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHISTGLSIFDTS LFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA >ZF7-VPR-tPT2a-ZF5.3-VPR mRNA SEQ ID NO.: 179 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAG CCGCAGCGACCAUCUGACCAAUCACCAACGCACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUA GUACCAGUGGCAGUCUGGUUCGUCAUCAGCGCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUU AGCCAAGCCGGUCAUCUGGCGAGCCAUCAACGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUU UAGCCGUAGCGAUAAACUGACCGAACACCAACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUU UCAGCACCAGCGGCAAUCUGACCGAGCAUCAACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGU UUUAGUCAGAGCAGUAAUCUGGUGCGCCAUCAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAG UUUUAGCACCCAUCUGGAUCUGAUCCGUCAUCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGUGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGAC CUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGACAUGCUGGGCAGCGACGCCCUGGACGACUUCGACCUGGA CAUGCUGAGCGGCGGCCCCAAGAAGAAGCGGAAGGUGGGCAGCCAGUACCUGCCCGACACCGACGACCGGCACCGGAUCGAGG AGAAGCGGAAGCGGACCUACGAGACCUUCAAGAGCAUCAUGAAGAAAUCCCCCUUCAGCGGCCCCACCGACCCCCGGCCCCCC CCCCGGCGGAUCGCCGUGCCCAGCCGGAGCAGCGCCAGCGUGCCCAAGCCCGCCCCCCAGCCCUACCCCUUCACCAGCAGCCU GAGCACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCAGCGGCCAGAUCAGCCAGGCCAGCGCCCUGGCCCCCGCCC CCCCCCAGGUGCUGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCAUGGUGAGCGCCCUGGCCCAGGCCCCCGCCCCCGUG CCCGUGCUGGCCCCCGGCCCCCCCCAGGCCGUGGCCCCCCCCGCCCCCAAGCCCACCCAGGCCGGCGAGGGCACCCUGAGCGA GGCCCUGCUGCAGCUGCAGUUCGACGACGAGGACCUGGGCGCCCUGCUGGGCAACAGCACCGACCCCGCCGUGUUCACCGACC UGGCCAGCGUGGACAACAGCGAGUUCCAGCAGCUGCUGAACCAGGGCAUCCCCGUGGCCCCCCACACCACCGAGCCCAUGCUG AUGGAGUACCCCGAGGCCAUCACCCGGCUGGUGACCGGCGCCCAGCGGCCCCCCGACCCCGCCCCCGCCCCCCUGGGCGCCCC CGGCCUGCCCAACGGCCUGCUGAGCGGCGACGAGGACUUCAGCAGCAUCGCCGACAUGGACUUCAGCGCCCUGCUGGGCAGCG GCAGCGGCAGCCGGGACAGCCGGGAGGGCAUGUUCCUGCCCAAGCCCGAGGCCGGCAGCGCCAUCAGCGACGUGUUCGAGGGC CGGGAGGUGUGCCAGCCCAAGCGGCUCCGGCCCUUCCACCCCCCCGGCAGCCCCUGGGCCAACCGGCCCCUGCCCGCCAGCCU GGCCCCCACCCCCACCGGCCCCGUGCACGAGCCCGUGGGCAGCCUGACCCCCGCCCCCGUGCCCCAGCCCCUGGACCCCGCCC CCGCCGUGACCCCCGAGGCCAGCCACCUGCUGGAGGACCCCGACGAGGAGACCAGCCAGGCCGUGAAGGCCCUGCGGGAGAUG GCCGACACCGUGAUCCCCCAGAAGGAGGAGGCCGCCAUCUGCGGCCAGAUGGACCUGAGCCACCCCCCCCCCCGGGGCCACCU GGACGAGCUGACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACAGCCCCCUGACCCCCGAGCUGAACGAGAUCC UGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCCAUGCACAUCAGCACCGGCCUGAGCAUCUUCGACACCAGCCUGUUC AGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGA CUACGCCGCCACCAACUUUUCUCUGCUGAAGCAAGCCGGAGAUGUGGAGGAGAAUCCCGGCCCUACCUCCGCCGGAAAACUGG GCUCCGGCGAAGGCAGAGGAAGCCUCCUCACAUGCGGCGACGUGGAGGAGAACCCCGGCCCUCUGGAGGGAUCCUCAGGCUCA CUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAAGAGCUUCUCGACCUCCGGGAACCUGACCGAGCACCAGCG CACCCACACCGGAGAGAAACCGUACAAGUGCCCCGAAUGCGGGAAAUCGUUCUCAGACUCGGGAAACCUCAGGGUGCACCAGC GGACCCACACGGGGGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCAUUCUCCCACAAGAACGCGCUGCAGAACCACCAA AGAACCCACACCGGCGAAAAACCGUACAAGUGCCCCGAGUGCGGAAAGUCCUUCUCCCGCAACGACACCCUCACCGAACACCA ACGCACCCACACCGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUCAGCCAGAGGGCCCACCUGGAAAGACACC AGAGAACCCACACCGGCGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCCUUCAGCCGGUCAGACAAGCUGGUCCGCCAC CAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAAUCGUUCAGCGACCCCGGACACCUGGUCCGGCA CCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCUCAGCGAGCGGAUCAGGAGGAGGAUCAGGGGGGGACGCAC UGGACGACUUCGACCUGGACAUGCUGGGAUCAGACGCACUGGACGACUUCGACCUAGACAUGCUCGGAUCGGACGCACUCGAC GACUUCGACCUCGACAUGCUAGGAUCAGACGCACUAGACGACUUCGACCUCGACAUGCUGUCGGGAGGACCGAAGAAAAAGCG GAAGGUCGGAUCACAGUACCUCCCGGACACCGACGACAGGCACAGAAUCGAAGAAAAACGCAAGCGCACCUACGAAACCUUCA AGAGCAUCAUGAAAAAGUCGCCGUUCUCAGGACCGACCGACCCCAGACCGCCACCGAGGAGAAUAGCCGUCCCGAGCCGAUCC UCCGCAUCCGUGCCGAAACCGGCACCGCAACCCUACCCGUUCACCUCGUCCCUGUCGACCAUCAACUACGACGAGUUCCCCAC CAUGGUGUUCCCCUCCGGGCAGAUCUCACAGGCCUCGGCACUGGCACCCGCACCACCGCAAGUGCUGCCCCAAGCACCGGCAC CCGCACCGGCGCCCGCAAUGGUGUCAGCGCUGGCACAGGCACCAGCACCGGUGCCAGUCCUCGCACCGGGACCGCCGCAAGCA GUGGCACCGCCGGCACCGAAACCGACCCAGGCCGGAGAAGGGACCCUGUCCGAGGCGCUGCUGCAACUCCAGUUCGACGACGA GGACCUGGGAGCACUCCUGGGAAACUCCACCGACCCGGCAGUGUUCACCGACCUCGCAUCGGUGGACAACUCCGAGUUCCAAC AGCUCCUGAACCAGGGGAUACCGGUGGCACCGCACACCACCGAACCGAUGCUGAUGGAAUACCCGGAAGCCAUCACCCGGCUC GUGACCGGAGCGCAAAGACCGCCCGACCCCGCGCCCGCACCGCUGGGAGCACCGGGACUACCGAACGGGCUGCUCUCAGGGGA CGAGGACUUCUCCAGCAUCGCAGACAUGGACUUCUCCGCCCUGCUGGGAUCAGGAUCAGGAUCACGCGACUCCCGGGAAGGAA UGUUCCUGCCGAAGCCGGAAGCAGGCAGCGCAAUCUCCGACGUGUUCGAAGGCCGCGAGGUCUGCCAGCCCAAGCGCCUGCGA CCGUUCCACCCGCCGGGAUCACCGUGGGCAAACCGCCCGCUACCGGCAUCACUGGCACCGACACCCACCGGACCGGUGCACGA ACCGGUCGGGUCACUGACCCCCGCACCGGUCCCGCAACCGCUAGACCCGGCACCGGCAGUGACCCCGGAAGCAUCGCACCUCC UGGAGGACCCGGACGAGGAAACCUCACAGGCAGUGAAGGCCCUGCGGGAGAUGGCCGACACCGUGAUACCGCAGAAGGAGGAG GCCGCCAUCUGCGGACAAAUGGACCUGUCACACCCGCCCCCGAGAGGACACCUGGACGAACUCACCACCACCCUGGAGAGCAU GACCGAGGACCUGAACCUGGACUCACCGCUGACCCCGGAGCUGAACGAAAUCCUGGACACCUUCCUGAACGACGAGUGCCUGC UGCACGCAAUGCACAUCAGCACCGGGCUGUCGAUCUUCGACACCAGCCUGUUCUCCGGAGGGAAAAGACCCGCCGCCACCAAG AAAGCGGGCCAAGCAAAGAAAAAGAAGGGAUCGUACCCCUACGACGUGCCGGACUACGCAUGAGCGGCCGCUUAAUUAAGCUG CCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGU AGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAA >Nucleotide Seqeunce of DNA binding domain of ZF7-VPR-tPT2a-ZF5.3-VPR; 1 SEQ ID NO.: 238 CUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAGCCGCAGCGACCAUCUGACCAAUCACCAACG CACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUAGUACCAGUGGCAGUCUGGUUCGUCAUCAGC GCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUUAGCCAAGCCGGUCAUCUGGCGAGCCAUCAA CGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUUUAGCCGUAGCGAUAAACUGACCGAACACCA ACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUUUCAGCACCAGCGGCAAUCUGACCGAGCAUC AACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGUUUUAGUCAGAGCAGUAAUCUGGUGCGCCAU CAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAGUUUUAGCACCCAUCUGGAUCUGAUCCGUCA UCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGU >Nucleotide Seqeunce of DNA binding domain of ZF7-VPR-tPT2a-ZF5.3-VPR; 2 SEQ ID NO.: 239 CTGGAACCGGGGGAAAAACCCTACAAGTGCCCGGAATGCGGCAAGAGCTTCTCGACCTCCGGGAACCTGACCGAGCACCAGCG CACCCACACCGGAGAGAAACCGTACAAGTGCCCCGAATGCGGGAAATCGTTCTCAGACTCGGGAAACCTCAGGGTGCACCAGC GGACCCACACGGGGGAAAAGCCGTACAAATGCCCGGAGTGCGGGAAGTCATTCTCCCACAAGAACGCGCTGCAGAACCACCAA AGAACCCACACCGGCGAAAAACCGTACAAGTGCCCCGAGTGCGGAAAGTCCTTCTCCCGCAACGACACCCTCACCGAACACCA ACGCACCCACACCGGAGAAAAGCCCTACAAGTGCCCGGAATGCGGAAAGAGCTTCAGCCAGAGGGCCCACCTGGAAAGACACC AGAGAACCCACACCGGCGAAAAGCCGTACAAATGCCCGGAGTGCGGGAAGTCCTTCAGCCGGTCAGACAAGCTGGTCCGCCAC CAAAGGACCCACACAGGAGAAAAGCCCTACAAGTGCCCGGAATGCGGAAAATCGTTCAGCGACCCCGGACACCTGGTCCGGCA CCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCTCA >ZF5.3-VPR-tPT2a-ZF7-p300 protein SEQ ID NO.: 180 MAPKKKRKVGIHGVPAAGSSGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQRTH TGEKPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSQRAHLERHQRT HTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDALDD FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSI MKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPAPAP APAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQQLL NQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREGMFL PKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHLLED PDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHA MHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLKQAGDVEENPGPTSAGKLGSGEGRGSLLTCG DVEENPGPLEGSSGSGSLEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGEKPYKC PECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYK CPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGIFKPEELRQALMP TLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCS KLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQPQTTI NKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLENRVNDF LRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRR VYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAV SERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSK NKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEF SSLRRAQWSTMCMLVELHTQSQDSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >ZE5.3-VPR-tPT2a-ZE7-p300 mRNA SEQ ID NO.: 181 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCAUCAGGCUCACUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAA GAGCUUCUCGACCUCCGGGAACCUGACCGAGCACCAGCGCACCCACACCGGAGAGAAACCGUACAAGUGCCCCGAAUGCGGGA AAUCGUUCUCAGACUCGGGAAACCUCAGGGUGCACCAGCGGACCCACACGGGGGAAAAGCCGUACAAAUGCCCGGAGUGCGGG AAGUCAUUCUCCCACAAGAACGCGCUGCAGAACCACCAAAGAACCCACACCGGCGAAAAACCGUACAAGUGCCCCGAGUGCGG AAAGUCCUUCUCCCGCAACGACACCCUCACCGAACACCAACGCACCCACACCGGAGAAAAGCCCUACAAGUGCCCGGAAUGCG GAAAGAGCUUCAGCCAGAGGGCCCACCUGGAAAGACACCAGAGAACCCACACCGGCGAAAAGCCGUACAAAUGCCCGGAGUGC GGGAAGUCCUUCAGCCGGUCAGACAAGCUGGUCCGCCACCAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUG CGGAAAAUCGUUCAGCGACCCCGGACACCUGGUCCGGCACCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCU CAGCGAGCGGAUCAGGAGGAGGAUCAGGGGGGGACGCACUGGACGACUUCGACCUGGACAUGCUGGGAUCAGACGCACUGGAC GACUUCGACCUAGACAUGCUCGGAUCGGACGCACUCGACGACUUCGACCUCGACAUGCUAGGAUCAGACGCACUAGACGACUU CGACCUCGACAUGCUGUCGGGAGGACCGAAGAAAAAGCGGAAGGUCGGAUCACAGUACCUCCCGGACACCGACGACAGGCACA GAAUCGAAGAAAAACGCAAGCGCACCUACGAAACCUUCAAGAGCAUCAUGAAAAAGUCGCCGUUCUCAGGACCGACCGACCCC AGACCGCCACCGAGGAGAAUAGCCGUCCCGAGCCGAUCCUCCGCAUCCGUGCCGAAACCGGCACCGCAACCCUACCCGUUCAC CUCGUCCCUGUCGACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCUCCGGGCAGAUCUCACAGGCCUCGGCACUGG CACCCGCACCACCGCAAGUGCUGCCCCAAGCACCGGCACCCGCACCGGCGCCCGCAAUGGUGUCAGCGCUGGCACAGGCACCA GCACCGGUGCCAGUCCUCGCACCGGGACCGCCGCAAGCAGUGGCACCGCCGGCACCGAAACCGACCCAGGCCGGAGAAGGGAC CCUGUCCGAGGCGCUGCUGCAACUCCAGUUCGACGACGAGGACCUGGGAGCACUCCUGGGAAACUCCACCGACCCGGCAGUGU UCACCGACCUCGCAUCGGUGGACAACUCCGAGUUCCAACAGCUCCUGAACCAGGGGAUACCGGUGGCACCGCACACCACCGAA CCGAUGCUGAUGGAAUACCCGGAAGCCAUCACCCGGCUCGUGACCGGAGCGCAAAGACCGCCCGACCCCGCGCCCGCACCGCU GGGAGCACCGGGACUACCGAACGGGCUGCUCUCAGGGGACGAGGACUUCUCCAGCAUCGCAGACAUGGACUUCUCCGCCCUGC UGGGAUCAGGAUCAGGAUCACGCGACUCCCGGGAAGGAAUGUUCCUGCCGAAGCCGGAAGCAGGCAGCGCAAUCUCCGACGUG UUCGAAGGCCGCGAGGUCUGCCAGCCCAAGCGCCUGCGACCGUUCCACCCGCCGGGAUCACCGUGGGCAAACCGCCCGCUACC GGCAUCACUGGCACCGACACCCACCGGACCGGUGCACGAACCGGUCGGGUCACUGACCCCCGCACCGGUCCCGCAACCGCUAG ACCCGGCACCGGCAGUGACCCCGGAAGCAUCGCACCUCCUGGAGGACCCGGACGAGGAAACCUCACAGGCAGUGAAGGCCCUG CGGGAGAUGGCCGACACCGUGAUACCGCAGAAGGAGGAGGCCGCCAUCUGCGGACAAAUGGACCUGUCACACCCGCCCCCGAG AGGACACCUGGACGAACUCACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACUCACCGCUGACCCCGGAGCUGA ACGAAAUCCUGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCAAUGCACAUCAGCACCGGGCUGUCGAUCUUCGACACC AGCCUGUUCUCCGGAGGGAAAAGACCCGCCGCCACCAAGAAAGCGGGCCAAGCAAAGAAAAAGAAGGGAUCGUACCCCUACGA CGUGCCGGACUACGCAGCCACCAACUUUUCUCUGCUGAAGCAAGCCGGAGAUGUGGAGGAGAAUCCCGGCCCUACCUCCGCCG GAAAACUGGGCUCCGGCGAAGGCAGAGGAAGCCUCCUCACAUGCGGCGACGUGGAGGAGAACCCCGGCCCUCUGGAGGGAUCC UCAGGCUCAGGAUCCCUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAGCCGCAGCGACCAUCU GACCAAUCACCAACGCACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUAGUACCAGUGGCAGUC UGGUUCGUCAUCAGCGCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUUAGCCAAGCCGGUCAU CUGGCGAGCCAUCAACGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUUUAGCCGUAGCGAUAA ACUGACCGAACACCAACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUUUCAGCACCAGCGGCA AUCUGACCGAGCAUCAACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGUUUUAGUCAGAGCAGU AAUCUGGUGCGCCAUCAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAGUUUUAGCACCCAUCU GGAUCUGAUCCGUCAUCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGUGCUAGCGGCAGCGGCGGCGGCA GCGGCGGCAUCUUCAAGCCCGAGGAGCUGCGGCAGGCCCUGAUGCCCACCCUGGAGGCCCUGUACCGGCAGGACCCCGAGAGC CUGCCCUUCCGGCAGCCCGUGGACCCCCAGCUGCUGGGCAUCCCCGACUACUUCGACAUCGUGAAAUCCCCCAUGGACCUGAG CACCAUCAAGCGGAAGCUGGACACCGGCCAGUACCAGGAGCCCUGGCAGUACGUGGACGACAUCUGGCUGAUGUUCAACAACG CCUGGCUGUACAACCGGAAAACCAGCCGGGUGUACAAGUACUGCAGCAAGCUGAGCGAGGUGUUCGAGCAGGAGAUCGACCCC GUGAUGCAGAGCCUGGGCUACUGCUGCGGCCGGAAGCUGGAGUUCAGCCCCCAGACCCUGUGCUGCUACGGCAAGCAGCUGUG CACCAUCCCCCGGGACGCCACCUACUACAGCUACCAGAACCGGUACCACUUCUGCGAGAAGUGCUUCAACGAGAUCCAGGGCG AGAGCGUGAGCCUGGGCGACGACCCCAGCCAGCCCCAGACCACCAUCAACAAGGAGCAGUUCAGCAAGCGGAAGAACGACACC CUGGACCCCGAGCUGUUCGUGGAGUGCACCGAGUGCGGCCGGAAGAUGCACCAGAUCUGCGUGCUGCACCACGAGAUCAUCUG GCCCGCCGGCUUCGUGUGCGACGGCUGCCUGAAGAAAUCCGCCCGGACCCGGAAGGAGAACAAGUUCAGCGCCAAGCGGCUGC CCAGCACCCGGCUGGGCACCUUCCUGGAGAACCGGGUGAACGACUUCCUGCGGCGGCAGAACCACCCCGAGAGCGGCGAGGUG ACCGUGCGGGUGGUGCACGCCAGCGACAAGACCGUGGAGGUGAAGCCCGGCAUGAAGGCCCGGUUCGUGGACAGCGGCGAGAU GGCCGAGAGCUUCCCCUACCGGACCAAGGCCCUGUUCGCCUUCGAGGAGAUCGACGGCGUGGACCUGUGCUUCUUCGGCAUGC ACGUGCAGGAGUACGGCAGCGACUGCCCCCCCCCCAACCAGCGGCGGGUGUACAUCAGCUACCUGGACAGCGUGCACUUCUUC CGGCCCAAGUGCCUGCGGACCGCCGUGUACCACGAGAUCCUGAUCGGCUACCUGGAGUACGUGAAGAAGCUGGGCUACACCAC CGGCCACAUCUGGGCCUGCCCCCCCAGCGAGGGCGACGACUACAUCUUCCACUGCCACCCCCCCGACCAGAAGAUCCCCAAGC CCAAGCGGCUGCAGGAGUGGUACAAGAAGAUGCUGGACAAGGCCGUGAGCGAGCGGAUCGUGCACGACUACAAGGACAUCUUC AAGCAGGCCACCGAGGACCGGCUGACCAGCGCCAAGGAGCUGCCCUACUUCGAGGGCGACUUCUGGCCCAACGUGCUGGAGGA GAGCAUCAAGGAGCUGGAGCAGGAGGAGGAGGAGCGGAAGCGGGAGGAGAACACCAGCAACGAGAGCACCGACGUGACCAAGG GCGACAGCAAGAACGCCAAGAAGAAGAACAACAAGAAAACCAGCAAGAACAAGAGCAGCCUGAGCCGGGGCAACAAGAAGAAG CCCGGCAUGCCCAACGUGAGCAACGACCUGAGCCAGAAGCUGUACGCCACCAUGGAGAAGCACAAGGAGGUGUUCUUCGUGAU CCGGCUGAUCGCCGGCCCCGCCGCCAACAGCCUGCCCCCCAUCGUGGACCCCGACCCCCUGAUCCCCUGCGACCUGAUGGACG GCCGGGACGCCUUCCUGACCCUGGCCCGGGACAAGCACCUGGAGUUCAGCAGCCUGCGGCGGGCCCAGUGGAGCACCAUGUGC AUGCUGGUGGAGCUGCACACCCAGAGCCAGGACAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAA GAAGAAGGGCAGCUACCCCUACGACGUGCCCGACUACGCCUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUU CUGGCCAUGCCCUUCUUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >Nucleotide Seqeunce of DNA binding domain of ZF5.3-VPR-tPT2a-ZF7-p300; 1 SEQ ID NO.: 240 CUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGAAUGCGGCAAGAGCUUCUCGACCUCCGGGAACCUGACCGAGCACCAGCG CACCCACACCGGAGAGAAACCGUACAAGUGCCCCGAAUGCGGGAAAUCGUUCUCAGACUCGGGAAACCUCAGGGUGCACCAGC GGACCCACACGGGGGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCAUUCUCCCACAAGAACGCGCUGCAGAACCACCAA AGAACCCACACCGGCGAAAAACCGUACAAGUGCCCCGAGUGCGGAAAGUCCUUCUCCCGCAACGACACCCUCACCGAACACCA ACGCACCCACACCGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAGAGCUUCAGCCAGAGGGCCCACCUGGAAAGACACC AGAGAACCCACACCGGCGAAAAGCCGUACAAAUGCCCGGAGUGCGGGAAGUCCUUCAGCCGGUCAGACAAGCUGGUCCGCCAC CAAAGGACCCACACAGGAGAAAAGCCCUACAAGUGCCCGGAAUGCGGAAAAUCGUUCAGCGACCCCGGACACCUGGUCCGGCA CCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCUCA >Nucleotide Seqeunce of DNA binding domain of ZF5.3-VPR-tPT2a-ZF7-p300; 2 SEQ ID NO.: 241 CTGGAACCGGGCGAGAAGCCATACAAGTGCCCAGAGTGCGGCAAAAGCTTCAGCCGCAGCGACCATCTGACCAATCACCAACG CACCCATACCGGTGAGAAGCCGTACAAATGCCCAGAGTGCGGTAAGAGCTTTAGTACCAGTGGCAGTCTGGTTCGTCATCAGC GCACGCACACGGGCGAAAAACCATACAAATGCCCGGAGTGCGGCAAAAGCTTTAGCCAAGCCGGTCATCTGGCGAGCCATCAA CGTACGCACACCGGCGAGAAGCCGTATAAATGTCCGGAGTGCGGTAAGAGCTTTAGCCGTAGCGATAAACTGACCGAACACCA ACGTACGCATACGGGCGAGAAACCATATAAATGTCCAGAGTGTGGCAAGAGTTTCAGCACCAGCGGCAATCTGACCGAGCATC AACGTACCCATACCGGTGAAAAGCCATATAAATGTCCAGAATGCGGTAAGAGTTTTAGTCAGAGCAGTAATCTGGTGCGCCAT CAGCGTACCCACACGGGTGAGAAACCATATAAGTGTCCGGAATGCGGCAAGAGTTTTAGCACCCATCTGGATCTGATCCGTCA TCAGCGCACCCACACCGGTGAAAAACCAACCGGCAAGAAAACCAGT >ZF7-p300-tPT2a-ZF5.3-VPR protein SEQ ID NO.: 182 MAPKKKRKVGIHGVPAAGSSGSLEPGEKPYKCPECGKSFSRSDHLTNHQRTHTGEKPYKCPECGKSFSTSGSLVRHQRTHTGE KPYKCPECGKSFSQAGHLASHQRTHTGEKPYKCPECGKSFSRSDKLTEHQRTHTGEKPYKCPECGKSFSTSGNLTEHQRTHTG EKPYKCPECGKSFSQSSNLVRHQRTHTGEKPYKCPECGKSFSTHLDLIRHQRTHTGEKPTGKKTSASGSGGGSGGIFKPEELR QALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRV YKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQ PQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLEN RVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPP PNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKM LDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNN KKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARD KHLEFSSLRRAQWSTMCMLVELHTQSQDSGGKRPAATKKAGQAKKKKGSYPYDVPDYAATNFSLLKQAGDVEENPGPTSAGKL GSGEGRGSLLTCGDVEENPGPLEGSSGSLEPGEKPYKCPECGKSFSTSGNLTEHQRTHTGEKPYKCPECGKSFSDSGNLRVHQ RTHTGEKPYKCPECGKSFSHKNALQNHQRTHTGEKPYKCPECGKSFSRNDTLTEHQRTHTGEKPYKCPECGKSFSQRAHLERH QRTHTGEKPYKCPECGKSFSRSDKLVRHQRTHTGEKPYKCPECGKSFSDPGHLVRHQRTHTGEKPTGKKTSASGSGGGSGGDA LDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETF KSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQAPA PAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSEFQ QLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSREG MFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEASHL LEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECL LHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >>ZF7-p300-tPT2a-ZF5.3-VPR mRNA SEQ ID NO.: 183 AGGAAAUAAGAGAGAAAAGAAGAGUAAGAAGAAAUAUAAGAGCCACCAUGGCCCCCAAGAAGAAGCGGAAGGUGGGCAUCCAC GGCGUGCCCGCCGCCGGCAGCAGCGGAUCCCUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAG CCGCAGCGACCAUCUGACCAAUCACCAACGCACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUA GUACCAGUGGCAGUCUGGUUCGUCAUCAGCGCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUU AGCCAAGCCGGUCAUCUGGCGAGCCAUCAACGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUU UAGCCGUAGCGAUAAACUGACCGAACACCAACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUU UCAGCACCAGCGGCAAUCUGACCGAGCAUCAACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGU UUUAGUCAGAGCAGUAAUCUGGUGCGCCAUCAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAG UUUUAGCACCCAUCUGGAUCUGAUCCGUCAUCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGUGCUAGCG GCAGCGGCGGCGGCAGCGGCGGCAUCUUCAAGCCCGAGGAGCUGCGGCAGGCCCUGAUGCCCACCCUGGAGGCCCUGUACCGG CAGGACCCCGAGAGCCUGCCCUUCCGGCAGCCCGUGGACCCCCAGCUGCUGGGCAUCCCCGACUACUUCGACAUCGUGAAAUC CCCCAUGGACCUGAGCACCAUCAAGCGGAAGCUGGACACCGGCCAGUACCAGGAGCCCUGGCAGUACGUGGACGACAUCUGGC UGAUGUUCAACAACGCCUGGCUGUACAACCGGAAAACCAGCCGGGUGUACAAGUACUGCAGCAAGCUGAGCGAGGUGUUCGAG CAGGAGAUCGACCCCGUGAUGCAGAGCCUGGGCUACUGCUGCGGCCGGAAGCUGGAGUUCAGCCCCCAGACCCUGUGCUGCUA CGGCAAGCAGCUGUGCACCAUCCCCCGGGACGCCACCUACUACAGCUACCAGAACCGGUACCACUUCUGCGAGAAGUGCUUCA ACGAGAUCCAGGGCGAGAGCGUGAGCCUGGGCGACGACCCCAGCCAGCCCCAGACCACCAUCAACAAGGAGCAGUUCAGCAAG CGGAAGAACGACACCCUGGACCCCGAGCUGUUCGUGGAGUGCACCGAGUGCGGCCGGAAGAUGCACCAGAUCUGCGUGCUGCA CCACGAGAUCAUCUGGCCCGCCGGCUUCGUGUGCGACGGCUGCCUGAAGAAAUCCGCCCGGACCCGGAAGGAGAACAAGUUCA GCGCCAAGCGGCUGCCCAGCACCCGGCUGGGCACCUUCCUGGAGAACCGGGUGAACGACUUCCUGCGGCGGCAGAACCACCCC GAGAGCGGCGAGGUGACCGUGCGGGUGGUGCACGCCAGCGACAAGACCGUGGAGGUGAAGCCCGGCAUGAAGGCCCGGUUCGU GGACAGCGGCGAGAUGGCCGAGAGCUUCCCCUACCGGACCAAGGCCCUGUUCGCCUUCGAGGAGAUCGACGGCGUGGACCUGU GCUUCUUCGGCAUGCACGUGCAGGAGUACGGCAGCGACUGCCCCCCCCCCAACCAGCGGCGGGUGUACAUCAGCUACCUGGAC AGCGUGCACUUCUUCCGGCCCAAGUGCCUGCGGACCGCCGUGUACCACGAGAUCCUGAUCGGCUACCUGGAGUACGUGAAGAA GCUGGGCUACACCACCGGCCACAUCUGGGCCUGCCCCCCCAGCGAGGGCGACGACUACAUCUUCCACUGCCACCCCCCCGACC AGAAGAUCCCCAAGCCCAAGCGGCUGCAGGAGUGGUACAAGAAGAUGCUGGACAAGGCCGUGAGCGAGCGGAUCGUGCACGAC UACAAGGACAUCUUCAAGCAGGCCACCGAGGACCGGCUGACCAGCGCCAAGGAGCUGCCCUACUUCGAGGGCGACUUCUGGCC CAACGUGCUGGAGGAGAGCAUCAAGGAGCUGGAGCAGGAGGAGGAGGAGCGGAAGCGGGAGGAGAACACCAGCAACGAGAGCA CCGACGUGACCAAGGGCGACAGCAAGAACGCCAAGAAGAAGAACAACAAGAAAACCAGCAAGAACAAGAGCAGCCUGAGCCGG GGCAACAAGAAGAAGCCCGGCAUGCCCAACGUGAGCAACGACCUGAGCCAGAAGCUGUACGCCACCAUGGAGAAGCACAAGGA GGUGUUCUUCGUGAUCCGGCUGAUCGCCGGCCCCGCCGCCAACAGCCUGCCCCCCAUCGUGGACCCCGACCCCCUGAUCCCCU GCGACCUGAUGGACGGCCGGGACGCCUUCCUGACCCUGGCCCGGGACAAGCACCUGGAGUUCAGCAGCCUGCGGCGGGCCCAG UGGAGCACCAUGUGCAUGCUGGUGGAGCUGCACACCCAGAGCCAGGACAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGC CGGCCAGGCCAAGAAGAAGAAGGGCAGCUACCCCUACGACGUGCCCGACUACGCCGCCACCAACUUUUCUCUGCUGAAGCAAG CCGGAGAUGUGGAGGAGAAUCCCGGCCCUACCUCCGCCGGAAAACUGGGCUCCGGCGAAGGCAGAGGAAGCCUCCUCACAUGC GGCGACGUGGAGGAGAACCCCGGCCCUCUGGAGGGAUCCUCAGGCUCACUGGAACCGGGGGAAAAACCCUACAAGUGCCCGGA AUGCGGCAAGAGCUUCUCGACCUCCGGGAACCUGACCGAGCACCAGCGCACCCACACCGGAGAGAAACCGUACAAGUGCCCCG AAUGCGGGAAAUCGUUCUCAGACUCGGGAAACCUCAGGGUGCACCAGCGGACCCACACGGGGGAAAAGCCGUACAAAUGCCCG GAGUGCGGGAAGUCAUUCUCCCACAAGAACGCGCUGCAGAACCACCAAAGAACCCACACCGGCGAAAAACCGUACAAGUGCCC CGAGUGCGGAAAGUCCUUCUCCCGCAACGACACCCUCACCGAACACCAACGCACCCACACCGGAGAAAAGCCCUACAAGUGCC CGGAAUGCGGAAAGAGCUUCAGCCAGAGGGCCCACCUGGAAAGACACCAGAGAACCCACACCGGCGAAAAGCCGUACAAAUGC CCGGAGUGCGGGAAGUCCUUCAGCCGGUCAGACAAGCUGGUCCGCCACCAAAGGACCCACACAGGAGAAAAGCCCUACAAGUG CCCGGAAUGCGGAAAAUCGUUCAGCGACCCCGGACACCUGGUCCGGCACCAGAGGACCCACACCGGGGAGAAGCCGACCGGCA AAAAGACCUCAGCGAGCGGAUCAGGAGGAGGAUCAGGGGGGGACGCACUGGACGACUUCGACCUGGACAUGCUGGGAUCAGAC GCACUGGACGACUUCGACCUAGACAUGCUCGGAUCGGACGCACUCGACGACUUCGACCUCGACAUGCUAGGAUCAGACGCACU AGACGACUUCGACCUCGACAUGCUGUCGGGAGGACCGAAGAAAAAGCGGAAGGUCGGAUCACAGUACCUCCCGGACACCGACG ACAGGCACAGAAUCGAAGAAAAACGCAAGCGCACCUACGAAACCUUCAAGAGCAUCAUGAAAAAGUCGCCGUUCUCAGGACCG ACCGACCCCAGACCGCCACCGAGGAGAAUAGCCGUCCCGAGCCGAUCCUCCGCAUCCGUGCCGAAACCGGCACCGCAACCCUA CCCGUUCACCUCGUCCCUGUCGACCAUCAACUACGACGAGUUCCCCACCAUGGUGUUCCCCUCCGGGCAGAUCUCACAGGCCU CGGCACUGGCACCCGCACCACCGCAAGUGCUGCCCCAAGCACCGGCACCCGCACCGGCGCCCGCAAUGGUGUCAGCGCUGGCA CAGGCACCAGCACCGGUGCCAGUCCUCGCACCGGGACCGCCGCAAGCAGUGGCACCGCCGGCACCGAAACCGACCCAGGCCGG AGAAGGGACCCUGUCCGAGGCGCUGCUGCAACUCCAGUUCGACGACGAGGACCUGGGAGCACUCCUGGGAAACUCCACCGACC CGGCAGUGUUCACCGACCUCGCAUCGGUGGACAACUCCGAGUUCCAACAGCUCCUGAACCAGGGGAUACCGGUGGCACCGCAC ACCACCGAACCGAUGCUGAUGGAAUACCCGGAAGCCAUCACCCGGCUCGUGACCGGAGCGCAAAGACCGCCCGACCCCGCGCC CGCACCGCUGGGAGCACCGGGACUACCGAACGGGCUGCUCUCAGGGGACGAGGACUUCUCCAGCAUCGCAGACAUGGACUUCU CCGCCCUGCUGGGAUCAGGAUCAGGAUCACGCGACUCCCGGGAAGGAAUGUUCCUGCCGAAGCCGGAAGCAGGCAGCGCAAUC UCCGACGUGUUCGAAGGCCGCGAGGUCUGCCAGCCCAAGCGCCUGCGACCGUUCCACCCGCCGGGAUCACCGUGGGCAAACCG CCCGCUACCGGCAUCACUGGCACCGACACCCACCGGACCGGUGCACGAACCGGUCGGGUCACUGACCCCCGCACCGGUCCCGC AACCGCUAGACCCGGCACCGGCAGUGACCCCGGAAGCAUCGCACCUCCUGGAGGACCCGGACGAGGAAACCUCACAGGCAGUG AAGGCCCUGCGGGAGAUGGCCGACACCGUGAUACCGCAGAAGGAGGAGGCCGCCAUCUGCGGACAAAUGGACCUGUCACACCC GCCCCCGAGAGGACACCUGGACGAACUCACCACCACCCUGGAGAGCAUGACCGAGGACCUGAACCUGGACUCACCGCUGACCC CGGAGCUGAACGAAAUCCUGGACACCUUCCUGAACGACGAGUGCCUGCUGCACGCAAUGCACAUCAGCACCGGGCUGUCGAUC UUCGACACCAGCCUGUUCUCCGGAGGGAAAAGACCCGCCGCCACCAAGAAAGCGGGCCAAGCAAAGAAAAAGAAGGGAUCGUA CCCCUACGACGUGCCGGACUACGCAUGAGCGGCCGCUUAAUUAAGCUGCCUUCUGCGGGGCUUGCCUUCUGGCCAUGCCCUUC UUCUCUCCCUUGCACCUGUACCUCUUGGUCUUUGAAUAAAGCCUGAGUAGGAAGUCUAGAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >Nucleotide Seqeunce of DNA binding domain of ZF7-p300-tPT2a-ZF5.3-VPR SEQ ID NO.: 242 CUGGAACCGGGCGAGAAGCCAUACAAGUGCCCAGAGUGCGGCAAAAGCUUCAGCCGCAGCGACCAUCUGACCAAUCACCAACG CACCCAUACCGGUGAGAAGCCGUACAAAUGCCCAGAGUGCGGUAAGAGCUUUAGUACCAGUGGCAGUCUGGUUCGUCAUCAGC GCACGCACACGGGCGAAAAACCAUACAAAUGCCCGGAGUGCGGCAAAAGCUUUAGCCAAGCCGGUCAUCUGGCGAGCCAUCAA CGUACGCACACCGGCGAGAAGCCGUAUAAAUGUCCGGAGUGCGGUAAGAGCUUUAGCCGUAGCGAUAAACUGACCGAACACCA ACGUACGCAUACGGGCGAGAAACCAUAUAAAUGUCCAGAGUGUGGCAAGAGUUUCAGCACCAGCGGCAAUCUGACCGAGCAUC AACGUACCCAUACCGGUGAAAAGCCAUAUAAAUGUCCAGAAUGCGGUAAGAGUUUUAGUCAGAGCAGUAAUCUGGUGCGCCAU CAGCGUACCCACACGGGUGAGAAACCAUAUAAGUGUCCGGAAUGCGGCAAGAGUUUUAGCACCCAUCUGGAUCUGAUCCGUCA UCAGCGCACCCACACCGGUGAAAAACCAACCGGCAAGAAAACCAGU >Nucleotide Seqeunce of DNA binding domain of ZF7-p300-tPT2a-ZF5.3-VPR SEQ ID NO.: 243 CTGGAACCGGGGGAAAAACCCTACAAGTGCCCGGAATGCGGCAAGAGCTTCTCGACCTCCGGGAACCTGACCGAGCACCAGCG CACCCACACCGGAGAGAAACCGTACAAGTGCCCCGAATGCGGGAAATCGTTCTCAGACTCGGGAAACCTCAGGGTGCACCAGC GGACCCACACGGGGGAAAAGCCGTACAAATGCCCGGAGTGCGGGAAGTCATTCTCCCACAAGAACGCGCTGCAGAACCACCAA AGAACCCACACCGGCGAAAAACCGTACAAGTGCCCCGAGTGCGGAAAGTCCTTCTCCCGCAACGACACCCTCACCGAACACCA ACGCACCCACACCGGAGAAAAGCCCTACAAGTGCCCGGAATGCGGAAAGAGCTTCAGCCAGAGGGCCCACCTGGAAAGACACC AGAGAACCCACACCGGCGAAAAGCCGTACAAATGCCCGGAGTGCGGGAAGTCCTTCAGCCGGTCAGACAAGCTGGTCCGCCAC CAAAGGACCCACACAGGAGAAAAGCCCTACAAGTGCCCGGAATGCGGAAAATCGTTCAGCGACCCCGGACACCTGGTCCGGCA CCAGAGGACCCACACCGGGGAGAAGCCGACCGGCAAAAAGACCTCA >TAL1-VPR protein SEQ ID NO.: 184 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLNLTPEQV VAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALET VQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLT PEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQA HGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNI GGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPV LCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASNNGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTNRRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >TAL1-VPR mRNA SEQ ID NO.: 185 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCCATGATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA TAATGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAACAATGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCACATGACGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAATAATGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTAATGGTGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAACAATGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAATAATGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTAACATTGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCAAATAATGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAACAATGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTCATGATGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCAATATAGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCAAATAATGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCAACA ATGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCAAATAATGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTAATATCGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAACAATGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL1 amino acid sequence SEQ ID NO.: 186 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQVVAIASHDGGKQALETVQRLL PVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVV AIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETV QRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTP EQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAH GLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNG GKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL1 mRNA SEQ ID NO.: 244 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCCAUGAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAAUAAUGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAACAAUG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCACAUGACGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAAUAAUGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUAAUGGUGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAACAAUGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAAUAAUGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUAACAUUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCAAAUAAUGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAACAAUGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUCA UGAUGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCAAUAUAGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCAAAUAAUGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCAACAAUGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCAAAUAAUGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUAAUAUCGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAACAAUGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL2-VPR protein SEQ ID NO.: 187 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQV VAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALET VQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLT PEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQA HGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNN GGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPV LCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASUNGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTNRRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >TAL2-VPR mRNA SEQ ID NO.: 188 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCAATGGTGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA TGGCGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCACATGATGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAATAATGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAACAATGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTAATAATGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAACAATGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAATGGGGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTAATAATGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCAAACAATGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAATAATGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTCATGATGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCAACAATGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCACATGACGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCCATG ATGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCACATGACGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTAACATTGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAACAATGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL2 amino acid sequence SEQ ID NO.: 189 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLNLTPEQVVAIASNGGGKQALETVQRLL PVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVV AIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETV QRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTP EQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAH GLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDG GKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL2 mRNA sequence SEQ ID NO.: 245 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCAAUGGUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAAUGGCGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCACAUGAUG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAAUAAUGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAACAAUGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUAAUAAUGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAACAAUGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAAUGGGGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUAAUAAUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCAAACAAUGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAAUAAUGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUCA UGAUGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCAACAAUGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCACAUGACGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCCAUGAUGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCACAUGACGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUAACAUUGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAACAAUGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL3-VPR protein SEQ ID NO.: 190 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQV VAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALET VQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLT PEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQA HGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNN GGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPV LCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASNIGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA >TAL3-VPR mRNA SEQ ID NO.: 191 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCAATAATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA TGGTGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAATGGCGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAATGGGGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAACAATGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTAACATTGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAATATCGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAATATAGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTAATAATGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCAAACAATGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAACATTGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTAATATCGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCAATAATGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCAAACAATGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCCATG ATGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCAAATATAGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTAATAATGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAACATTGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL3 amino acid sequence SEQ ID NO.: 192 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQVVAIASUNGGKQALETVQRLL PVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVV AIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETV QRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTP EQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAH GLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIG GKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL3 mRNA sequence SEQ ID NO.: 246 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCAAUAAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAAUGGUGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAAUGGCG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAAUGGGGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAACAAUGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUAACAUUGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAAUAUCGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAAUAUAGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUAAUAAUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCAAACAAUGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAACAUUGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUAA UAUCGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCAAUAAUGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCAAACAAUGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCCAUGAUGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCAAAUAUAGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUAAUAAUGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAACAUUGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL4-VPR protein SEQ ID NO.: 193 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLNLTPEQV VAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALET VQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLT PEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQA HGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHD GGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPV LCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASNIGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTNRRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDY* >TAL4-VPR mRNA SEQ ID NO.: 194 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCCATGATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCCA TGACGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAACATTGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAATAATGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTCATGATGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTAATATCGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAACAATGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAATATAGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTAATGGTGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCACATGACGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAATGGCGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTAATGGGGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCCATGATGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCACATGACGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCCATG ATGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCAAACATTGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTAATAATGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAATATCGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL4 amino acid sequence SEQ ID NO.: 195 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQVVAIASHDGGKQALETVQRLL PVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVV AIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETV QRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTP EQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAH GLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIG GKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL4 mRNA sequence SEQ ID NO.: 247 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCCAUGAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCCAUGACGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAACAUUG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAAUAAUGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUCAUGAUGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUAAUAUCGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAACAAUGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAAUAUAGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUAAUGGUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCACAUGACGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAAUGGCGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUAA UGGGGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCCAUGAUGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCACAUGACGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCCAUGAUGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCAAACAUUGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUAAUAAUGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAAUAUCGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL5-VPR protein SEQ ID NO.: 196 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLNLTPEQV VAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALET VQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLT PEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQA HGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNI GGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPV LCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASNGGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTNRRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA >TAL5-VPR mRNA SEQ ID NO.: 197 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCAATAATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA CAATGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAATAATGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAACAATGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAATAATGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTAACATTGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTCATGATGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCCATGACGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTAACAATGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCAAATATCGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAATGGTGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTAATGGCGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCAATATAGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCAAACATTGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCCATG ATGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCACATGACGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTAATATCGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAATGGGGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL5 amino acid SEQ ID NO.: 198 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQVVAIASUNGGKQALETVQRLL PVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVV AIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETV QRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTP EQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAH GLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDG GKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL5 mRNA SEQ ID NO.: 248 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCAAUAAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAACAAUGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAAUAAUG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAACAAUGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAAUAAUGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUAACAUUGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUCAUGAUGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCCAUGACGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUAACAAUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCAAAUAUCGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAAUGGUGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUAA UGGCGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCAAUAUAGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCAAACAUUGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCCAUGAUGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCACAUGACGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUAAUAUCGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAAUGGGGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL6-VPR protein SEQ ID NO.: 199 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQV VAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALET VQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLT PEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQA HGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNI GGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPV LCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASNIGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTNRRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDY* >TAL6-VPR mRNA SEQ ID NO.: 200 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCAATAATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA CAATGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAATGGTGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAATAATGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAATGGCGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTCATGATGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAACATTGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAACAATGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTCATGACGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCACATGATGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAATATCGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTAATAATGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCAATATAGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCAAACATTGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCAATA TCGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCACATGATGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTCATGACGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAATATAGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL6 amino acid sequence SEQ ID NO.: 201 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQVVAIASUNGGKQALETVQRLL PVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVV AIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETV QRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTP EQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAH GLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDG GKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL6 mRNA sequence SEQ ID NO.: 249 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCAAUAAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAACAAUGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAAUGGUG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAAUAAUGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAAUGGCGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUCAUGAUGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAACAUUGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAACAAUGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUCAUGACGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCACAUGAUGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAAUAUCGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUAA UAAUGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCAAUAUAGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCAAACAUUGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCAAUAUCGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCACAUGAUGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUCAUGACGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAAUAUAGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL7-VPR protein SEQ ID NO.: 202 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQV VAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALET VQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLT PEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQA HGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNN GGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPV LCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASNIGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >TAL7-VPR mRNA SEQ ID NO.: 203 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCCATGATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA TGGTGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAATAATGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAACATTGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAATATCGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTCATGACGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAATATAGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAATGGCGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTCATGATGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCAAATAATGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAACAATGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTAATGGGGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCAATAATGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCAAACATTGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCAACA ATGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCAAACGGTGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTAATGGTGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAATATCGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL7 amino acid sequence SEQ ID NO.: 204 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLNLTPEQVVAIASHDGGKQALETVQRLL PVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVV AIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETV QRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTP EQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAH GLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGG GKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTNRRIPERTSHRVAS >TAL7 mRNA sequence SEQ ID NO.: 250 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCCAUGAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAAUGGUGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAAUAAUG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAACAUUGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAAUAUCGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUCAUGACGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAAUAUAGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAAUGGCGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUCAUGAUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCAAAUAAUGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAACAAUGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUAA UGGGGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCAAUAAUGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCAAACAUUGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCAACAAUGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCAAACGGUGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUAAUGGUGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAAUAUCGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL8-VPR protein SEQ ID NO.: 205 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQV VAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALET VQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLT PEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNGGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQA HGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNI GGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPV LCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASUGGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >TAL8-VPR mRNA SEQ ID NO.: 206 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCCATGATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA TGGTGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAATGGCGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAATAATGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAACAATGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTAATAATGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAACAATGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAATGGGGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTAATAATGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCAAACATTGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTCATGACGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTAATATCGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCAATATAGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCAAACGGTGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCAACA ATGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCAAATAATGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTCATGATGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAATGGTGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL8 amino acid sequence SEQ ID NO.: 207 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQVVAIASHDGGKQALETVQRLL PVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVV AIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNGGKQALETV QRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTP EQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAH GLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNNG GKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL8 mRNA sequence SEQ ID NO.: 251 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCCAUGAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAAUGGUGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAAUGGCG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAAUAAUGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAACAAUGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUAAUAAUGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAACAAUGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAAUGGGGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUAAUAAUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCAAACAUUGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUCAUGACGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUAA UAUCGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCAAUAUAGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCAAACGGUGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCAACAAUGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCAAAUAAUGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUCAUGAUGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAAUGGUGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC >TAL9-VPR protein SEQ ID NO.: 208 MAPKKKRKVGIHGVPAAGSSGSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQ DMIAALPEATHEAIVGVGKRGAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQV VAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALET VQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLT PEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQ ALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQA HGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHD GGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPV LCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAI ASNIGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVASGSGGGSGG DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYE TFKSIMKKSPFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDEFPTMVFPSGQISQASALAPAPPQVLPQA PAPAPAPAMVSALAQAPAPVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALLGNSTDPAVFTDLASVDNSE FQQLLNQGIPVAPHTTEPMLMEYPEAITRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALLGSGSGSRDSR EGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPGSPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEAS HLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPRGHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDE CLLHAMHISTGLSIFDTSLFSGGKRPAATKKAGQAKKKKGSYPYDVPDYA* >TAL9-VPR mRNA SEQ ID NO.: 209 AGGAAATAAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATGGCCCCCAAGAAGAAGCGGAAGGTGGGCATCCAC GGCGTGCCCGCCGCCGGCAGCAGCGGATCCCATATGGTTGATCTGCGTACCCTGGGTTATAGCCAGCAGCAGCAAGAAAAAAT CAAACCGAAAGTTCGTAGCACCGTTGCACAGCATCATGAAGCACTGGTTGGTCATGGTTTTACCCATGCACATATTGTTGCAC TGAGCCAGCATCCGGCAGCACTGGGCACCGTTGCAGTTAAATATCAGGATATGATTGCAGCACTGCCGGAAGCAACCCATGAA GCAATTGTTGGTGTTGGTAAACGCGGAGCTGGTGCACGTGCCCTGGAAGCACTGCTGACCGTTGCCGGTGAACTGCGTGGTCC GCCTCTGCAGCTGGATACCGGTCAGCTGCTGAAAATTGCAAAACGTGGTGGTGTTACCGCAGTTGAAGCAGTTCATGCATGGC GTAATGCACTGACCGGTGCACCGCTGAATCTGACACCGGAACAGGTTGTTGCAATTGCCAGCAATAATGGTGGCAAACAGGCA CTGGAAACCGTTCAGCGTCTGCTGCCGGTTCTGTGTCAGGCACATGGTCTGACCCCTGAACAGGTGGTGGCCATTGCAAGCAA CATTGGCGGTAAACAAGCCCTGGAAACAGTGCAGCGCCTGTTACCGGTGCTGTGCCAGGCCCATGGCTTAACTCCGGAACAGG TGGTAGCGATCGCATCAAATATCGGAGGTAAACAGGCCTTAGAAACCGTACAGCGCTTACTGCCGGTGTTATGCCAGGCGCAC GGCCTGACGCCAGAACAGGTAGTGGCAATCGCCTCAAATGGTGGTGGAAAACAGGCGTTAGAGACAGTCCAGCGCCTGCTGCC TGTATTATGTCAAGCCCATGGCCTGACCCCAGAGCAAGTTGTTGCGATTGCAAGTAATGGCGGGGGTAAACAGGCACTTGAGA CAGTTCAACGTTTACTGCCTGTACTGTGCCAAGCTCACGGTCTGACTCCGGAACAAGTCGTCGCGATTGCGAGTAATATAGGT GGCAAACAAGCATTAGAAACGGTGCAACGCCTGCTGCCAGTTCTTTGCCAGGCTCACGGTTTAACCCCTGAGCAGGTTGTAGC TATTGCGAGTAACAATGGTGGTAAGCAGGCGTTGGAAACTGTGCAAAGACTGCTGCCCGTGTTGTGCCAAGCACATGGTTTAA CCCCAGAACAAGTCGTAGCAATCGCAAGCAATAATGGTGGCAAGCAAGCGCTTGAAACAGTACAGCGTTTATTACCGGTACTT TGTCAGGCCCACGGTCTTACACCAGAACAAGTTGTGGCCATAGCCAGTAACAATGGCGGAAAGCAGGCTCTGGAAACGGTACA ACGTCTGTTACCTGTTCTGTGTCAAGCGCACGGATTAACACCTGAACAAGTAGTTGCCATTGCGTCAAATAATGGAGGCAAGC AGGCCTTGGAGACAGTGCAGAGATTACTGCCAGTGTTGTGTCAGGCTCATGGCCTTACACCCGAGCAGGTCGTGGCAATTGCA TCTAACATTGGCGGTAAGCAAGCTTTAGAGACTGTTCAGAGACTGCTTCCTGTCCTGTGCCAGGCACACGGACTTACGCCTGA GCAAGTGGTTGCAATCGCCTCTAATGGGGGTGGTAAGCAAGCACTGGAAACTGTCCAACGCTTACTTCCGGTGCTTTGTCAAG CACACGGCTTAACGCCAGAGCAGGTCGTCGCCATAGCCAGCCATGATGGTGGTAAACAGGCCCTTGAAACGGTCCAAAGACTT CTGCCGGTCCTTTGCCAAGCGCATGGGCTGACACCTGAGCAGGTAGTCGCGATTGCCTCAAACGGTGGTGGGAAGCAGGCATT AGAAACAGTTCAAAGATTATTACCAGTCCTGTGTCAGGCGCATGGGTTAACCCCAGAGCAGGTAGTTGCAATAGCATCCCATG ACGGCGGAAAACAAGCGTTGGAAACGGTTCAGCGGTTATTGCCTGTTTTGTGCCAGGCGCATGGTTTGACACCCGAGCAAGTG GTAGCCATAGCCTCAAACAATGGGGGTAAACAAGCTTTGGAGACAGTACAACGGCTGCTTCCAGTTTTATGTCAGGCCCATGG ATTGACGCCTGAACAAGTTGTCGCTATCGCAAGTAATAATGGTGGTAAACAAGCGCTTGAAACCGTTCAACGCCTTCTGCCTG TGCTTTGTCAGGCACATGGATTAACACCCGAACAGGTTGTCGCGATAGCTTCAAATATCGGTGGTCGTCCGGCACTGGAAAGC ATTGTTGCACAGCTGAGCCGTCCTGATCCGGCACTGGCAGCACTGACCAATGATCATCTGGTTGCACTGGCATGTCTGGGTGG TCGCCCTGCCCTGGATGCAGTTAAAAAAGGTCTGCCGCATGCACCGGCACTGATTAAACGTACCAATCGTCGTATTCCGGAAC GTACCAGCCATCGTGTTGCTAGCGGCAGCGGCGGCGGCAGCGGCGGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGC AGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGACGCCCTGGACGACTTCGACCTGGACATGCTGGGCAGCGA CGCCCTGGACGACTTCGACCTGGACATGCTGAGCGGCGGCCCCAAGAAGAAGCGGAAGGTGGGCAGCCAGTACCTGCCCGACA CCGACGACCGGCACCGGATCGAGGAGAAGCGGAAGCGGACCTACGAGACCTTCAAGAGCATCATGAAGAAATCCCCCTTCAGC GGCCCCACCGACCCCCGGCCCCCCCCCCGGCGGATCGCCGTGCCCAGCCGGAGCAGCGCCAGCGTGCCCAAGCCCGCCCCCCA GCCCTACCCCTTCACCAGCAGCCTGAGCACCATCAACTACGACGAGTTCCCCACCATGGTGTTCCCCAGCGGCCAGATCAGCC AGGCCAGCGCCCTGGCCCCCGCCCCCCCCCAGGTGCTGCCCCAGGCCCCCGCCCCCGCCCCCGCCCCCGCCATGGTGAGCGCC CTGGCCCAGGCCCCCGCCCCCGTGCCCGTGCTGGCCCCCGGCCCCCCCCAGGCCGTGGCCCCCCCCGCCCCCAAGCCCACCCA GGCCGGCGAGGGCACCCTGAGCGAGGCCCTGCTGCAGCTGCAGTTCGACGACGAGGACCTGGGCGCCCTGCTGGGCAACAGCA CCGACCCCGCCGTGTTCACCGACCTGGCCAGCGTGGACAACAGCGAGTTCCAGCAGCTGCTGAACCAGGGCATCCCCGTGGCC CCCCACACCACCGAGCCCATGCTGATGGAGTACCCCGAGGCCATCACCCGGCTGGTGACCGGCGCCCAGCGGCCCCCCGACCC CGCCCCCGCCCCCCTGGGCGCCCCCGGCCTGCCCAACGGCCTGCTGAGCGGCGACGAGGACTTCAGCAGCATCGCCGACATGG ACTTCAGCGCCCTGCTGGGCAGCGGCAGCGGCAGCCGGGACAGCCGGGAGGGCATGTTCCTGCCCAAGCCCGAGGCCGGCAGC GCCATCAGCGACGTGTTCGAGGGCCGGGAGGTGTGCCAGCCCAAGCGGCTCCGGCCCTTCCACCCCCCCGGCAGCCCCTGGGC CAACCGGCCCCTGCCCGCCAGCCTGGCCCCCACCCCCACCGGCCCCGTGCACGAGCCCGTGGGCAGCCTGACCCCCGCCCCCG TGCCCCAGCCCCTGGACCCCGCCCCCGCCGTGACCCCCGAGGCCAGCCACCTGCTGGAGGACCCCGACGAGGAGACCAGCCAG GCCGTGAAGGCCCTGCGGGAGATGGCCGACACCGTGATCCCCCAGAAGGAGGAGGCCGCCATCTGCGGCCAGATGGACCTGAG CCACCCCCCCCCCCGGGGCCACCTGGACGAGCTGACCACCACCCTGGAGAGCATGACCGAGGACCTGAACCTGGACAGCCCCC TGACCCCCGAGCTGAACGAGATCCTGGACACCTTCCTGAACGACGAGTGCCTGCTGCACGCCATGCACATCAGCACCGGCCTG AGCATCTTCGACACCAGCCTGTTCAGCGGCGGCAAGCGGCCCGCCGCCACCAAGAAGGCCGGCCAGGCCAAGAAGAAGAAGGG CAGCTACCCCTACGACGTGCCCGACTACGCCTGAGCGGCCGCTTAATTAAGCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATG CCCTTCTTCTCTCCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAGTCTAGAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA >TAL9 amino acid sequence SEQ ID NO.: 210 GSHMVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVKYQDMIAALPEATHEAIVGVGKR GAGARALEALLTVAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLULTPEQVVAIASUNGGKQALETVQRLL PVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETVQRLLPVLCQAHGLTPEQVV AIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQALETV QRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTP EQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGKQA LETVQRLLPVLCQAHGLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAH GLTPEQVVAIASUGGGKQALETVQRLLPVLCQAHGLTPEQVVAIASHDGGKQALETVQRLLPVLCQAHGLTPEQVVAIASUNG GKQALETVQRLLPVLCQAHGLTPEQVVAIASUNGGKQALETVQRLLPVLCQAHGLTPEQVVAIASNIGGRPALESIVAQLSRP DPALAALTNDHLVALACLGGRPALDAVKKGLPHAPALIKRTURRIPERTSHRVAS >TAL9 mRNA sequence SEQ ID NO.: 252 GGAUCCCAUAUGGUUGAUCUGCGUACCCUGGGUUAUAGCCAGCAGCAGCAAGAAAAAAUCAAACCGAAAGUUCGUAGCACCGU UGCACAGCAUCAUGAAGCACUGGUUGGUCAUGGUUUUACCCAUGCACAUAUUGUUGCACUGAGCCAGCAUCCGGCAGCACUGG GCACCGUUGCAGUUAAAUAUCAGGAUAUGAUUGCAGCACUGCCGGAAGCAACCCAUGAAGCAAUUGUUGGUGUUGGUAAACGC GGAGCUGGUGCACGUGCCCUGGAAGCACUGCUGACCGUUGCCGGUGAACUGCGUGGUCCGCCUCUGCAGCUGGAUACCGGUCA GCUGCUGAAAAUUGCAAAACGUGGUGGUGUUACCGCAGUUGAAGCAGUUCAUGCAUGGCGUAAUGCACUGACCGGUGCACCGC UGAAUCUGACACCGGAACAGGUUGUUGCAAUUGCCAGCAAUAAUGGUGGCAAACAGGCACUGGAAACCGUUCAGCGUCUGCUG CCGGUUCUGUGUCAGGCACAUGGUCUGACCCCUGAACAGGUGGUGGCCAUUGCAAGCAACAUUGGCGGUAAACAAGCCCUGGA AACAGUGCAGCGCCUGUUACCGGUGCUGUGCCAGGCCCAUGGCUUAACUCCGGAACAGGUGGUAGCGAUCGCAUCAAAUAUCG GAGGUAAACAGGCCUUAGAAACCGUACAGCGCUUACUGCCGGUGUUAUGCCAGGCGCACGGCCUGACGCCAGAACAGGUAGUG GCAAUCGCCUCAAAUGGUGGUGGAAAACAGGCGUUAGAGACAGUCCAGCGCCUGCUGCCUGUAUUAUGUCAAGCCCAUGGCCU GACCCCAGAGCAAGUUGUUGCGAUUGCAAGUAAUGGCGGGGGUAAACAGGCACUUGAGACAGUUCAACGUUUACUGCCUGUAC UGUGCCAAGCUCACGGUCUGACUCCGGAACAAGUCGUCGCGAUUGCGAGUAAUAUAGGUGGCAAACAAGCAUUAGAAACGGUG CAACGCCUGCUGCCAGUUCUUUGCCAGGCUCACGGUUUAACCCCUGAGCAGGUUGUAGCUAUUGCGAGUAACAAUGGUGGUAA GCAGGCGUUGGAAACUGUGCAAAGACUGCUGCCCGUGUUGUGCCAAGCACAUGGUUUAACCCCAGAACAAGUCGUAGCAAUCG CAAGCAAUAAUGGUGGCAAGCAAGCGCUUGAAACAGUACAGCGUUUAUUACCGGUACUUUGUCAGGCCCACGGUCUUACACCA GAACAAGUUGUGGCCAUAGCCAGUAACAAUGGCGGAAAGCAGGCUCUGGAAACGGUACAACGUCUGUUACCUGUUCUGUGUCA AGCGCACGGAUUAACACCUGAACAAGUAGUUGCCAUUGCGUCAAAUAAUGGAGGCAAGCAGGCCUUGGAGACAGUGCAGAGAU UACUGCCAGUGUUGUGUCAGGCUCAUGGCCUUACACCCGAGCAGGUCGUGGCAAUUGCAUCUAACAUUGGCGGUAAGCAAGCU UUAGAGACUGUUCAGAGACUGCUUCCUGUCCUGUGCCAGGCACACGGACUUACGCCUGAGCAAGUGGUUGCAAUCGCCUCUAA UGGGGGUGGUAAGCAAGCACUGGAAACUGUCCAACGCUUACUUCCGGUGCUUUGUCAAGCACACGGCUUAACGCCAGAGCAGG UCGUCGCCAUAGCCAGCCAUGAUGGUGGUAAACAGGCCCUUGAAACGGUCCAAAGACUUCUGCCGGUCCUUUGCCAAGCGCAU GGGCUGACACCUGAGCAGGUAGUCGCGAUUGCCUCAAACGGUGGUGGGAAGCAGGCAUUAGAAACAGUUCAAAGAUUAUUACC AGUCCUGUGUCAGGCGCAUGGGUUAACCCCAGAGCAGGUAGUUGCAAUAGCAUCCCAUGACGGCGGAAAACAAGCGUUGGAAA CGGUUCAGCGGUUAUUGCCUGUUUUGUGCCAGGCGCAUGGUUUGACACCCGAGCAAGUGGUAGCCAUAGCCUCAAACAAUGGG GGUAAACAAGCUUUGGAGACAGUACAACGGCUGCUUCCAGUUUUAUGUCAGGCCCAUGGAUUGACGCCUGAACAAGUUGUCGC UAUCGCAAGUAAUAAUGGUGGUAAACAAGCGCUUGAAACCGUUCAACGCCUUCUGCCUGUGCUUUGUCAGGCACAUGGAUUAA CACCCGAACAGGUUGUCGCGAUAGCUUCAAAUAUCGGUGGUCGUCCGGCACUGGAAAGCAUUGUUGCACAGCUGAGCCGUCCU GAUCCGGCACUGGCAGCACUGACCAAUGAUCAUCUGGUUGCACUGGCAUGUCUGGGUGGUCGCCCUGCCCUGGAUGCAGUUAA AAAAGGUCUGCCGCAUGCACCGGCACUGAUUAAACGUACCAAUCGUCGUAUUCCGGAACGUACCAGCCAUCGUGUUGCUAGC

EQUIVALENTS

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the present invention described herein. Such equivalents are intended to be encompassed by the following claims. 

1. A site-specific HNF4α disrupting agent, comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region. 2-4. (canceled)
 5. The site-specific HNF4α disrupting agent of claim 1, wherein the expression control region comprises an HNF4α-specific transcriptional control element.
 6. The site-specific HNF4α disrupting agent of claim 5, wherein the transcriptional control element comprises an HNF4α promoter.
 7. The site-specific HNF4α disrupting agent of claim 1, wherein the HNF4α expression control region comprises the nucleotide sequence of HNF4α promoter 1, or a fragment thereof.
 8. The site-specific HNF4α disrupting agent of claim 7, wherein the HNF4α expression control region comprises the nucleotide sequence of any one of the nucleotide sequences in column 3 of Table 1 or column 1 of Table
 10. 9-10. (canceled)
 11. The site-specific HNF4α disrupting agent of claim 1, wherein the HNF4α targeting moiety comprises a nucleotide sequence having at least 85% nucleotide identity to the entire nucleotide sequence of any of the nucleotide sequences in any one of Tables 2, 3, 4, and
 9. 12. The site-specific HNF4α disrupting agent of claim 1, wherein the HNF4α target moiety comprises a polynucleotide encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically binds to the HNF4α expression control region.
 13. The site-specific HNF4α disrupting agent of claim 12, wherein the DNA-binding domain of the TALE or ZNF polypeptide comprises an amino acid sequence having at least about 85% amino acid identity to the entire amino acid sequence of any one of the amino acid sequences listed in column 5 of Table 6A or column 4 of Table
 10. 14. The site-specific HNF4α disrupting agent of claim 1, wherein the expression control region comprises one or more HNF4α-associated anchor sequences within an anchor sequence-mediated conjunction comprising a first and a second HNF4α-associated anchor sequence.
 15. The site-specific HNF4α disrupting agent of claim 14, wherein the anchor sequence comprises a CCCTC-binding factor (CTCF) binding motif.
 16. The site-specific HNF4α disrupting agent of claim 14, wherein the anchor sequence-mediated conjunction comprises one or more transcriptional control elements internal to the conjunction.
 17. The site-specific HNF4α disrupting agent of claim 14, wherein the anchor sequence-mediated conjunction comprises one or more transcriptional control elements external to the conjunction.
 18. The site-specific HNF4α disrupting agent of claim 14, wherein the first and/or the second anchor sequence is located within about 500 kb of the transcriptional control element.
 19. The site-specific HNF4α disrupting agent of claim 18, wherein the first and/or the second anchor sequence is located within 300 kb of the transcriptional control element. 20-24. (canceled)
 25. The site-specific HNF4α disrupting agent of claim 1, wherein the site-specific HNF4α disrupting agent is present in a composition. 26.-29. (canceled)
 30. A site-specific HNF4α disrupting agent, comprising a nucleic acid molecule encoding a fusion protein, the fusion protein comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region and an effector molecule.
 31. The site-specific HNF4α disrupting agent of claim 30, wherein the site-specific HNF4α targeting moiety comprises a polynucleotide encoding a DNA-binding domain of a Transcription activator-like effector (TALE) polypeptide or a zinc finger (ZNF) polypeptide, or fragment thereof, that specifically binds to the HNF4α expression control region.
 32. The site-specific HNF4α disrupting agent of claim 31, wherein the DNA-binding domain of the TALE or zinc finger polypeptide comprises an amino acid sequence having at least 85% amino acid identity to the entire amino acid sequence of an amino acid sequence selected from the amino acid sequences listed in column 5 of Table 6A or column 4 of Table
 10. 33. The site-specific HNF4α disrupting agent of claim 30, wherein the HNF4α expression control region comprises the nucleotide sequence of HNF4α promoter 1, or a fragment thereof.
 34. The site-specific HNF4α disrupting agent of claim 33, wherein the HNF4α expression control region comprises the nucleotide sequence of any one of the nucleotide sequences in column 3 of Table 1 or column 1 of Table
 10. 35. The site-specific HNF4α disrupting agent of claim 30, wherein the effector is selected from the group consisting of a nuclease, a physical blocker, an epigenetic recruiter, and an epigenetic CpG modifier, and combinations of any of the foregoing. 36-39. (canceled)
 40. The site-specific HNF4α disrupting agent of claim 30, wherein the effector is a VPR (VP64-p65-Rta).
 41. The site-specific HNF4α disrupting agent of claim 40, wherein the VPR comprises an amino acid sequence having at least about 85% amino acid identity to the entire amino acid sequence of (SEQ ID NO: 66) DALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFD LDMLSGGPKKKRKVGSQYLPDTDDRHRIEEKRKRTYETFKSIMKKS PFSGPTDPRPPPRRIAVPSRSSASVPKPAPQPYPFTSSLSTINYDE FPTMVFPSGQISQASALAPAPPQVLPQAPAPAPAPAMVSALAQAPA PVPVLAPGPPQAVAPPAPKPTQAGEGTLSEALLQLQFDDEDLGALL GNSTDPAVFTDLASVDNSEFQQLLNQGIPVAPHTTEPMLMEYPEAI TRLVTGAQRPPDPAPAPLGAPGLPNGLLSGDEDFSSIADMDFSALL GSGSGSRDSREGMFLPKPEAGSAISDVFEGREVCQPKRLRPFHPPG SPWANRPLPASLAPTPTGPVHEPVGSLTPAPVPQPLDPAPAVTPEA SHLLEDPDEETSQAVKALREMADTVIPQKEEAAICGQMDLSHPPPR GHLDELTTTLESMTEDLNLDSPLTPELNEILDTFLNDECLLHAMHI STGLSIFDTSLF.


42. (canceled)
 43. The site-specific HNF4α disrupting agent of claim 30, wherein the effector is a p300.
 44. The site-specific HNF4α disrupting agent of claim 43, wherein the p300 comprises an amino acid sequence having at least about 85% identity to the entire amino acid sequence of (SEQ ID NO: 67) IFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIV KSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVY KYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTI PRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQF SKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLK KSARTRKENKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTV RVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGV DLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYH EILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPK RLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGD FWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNN KKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIR LIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLR RAQWSTMCMLVELHTQSQD.

45-47. (canceled)
 48. The site-specific HNF4α disrupting agent of claim 30, further comprising a second nucleic acid molecule encoding a second fusion protein, wherein the second fusion comprises a second site-specific HNF4α targeting moiety which targets a second HNF4α expression control region and a second effector molecule, wherein the second HNF4α expression control region is different than the HNF4α expression control region. 49-51. (canceled)
 52. The site-specific HNF4α disrupting agent of claim 48, wherein the fusion protein and the second fusion protein are operably linked. 53-58. (canceled)
 59. A vector comprising a nucleic acid molecule encoding the site-specific HNF4α disrupting agent of claim
 30. 60. The vector of claim 59, wherein the vector is a viral expression vector.
 61. A cell comprising the site-specific HNF4α disrupting agent of claim
 30. 62. The site-specific HNF4α disrupting agent of claim 30, wherein the site-specific HNF4α disrupting agent is present in a composition comprising a lipid formulation. 63-65. (canceled)
 66. The site-specific HNF4α disrupting agent of claim 62, wherein the composition comprises a lipid nanoparticle.
 67. A method of modulating expression of hepatocyte nuclear factor 4 alpha-(HNF4α) in a cell, the method comprising contacting the cell with a site-specific HNF4α disrupting agent, the disrupting agent comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, and an effector molecule, thereby modulating expression of HNF4α in the cell. 68-107. (canceled)
 108. The method of claim 67, wherein the site-specific HNF4α disrupting agent comprises a nucleic acid molecule encoding a first fusion protein, wherein the first fusion protein comprises a first site-specific HNF4α targeting moiety which targets a first HNF4α expression control region and a first effector molecule; and a second nucleic acid molecule encoding a second fusion protein, wherein the second fusion protein comprises a second site-specific HNF4α targeting moiety which targets a second HNF4α expression control region and a second effector molecule, wherein the second HNF4α expression control region is different than the HNF4α expression control region. 109-140. (canceled)
 141. The method of claim 67, wherein the cell is within a subject, wherein the subject has an HNF4α-associated disease.
 142. (canceled)
 143. The method of claim 141, wherein the HNF4α-associated disease is selected from the group consisting of fatty liver (steatosis), nonalcoholic steatohepatitis (NASH), cirrhosis of the liver, accumulation of fat in the liver, inflammation of the liver, hepatocellular necrosis, liver fibrosis, and nonalcoholic fatty liver disease (NAFLD), polycystic kidney disease, inflammatory bowel disease (IBD), and MODY I.
 144. A method for treating a subject having an HNF4α-associated disease, comprising administering to the subject a therapeutically effective amount of the site-specific HNF4α disrupting agent, the disrupting agent comprising a site-specific HNF4α targeting moiety which targets an HNF4α expression control region, and an effector molecule, thereby treating the subject.
 145. (canceled)
 146. The method of claim 144, wherein the HNF4α-associated disease is selected from the group consisting of fatty liver (steatosis), nonalcoholic steatohepatitis (NASH), cirrhosis of the liver, accumulation of fat in the liver, inflammation of the liver, hepatocellular necrosis, liver fibrosis, and nonalcoholic fatty liver disease (NAFLD) and the site-specific HNF4α disrupting agent enhances expression of HNF4α in the subject. 147-179. (canceled) 